data_2myv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2myv _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.564 ' CE3' HG22 ' A' ' 41' ' ' THR . 12.1 m95 . . . . . 0 N--CA 1.44 -0.96 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.48 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 34.4 mmtp -83.34 -173.87 4.96 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.513 0.673 . . . . 0.0 110.102 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.97 -37.47 55.14 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.775 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.2 m -122.02 144.32 48.97 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.87 -176.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.1 tt -118.89 133.24 66.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.3 mm -121.97 112.72 36.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -92.91 128.72 38.87 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.074 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -98.31 114.28 26.52 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 . . . . . 0 N--CA 1.421 -1.896 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 177.324 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.437 -1.114 0 CA-C-O 122.442 1.115 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -97.16 -60.49 1.57 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.445 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -121.92 156.83 32.53 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.512 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 mp -120.05 118.04 55.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -119.93 169.12 10.46 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.564 HG22 ' CE3' ' A' ' 23' ' ' TRP . 4.2 t -155.37 147.95 24.1 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.76 157.85 43.61 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.582 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -72.64 155.35 40.11 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -57.65 121.11 9.59 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 166.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.514 HD22 ' HB3' ' A' ' 59' ' ' GLU . 2.0 m120 74.9 55.05 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 126.464 1.906 . . . . 0.0 110.054 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -139.54 139.54 36.9 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.803 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -95.85 125.8 40.66 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.4 pt -105.47 -176.94 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 172.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 m -136.93 134.67 37.01 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 80.1 mt -126.77 105.05 13.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 54.26 46.08 25.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.721 0.772 . . . . 0.0 111.841 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 69.7 9.42 7.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -103.92 115.26 30.14 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.45 142.62 31.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.003 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.1 t -134.33 125.04 46.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.768 -172.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -94.74 122.03 36.93 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.0 t -97.53 121.75 48.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.42 ' OD1' ' HG2' ' A' ' 59' ' ' GLU . 40.1 t30 -71.53 165.77 23.18 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 124.923 1.389 . . . . 0.0 109.3 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.514 ' HB3' HD22 ' A' ' 45' ' ' ASN . 10.7 pt-20 -58.28 -24.3 59.01 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 126.012 1.725 . . . . 0.0 114.1 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.12 16.6 22.2 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.2 m 64.85 69.45 0.49 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.341 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -148.07 124.42 5.4 Favored Pre-proline 0 C--N 1.313 -0.981 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.421 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 52.2 Cg_endo -83.58 140.49 9.43 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.252 2.635 . . . . 0.0 114.033 -176.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -129.41 131.68 23.78 Favored Pre-proline 0 CA--C 1.494 -1.183 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.148 174.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.28 166.62 81.63 Favored 'Cis proline' 0 C--N 1.325 -0.704 0 C-N-CA 122.726 -1.781 . . . . 0.0 112.74 -1.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.33 -28.43 5.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.565 0.698 . . . . 0.0 110.344 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.442 HG22 ' HA ' ' A' ' 71' ' ' ARG . 32.4 mm -108.75 132.56 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-O 121.525 0.679 . . . . 0.0 109.936 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.408 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 45.3 mt -91.15 171.87 7.5 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.582 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.408 ' CD ' ' HB3' ' A' ' 68' ' ' LEU . 25.5 Cg_exo -67.99 -15.33 43.27 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.593 2.195 . . . . 0.0 111.85 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -86.41 -12.29 49.56 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.55 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.442 ' HA ' HG22 ' A' ' 67' ' ' ILE . 23.7 ttm180 72.17 31.11 1.99 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 124.081 1.896 . . . . 0.0 109.013 -173.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 m -70.24 138.85 52.01 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 169.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.4 t -96.8 125.58 49.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 O-C-N 125.01 1.444 . . . . 0.0 109.571 -175.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 mp -103.96 138.66 40.2 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 121.438 0.637 . . . . 0.0 109.63 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.9 m -136.34 122.06 19.79 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.505 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.421 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -107.12 142.81 15.78 Favored Glycine 0 N--CA 1.428 -1.899 0 C-N-CA 120.247 -0.977 . . . . 0.0 110.973 -177.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -147.05 173.01 12.86 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -79.69 138.45 37.36 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.9 m -68.49 -15.36 63.51 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.465 0.65 . . . . 0.0 110.437 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.5 t -56.59 -42.23 78.33 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 126.079 1.752 . . . . 0.0 108.903 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.15 21.33 11.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.555 0.693 . . . . 0.0 112.107 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 . . . . . 0 C--N 1.303 -1.445 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.826 -179.366 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.566 ' CE3' HG23 ' A' ' 41' ' ' THR . 11.3 m95 . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 120.809 0.338 . . . . 0.0 111.632 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.495 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 50.8 mmtt -85.15 -171.91 3.89 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.421 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 2.0 m-20 -82.26 -29.85 31.0 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.453 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 71.9 m -127.21 141.99 51.6 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.173 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 79' ' ' THR . 11.0 tt -119.17 133.06 67.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.6 mm -123.56 111.92 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -95.48 125.99 40.46 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.577 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -94.76 113.75 25.56 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.452 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 11.3 m-85 . . . . . 0 C--N 1.293 -1.855 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 9.2 p . . . . . 0 N--CA 1.433 -1.321 0 CA-C-O 122.599 1.19 . . . . 0.0 107.824 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -87.15 -50.96 6.27 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.439 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -128.97 155.32 45.54 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.202 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -119.14 119.04 59.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -120.25 167.83 11.87 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.566 HG23 ' CE3' ' A' ' 23' ' ' TRP . 4.3 t -154.55 147.33 24.36 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.11 160.74 43.08 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -82.06 162.34 22.6 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.794 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.421 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 6.5 ptt85 -60.86 113.48 2.53 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.297 174.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.589 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 32.1 m-80 73.46 67.79 0.11 Allowed 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 126.489 1.916 . . . . 0.0 109.102 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -147.38 130.02 15.99 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.069 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 43.0 tt0 -97.62 116.84 30.62 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.501 0.667 . . . . 0.0 109.868 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.0 pt -98.26 -178.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 3.0 m -137.06 136.22 38.19 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 92.1 mt -128.01 107.96 17.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 56.8 34.78 25.27 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 74.7 14.56 3.37 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 127.015 2.126 . . . . 0.0 112.719 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -102.64 110.31 22.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 172.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -78.67 145.31 34.66 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.72 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -137.23 118.99 18.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.663 -173.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 69.2 t80 -89.89 118.71 29.67 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.2 t -94.11 117.97 38.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -71.98 168.29 18.34 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.589 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 13.5 pt-20 -64.38 -15.48 60.55 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.653 1.181 . . . . 0.0 113.663 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.13 6.18 43.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.8 m 69.48 36.55 2.2 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.595 1.158 . . . . 0.0 112.127 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -122.39 124.3 26.85 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 113.632 -1.622 . . . . 0.0 107.52 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.72 153.62 17.57 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.218 2.612 . . . . 0.0 115.047 -176.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -136.39 131.45 18.51 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.174 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.07 161.69 88.06 Favored 'Cis proline' 0 C--N 1.322 -0.843 0 C-N-CA 122.526 -1.864 . . . . 0.0 111.513 -3.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.3 t -78.92 -36.68 19.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.373 0.606 . . . . 0.0 110.125 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.29 126.74 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 121.614 0.721 . . . . 0.0 110.782 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.62 170.7 10.07 Favored Pre-proline 0 C--N 1.305 -1.336 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.017 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -69.3 -9.48 26.39 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.551 2.167 . . . . 0.0 112.456 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.69 -11.07 54.66 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.463 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 71' ' ' ARG . 11.5 tpt180 76.16 22.58 1.35 Allowed 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 126.375 1.87 . . . . 0.0 107.925 -172.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.4 m -67.45 134.68 51.83 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.379 -1.282 . . . . 0.0 107.657 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -92.93 116.74 34.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 126.002 1.721 . . . . 0.0 108.796 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 mp -96.84 122.55 39.93 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.117 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.9 m -114.36 118.7 34.59 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.27 134.99 11.55 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 119.933 -1.127 . . . . 0.0 112.551 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -141.35 168.37 19.94 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -72.6 139.98 47.75 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.428 HG22 HD11 ' A' ' 27' ' ' ILE . 1.7 m -71.93 -15.71 62.09 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.798 0.808 . . . . 0.0 109.709 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . 0.276 0.7 OUTLIER -56.82 -32.64 65.93 Favored 'General case' 0 N--CA 1.414 -2.244 0 C-N-CA 126.399 1.88 . . . . 0.0 111.015 179.01 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.69 19.41 20.52 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.1 0.952 . . . . 0.0 109.851 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 . . . . . 0 C--N 1.299 -1.591 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.236 -176.346 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.467 ' CE3' HG23 ' A' ' 41' ' ' THR . 14.3 m0 . . . . . 0 N--CA 1.441 -0.896 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -88.51 -170.75 3.06 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -77.96 -29.87 50.05 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.075 0.941 . . . . 0.0 111.116 -171.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.2 m -124.55 143.22 50.8 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.709 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.5 tt -117.89 133.05 65.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.8 mm -126.45 114.24 37.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -172.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -98.92 135.14 40.78 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -103.8 112.88 26.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.478 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 33.7 m-85 . . . . . 0 C--N 1.293 -1.863 0 C-N-CA 124.367 1.067 . . . . 0.0 110.016 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 N--CA 1.445 -0.693 0 CA-C-O 121.72 0.771 . . . . 0.0 111.604 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -111.4 -62.68 1.51 Allowed 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 125.016 1.326 . . . . 0.0 112.537 -174.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -121.61 167.32 13.03 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 122.764 0.426 . . . . 0.0 111.041 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mp -131.71 135.88 58.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 125.118 1.367 . . . . 0.0 108.426 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -141.79 163.83 31.84 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.467 HG23 ' CE3' ' A' ' 23' ' ' TRP . 1.7 t -149.14 139.53 22.41 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.72 163.77 31.71 Favored 'General case' 0 C--N 1.311 -1.068 0 O-C-N 124.003 0.815 . . . . 0.0 109.272 -173.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -77.56 159.73 29.08 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 120.467 -0.493 . . . . 0.0 109.836 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -67.75 116.37 8.36 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 120.924 0.392 . . . . 0.0 110.029 173.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.571 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 26.3 m-80 75.36 67.63 0.07 Allowed 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 126.901 2.08 . . . . 0.0 109.332 -174.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -149.68 134.57 17.86 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.609 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 44.3 tt0 -101.19 119.46 38.79 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-O 121.839 0.828 . . . . 0.0 110.209 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.5 pt -100.01 179.27 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.789 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 m -136.9 134.25 36.62 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 95.2 mt -124.88 106.63 16.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 59.05 34.9 23.71 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.119 0.961 . . . . 0.0 111.193 176.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.26 42.9 mm-40 67.39 21.19 9.79 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.625 1.57 . . . . 0.0 113.523 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -104.2 111.28 23.82 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 169.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -81.45 133.64 35.43 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.649 0.737 . . . . 0.0 109.241 -176.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.1 t -127.38 119.12 51.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.744 -173.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 79.4 t80 -92.89 121.52 34.33 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.9 t -94.01 114.62 31.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -69.03 165.03 21.04 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.571 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 9.1 pt-20 -70.14 -7.81 44.66 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 123.768 0.827 . . . . 0.0 112.428 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.41 -2.37 52.9 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 79.1 m 69.35 32.81 3.4 Favored 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.917 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -122.05 128.37 25.56 Favored Pre-proline 0 C--N 1.293 -1.85 0 CA-C-N 113.027 -1.897 . . . . 0.0 106.708 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -85.01 156.07 11.35 Favored 'Trans proline' 0 C--N 1.329 -0.447 0 C-N-CA 123.267 2.645 . . . . 0.0 115.4 -175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -135.17 131.32 19.66 Favored Pre-proline 0 N--CA 1.441 -0.906 0 C-N-CA 124.678 1.191 . . . . 0.0 111.571 172.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.5 169.7 70.17 Favored 'Cis proline' 0 C--N 1.322 -0.82 0 C-N-CA 122.435 -1.902 . . . . 0.0 112.306 -1.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.8 t -86.79 -42.17 15.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.093 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.424 HG12 ' NH2' ' A' ' 71' ' ' ARG . 1.7 mp -98.3 128.02 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.71 0.767 . . . . 0.0 110.49 173.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.6 mt -88.41 169.11 14.31 Favored Pre-proline 0 C--N 1.306 -1.298 0 CA-C-N 114.297 -1.319 . . . . 0.0 108.243 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.35 -9.18 25.34 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.281 1.988 . . . . 0.0 110.904 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -88.7 1.2 55.54 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.687 -1.597 . . . . 0.0 109.492 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.424 ' NH2' HG12 ' A' ' 67' ' ' ILE . 8.3 tpm_? 74.93 9.43 4.0 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 125.253 1.421 . . . . 0.0 109.671 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 67' ' ' ILE . 0.9 OUTLIER -70.86 138.15 50.0 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.703 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.3 t -92.1 124.07 44.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 125.614 1.566 . . . . 0.0 109.479 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.6 mp -100.23 122.74 43.51 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.959 0.885 . . . . 0.0 110.307 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 52.3 m -118.03 117.74 30.04 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -118.07 152.28 17.6 Favored Glycine 0 N--CA 1.422 -2.279 0 C-N-CA 119.395 -1.383 . . . . 0.0 111.38 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -155.84 177.13 11.75 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -79.65 139.2 37.49 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 m -72.11 -10.9 60.4 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.568 0.699 . . . . 0.0 110.409 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.4 p -69.09 -22.93 63.97 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.425 0.631 . . . . 0.0 111.034 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.36 17.14 24.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 122.07 0.938 . . . . 0.0 109.909 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 . . . . . 0 C--N 1.3 -1.578 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.955 -175.426 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.417 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.5 m0 . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . 11.2 mmpt? -88.55 -170.58 2.99 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 121.923 -0.485 . . . . 0.0 110.759 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -29.18 54.7 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.091 0.472 . . . . 0.0 112.013 -175.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 68.1 m -122.34 144.81 48.79 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.884 0.85 . . . . 0.0 110.766 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 79' ' ' THR . 8.6 tt -119.48 133.66 65.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.4 mm -119.01 133.07 67.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -174.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -117.23 132.56 56.6 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -174.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -94.6 112.98 24.74 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.442 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 23.2 m-85 . . . . . 0 C--N 1.301 -1.539 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.433 -1.312 0 CA-C-O 122.524 1.154 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -88.19 -57.54 2.89 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.801 -173.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -121.09 159.88 24.82 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.876 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.6 tp -122.73 155.85 28.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -151.02 167.88 26.3 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.417 HG21 ' CE3' ' A' ' 23' ' ' TRP . 2.0 t -149.63 146.82 27.49 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.374 0.606 . . . . 0.0 110.029 177.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.85 158.87 44.25 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -80.99 158.82 25.04 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 59' ' ' GLU . 6.8 ptt85 -61.58 114.42 3.25 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 171.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.427 HD22 ' HB3' ' A' ' 59' ' ' GLU . 9.4 m-80 76.52 67.15 0.06 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 127.112 2.165 . . . . 0.0 108.914 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -146.72 128.5 15.29 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.561 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 44.5 mp0 -89.86 109.93 20.9 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.368 0.604 . . . . 0.0 109.696 176.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.9 pt -96.7 -178.97 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.9 m -133.24 130.68 39.34 Favored 'General case' 0 N--CA 1.403 -2.789 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 174.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.7 mt -122.75 101.82 10.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 61.14 36.96 17.95 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.947 0.879 . . . . 0.0 111.251 172.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 70.64 18.94 6.25 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 113.751 -1.568 . . . . 0.0 113.798 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -112.52 107.66 16.48 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 172.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.467 ' C ' ' HE2' ' A' ' 54' ' ' LYS 0.31 0.0 OUTLIER -78.78 152.92 31.16 Favored 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 117.654 -1.618 . . . . 0.0 111.81 -179.534 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 91.8 t -142.72 129.83 18.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.299 -170.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -100.34 120.8 40.5 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 66.2 t -98.32 117.68 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -71.76 167.65 19.47 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 124.586 1.179 . . . . 0.0 109.336 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.437 ' HA ' ' HB2' ' A' ' 44' ' ' ARG . 9.5 pt-20 -58.65 -20.8 51.05 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 126.0 1.72 . . . . 0.0 114.851 -174.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.56 19.89 18.16 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 120.953 0.406 . . . . 0.0 109.965 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.9 m 62.33 69.97 0.59 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.403 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -148.0 121.79 4.84 Favored Pre-proline 0 N--CA 1.439 -0.997 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.443 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 48.7 Cg_endo -87.73 142.74 5.9 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.564 2.843 . . . . 0.0 114.912 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -131.79 134.61 25.56 Favored Pre-proline 0 C--N 1.309 -1.165 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.491 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.01 158.08 96.84 Favored 'Cis proline' 0 C--N 1.332 -0.342 0 C-N-CA 122.572 -1.845 . . . . 0.0 112.831 0.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.14 -40.13 21.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.362 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.9 mm -98.76 124.17 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.926 -1.109 . . . . 0.0 109.39 175.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 mt -85.61 168.24 20.88 Favored Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.644 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -68.64 -11.96 33.35 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.126 1.884 . . . . 0.0 111.177 -176.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -91.98 10.82 27.37 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.155 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 68.62 9.59 7.4 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.473 1.909 . . . . 0.0 111.45 172.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.9 m -82.21 150.7 27.21 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.825 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.3 t -91.29 131.0 39.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 126.436 1.894 . . . . 0.0 109.751 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.94 123.56 48.17 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.09 0.948 . . . . 0.0 111.03 173.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.4 t -107.62 147.09 31.11 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.443 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -130.58 140.35 11.69 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -152.86 175.75 12.57 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -86.21 132.78 33.93 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.419 HG21 HD13 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -67.52 -21.96 65.46 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.278 0.561 . . . . 0.0 111.503 -175.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.4 p -65.95 -26.81 67.75 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.916 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.33 21.13 17.46 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.822 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.312 -1.05 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -174.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.513 ' CE3' HG23 ' A' ' 41' ' ' THR . 17.9 m95 . . . . . 0 N--CA 1.43 -1.472 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.407 ' HB3' ' OD1' ' A' ' 43' ' ' ASN . 61.4 mttp -101.87 -171.35 1.96 Allowed 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.541 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.49 -27.49 58.81 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -173.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.8 m -126.28 142.56 51.48 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.022 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 79' ' ' THR . 12.7 tt -115.22 133.46 61.39 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.402 HD11 ' O ' ' A' ' 27' ' ' ILE . 34.9 mm -127.22 116.94 45.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -173.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.411 ' HB2' ' HB3' ' A' ' 75' ' ' SER . 95.9 mt-30 -105.75 139.12 40.82 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.759 -0.588 . . . . 0.0 110.358 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.471 ' HD2' HG23 ' A' ' 50' ' ' ILE . 24.1 mtp180 -95.82 115.74 27.87 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 121.528 -0.069 . . . . 0.0 110.971 175.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.486 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 29.2 m-85 . . . . . 0 C--N 1.295 -1.761 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 3.3 p . . . . . 0 N--CA 1.431 -1.375 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -94.78 -51.78 4.55 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.037 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -119.8 154.25 34.52 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.893 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -121.92 127.26 75.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -133.73 168.99 17.71 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.513 HG23 ' CE3' ' A' ' 23' ' ' TRP . 2.3 t -155.45 139.63 16.55 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.23 152.96 46.38 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.456 -174.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.407 ' OD1' ' HB3' ' A' ' 24' ' ' LYS . 82.2 m-20 -76.69 160.6 29.22 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 120.881 0.372 . . . . 0.0 110.562 175.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.523 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 4.0 ptt180 -60.56 115.59 3.72 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.895 172.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.424 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 82.9 m-20 73.62 65.01 0.09 Allowed 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.969 1.708 . . . . 0.0 109.678 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -145.74 137.46 25.17 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.26 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -107.75 109.5 21.09 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.733 0.778 . . . . 0.0 109.225 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.4 pt -90.59 -177.33 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.812 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.2 m -130.98 134.34 46.63 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.471 HG23 ' HD2' ' A' ' 30' ' ' ARG . 82.1 mt -128.95 110.31 20.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 51.79 38.04 22.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.07 0.938 . . . . 0.0 112.676 177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 69.12 29.05 4.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 113.337 -1.756 . . . . 0.0 112.829 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -118.35 116.82 27.52 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 169.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -82.12 140.9 33.54 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 118.494 -1.283 . . . . 0.0 109.7 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.2 t -132.22 125.99 55.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.837 -172.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -96.03 121.01 37.32 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.34 116.99 44.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -70.78 164.72 24.6 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 124.295 0.997 . . . . 0.0 108.374 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.523 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 9.3 pt-20 -62.76 -13.14 29.45 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.39 11.63 29.91 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.009 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.2 m 62.14 69.44 0.62 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.882 0.848 . . . . 0.0 111.937 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -152.01 124.87 4.08 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.49 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 64.0 Cg_endo -87.03 141.2 6.01 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.323 2.682 . . . . 0.0 114.226 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -126.48 129.22 24.18 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 174.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.16 159.68 92.72 Favored 'Cis proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.613 -1.828 . . . . 0.0 112.585 -0.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.8 t -78.94 -44.02 24.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.445 HG21 ' NH2' ' A' ' 71' ' ' ARG . 1.7 mp -94.7 123.69 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 121.597 0.713 . . . . 0.0 109.151 171.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.6 mt -83.19 169.51 17.36 Favored Pre-proline 0 C--N 1.299 -1.596 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.774 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -71.61 -2.51 11.47 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.498 2.132 . . . . 0.0 111.343 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -97.48 4.72 50.38 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.62 -1.627 . . . . 0.0 109.401 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.445 ' NH2' HG21 ' A' ' 67' ' ' ILE . 0.4 OUTLIER 66.14 21.26 11.16 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.111 1.364 . . . . 0.0 109.323 177.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.2 m -85.5 139.73 31.25 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -90.5 125.48 43.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 125.956 1.702 . . . . 0.0 108.409 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.8 mp -101.56 130.13 47.79 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 122.201 1.001 . . . . 0.0 111.214 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.411 ' HB3' ' HB2' ' A' ' 29' ' ' GLN . 37.6 t -106.02 121.34 43.91 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.49 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -117.69 131.98 9.65 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.293 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -150.12 172.97 14.43 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -80.8 135.44 35.96 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.427 HG21 HD13 ' A' ' 27' ' ' ILE . 2.4 m -70.61 -14.46 62.49 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 121.867 -0.521 . . . . 0.0 111.795 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.9 t -69.45 -28.93 66.53 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 122.27 1.033 . . . . 0.0 108.879 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.56 16.17 16.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.681 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 C--N 1.305 -1.367 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.172 -177.662 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 12.4 m0 . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 120.917 0.389 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.434 ' HB3' ' OD1' ' A' ' 43' ' ' ASN . 10.5 mmpt? -84.93 -174.57 5.34 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.886 0.374 . . . . 0.0 110.229 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.19 -38.38 75.34 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 74.2 m -123.78 145.28 49.15 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.717 -174.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.407 ' C ' HD11 ' A' ' 28' ' ' ILE . 9.8 tt -118.13 127.66 75.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.407 HD11 ' C ' ' A' ' 27' ' ' ILE . 1.6 mp -117.14 114.54 46.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.915 0.864 . . . . 0.0 110.094 -175.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -91.69 124.84 36.14 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.793 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.446 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 63.9 ttt180 -96.51 110.38 22.78 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . 83.1 m-85 . . . . . 0 C--N 1.301 -1.523 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 9.0 p . . . . . 0 N--CA 1.431 -1.386 0 CA-C-O 122.694 1.235 . . . . 0.0 112.782 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -96.96 -55.56 2.83 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.918 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.446 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 16.3 m120 -120.12 153.37 36.27 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.477 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 mp -119.2 116.36 50.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.442 ' HH ' HG21 ' A' ' 50' ' ' ILE . 47.0 m-85 -118.72 166.78 12.35 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.0 t -146.84 139.86 25.32 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.2 161.2 38.21 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.165 -1.38 . . . . 0.0 107.771 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.434 ' OD1' ' HB3' ' A' ' 24' ' ' LYS . 90.5 m-20 -87.02 160.99 18.43 Favored 'General case' 0 C--N 1.284 -2.281 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.632 176.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.436 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 3.5 ptt85 -58.68 119.43 7.08 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.956 171.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.1 m120 68.33 64.36 0.35 Allowed 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 125.57 1.548 . . . . 0.0 108.643 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -144.58 133.29 22.3 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 113.755 -1.566 . . . . 0.0 108.403 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 36.4 tt0 -108.13 109.31 20.7 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.753 0.787 . . . . 0.0 109.766 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 32.0 pt -87.8 -178.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.214 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.8 m -136.4 135.63 38.9 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.442 HG21 ' HH ' ' A' ' 40' ' ' TYR . 96.9 mt -127.38 108.34 18.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 53.28 42.88 32.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.356 1.074 . . . . 0.0 112.201 177.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 72.72 8.91 5.6 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.766 2.026 . . . . 0.0 113.865 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -100.12 115.77 30.57 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.63 144.51 33.72 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.702 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.2 t -137.05 117.42 16.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.358 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 64.3 t80 -92.06 123.04 35.12 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.023 0.44 . . . . 0.0 110.841 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.0 t -97.46 123.39 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -76.03 173.87 10.72 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 124.611 1.194 . . . . 0.0 108.822 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.436 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 1.3 pm0 -71.51 -20.73 62.01 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -173.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.5 19.92 11.46 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.559 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.7 m 61.69 79.63 0.25 Allowed 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 124.639 1.212 . . . . 0.0 113.103 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -162.62 128.56 2.29 Favored Pre-proline 0 C--N 1.314 -0.936 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.471 ' CG ' ' HB3' ' A' ' 74' ' ' LEU . 42.6 Cg_endo -88.54 149.93 6.32 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.248 2.632 . . . . 0.0 114.604 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -135.86 134.07 20.34 Favored Pre-proline 0 CA--C 1.498 -1.053 0 C-N-CA 125.167 1.387 . . . . 0.0 110.265 173.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.35 163.63 84.22 Favored 'Cis proline' 0 C--N 1.317 -1.093 0 C-N-CA 122.633 -1.82 . . . . 0.0 112.219 0.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.0 t -82.47 -40.88 17.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.553 -174.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 72' ' ' SER . 1.7 mp -104.16 127.68 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-O 121.45 0.643 . . . . 0.0 110.034 172.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.0 mt -94.77 170.82 7.46 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.193 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -69.94 -12.5 32.67 Favored 'Trans proline' 0 N--CA 1.486 1.086 0 C-N-CA 122.669 2.246 . . . . 0.0 111.56 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -84.83 -0.22 53.18 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.778 -1.556 . . . . 0.0 108.646 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 59.72 37.79 22.04 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.461 1.904 . . . . 0.0 109.118 -177.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 67' ' ' ILE . 21.5 m -85.92 127.57 34.64 Favored 'General case' 0 N--CA 1.409 -2.485 0 CA-C-N 113.438 -1.71 . . . . 0.0 106.54 172.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.3 t -90.99 116.66 32.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 127.673 2.389 . . . . 0.0 106.748 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.471 ' HB3' ' CG ' ' A' ' 63' ' ' PRO . 6.6 mp -102.09 124.36 47.56 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 122.208 1.004 . . . . 0.0 113.44 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.5 m -117.93 129.11 55.42 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.679 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 27' ' ' ILE . . . -119.84 137.36 12.33 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.397 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -141.8 172.46 12.65 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -77.82 138.41 38.94 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.4 m -66.78 -21.21 66.06 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.418 ' C ' ' H ' ' A' ' 82' ' ' TYR . 8.7 t -71.57 -40.22 70.1 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -174.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.28 9.07 2.26 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.258 1.028 . . . . 0.0 113.296 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.418 ' H ' ' C ' ' A' ' 80' ' ' SER . 8.1 m-85 . . . . . 0 C--N 1.291 -1.936 0 CA-C-N 114.038 -1.437 . . . . 0.0 109.873 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.492 ' CE3' HG21 ' A' ' 41' ' ' THR . 17.7 m95 . . . . . 0 N--CA 1.443 -0.792 0 CA-C-O 121.254 0.549 . . . . 0.0 109.777 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.437 ' HD2' ' O ' ' A' ' 41' ' ' THR . 95.6 mttt -90.34 -172.57 3.5 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.155 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -74.55 -36.04 63.1 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.841 0.829 . . . . 0.0 111.858 -172.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.0 m -122.1 143.31 49.61 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.222 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.0 tt -115.79 133.05 63.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.0 mm -122.93 119.33 57.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -95.53 127.57 41.68 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -99.25 111.28 23.69 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.466 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 31.5 m-85 . . . . . 0 C--N 1.301 -1.509 0 CA-C-O 121.486 0.66 . . . . 0.0 109.228 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 7.7 p . . . . . 0 N--CA 1.432 -1.368 0 CA-C-O 122.493 1.14 . . . . 0.0 109.82 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -85.64 -58.64 2.58 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.518 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -119.91 161.25 21.18 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.938 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.5 tp -115.48 151.04 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 N-CA-C 103.372 -2.825 . . . . 0.0 103.372 171.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.4 ' HH ' HG21 ' A' ' 50' ' ' ILE . 94.0 m-85 -147.06 166.11 27.86 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.492 HG21 ' CE3' ' A' ' 23' ' ' TRP . 2.1 t -151.99 142.74 22.88 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.13 149.73 44.83 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -75.71 156.97 34.19 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -57.13 121.51 10.21 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 121.206 0.526 . . . . 0.0 110.415 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.9 m120 70.32 63.1 0.22 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 112.957 -1.929 . . . . 0.0 108.677 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -141.83 131.68 24.35 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.54 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 33.8 tt0 -95.44 114.18 25.91 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.034 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.0 pt -96.65 -177.24 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.84 138.12 42.2 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 175.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.4 HG21 ' HH ' ' A' ' 40' ' ' TYR . 92.9 mt -129.61 106.96 14.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 50.73 49.37 21.09 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 70.86 1.61 3.83 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 125.042 1.337 . . . . 0.0 114.489 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -95.33 115.82 27.95 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 147.12 30.58 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 119.714 -0.794 . . . . 0.0 108.934 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 96.9 t -139.9 118.34 11.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.881 -174.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 80.4 t80 -93.21 119.41 32.36 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.0 t -98.36 120.87 48.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -73.24 168.51 18.99 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 124.647 1.217 . . . . 0.0 110.199 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -68.35 -8.02 36.4 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 125.771 1.628 . . . . 0.0 114.572 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.89 14.7 27.69 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.8 m 63.84 71.25 0.49 Allowed 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 124.415 1.072 . . . . 0.0 111.455 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -151.05 124.66 4.33 Favored Pre-proline 0 N--CA 1.435 -1.219 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.417 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 88.7 Cg_endo -84.89 143.04 9.22 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.112 2.541 . . . . 0.0 114.964 -177.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -129.63 127.4 22.95 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.038 170.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.87 163.49 76.77 Favored 'Cis proline' 0 C--N 1.319 -1.007 0 C-N-CA 122.876 -1.718 . . . . 0.0 112.26 -0.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.436 HG11 ' O ' ' A' ' 74' ' ' LEU . 85.0 t -81.53 -39.83 17.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.708 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.04 128.07 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 121.574 0.702 . . . . 0.0 109.483 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.2 mt -88.0 172.07 8.45 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.757 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -73.99 -13.32 23.88 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.295 1.997 . . . . 0.0 109.703 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -84.82 -6.6 59.35 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.115 -2.311 . . . . 0.0 108.349 177.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.387 12.3 ttm180 52.61 55.92 8.38 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 124.631 2.158 . . . . 0.0 112.224 -176.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.9 m -101.95 135.23 43.87 Favored 'General case' 0 N--CA 1.398 -3.048 0 CA-C-N 111.098 -2.774 . . . . 0.0 104.961 170.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -91.3 117.03 33.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 O-C-N 126.105 2.128 . . . . 0.0 108.395 -176.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.436 ' O ' HG11 ' A' ' 66' ' ' VAL . 5.6 mp -101.49 134.46 44.57 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 122.016 0.912 . . . . 0.0 111.703 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.8 m -120.77 137.12 54.68 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.834 175.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.417 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -129.01 133.67 7.68 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 119.659 -1.258 . . . . 0.0 113.021 -175.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -146.82 171.83 14.59 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -71.91 139.37 48.74 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.2 m -67.2 -18.04 65.08 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 123.093 0.557 . . . . 0.0 111.624 -176.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -69.21 -23.85 63.95 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.362 0.601 . . . . 0.0 111.719 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.6 20.61 15.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.752 0.786 . . . . 0.0 110.824 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 . . . . . 0 C--N 1.307 -1.252 0 C-N-CA 125.713 1.605 . . . . 0.0 108.816 -177.495 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.441 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.5 m95 . . . . . 0 N--CA 1.446 -0.627 0 CA-C-O 120.709 0.29 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -88.95 -172.38 3.67 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.904 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.413 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 2.8 m-20 -74.76 -34.34 62.48 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -174.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.5 m -121.49 140.87 51.63 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.942 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 79' ' ' THR . 9.7 tt -112.85 128.54 69.51 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -177.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.0 mm -113.39 120.57 63.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.421 ' HA ' HD13 ' A' ' 39' ' ' ILE . 43.5 mt-30 -100.77 116.68 33.23 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 114.236 -1.347 . . . . 0.0 107.678 -172.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -96.44 109.47 22.01 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.524 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 69.2 m-85 . . . . . 0 C--N 1.298 -1.661 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 9.6 p . . . . . 0 N--CA 1.43 -1.445 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -83.8 -45.18 13.58 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.308 -175.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -130.69 153.27 49.15 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.206 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 29' ' ' GLN . 7.8 tp -116.32 153.86 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 173.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -148.63 168.11 23.68 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.441 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.7 t -150.48 145.57 26.09 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.92 155.97 45.5 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -175.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -79.94 161.65 25.38 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.566 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.413 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 8.2 ptt180 -59.12 116.21 3.69 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.744 170.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 75.07 50.07 0.08 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.056 1.743 . . . . 0.0 110.728 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -130.57 134.56 47.11 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.526 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 44.1 tt0 -102.7 109.22 20.74 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.7 pt -90.64 -177.65 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.2 m -135.52 129.1 32.54 Favored 'General case' 0 N--CA 1.401 -2.897 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 173.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 67.5 mt -118.72 105.07 16.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 60.21 36.69 20.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.93 0.871 . . . . 0.0 111.605 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 69.88 17.07 7.64 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.159 1.783 . . . . 0.0 113.221 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -106.49 111.36 23.89 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.44 141.59 41.32 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.448 -177.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.0 t -135.42 114.5 16.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.738 -173.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 64.4 t80 -90.08 118.72 29.84 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.3 t -101.3 116.91 45.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -73.95 166.09 23.98 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.098 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -56.04 -21.4 21.41 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 126.861 2.064 . . . . 0.0 113.454 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.22 11.06 26.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.841 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.8 m 59.37 66.08 1.08 Allowed 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.264 1.03 . . . . 0.0 111.763 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.431 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 9.7 t-80 -149.79 124.91 4.83 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 175.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.431 ' HD2' ' CD2' ' A' ' 62' ' ' HIS . 64.6 Cg_endo -82.59 152.32 15.25 Favored 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 123.463 2.775 . . . . 0.0 114.972 -175.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -134.87 137.11 26.53 Favored Pre-proline 0 CA--C 1.493 -1.231 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.32 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -78.93 168.29 75.09 Favored 'Cis proline' 0 C--N 1.314 -1.287 0 C-N-CA 122.671 -1.804 . . . . 0.0 111.442 -3.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.4 t -86.5 -30.7 6.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.993 -173.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.5 mm -107.44 129.28 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.972 0.891 . . . . 0.0 110.625 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.1 mt -88.32 165.74 27.02 Favored Pre-proline 0 C--N 1.305 -1.331 0 CA-C-N 114.383 -1.28 . . . . 0.0 108.907 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -72.5 -4.57 15.53 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.77 2.313 . . . . 0.0 111.839 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -95.78 -1.96 48.67 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.309 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 71' ' ' ARG . 9.0 tpt180 71.7 13.64 6.21 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 126.514 1.926 . . . . 0.0 110.045 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.81 137.05 53.65 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 175.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 3.1 t -90.69 117.97 35.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 125.859 1.663 . . . . 0.0 109.044 -175.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.1 mp -97.29 139.43 33.26 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.06 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.6 m -138.93 154.07 48.3 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.2 146.08 17.57 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 118.829 -1.653 . . . . 0.0 111.852 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -141.76 171.78 13.59 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -80.98 134.86 35.77 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.406 HG21 HD13 ' A' ' 27' ' ' ILE . 1.7 m -70.83 -13.99 62.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.419 0.628 . . . . 0.0 110.556 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 p -66.29 -21.96 66.28 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.128 0.971 . . . . 0.0 111.449 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.48 13.69 28.13 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.285 1.041 . . . . 0.0 110.367 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 C--N 1.301 -1.515 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.363 -174.205 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.526 ' CE3' HG23 ' A' ' 41' ' ' THR . 11.0 m0 . . . . . 0 N--CA 1.438 -1.073 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -86.77 -170.6 3.14 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.165 0.507 . . . . 0.0 109.994 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.454 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 1.1 m-20 -78.57 -25.92 45.44 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.7 m -131.32 152.75 50.28 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.535 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.9 tt -125.08 133.86 68.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.4 mm -120.24 112.3 35.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -173.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -96.62 117.76 31.66 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -176.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -91.62 110.38 21.7 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.488 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 14.5 m-85 . . . . . 0 C--N 1.289 -2.023 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.437 -1.089 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -109.9 -60.09 1.84 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.043 -1.036 . . . . 0.0 111.784 -173.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -127.96 159.94 33.4 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -123.01 130.57 74.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 124.106 0.962 . . . . 0.0 109.264 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -134.34 168.74 18.35 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.526 HG23 ' CE3' ' A' ' 23' ' ' TRP . 1.7 t -150.03 142.36 24.23 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.2 157.91 44.33 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.872 -172.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -81.36 160.21 24.18 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 176.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.454 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 6.8 ptt85 -67.92 108.92 3.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.444 0.64 . . . . 0.0 111.73 175.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.524 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 42.3 m-80 83.7 57.07 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.136 2.575 . . . . 0.0 110.087 -175.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -133.76 129.72 37.04 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.106 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 45.1 tt0 -99.18 108.87 21.57 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 pt -94.12 -176.62 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 6.1 m -133.72 136.28 44.55 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 95.0 mt -132.07 106.65 11.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.05 36.4 25.99 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 122.432 1.111 . . . . 0.0 111.256 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 70.5 16.01 7.1 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 112.687 -2.051 . . . . 0.0 113.994 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -103.64 118.18 36.12 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 172.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -82.14 144.62 30.62 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 118.385 -1.326 . . . . 0.0 108.666 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 88.9 t -135.19 122.35 35.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.609 -173.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 93.9 t80 -93.34 118.16 30.95 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.7 t -96.8 114.02 32.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -73.97 173.28 10.21 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.524 ' HB3' ' ND2' ' A' ' 45' ' ' ASN 0.262 10.3 pt-20 -74.38 0.67 13.74 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -173.32 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.17 12.24 37.95 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.6 m 69.18 33.06 3.44 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.545 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -111.65 117.39 48.88 Favored Pre-proline 0 C--N 1.291 -1.946 0 CA-C-N 113.45 -1.704 . . . . 0.0 108.398 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.513 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 40.8 Cg_endo -88.86 144.69 5.32 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.983 3.122 . . . . 0.0 114.861 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.408 ' HA ' ' C ' ' A' ' 65' ' ' PRO . 26.5 m-85 -130.06 134.76 26.51 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.044 173.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.408 ' C ' ' HA ' ' A' ' 64' ' ' TYR . 42.8 Cg_endo -74.87 157.15 99.77 Favored 'Cis proline' 0 CA--C 1.529 0.246 0 C-N-CA 123.045 -1.648 . . . . 0.0 113.307 0.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.9 t -82.1 -37.37 14.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.6 mm -103.18 118.61 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-O 122.008 0.909 . . . . 0.0 108.704 172.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.7 mt -82.36 170.32 15.21 Favored Pre-proline 0 C--N 1.293 -1.867 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.162 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -69.25 -13.06 35.31 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.437 2.092 . . . . 0.0 111.944 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -92.28 1.38 57.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 122.136 0.97 . . . . 0.0 108.42 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 63.7 29.77 14.89 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 124.288 1.995 . . . . 0.0 109.954 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.1 m -75.07 136.42 41.17 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-N 112.457 -2.156 . . . . 0.0 106.309 173.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 6.3 t -91.53 119.11 38.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 125.352 1.461 . . . . 0.0 108.614 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.72 122.84 43.32 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 122.052 0.929 . . . . 0.0 111.427 175.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.8 m -111.2 123.83 50.98 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.513 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -115.38 124.18 6.21 Favored Glycine 0 N--CA 1.419 -2.443 0 C-N-CA 119.865 -1.16 . . . . 0.0 112.192 -175.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -139.07 172.89 12.17 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -81.65 137.0 35.5 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.01 -21.52 64.95 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 124.24 1.016 . . . . 0.0 112.18 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.8 p -64.84 -31.75 73.13 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.247 1.019 . . . . 0.0 110.881 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.42 16.69 23.71 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.649 0.738 . . . . 0.0 110.765 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 . . . . . 0 C--N 1.31 -1.144 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.819 -175.824 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.477 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.0 m0 . . . . . 0 N--CA 1.441 -0.918 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -89.23 -178.62 5.69 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.428 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 1.1 m-20 -71.12 -34.24 70.88 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.573 -175.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.8 m -121.07 143.14 49.23 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.063 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.416 ' O ' ' HA2' ' A' ' 76' ' ' GLY . 6.1 tt -113.69 133.32 60.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.8 mm -121.43 115.31 46.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -173.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -95.17 127.5 41.27 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -98.24 110.83 23.35 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.446 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 7.4 m-85 . . . . . 0 C--N 1.299 -1.609 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.444 -0.744 0 CA-C-O 122.372 1.082 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -97.55 -52.71 3.68 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.354 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -121.74 161.76 22.02 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.718 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.7 mm -124.9 128.49 73.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 124.496 1.118 . . . . 0.0 109.118 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -135.14 169.51 17.34 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.477 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.8 t -153.68 144.01 22.3 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.8 152.61 40.59 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -74.16 164.11 27.02 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.592 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.432 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 3.4 ptt180 -62.88 116.56 5.38 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 171.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 84.9 m-20 74.4 50.08 0.1 Allowed 'General case' 0 C--O 1.242 0.695 0 C-N-CA 126.237 1.815 . . . . 0.0 110.744 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -128.59 131.34 48.15 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.671 -175.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 44.2 tt0 -101.98 114.62 28.9 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.53 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 pt -98.94 -176.75 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 124.25 1.02 . . . . 0.0 108.49 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.47 131.2 43.32 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 97.5 mt -127.62 106.52 15.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 54.19 43.02 31.23 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.958 0.885 . . . . 0.0 112.001 175.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 75.53 -1.51 3.0 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.14 2.176 . . . . 0.0 115.116 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -95.16 118.22 31.57 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.26 141.57 32.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 118.173 -1.411 . . . . 0.0 108.74 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 92.5 t -133.29 122.41 44.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.406 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -96.54 121.47 38.39 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.336 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 45' ' ' ASN . 90.8 t -100.23 118.78 47.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -68.07 163.7 21.83 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.979 1.712 . . . . 0.0 108.465 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.432 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 1.4 pm0 -66.15 -17.68 64.87 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -171.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.02 14.37 22.06 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.233 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.6 m 65.83 76.82 0.31 Allowed 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 124.64 1.213 . . . . 0.0 112.281 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -157.18 120.54 2.21 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.421 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 73.7 Cg_endo -82.54 143.9 12.41 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 123.391 2.727 . . . . 0.0 114.399 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -130.51 131.16 23.17 Favored Pre-proline 0 CA--C 1.489 -1.391 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.654 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -72.08 162.12 90.49 Favored 'Cis proline' 0 C--N 1.313 -1.301 0 C-N-CA 124.416 -1.077 . . . . 0.0 114.225 -1.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 65.6 t -89.34 -42.68 14.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.075 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mp -99.22 129.49 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.476 0.655 . . . . 0.0 109.533 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.0 mt -97.56 171.12 6.28 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.032 177.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -67.09 -13.78 41.04 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.986 2.457 . . . . 0.0 112.362 -176.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -85.35 -12.28 52.59 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.1 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 71' ' ' ARG . 16.2 tpt180 72.32 31.9 1.76 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-O 123.886 1.803 . . . . 0.0 107.261 -171.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -74.27 127.27 32.55 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -92.46 115.81 32.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 125.492 1.517 . . . . 0.0 108.062 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.404 ' HB3' ' CG ' ' A' ' 63' ' ' PRO . 5.8 mp -97.48 129.07 44.7 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 122.326 1.06 . . . . 0.0 111.805 177.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.1 m -121.9 137.38 54.81 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.421 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -131.72 150.38 19.52 Favored Glycine 0 CA--C 1.474 -2.52 0 C-N-CA 119.331 -1.414 . . . . 0.0 109.672 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.499 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 11.1 t0 -163.4 173.91 12.61 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 174.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -69.95 134.94 48.9 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 118.853 0.751 . . . . 0.0 109.718 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.2 m -65.27 -28.19 69.16 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-O 121.756 0.789 . . . . 0.0 110.857 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 p -67.66 -29.47 68.77 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.679 -176.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.93 11.9 34.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 122.438 1.113 . . . . 0.0 111.199 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.499 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 6.5 m-85 . . . . . 0 C--N 1.301 -1.508 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.465 -178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.524 ' CE3' HG21 ' A' ' 41' ' ' THR . 18.6 m95 . . . . . 0 N--CA 1.44 -0.936 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -77.96 -171.94 2.5 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.429 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 1.2 t70 -80.74 -31.38 36.0 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.205 1.002 . . . . 0.0 110.856 -172.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.4 m -120.44 146.63 46.03 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.239 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.446 HD12 HG21 ' A' ' 79' ' ' THR . 11.4 tt -118.01 133.46 64.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 75' ' ' SER . 28.3 mm -124.94 113.25 35.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -173.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.512 ' HB2' ' OG ' ' A' ' 75' ' ' SER . 82.2 mt-30 -96.01 133.22 40.5 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.723 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.489 HH11 ' ND2' ' A' ' 38' ' ' ASN . 27.3 ttt180 -98.87 110.97 23.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.472 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 59.8 m-85 . . . . . 0 C--N 1.296 -1.719 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 8.4 p . . . . . 0 N--CA 1.435 -1.183 0 CA-C-O 122.295 1.045 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -93.0 -60.68 1.74 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.615 -174.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.489 ' ND2' HH11 ' A' ' 30' ' ' ARG . 97.6 m-20 -122.27 161.72 22.78 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.779 -176.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.8 mm -121.17 137.32 55.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.889 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -142.2 164.52 29.93 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.524 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.6 t -152.66 144.49 23.62 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.24 150.14 45.15 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 123.506 0.504 . . . . 0.0 110.98 -173.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -75.12 156.0 36.47 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.481 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 6.8 ptt180 -60.61 109.82 1.13 Allowed 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 171.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 88.1 m-20 78.65 62.48 0.03 OUTLIER 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.254 1.822 . . . . 0.0 110.37 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -138.9 134.93 33.89 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.987 -178.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -91.84 118.95 31.19 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 172.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.7 pt -98.37 174.08 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.324 0 N-CA-C 105.609 -1.996 . . . . 0.0 105.609 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 m -136.3 117.88 14.88 Favored 'General case' 0 N--CA 1.404 -2.755 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 73.1 mt -108.17 102.04 13.41 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.662 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 58.81 40.27 23.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.387 0.613 . . . . 0.0 112.483 170.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 73.27 9.6 5.18 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.246 1.818 . . . . 0.0 113.803 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -104.42 106.19 16.6 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.05 141.36 33.26 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.534 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.0 t -132.79 119.46 37.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.518 -171.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -93.13 121.72 34.78 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.9 t -102.99 125.11 57.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 174.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -74.58 176.76 6.59 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 124.555 1.16 . . . . 0.0 108.657 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.481 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 9.8 pt-20 -65.44 -20.15 66.24 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.9 106.57 17.12 Favored 'General case' 0 N--CA 1.413 -2.318 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 170.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.4 m -40.42 89.45 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 127.578 2.351 . . . . 0.0 115.344 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -159.72 126.04 2.45 Favored Pre-proline 0 N--CA 1.438 -1.026 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.526 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 56.1 Cg_endo -85.76 146.68 9.34 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.888 2.392 . . . . 0.0 114.333 -175.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -131.02 126.23 21.54 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.513 172.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.95 164.11 75.47 Favored 'Cis proline' 0 C--N 1.323 -0.808 0 C-N-CA 122.742 -1.774 . . . . 0.0 113.173 -0.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.407 HG11 ' O ' ' A' ' 74' ' ' LEU . 92.6 t -82.59 -43.72 19.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.305 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.7 mm -91.89 124.48 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 172.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.2 mt -89.27 168.38 15.43 Favored Pre-proline 0 C--N 1.303 -1.445 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.449 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -73.95 -1.17 10.47 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 123.198 2.598 . . . . 0.0 111.703 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -95.77 -9.06 32.69 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.186 -1.824 . . . . 0.0 109.073 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 60.25 57.22 2.99 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 123.572 1.653 . . . . 0.0 108.2 -169.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 m -102.57 135.05 44.91 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 173.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.6 t -91.61 115.61 31.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 125.496 1.748 . . . . 0.0 107.783 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.407 ' O ' HG11 ' A' ' 66' ' ' VAL . 4.7 mp -101.04 135.82 41.87 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.426 -0.796 . . . . 0.0 111.758 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.512 ' OG ' ' HB2' ' A' ' 29' ' ' GLN . 81.1 p -117.36 142.76 46.71 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.526 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -128.68 132.99 7.46 Favored Glycine 0 CA--C 1.479 -2.173 0 C-N-CA 119.64 -1.267 . . . . 0.0 110.345 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -150.69 172.54 15.4 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -75.56 135.05 40.58 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.446 HG21 HD12 ' A' ' 27' ' ' ILE . 2.8 m -59.93 -19.91 54.45 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -175.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.8 p -66.94 -40.05 87.48 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.594 1.158 . . . . 0.0 110.947 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.24 11.29 6.78 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.397 1.094 . . . . 0.0 112.009 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 . . . . . 0 C--N 1.298 -1.665 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.561 -178.645 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.483 ' CE3' HG23 ' A' ' 41' ' ' THR . 11.2 m95 . . . . . 0 N--CA 1.437 -1.1 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -84.59 -172.2 4.04 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.956 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -78.47 -27.39 46.29 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.956 0.884 . . . . 0.0 112.571 -171.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.8 m -124.29 148.54 47.34 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.611 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.43 ' O ' HD13 ' A' ' 28' ' ' ILE . 13.9 tt -120.79 133.62 66.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.43 HD13 ' O ' ' A' ' 27' ' ' ILE . 31.8 mm -128.75 112.29 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -173.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -97.45 131.67 43.88 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.582 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 46.3 ttt180 -97.13 114.17 25.82 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . 21.3 m-85 . . . . . 0 N--CA 1.427 -1.617 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 9.5 p . . . . . 0 N--CA 1.447 -0.602 0 CA-C-O 121.656 0.741 . . . . 0.0 112.227 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.68 -50.79 2.97 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.663 0.744 . . . . 0.0 110.483 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.582 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 8.2 m120 -119.22 151.87 37.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.914 -173.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 mp -120.06 122.59 68.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -126.18 167.32 15.58 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.483 HG23 ' CE3' ' A' ' 23' ' ' TRP . 1.4 t -153.45 142.31 21.12 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.73 154.19 43.22 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 124.232 0.958 . . . . 0.0 108.914 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -75.71 161.71 28.84 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.021 0.438 . . . . 0.0 111.045 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -66.14 116.79 7.6 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.454 0.645 . . . . 0.0 110.303 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.582 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 38.8 m-80 72.95 64.79 0.1 Allowed 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 126.826 2.05 . . . . 0.0 109.161 -172.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -142.23 131.16 23.02 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 33.9 tt0 -98.19 113.66 25.65 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.443 177.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.8 pt -94.3 -176.2 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.2 m -135.97 136.69 40.58 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 173.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.3 mt -127.64 108.49 18.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 54.46 40.49 31.84 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.781 0.801 . . . . 0.0 111.695 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.257 36.0 mm-40 70.23 12.91 7.68 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 126.03 1.732 . . . . 0.0 115.068 -178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -103.37 122.2 44.35 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 172.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.77 142.08 29.22 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 118.591 -1.243 . . . . 0.0 109.853 -178.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.1 t -133.29 124.62 49.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.571 -175.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 62.8 t80 -96.08 119.02 33.83 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.0 t -94.97 120.14 43.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -77.16 174.54 10.59 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.582 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 9.7 pt-20 -75.63 -6.27 49.56 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -172.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.66 11.18 36.3 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.816 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 80.3 m 66.2 55.26 0.89 Allowed 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.377 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -136.74 122.59 13.35 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -81.71 146.51 14.98 Favored 'Trans proline' 0 C--N 1.328 -0.512 0 C-N-CA 123.436 2.757 . . . . 0.0 114.098 -177.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -129.84 134.84 26.64 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.651 172.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.87 161.35 79.03 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.158 -2.017 . . . . 0.0 111.495 -2.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.4 t -79.15 -29.78 13.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.274 -176.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.3 mm -103.96 121.83 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-O 121.773 0.797 . . . . 0.0 110.265 173.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.3 mt -85.75 165.57 34.32 Favored Pre-proline 0 C--N 1.3 -1.58 0 CA-C-N 113.899 -1.501 . . . . 0.0 109.135 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.47 -18.11 54.23 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.723 2.282 . . . . 0.0 112.737 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -87.19 -0.18 56.3 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.231 -1.349 . . . . 0.0 109.598 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 64.48 58.33 1.07 Allowed 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 124.725 2.202 . . . . 0.0 108.823 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.1 m -115.29 135.08 54.52 Favored 'General case' 0 N--CA 1.403 -2.821 0 CA-C-N 111.95 -2.386 . . . . 0.0 106.331 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.2 t -91.13 123.8 43.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 127.197 2.199 . . . . 0.0 107.792 -176.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mp -100.72 122.28 43.09 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.922 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.8 t -101.85 118.63 37.33 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -125.66 139.84 11.8 Favored Glycine 0 N--CA 1.424 -2.159 0 C-N-CA 119.015 -1.564 . . . . 0.0 111.647 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -159.57 177.39 10.96 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -73.47 139.88 46.08 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.425 HG21 HD13 ' A' ' 27' ' ' ILE . 1.3 m -67.66 -10.55 53.32 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.643 0.735 . . . . 0.0 111.535 -177.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.9 t -67.53 -40.24 85.07 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.46 14.69 12.35 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.486 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 . . . . . 0 C--N 1.293 -1.863 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.059 -177.201 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.521 ' CE3' HG21 ' A' ' 41' ' ' THR . 16.7 m95 . . . . . 0 N--CA 1.44 -0.974 0 CA-C-O 121.119 0.485 . . . . 0.0 111.537 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.455 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 70.6 mmtt -91.96 -171.89 2.99 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.464 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -81.28 -33.99 32.32 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 122.069 0.937 . . . . 0.0 110.835 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 70.3 m -120.5 144.31 48.09 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.57 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.445 HD13 HG22 ' A' ' 79' ' ' THR . 14.7 tt -121.09 133.49 67.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-O 121.225 0.536 . . . . 0.0 109.952 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.07 112.77 41.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 122.564 1.173 . . . . 0.0 109.529 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.501 ' OE1' HG22 ' A' ' 36' ' ' VAL . 66.2 mm-40 -91.51 112.33 24.2 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 113.245 -1.798 . . . . 0.0 106.761 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -92.22 110.89 22.29 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.531 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 76.4 m-85 . . . . . 0 C--N 1.304 -1.398 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.501 HG22 ' OE1' ' A' ' 29' ' ' GLN . 7.7 p . . . . . 0 N--CA 1.439 -0.989 0 CA-C-O 122.1 0.952 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -91.25 -48.48 6.9 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.118 0.961 . . . . 0.0 111.027 -174.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -123.26 152.83 40.95 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.694 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.2 mt -128.31 120.77 53.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.717 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -118.69 165.75 13.6 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.521 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.5 t -150.64 143.65 24.72 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.53 153.88 45.15 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.162 -174.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -78.71 160.29 27.54 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.746 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -56.81 118.38 4.86 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.58 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' A' ' 59' ' ' GLU 0.266 58.8 m-80 68.35 68.69 0.32 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.704 1.602 . . . . 0.0 110.488 -173.432 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -146.89 136.28 22.78 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.755 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 42.1 tt0 -104.83 120.38 41.27 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.336 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.7 pt -103.04 -177.54 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.2 m -137.87 139.57 39.95 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.2 mt -134.49 113.21 16.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 53.39 39.04 29.3 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.88 0.848 . . . . 0.0 111.938 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 69.61 17.62 7.82 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 125.494 1.518 . . . . 0.0 112.826 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -103.93 117.77 35.11 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 172.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.95 146.25 33.56 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.984 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.8 t -138.08 115.84 12.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.828 -174.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 90.7 t80 -94.57 127.11 40.3 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.157 0.503 . . . . 0.0 110.205 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 45' ' ' ASN . 60.8 t -104.25 122.01 56.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -78.7 175.24 10.62 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 123.639 0.587 . . . . 0.0 109.539 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.5 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -64.99 -21.9 66.92 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -171.524 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.75 12.15 28.9 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.664 -177.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 56.4 m 66.29 80.86 0.21 Allowed 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 124.032 0.833 . . . . 0.0 111.535 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -161.44 127.68 2.4 Favored Pre-proline 0 N--CA 1.442 -0.858 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.466 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 28.3 Cg_endo -92.19 149.9 3.1 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.069 2.513 . . . . 0.0 114.985 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -131.21 135.8 27.74 Favored Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.734 169.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -77.06 165.62 84.45 Favored 'Cis proline' 0 C--N 1.326 -0.641 0 C-N-CA 122.865 -1.723 . . . . 0.0 112.479 -1.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.44 HG11 ' O ' ' A' ' 74' ' ' LEU . 57.6 t -87.41 -47.98 15.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -176.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -92.02 121.3 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 121.883 0.849 . . . . 0.0 109.186 170.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.3 mt -85.31 164.78 39.4 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 114.247 -1.342 . . . . 0.0 108.274 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -70.33 -10.56 28.37 Favored 'Trans proline' 0 N--CA 1.483 0.909 0 C-N-CA 122.849 2.366 . . . . 0.0 111.658 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -84.89 -11.05 56.45 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.565 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.404 17.2 ttm180 65.69 58.69 0.78 Allowed 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 124.528 2.109 . . . . 0.0 111.813 -174.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.9 m -114.25 138.27 50.7 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 111.231 -2.713 . . . . 0.0 106.616 172.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -91.42 115.92 31.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 125.408 1.692 . . . . 0.0 107.993 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.44 ' O ' HG11 ' A' ' 66' ' ' VAL . 6.6 mp -99.89 122.76 43.32 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.975 0.893 . . . . 0.0 112.091 177.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.8 m -119.12 118.81 32.39 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.268 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.466 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -101.82 131.39 10.57 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -139.76 168.93 18.7 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -75.61 139.5 42.08 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.445 HG22 HD13 ' A' ' 27' ' ' ILE . 2.4 m -68.54 -20.38 64.55 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.244 0.545 . . . . 0.0 110.966 -177.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.4 t -58.73 -38.58 78.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.157 -177.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.72 21.26 8.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.392 0.615 . . . . 0.0 112.371 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 . . . . . 0 C--N 1.302 -1.461 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -178.236 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.55 ' CE3' HG23 ' A' ' 41' ' ' THR . 10.7 m95 . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.402 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 32.3 mmtp -96.14 -175.63 3.43 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 175.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.462 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 3.6 m-20 -75.24 -33.16 61.28 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.505 0.669 . . . . 0.0 112.592 -176.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.2 m -121.64 140.01 52.82 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.654 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.4 tt -113.36 131.72 64.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -177.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.7 mm -119.57 112.37 36.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-O 121.891 0.853 . . . . 0.0 108.732 -173.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -94.69 125.5 39.38 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.488 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.424 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 52.8 ttt180 -95.09 112.72 24.4 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.516 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 25.8 m-85 . . . . . 0 CA--C 1.484 -1.569 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.432 -1.361 0 CA-C-O 121.979 0.895 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -84.99 -50.69 7.26 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.486 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.424 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 16.9 m120 -119.07 149.76 41.12 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.95 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.9 mp -116.51 116.33 51.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.445 ' HH ' HG21 ' A' ' 50' ' ' ILE . 79.9 m-85 -119.07 169.44 9.92 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.55 HG23 ' CE3' ' A' ' 23' ' ' TRP . 3.6 t -154.43 146.86 23.98 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.4 154.51 40.95 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -75.51 157.09 34.45 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.586 176.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.485 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 2.1 ptt180 -59.91 116.4 4.09 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 121.333 0.587 . . . . 0.0 109.986 170.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.6 m120 75.23 67.27 0.07 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.193 -1.822 . . . . 0.0 108.331 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -152.64 128.84 10.47 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.478 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 2.7 mp0 -86.85 135.89 33.16 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.004 173.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.7 pt -113.99 -179.99 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.12 132.09 37.68 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.445 HG21 ' HH ' ' A' ' 40' ' ' TYR . 86.5 mt -125.53 107.01 17.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 177.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 55.06 41.26 31.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.302 1.049 . . . . 0.0 112.65 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 71.51 6.87 5.87 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.943 2.097 . . . . 0.0 112.433 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -93.87 112.34 24.17 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 175.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -83.1 130.61 35.13 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 63.3 t -126.43 120.61 56.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.05 -173.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 56.8 t80 -94.5 121.99 36.62 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.4 t -97.25 125.07 50.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -78.67 175.28 10.56 Favored 'General case' 0 N--CA 1.439 -1.018 0 O-C-N 124.72 1.263 . . . . 0.0 108.002 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.485 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -74.12 -16.52 61.01 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -173.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.63 6.13 21.91 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.089 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 76.7 m 71.49 30.32 2.5 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 122.29 1.043 . . . . 0.0 113.319 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -114.54 124.07 31.22 Favored Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 113.736 -1.575 . . . . 0.0 107.898 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.446 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 60.3 Cg_endo -83.97 147.25 11.81 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 123.469 2.779 . . . . 0.0 114.549 -177.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -132.38 131.25 22.21 Favored Pre-proline 0 CA--C 1.493 -1.229 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.065 172.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -76.65 161.66 93.23 Favored 'Cis proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.644 -1.815 . . . . 0.0 112.948 -0.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 74' ' ' LEU . 57.3 t -82.98 -48.24 17.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.515 HG12 ' NH2' ' A' ' 71' ' ' ARG . 1.7 mp -96.38 122.6 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.261 172.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.434 ' C ' ' H ' ' A' ' 70' ' ' ASP . 54.0 mt -80.19 169.61 19.13 Favored Pre-proline 0 C--N 1.296 -1.76 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.101 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -76.04 5.64 4.36 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.99 2.46 . . . . 0.0 109.72 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 68' ' ' LEU . 27.5 t70 -99.93 -10.52 21.59 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 112.686 -2.052 . . . . 0.0 111.223 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.515 ' NH2' HG12 ' A' ' 67' ' ' ILE . 8.6 tpm_? 75.38 18.28 2.37 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.57 1.148 . . . . 0.0 110.243 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.4 m -82.6 140.52 33.17 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 170.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 7.7 t -90.85 124.76 43.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 126.336 1.854 . . . . 0.0 108.063 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.432 ' O ' HG11 ' A' ' 66' ' ' VAL . 5.4 mp -103.74 122.68 45.58 Favored 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.689 173.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.5 m -117.28 118.2 31.62 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.446 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -114.03 147.38 18.72 Favored Glycine 0 N--CA 1.419 -2.482 0 C-N-CA 118.84 -1.647 . . . . 0.0 110.546 -177.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -150.2 176.51 10.79 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.403 ' HB3' ' OG ' ' A' ' 80' ' ' SER . 52.5 m-85 -78.08 136.55 37.91 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 m -69.76 -19.11 63.53 Favored 'General case' 0 C--O 1.242 0.686 0 O-C-N 122.058 -0.401 . . . . 0.0 110.014 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.403 ' OG ' ' HB3' ' A' ' 78' ' ' PHE . 12.3 p -56.53 -33.16 65.79 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.33 1.452 . . . . 0.0 111.761 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.54 12.71 31.0 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.648 0.737 . . . . 0.0 112.511 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 C--N 1.302 -1.459 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -175.818 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.595 ' CE3' HG23 ' A' ' 41' ' ' THR . 82.2 m95 . . . . . 0 N--CA 1.427 -1.614 0 CA-C-O 121.581 0.705 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -87.0 -170.88 3.25 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.499 178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.523 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 21.2 m-20 -76.02 -28.87 57.92 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.707 0.765 . . . . 0.0 112.298 -174.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.8 m -127.18 147.11 50.2 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.421 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.404 ' O ' ' HA2' ' A' ' 76' ' ' GLY . 10.7 tt -118.42 133.35 65.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.9 mm -123.98 112.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -97.21 125.54 41.81 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -93.26 111.02 22.55 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . 34.7 m-85 . . . . . 0 C--N 1.303 -1.456 0 C-N-CA 123.61 0.764 . . . . 0.0 110.453 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 4.1 p . . . . . 0 N--CA 1.429 -1.522 0 CA-C-O 122.366 1.079 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -84.31 -58.74 2.63 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.473 -175.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -121.93 157.67 30.73 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.246 0.546 . . . . 0.0 111.443 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.0 mm -116.35 136.17 54.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.506 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -142.73 164.3 30.49 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.595 HG23 ' CE3' ' A' ' 23' ' ' TRP . 1.6 t -152.15 142.61 22.6 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 176.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.12 155.52 46.95 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.495 -173.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -73.16 154.44 40.31 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.523 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 14.1 ptt180 -66.62 116.22 7.32 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 121.819 -0.551 . . . . 0.0 110.651 172.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.7 m120 76.95 67.33 0.05 Allowed 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 126.059 1.744 . . . . 0.0 108.62 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -146.27 131.25 18.21 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.521 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 42.2 tt0 -97.66 109.0 21.84 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.415 ' CG1' ' HB ' ' A' ' 55' ' ' VAL . 23.6 pt -92.53 -179.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 m -136.89 129.79 30.73 Favored 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 172.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.401 HD11 HD23 ' A' ' 74' ' ' LEU . 68.7 mt -119.43 110.23 28.86 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 57.51 39.37 27.94 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.879 0.847 . . . . 0.0 111.625 172.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 73.67 7.22 5.02 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.411 1.884 . . . . 0.0 113.312 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -102.42 119.57 39.04 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.0 153.38 27.47 Favored 'General case' 0 N--CA 1.435 -1.225 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.849 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.415 ' HB ' ' CG1' ' A' ' 48' ' ' ILE . 95.9 t -146.24 125.08 4.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.993 -175.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 77.7 t80 -98.66 118.9 36.41 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.9 t -97.98 118.08 43.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -81.28 170.86 15.53 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -65.75 -15.58 62.98 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -172.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.13 0.51 31.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.938 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 71.9 m 72.44 26.79 2.53 Favored 'General case' 0 CA--C 1.487 -1.449 0 C-N-CA 124.55 1.14 . . . . 0.0 112.625 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -113.22 121.19 38.54 Favored Pre-proline 0 C--N 1.287 -2.113 0 CA-C-N 112.9 -1.955 . . . . 0.0 108.306 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.504 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 45.7 Cg_endo -85.66 144.19 8.72 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 124.093 3.195 . . . . 0.0 115.26 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -129.58 134.07 25.8 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.729 172.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -79.05 153.52 89.8 Favored 'Cis proline' 0 C--N 1.323 -0.815 0 C-N-CA 122.67 -1.804 . . . . 0.0 112.603 1.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 74' ' ' LEU . 86.2 t -75.05 -35.39 34.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.82 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.0 mm -102.87 125.18 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.359 174.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.1 mt -84.68 165.46 37.55 Favored Pre-proline 0 C--N 1.29 -1.983 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.17 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -70.4 -8.85 24.59 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 C-N-CA 123.038 2.492 . . . . 0.0 112.167 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -88.61 -7.62 56.09 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.587 177.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 67.82 57.76 0.51 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 123.886 1.803 . . . . 0.0 108.817 -173.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.9 m -112.8 140.63 47.43 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-N 112.665 -2.061 . . . . 0.0 107.082 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.7 t -91.81 115.93 31.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 125.233 1.583 . . . . 0.0 108.696 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.43 ' O ' HG11 ' A' ' 66' ' ' VAL . 3.6 mp -96.24 122.68 39.36 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.049 174.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 64.9 m -117.82 117.46 29.36 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.504 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -120.82 137.8 12.25 Favored Glycine 0 N--CA 1.411 -2.993 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.963 -177.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.428 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 9.3 m-20 -145.56 173.73 11.79 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -72.58 138.43 46.83 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.509 HG23 ' CB ' ' A' ' 23' ' ' TRP . 1.8 m -68.84 -18.54 64.17 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.224 0.535 . . . . 0.0 111.802 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 p -63.02 -25.5 68.41 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.368 0.604 . . . . 0.0 111.523 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.71 20.2 18.34 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.026 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 77' ' ' ASP . 7.7 m-85 . . . . . 0 C--N 1.308 -1.224 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.794 -174.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.501 ' CE3' HG23 ' A' ' 41' ' ' THR . 71.4 m95 . . . . . 0 N--CA 1.429 -1.506 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . 10.8 mmpt? -88.91 -170.21 2.82 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 123.498 0.719 . . . . 0.0 111.449 -176.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.499 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 4.7 m-20 -69.3 -34.46 74.73 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -173.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.0 m -126.97 147.22 50.12 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.869 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.412 ' O ' HD13 ' A' ' 28' ' ' ILE . 8.2 tt -116.74 133.35 63.66 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 75' ' ' SER . 33.4 mm -125.94 111.61 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -174.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 75' ' ' SER . 25.6 mt-30 -102.51 132.09 48.79 Favored 'General case' 0 C--N 1.282 -2.336 0 O-C-N 121.652 -0.655 . . . . 0.0 109.675 -177.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -92.9 109.85 21.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . 10.2 m-85 . . . . . 0 C--N 1.297 -1.696 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 31' ' ' TYR 0.253 7.1 p . . . . . 0 N--CA 1.432 -1.361 0 CA-C-O 122.108 0.956 . . . . 0.0 110.894 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -97.11 -60.67 1.54 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.689 -174.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -119.91 158.38 26.8 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.35 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mp -125.54 121.75 60.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -123.02 169.94 10.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.501 HG23 ' CE3' ' A' ' 23' ' ' TRP . 1.6 t -149.95 142.08 24.04 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.4 160.06 40.49 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.496 -173.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -79.73 158.49 26.9 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.499 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 5.2 ptt180 -64.94 111.89 3.05 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 170.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.544 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 89.4 m-20 76.63 67.53 0.06 Allowed 'General case' 0 C--O 1.243 0.735 0 CA-C-O 123.321 1.534 . . . . 0.0 109.949 -176.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -144.16 123.08 12.74 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 112.581 -2.099 . . . . 0.0 110.46 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 46.6 tt0 -89.4 109.73 20.61 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 173.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.6 pt -92.99 -176.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 177.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 4.5 m -136.32 131.37 34.24 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 176.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 97.5 mt -132.62 108.45 13.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 58.81 35.01 24.08 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 122.91 1.338 . . . . 0.0 110.342 176.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 72.79 5.13 5.16 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 127.847 2.459 . . . . 0.0 113.683 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -92.01 114.27 26.77 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 174.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -80.36 140.54 36.03 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 117.925 -1.51 . . . . 0.0 108.135 178.316 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 86.1 t -133.23 123.18 46.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.011 -170.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 92.7 t80 -91.26 118.69 30.69 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.276 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 45' ' ' ASN . 64.6 t -95.67 119.33 43.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 174.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -77.33 165.03 24.98 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 124.33 1.018 . . . . 0.0 108.738 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.544 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -62.33 -19.98 63.88 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -173.338 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.82 11.36 11.37 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.401 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.6 m 62.65 68.05 0.67 Allowed 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.163 0.982 . . . . 0.0 110.438 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -153.19 120.54 3.01 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.526 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 55.6 Cg_endo -86.24 154.27 9.49 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.768 2.979 . . . . 0.0 114.314 -177.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -135.78 132.09 19.37 Favored Pre-proline 0 CA--C 1.483 -1.634 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.898 172.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.42 168.19 75.97 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.805 -1.748 . . . . 0.0 112.378 -2.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.0 t -88.61 -48.09 15.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.752 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -92.5 124.81 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.683 0.754 . . . . 0.0 109.893 173.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.5 mt -83.82 168.22 23.34 Favored Pre-proline 0 C--N 1.299 -1.593 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.983 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -64.67 -21.24 65.37 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.458 2.105 . . . . 0.0 111.135 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -83.43 -3.55 57.68 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 125.848 1.659 . . . . 0.0 110.934 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.522 ' HG3' ' O ' ' A' ' 71' ' ' ARG . 18.4 tpt180 77.38 6.44 3.0 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.049 1.74 . . . . 0.0 110.747 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.1 m -67.95 134.09 50.19 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 122.134 0.969 . . . . 0.0 109.601 173.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.7 t -91.07 125.32 43.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 C-N-CA 128.493 2.717 . . . . 0.0 107.647 -175.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 mp -98.28 122.35 41.34 Favored 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.964 174.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.489 ' HB3' ' HB2' ' A' ' 29' ' ' GLN . 30.3 t -97.83 118.36 34.22 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.526 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -122.0 126.04 6.31 Favored Glycine 0 N--CA 1.416 -2.686 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.448 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 5.4 t70 -153.71 172.06 17.87 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -73.31 140.87 47.05 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 23' ' ' TRP . 3.7 m -71.68 -16.45 62.24 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.559 0.695 . . . . 0.0 109.632 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . 0.264 1.5 m -59.99 -22.55 62.7 Favored 'General case' 0 N--CA 1.411 -2.417 0 C-N-CA 126.238 1.815 . . . . 0.0 111.627 178.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.8 15.99 16.33 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 122.541 1.162 . . . . 0.0 110.066 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.448 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 31.9 m-85 . . . . . 0 C--N 1.296 -1.732 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.202 -176.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.547 ' CE3' HG21 ' A' ' 41' ' ' THR . 13.5 m0 . . . . . 0 N--CA 1.445 -0.676 0 CA-C-O 121.518 0.675 . . . . 0.0 109.919 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.498 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 34.8 mmtp -73.51 -173.47 1.43 Allowed 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.129 0.966 . . . . 0.0 108.675 174.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.558 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 6.7 m-20 -83.5 -33.58 25.52 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.704 -174.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 69.2 m -123.5 140.41 53.03 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.358 -176.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.42 HD13 HG23 ' A' ' 79' ' ' THR . 7.2 tt -113.87 133.26 60.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.4 mm -122.23 112.33 34.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -174.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.611 ' HB2' ' OG ' ' A' ' 75' ' ' SER . 96.8 mt-30 -96.69 127.63 42.86 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.491 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 58.5 ttt180 -95.78 112.33 24.08 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . 56.9 m-85 . . . . . 0 C--N 1.3 -1.549 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 10.9 p . . . . . 0 N--CA 1.433 -1.319 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -99.44 -46.52 5.46 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.316 -173.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.491 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 14.6 m120 -130.18 159.01 38.13 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.841 -176.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.8 mm -118.73 134.11 63.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 123.524 0.73 . . . . 0.0 110.799 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -141.18 165.09 28.48 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.547 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.4 t -157.33 144.35 18.4 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.17 156.43 46.53 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.189 0.596 . . . . 0.0 110.733 -174.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -74.88 157.58 34.82 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.558 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 8.1 ptt180 -62.81 107.86 1.06 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 171.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 83.57 62.09 0.01 OUTLIER 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.95 2.1 . . . . 0.0 110.681 -176.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -144.79 132.28 20.87 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.872 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 3.5 mp0 -87.3 112.45 22.08 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 172.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.1 pt -88.79 179.65 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 172.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.7 m -132.13 133.83 44.73 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 85.8 mt -127.1 106.08 14.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 56.24 38.83 30.18 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.408 1.099 . . . . 0.0 111.821 176.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 64.78 28.7 12.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.742 -1.572 . . . . 0.0 114.335 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -113.42 109.98 19.56 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 169.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.67 136.96 37.59 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 118.005 -1.478 . . . . 0.0 108.827 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 92.4 t -124.4 114.35 40.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.513 -174.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -82.92 115.79 21.93 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.1 t -97.18 118.75 44.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -75.38 173.07 11.41 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 125.162 1.539 . . . . 0.0 108.415 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -20.83 65.99 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -172.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.73 12.19 11.34 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.51 0.671 . . . . 0.0 110.006 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.9 m 68.58 31.1 4.87 Favored 'General case' 0 C--O 1.199 -1.585 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.925 175.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -109.72 119.79 46.79 Favored Pre-proline 0 C--N 1.288 -2.069 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.349 -177.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.482 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 83.7 Cg_endo -83.34 143.16 11.01 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.447 2.765 . . . . 0.0 113.516 -177.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -129.43 132.02 24.0 Favored Pre-proline 0 N--CA 1.432 -1.329 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.691 173.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -80.7 165.97 76.04 Favored 'Cis proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.514 -1.869 . . . . 0.0 112.181 -2.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.3 t -83.44 -39.7 15.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.866 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 mp -96.67 123.55 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 CA-C-O 121.386 0.612 . . . . 0.0 109.503 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.4 mt -84.6 167.44 26.85 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.012 177.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -70.72 -7.3 21.03 Favored 'Trans proline' 0 N--CA 1.484 0.951 0 C-N-CA 122.915 2.41 . . . . 0.0 112.671 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -89.82 -12.01 40.38 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.048 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.38 37.1 ttm180 67.62 58.69 0.5 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 124.032 1.872 . . . . 0.0 110.516 -169.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.7 m -103.48 136.44 43.21 Favored 'General case' 0 N--CA 1.408 -2.527 0 CA-C-N 111.861 -2.427 . . . . 0.0 105.11 172.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.3 t -93.27 115.69 32.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 124.855 1.347 . . . . 0.0 108.29 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.6 mp -97.22 126.87 42.7 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.452 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.611 ' OG ' ' HB2' ' A' ' 29' ' ' GLN . 51.4 p -107.69 129.7 55.0 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.482 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -114.42 118.01 4.26 Favored Glycine 0 N--CA 1.418 -2.534 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.953 -177.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -131.28 169.48 15.92 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -86.84 134.07 33.58 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 177.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.42 HG23 HD13 ' A' ' 27' ' ' ILE . 1.5 m -71.55 -13.85 61.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.954 0.407 . . . . 0.0 111.854 -175.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.4 p -69.69 -31.83 70.08 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.53 0.681 . . . . 0.0 110.765 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.24 17.46 21.27 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 122.437 1.113 . . . . 0.0 110.222 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 . . . . . 0 C--N 1.302 -1.489 0 C-N-CA 125.83 1.652 . . . . 0.0 108.55 -178.422 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.573 ' CE3' HG23 ' A' ' 41' ' ' THR . 41.7 m95 . . . . . 0 N--CA 1.435 -1.215 0 CA-C-O 121.283 0.564 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.457 ' HB3' ' OD1' ' A' ' 43' ' ' ASN . 9.1 mmpt? -79.47 -173.68 3.85 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.151 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -76.15 -24.38 54.84 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 64.5 m -132.52 155.58 48.36 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.43 ' O ' HD13 ' A' ' 28' ' ' ILE . 8.6 tt -125.37 133.68 68.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -178.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.43 HD13 ' O ' ' A' ' 27' ' ' ILE . 25.6 mm -125.08 111.3 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -175.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -103.38 130.33 50.66 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.144 0.497 . . . . 0.0 110.21 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -99.44 115.27 28.89 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.404 -175.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.558 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 27.9 m-85 . . . . . 0 C--N 1.294 -1.847 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.435 -1.176 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -91.61 -43.79 9.42 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.217 -171.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -129.72 151.16 50.61 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -119.72 115.06 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.423 ' HH ' HG21 ' A' ' 50' ' ' ILE . 45.5 m-85 -119.17 166.01 13.48 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.573 HG23 ' CE3' ' A' ' 23' ' ' TRP . 1.3 t -150.81 142.72 23.89 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 26' ' ' CYS . . . -147.11 160.91 41.85 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -174.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.457 ' OD1' ' HB3' ' A' ' 24' ' ' LYS . 90.7 m-20 -85.27 164.93 17.73 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 121.769 0.795 . . . . 0.0 112.217 176.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.425 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 5.5 ptt85 -62.26 110.16 1.55 Allowed 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.947 169.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 75.6 67.21 0.07 Allowed 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.719 1.208 . . . . 0.0 109.015 -177.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -152.48 143.71 23.22 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 124.662 1.185 . . . . 0.0 107.932 -178.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -115.56 135.96 53.55 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 121.489 0.661 . . . . 0.0 110.655 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.472 ' CG1' ' HB ' ' A' ' 55' ' ' VAL . 29.1 pt -119.05 -179.99 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.7 m -137.62 135.13 36.3 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.423 HG21 ' HH ' ' A' ' 40' ' ' TYR . 82.6 mt -127.55 108.2 17.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.85 49.54 20.85 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 70.09 5.73 5.43 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.023 1.329 . . . . 0.0 113.277 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -104.16 109.63 21.5 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.1 154.11 38.0 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.991 0.9 . . . . 0.0 112.245 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.472 ' HB ' ' CG1' ' A' ' 48' ' ' ILE . 88.6 t -142.59 118.08 5.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 CA-C-N 113.546 -1.661 . . . . 0.0 109.842 -173.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -102.51 123.7 46.74 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.2 t -97.99 119.38 45.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -80.62 172.0 14.31 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.425 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 9.9 pt-20 -67.27 -5.58 14.67 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -172.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.61 13.68 31.16 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.711 172.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.0 m 69.83 33.96 2.74 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.518 1.152 . . . . 0.0 111.8 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -114.88 119.05 39.91 Favored Pre-proline 0 C--N 1.286 -2.17 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.672 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.463 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 83.6 Cg_endo -83.98 147.95 11.96 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.795 2.997 . . . . 0.0 114.115 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 70.7 m-85 -130.07 129.91 23.02 Favored Pre-proline 0 CA--C 1.488 -1.433 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.227 172.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.27 161.25 81.46 Favored 'Cis proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.923 -1.699 . . . . 0.0 112.354 -2.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.1 t -81.88 -36.76 14.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.265 0.555 . . . . 0.0 109.631 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.9 mm -106.42 127.08 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 173.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 39.4 mt -87.44 171.77 9.2 Favored Pre-proline 0 C--N 1.289 -2.035 0 CA-C-N 114.174 -1.376 . . . . 0.0 109.865 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -71.29 -12.02 29.38 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.551 2.167 . . . . 0.0 110.864 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -87.56 -0.14 56.43 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 125.836 1.654 . . . . 0.0 108.303 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 60.34 26.93 16.47 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 127.849 2.46 . . . . 0.0 109.361 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.13 135.57 47.72 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.558 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 5.5 t -90.89 117.48 34.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 125.704 1.878 . . . . 0.0 108.301 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.45 121.83 42.66 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.586 -1.246 . . . . 0.0 112.265 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.0 m -97.51 118.04 33.12 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 175.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -116.93 111.66 2.35 Favored Glycine 0 N--CA 1.422 -2.262 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.498 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.457 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 19.3 m-20 -142.69 177.21 8.47 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -78.03 139.53 39.11 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.8 -21.77 66.13 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.139 0.975 . . . . 0.0 112.854 -176.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 p -71.49 -24.85 62.06 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.595 0.712 . . . . 0.0 111.32 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.37 14.9 24.62 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.916 0.865 . . . . 0.0 111.178 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 77' ' ' ASP . 37.5 m-85 . . . . . 0 C--N 1.305 -1.354 0 C-N-CA 124.716 1.206 . . . . 0.0 111.432 -176.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.549 ' CE3' HG23 ' A' ' 41' ' ' THR . 12.1 m95 . . . . . 0 N--CA 1.438 -1.056 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -92.37 -173.74 3.49 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.87 -33.86 64.23 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.935 -178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.6 m -122.16 145.21 48.4 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.787 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 79' ' ' THR . 9.2 tt -114.8 133.31 61.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.8 mm -124.36 112.51 32.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -174.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -95.92 127.53 42.02 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 28.1 ttt180 -95.24 110.93 22.85 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.479 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 30.3 m-85 . . . . . 0 CA--C 1.483 -1.612 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 5.6 p . . . . . 0 N--CA 1.432 -1.371 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -88.98 -45.98 9.24 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.588 -171.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 30' ' ' ARG . 18.6 m120 -122.03 157.48 31.27 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.676 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.4 mm -121.42 134.87 63.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.671 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -141.49 166.64 24.19 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.549 HG23 ' CE3' ' A' ' 23' ' ' TRP . 1.8 t -158.13 141.49 15.2 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.34 156.84 45.27 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -173.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -79.72 157.98 27.03 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.898 175.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.421 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 4.1 ptt180 -59.06 115.78 3.39 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 169.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 75.49 59.34 0.06 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 126.163 1.785 . . . . 0.0 109.173 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -141.65 136.12 30.62 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.114 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 45.3 tt0 -101.67 109.94 21.82 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.7 pt -91.6 -178.11 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.5 m -136.36 126.78 26.74 Favored 'General case' 0 N--CA 1.405 -2.712 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 68.4 mt -118.34 104.15 15.71 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 56.3 43.49 26.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 122.108 0.956 . . . . 0.0 112.154 170.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 71.96 8.92 6.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.242 1.817 . . . . 0.0 114.512 -178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -103.3 118.13 36.06 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 104.411 -2.441 . . . . 0.0 104.411 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 139.96 30.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 117.665 -1.614 . . . . 0.0 109.038 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.0 t -131.81 124.1 52.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.463 -173.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 75.5 t80 -96.7 121.76 38.89 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.1 t -100.74 124.28 54.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 175.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -83.41 -175.46 5.83 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.421 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 4.3 pm0 -70.59 -17.93 62.9 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -173.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.48 14.79 13.82 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.08 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 84.7 m 66.27 36.61 5.31 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.849 1.309 . . . . 0.0 112.355 174.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -116.48 120.4 34.73 Favored Pre-proline 0 C--N 1.293 -1.861 0 CA-C-N 113.223 -1.808 . . . . 0.0 108.169 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 63.9 Cg_endo -84.79 144.9 10.02 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.672 2.915 . . . . 0.0 114.422 -177.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -131.1 129.92 22.61 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.646 172.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.57 164.94 81.11 Favored 'Cis proline' 0 C--N 1.325 -0.67 0 C-N-CA 122.965 -1.681 . . . . 0.0 112.93 0.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.01 -36.59 10.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.638 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.7 mm -101.13 127.95 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.92 173.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.5 mt -86.42 169.86 14.08 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.608 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -72.09 -11.21 26.97 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.342 2.028 . . . . 0.0 111.329 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -99.15 12.94 34.66 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.196 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 71' ' ' ARG . 9.8 tpt180 61.76 27.6 16.9 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 123.274 1.511 . . . . 0.0 110.102 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.35 139.82 32.8 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 3.0 t -91.35 124.43 43.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 125.996 1.719 . . . . 0.0 108.843 -177.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mp -101.79 125.99 48.57 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.566 173.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.5 m -116.64 118.62 33.08 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.265 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.406 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -110.55 142.0 16.53 Favored Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 120.503 -0.855 . . . . 0.0 112.78 -176.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -156.26 177.35 11.54 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -80.33 136.02 36.32 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.412 HG21 HD13 ' A' ' 27' ' ' ILE . 2.3 m -61.78 -25.61 67.58 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 p -64.44 -40.64 96.12 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.42 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.35 13.17 10.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.988 0.899 . . . . 0.0 111.654 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 C--N 1.298 -1.649 0 CA-C-N 114.815 -1.084 . . . . 0.0 113.505 -178.079 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.473 ' CE3' HG21 ' A' ' 41' ' ' THR . 14.8 m0 . . . . . 0 N--CA 1.441 -0.922 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -84.2 -171.48 3.63 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.451 ' CG ' ' HE ' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -81.8 -28.39 33.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -172.737 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.6 m -123.5 144.26 49.65 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.044 -177.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 79' ' ' THR . 11.0 tt -117.31 133.08 65.19 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.7 mm -125.48 112.77 32.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -172.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -101.05 136.26 41.18 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -99.58 111.02 23.41 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.476 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 29.6 m-85 . . . . . 0 C--N 1.296 -1.76 0 C-N-CA 123.223 0.609 . . . . 0.0 109.861 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.424 -1.754 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -89.17 -43.46 11.0 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.85 -168.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -129.12 148.97 51.12 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -118.0 120.74 65.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -126.6 169.22 13.32 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.473 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.5 t -149.76 145.34 26.58 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.33 154.02 44.33 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 123.673 0.789 . . . . 0.0 110.016 -174.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -75.05 151.05 38.72 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 122.026 -0.421 . . . . 0.0 110.049 173.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.451 ' HE ' ' CG ' ' A' ' 25' ' ' ASP . 8.6 ptt85 -57.55 114.83 2.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 171.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 74.67 67.74 0.08 Allowed 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 125.477 1.511 . . . . 0.0 109.553 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -151.46 139.6 20.19 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.764 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -97.13 121.88 39.51 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.2 pt -102.08 177.06 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 172.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.4 m -136.62 124.6 22.8 Favored 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 98.8 mt -114.88 105.59 18.94 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 57.26 46.75 18.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.605 0.717 . . . . 0.0 112.564 174.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 71.65 3.01 4.51 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.861 1.665 . . . . 0.0 112.897 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -99.36 109.36 21.97 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.45 143.52 34.89 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 117.959 -1.496 . . . . 0.0 109.707 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -133.74 121.21 39.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.113 -174.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -91.56 128.81 37.53 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.4 t -108.83 121.71 62.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -78.14 169.09 18.84 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 124.407 1.083 . . . . 0.0 108.223 178.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.437 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 10.5 pt-20 -72.35 -4.0 27.28 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.86 7.42 45.02 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 172.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 70.8 m 64.83 35.59 8.46 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.097 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -123.01 129.07 25.11 Favored Pre-proline 0 C--N 1.29 -2.013 0 CA-C-N 114.308 -1.314 . . . . 0.0 107.789 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -84.73 159.43 12.19 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.038 2.492 . . . . 0.0 116.01 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -134.7 131.03 20.0 Favored Pre-proline 0 C--N 1.312 -1.064 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.101 171.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.85 161.06 70.84 Favored 'Cis proline' 0 C--N 1.319 -1.022 0 C-N-CA 122.907 -1.705 . . . . 0.0 111.425 -2.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 74' ' ' LEU . 90.7 t -81.17 -38.44 16.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.695 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.3 mm -97.44 116.61 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-O 122.106 0.955 . . . . 0.0 109.932 173.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.9 mt -76.87 165.77 49.88 Favored Pre-proline 0 C--N 1.297 -1.701 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.935 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.07 -3.41 13.6 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.428 2.085 . . . . 0.0 111.366 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -93.17 -12.15 31.02 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.019 -1.901 . . . . 0.0 110.462 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.278 40.0 ttm180 66.88 59.05 0.57 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 123.819 1.771 . . . . 0.0 109.763 -171.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.3 m -120.7 139.55 52.89 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 112.269 -2.241 . . . . 0.0 106.743 172.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.7 t -90.62 115.78 30.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 125.439 1.712 . . . . 0.0 108.975 -175.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.442 ' O ' HG11 ' A' ' 66' ' ' VAL . 4.0 mp -92.92 122.64 35.5 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 118.693 -1.203 . . . . 0.0 109.794 173.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.6 m -118.67 118.71 32.37 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.85 152.72 17.41 Favored Glycine 0 N--CA 1.415 -2.763 0 C-N-CA 119.763 -1.208 . . . . 0.0 111.405 -177.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 61' ' ' CYS . 2.9 t70 -157.53 177.1 11.79 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 174.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -82.91 137.05 34.37 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.419 HG21 HD13 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -68.19 -25.31 65.17 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 118.213 0.461 . . . . 0.0 111.867 -175.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.2 t -67.91 -38.15 82.58 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.19 17.41 4.32 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.434 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.303 -1.442 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.939 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -143.32 176.24 9.3 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -94.91 113.41 25.14 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.955 1.359 . . . . 0.0 113.238 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -134.29 -59.04 0.83 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 171.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.92 159.21 27.36 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 172.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -83.37 79.25 9.47 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.685 0.755 . . . . 0.0 110.495 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -143.68 91.42 2.24 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.329 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -138.6 132.04 30.38 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.98 -71.46 0.23 Allowed Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -136.9 148.48 47.05 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.429 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -152.97 88.3 1.32 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.865 0.841 . . . . 0.0 111.373 -173.081 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.24 95.6 1.02 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.03 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.564 ' CE3' HG22 ' A' ' 41' ' ' THR . 12.1 m95 -99.33 -177.83 3.72 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.391 173.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.48 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 34.4 mmtp -83.34 -173.87 4.96 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.513 0.673 . . . . 0.0 110.102 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.97 -37.47 55.14 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.775 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.2 m -122.02 144.32 48.97 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.87 -176.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.1 tt -118.89 133.24 66.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.3 mm -121.97 112.72 36.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -92.91 128.72 38.87 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.074 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -98.31 114.28 26.52 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -96.41 130.72 43.49 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -122.64 119.27 30.26 Favored 'General case' 0 N--CA 1.4 -2.965 0 N-CA-C 105.326 -2.102 . . . . 0.0 105.326 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 60.99 30.85 19.85 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.41 5.66 65.08 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.895 -0.593 . . . . 0.0 114.473 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -135.25 151.13 50.3 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.67 114.04 12.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-O 122.442 1.115 . . . . 0.0 109.523 -175.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -97.16 -60.49 1.57 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.445 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -121.92 156.83 32.53 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.512 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 mp -120.05 118.04 55.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -119.93 169.12 10.46 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.564 HG22 ' CE3' ' A' ' 23' ' ' TRP . 4.2 t -155.37 147.95 24.1 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.76 157.85 43.61 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.582 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -72.64 155.35 40.11 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -57.65 121.11 9.59 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 166.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.514 HD22 ' HB3' ' A' ' 59' ' ' GLU . 2.0 m120 74.9 55.05 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 126.464 1.906 . . . . 0.0 110.054 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -139.54 139.54 36.9 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.803 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -95.85 125.8 40.66 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.4 pt -105.47 -176.94 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 172.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 m -136.93 134.67 37.01 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 80.1 mt -126.77 105.05 13.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 54.26 46.08 25.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.721 0.772 . . . . 0.0 111.841 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 69.7 9.42 7.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -103.92 115.26 30.14 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.45 142.62 31.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.003 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.1 t -134.33 125.04 46.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.768 -172.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -94.74 122.03 36.93 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.0 t -97.53 121.75 48.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.42 ' OD1' ' HG2' ' A' ' 59' ' ' GLU . 40.1 t30 -71.53 165.77 23.18 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 124.923 1.389 . . . . 0.0 109.3 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.514 ' HB3' HD22 ' A' ' 45' ' ' ASN . 10.7 pt-20 -58.28 -24.3 59.01 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 126.012 1.725 . . . . 0.0 114.1 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.12 16.6 22.2 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.2 m 64.85 69.45 0.49 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.341 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -148.07 124.42 5.4 Favored Pre-proline 0 C--N 1.313 -0.981 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.421 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 52.2 Cg_endo -83.58 140.49 9.43 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.252 2.635 . . . . 0.0 114.033 -176.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -129.41 131.68 23.78 Favored Pre-proline 0 CA--C 1.494 -1.183 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.148 174.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.28 166.62 81.63 Favored 'Cis proline' 0 C--N 1.325 -0.704 0 C-N-CA 122.726 -1.781 . . . . 0.0 112.74 -1.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.33 -28.43 5.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.565 0.698 . . . . 0.0 110.344 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.442 HG22 ' HA ' ' A' ' 71' ' ' ARG . 32.4 mm -108.75 132.56 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-O 121.525 0.679 . . . . 0.0 109.936 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.408 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 45.3 mt -91.15 171.87 7.5 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.582 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.408 ' CD ' ' HB3' ' A' ' 68' ' ' LEU . 25.5 Cg_exo -67.99 -15.33 43.27 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.593 2.195 . . . . 0.0 111.85 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -86.41 -12.29 49.56 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.55 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.442 ' HA ' HG22 ' A' ' 67' ' ' ILE . 23.7 ttm180 72.17 31.11 1.99 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 124.081 1.896 . . . . 0.0 109.013 -173.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 m -70.24 138.85 52.01 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 169.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 1.4 t -96.8 125.58 49.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 O-C-N 125.01 1.444 . . . . 0.0 109.571 -175.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.0 mp -103.96 138.66 40.2 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 121.438 0.637 . . . . 0.0 109.63 174.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.9 m -136.34 122.06 19.79 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.505 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.421 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -107.12 142.81 15.78 Favored Glycine 0 N--CA 1.428 -1.899 0 C-N-CA 120.247 -0.977 . . . . 0.0 110.973 -177.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -147.05 173.01 12.86 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -79.69 138.45 37.36 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.9 m -68.49 -15.36 63.51 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.465 0.65 . . . . 0.0 110.437 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.5 t -56.59 -42.23 78.33 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 126.079 1.752 . . . . 0.0 108.903 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.15 21.33 11.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.555 0.693 . . . . 0.0 112.107 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -129.45 -78.84 0.55 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.826 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.23 -30.48 34.18 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.5 t70 73.16 -56.84 0.65 Allowed 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 125.328 1.451 . . . . 0.0 114.368 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 21' ' ' MET . 25.8 t70 63.16 99.11 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 124.828 1.33 . . . . 0.0 108.168 -172.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.21 111.36 1.32 Allowed 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -81.65 129.51 34.72 Favored 'General case' 0 N--CA 1.425 -1.7 0 C-N-CA 119.509 -0.876 . . . . 0.0 113.223 -173.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -63.41 130.52 44.81 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.341 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 61.6 m . . . . . 0 C--N 1.301 -1.508 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 179.405 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.925 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -83.75 117.92 23.56 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.43 -61.57 2.35 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 124.219 1.008 . . . . 0.0 110.618 -169.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -126.17 -58.41 1.37 Allowed 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -163.2 177.63 8.89 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 175.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.43 ' HE2' ' O ' ' A' ' 22' ' ' ALA . 68.1 t80 -82.8 85.42 7.09 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 65.91 -99.43 0.06 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.618 1.567 . . . . 0.0 108.881 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -146.9 77.93 1.48 Allowed 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 169.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.28 153.17 20.75 Favored Glycine 0 N--CA 1.417 -2.632 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -71.58 -39.29 70.68 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 176.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -161.18 136.0 7.4 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.693 1.997 . . . . 0.0 105.854 171.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.43 ' O ' ' HE2' ' A' ' 16' ' ' TYR . . . -153.21 90.02 1.4 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.566 ' CE3' HG23 ' A' ' 41' ' ' THR . 11.3 m95 -115.36 -167.73 1.29 Allowed 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.632 -174.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.495 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 50.8 mmtt -85.15 -171.91 3.89 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.421 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 2.0 m-20 -82.26 -29.85 31.0 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.453 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 71.9 m -127.21 141.99 51.6 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.173 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 79' ' ' THR . 11.0 tt -119.17 133.06 67.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.6 mm -123.56 111.92 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -95.48 125.99 40.46 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.577 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -94.76 113.75 25.56 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.452 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 11.3 m-85 -95.37 136.28 35.93 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 37' ' ' ASN . 11.5 tmtt? -155.31 128.38 8.19 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 -173.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.8 29.8 18.1 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.79 -0.63 76.99 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 114.588 0.595 . . . . 0.0 114.588 174.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -140.7 161.19 38.36 Favored 'General case' 0 CA--C 1.486 -1.515 0 CA-C-N 117.993 0.896 . . . . 0.0 109.045 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 9.2 p -70.68 110.63 3.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 122.599 1.19 . . . . 0.0 107.824 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 27.1 t-20 -87.15 -50.96 6.27 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.439 -174.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -128.97 155.32 45.54 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.202 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -119.14 119.04 59.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -120.25 167.83 11.87 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.566 HG23 ' CE3' ' A' ' 23' ' ' TRP . 4.3 t -154.55 147.33 24.36 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.11 160.74 43.08 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -82.06 162.34 22.6 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.794 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.421 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 6.5 ptt85 -60.86 113.48 2.53 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.297 174.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.589 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 32.1 m-80 73.46 67.79 0.11 Allowed 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 126.489 1.916 . . . . 0.0 109.102 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -147.38 130.02 15.99 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.069 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 43.0 tt0 -97.62 116.84 30.62 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.501 0.667 . . . . 0.0 109.868 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.0 pt -98.26 -178.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 3.0 m -137.06 136.22 38.19 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 92.1 mt -128.01 107.96 17.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 56.8 34.78 25.27 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 74.7 14.56 3.37 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 127.015 2.126 . . . . 0.0 112.719 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -102.64 110.31 22.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 172.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -78.67 145.31 34.66 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.72 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -137.23 118.99 18.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.663 -173.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 69.2 t80 -89.89 118.71 29.67 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.2 t -94.11 117.97 38.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -71.98 168.29 18.34 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.589 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 13.5 pt-20 -64.38 -15.48 60.55 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.653 1.181 . . . . 0.0 113.663 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.13 6.18 43.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.8 m 69.48 36.55 2.2 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.595 1.158 . . . . 0.0 112.127 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -122.39 124.3 26.85 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 113.632 -1.622 . . . . 0.0 107.52 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.72 153.62 17.57 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.218 2.612 . . . . 0.0 115.047 -176.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -136.39 131.45 18.51 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.174 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.07 161.69 88.06 Favored 'Cis proline' 0 C--N 1.322 -0.843 0 C-N-CA 122.526 -1.864 . . . . 0.0 111.513 -3.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.3 t -78.92 -36.68 19.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.373 0.606 . . . . 0.0 110.125 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.29 126.74 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 121.614 0.721 . . . . 0.0 110.782 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.62 170.7 10.07 Favored Pre-proline 0 C--N 1.305 -1.336 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.017 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -69.3 -9.48 26.39 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.551 2.167 . . . . 0.0 112.456 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.69 -11.07 54.66 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.463 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 71' ' ' ARG . 11.5 tpt180 76.16 22.58 1.35 Allowed 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 126.375 1.87 . . . . 0.0 107.925 -172.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.4 m -67.45 134.68 51.83 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.379 -1.282 . . . . 0.0 107.657 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -92.93 116.74 34.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 126.002 1.721 . . . . 0.0 108.796 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 mp -96.84 122.55 39.93 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.117 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.9 m -114.36 118.7 34.59 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.27 134.99 11.55 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 119.933 -1.127 . . . . 0.0 112.551 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -141.35 168.37 19.94 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -72.6 139.98 47.75 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.428 HG22 HD11 ' A' ' 27' ' ' ILE . 1.7 m -71.93 -15.71 62.09 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.798 0.808 . . . . 0.0 109.709 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . 0.276 0.7 OUTLIER -56.82 -32.64 65.93 Favored 'General case' 0 N--CA 1.414 -2.244 0 C-N-CA 126.399 1.88 . . . . 0.0 111.015 179.01 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.69 19.41 20.52 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.1 0.952 . . . . 0.0 109.851 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -141.74 -174.72 4.14 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.236 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 58.01 9.27 0.89 Allowed 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 125.781 1.632 . . . . 0.0 115.356 171.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -77.43 64.86 2.87 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.8 t70 42.68 56.03 4.03 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 127.175 2.19 . . . . 0.0 108.867 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -133.41 116.89 16.59 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 112.757 -2.019 . . . . 0.0 110.852 -171.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -101.84 154.27 19.08 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.0 m -81.82 90.55 6.41 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.32 0.581 . . . . 0.0 110.412 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 67.3 m . . . . . 0 C--O 1.25 1.114 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.159 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 37' ' ' ASN . . . . . . . . 0 CA--C 1.498 -0.982 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.484 ' HD3' ' O ' ' A' ' 39' ' ' ILE . 67.8 ttt180 79.44 85.47 0.06 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 125.625 1.57 . . . . 0.0 112.771 -177.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -96.6 109.22 21.87 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 172.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -64.85 -59.16 4.51 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.604 0.716 . . . . 0.0 110.383 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.5 mt -151.19 176.7 10.95 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -80.82 83.95 6.45 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 172.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.446 ' CE2' ' HG2' ' A' ' 87' ' ' GLU . 38.6 p90 -96.64 99.37 10.99 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.225 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -92.57 103.8 16.16 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -157.66 -171.17 23.32 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 119.558 -1.306 . . . . 0.0 111.838 -176.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -95.13 148.74 22.05 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.59 ' HG3' ' O ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -70.85 118.9 14.22 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.911 0.862 . . . . 0.0 111.686 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.24 77.94 1.5 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 174.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.467 ' CE3' HG23 ' A' ' 41' ' ' THR . 14.3 m0 -94.89 -165.52 1.32 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 113.235 -1.802 . . . . 0.0 109.876 -175.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -88.51 -170.75 3.06 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -77.96 -29.87 50.05 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.075 0.941 . . . . 0.0 111.116 -171.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.2 m -124.55 143.22 50.8 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.709 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.5 tt -117.89 133.05 65.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.8 mm -126.45 114.24 37.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -172.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -98.92 135.14 40.78 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -103.8 112.88 26.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.478 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 33.7 m-85 -96.45 147.88 23.38 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 124.367 1.067 . . . . 0.0 110.016 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -144.9 120.0 10.09 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 60.9 30.6 19.73 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.57 -13.37 64.21 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.851 -0.69 . . . . 0.0 114.449 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -123.59 159.07 30.02 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.2 p -73.23 135.21 28.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-O 121.72 0.771 . . . . 0.0 111.604 -175.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.465 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 16.1 t-20 -111.4 -62.68 1.51 Allowed 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 125.016 1.326 . . . . 0.0 112.537 -174.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -121.61 167.32 13.03 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 122.764 0.426 . . . . 0.0 111.041 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.484 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 1.7 mp -131.71 135.88 58.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 125.118 1.367 . . . . 0.0 108.426 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -141.79 163.83 31.84 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.467 HG23 ' CE3' ' A' ' 23' ' ' TRP . 1.7 t -149.14 139.53 22.41 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.72 163.77 31.71 Favored 'General case' 0 C--N 1.311 -1.068 0 O-C-N 124.003 0.815 . . . . 0.0 109.272 -173.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -77.56 159.73 29.08 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 120.467 -0.493 . . . . 0.0 109.836 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -67.75 116.37 8.36 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 120.924 0.392 . . . . 0.0 110.029 173.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.571 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 26.3 m-80 75.36 67.63 0.07 Allowed 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 126.901 2.08 . . . . 0.0 109.332 -174.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -149.68 134.57 17.86 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.609 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 44.3 tt0 -101.19 119.46 38.79 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-O 121.839 0.828 . . . . 0.0 110.209 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.5 pt -100.01 179.27 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.789 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 m -136.9 134.25 36.62 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 95.2 mt -124.88 106.63 16.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 59.05 34.9 23.71 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.119 0.961 . . . . 0.0 111.193 176.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.26 42.9 mm-40 67.39 21.19 9.79 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.625 1.57 . . . . 0.0 113.523 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -104.2 111.28 23.82 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 169.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -81.45 133.64 35.43 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.649 0.737 . . . . 0.0 109.241 -176.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.1 t -127.38 119.12 51.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.744 -173.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 79.4 t80 -92.89 121.52 34.33 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.9 t -94.01 114.62 31.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -69.03 165.03 21.04 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.571 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 9.1 pt-20 -70.14 -7.81 44.66 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 123.768 0.827 . . . . 0.0 112.428 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.41 -2.37 52.9 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 79.1 m 69.35 32.81 3.4 Favored 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.917 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -122.05 128.37 25.56 Favored Pre-proline 0 C--N 1.293 -1.85 0 CA-C-N 113.027 -1.897 . . . . 0.0 106.708 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -85.01 156.07 11.35 Favored 'Trans proline' 0 C--N 1.329 -0.447 0 C-N-CA 123.267 2.645 . . . . 0.0 115.4 -175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -135.17 131.32 19.66 Favored Pre-proline 0 N--CA 1.441 -0.906 0 C-N-CA 124.678 1.191 . . . . 0.0 111.571 172.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.5 169.7 70.17 Favored 'Cis proline' 0 C--N 1.322 -0.82 0 C-N-CA 122.435 -1.902 . . . . 0.0 112.306 -1.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.8 t -86.79 -42.17 15.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.093 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.424 HG12 ' NH2' ' A' ' 71' ' ' ARG . 1.7 mp -98.3 128.02 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.71 0.767 . . . . 0.0 110.49 173.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.6 mt -88.41 169.11 14.31 Favored Pre-proline 0 C--N 1.306 -1.298 0 CA-C-N 114.297 -1.319 . . . . 0.0 108.243 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.35 -9.18 25.34 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.281 1.988 . . . . 0.0 110.904 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -88.7 1.2 55.54 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.687 -1.597 . . . . 0.0 109.492 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.424 ' NH2' HG12 ' A' ' 67' ' ' ILE . 8.3 tpm_? 74.93 9.43 4.0 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 125.253 1.421 . . . . 0.0 109.671 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 67' ' ' ILE . 0.9 OUTLIER -70.86 138.15 50.0 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.703 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.3 t -92.1 124.07 44.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 125.614 1.566 . . . . 0.0 109.479 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.6 mp -100.23 122.74 43.51 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.959 0.885 . . . . 0.0 110.307 172.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 52.3 m -118.03 117.74 30.04 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -118.07 152.28 17.6 Favored Glycine 0 N--CA 1.422 -2.279 0 C-N-CA 119.395 -1.383 . . . . 0.0 111.38 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -155.84 177.13 11.75 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -79.65 139.2 37.49 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 m -72.11 -10.9 60.4 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.568 0.699 . . . . 0.0 110.409 -178.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.4 p -69.09 -22.93 63.97 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.425 0.631 . . . . 0.0 111.034 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.36 17.14 24.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 122.07 0.938 . . . . 0.0 109.909 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -145.1 -169.3 3.16 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.955 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.59 ' O ' ' HG3' ' A' ' 21' ' ' MET 0.284 . . 60.49 87.55 0.09 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 126.084 1.754 . . . . 0.0 114.459 175.817 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -151.47 29.88 0.61 Allowed 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 110.566 -3.015 . . . . 0.0 102.954 173.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.16 154.42 27.3 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 111.857 -2.429 . . . . 0.0 113.13 -175.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -97.79 74.41 2.35 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.327 -172.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.446 ' HG2' ' CE2' ' A' ' 17' ' ' PHE . 3.2 mp0 -96.16 -43.49 7.71 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.0 m -82.02 81.17 8.07 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 3.8 p . . . . . 0 C--N 1.307 -1.266 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.814 -175.616 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.8 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -71.36 -28.99 64.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.608 0.718 . . . . 0.0 110.371 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -170.73 96.5 0.22 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 102.792 -3.04 . . . . 0.0 102.792 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -120.3 167.7 12.03 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.49 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.6 mt -87.2 168.32 13.33 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 123.889 0.743 . . . . 0.0 110.504 -174.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.429 ' HE1' ' SD ' ' A' ' 21' ' ' MET . 83.6 t80 -78.2 81.53 4.57 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 171.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -86.04 -45.28 11.57 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.539 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -101.11 150.49 22.88 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.308 -174.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.75 -39.25 93.57 Favored Glycine 0 C--N 1.331 0.263 0 O-C-N 124.247 0.967 . . . . 0.0 111.481 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.3 m170 -97.37 87.9 4.27 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.429 ' SD ' ' HE1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -65.45 147.76 52.88 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.056 175.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.48 90.94 2.93 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.186 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.417 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.5 m0 -93.43 -171.63 2.69 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.41 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . 11.2 mmpt? -88.55 -170.58 2.99 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 121.923 -0.485 . . . . 0.0 110.759 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -29.18 54.7 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.091 0.472 . . . . 0.0 112.013 -175.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 68.1 m -122.34 144.81 48.79 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.884 0.85 . . . . 0.0 110.766 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 79' ' ' THR . 8.6 tt -119.48 133.66 65.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.4 mm -119.01 133.07 67.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -174.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -117.23 132.56 56.6 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -174.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -94.6 112.98 24.74 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.442 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 23.2 m-85 -95.54 110.82 22.84 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.45 ' HB3' ' HB2' ' A' ' 37' ' ' ASN . 11.8 tmtt? -121.07 126.32 49.54 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 -175.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 61.04 29.59 19.05 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 124.913 1.285 . . . . 0.0 111.765 -175.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.71 -10.0 76.02 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 114.646 0.618 . . . . 0.0 114.646 177.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -123.73 155.12 38.45 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.7 p -73.12 110.29 6.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-O 122.524 1.154 . . . . 0.0 109.53 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.45 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 4.6 t-20 -88.19 -57.54 2.89 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.801 -173.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -121.09 159.88 24.82 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.876 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.6 tp -122.73 155.85 28.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -151.02 167.88 26.3 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.417 HG21 ' CE3' ' A' ' 23' ' ' TRP . 2.0 t -149.63 146.82 27.49 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.374 0.606 . . . . 0.0 110.029 177.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.85 158.87 44.25 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -80.99 158.82 25.04 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 59' ' ' GLU . 6.8 ptt85 -61.58 114.42 3.25 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 171.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.427 HD22 ' HB3' ' A' ' 59' ' ' GLU . 9.4 m-80 76.52 67.15 0.06 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 127.112 2.165 . . . . 0.0 108.914 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -146.72 128.5 15.29 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.561 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 44.5 mp0 -89.86 109.93 20.9 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.368 0.604 . . . . 0.0 109.696 176.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.9 pt -96.7 -178.97 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.9 m -133.24 130.68 39.34 Favored 'General case' 0 N--CA 1.403 -2.789 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 174.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.7 mt -122.75 101.82 10.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 61.14 36.96 17.95 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.947 0.879 . . . . 0.0 111.251 172.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 70.64 18.94 6.25 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 113.751 -1.568 . . . . 0.0 113.798 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -112.52 107.66 16.48 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 172.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.467 ' C ' ' HE2' ' A' ' 54' ' ' LYS 0.31 0.0 OUTLIER -78.78 152.92 31.16 Favored 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 117.654 -1.618 . . . . 0.0 111.81 -179.534 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 91.8 t -142.72 129.83 18.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.299 -170.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -100.34 120.8 40.5 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 66.2 t -98.32 117.68 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -71.76 167.65 19.47 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 124.586 1.179 . . . . 0.0 109.336 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.437 ' HA ' ' HB2' ' A' ' 44' ' ' ARG . 9.5 pt-20 -58.65 -20.8 51.05 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 126.0 1.72 . . . . 0.0 114.851 -174.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.56 19.89 18.16 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 120.953 0.406 . . . . 0.0 109.965 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.9 m 62.33 69.97 0.59 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.403 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -148.0 121.79 4.84 Favored Pre-proline 0 N--CA 1.439 -0.997 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.443 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 48.7 Cg_endo -87.73 142.74 5.9 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.564 2.843 . . . . 0.0 114.912 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -131.79 134.61 25.56 Favored Pre-proline 0 C--N 1.309 -1.165 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.491 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.01 158.08 96.84 Favored 'Cis proline' 0 C--N 1.332 -0.342 0 C-N-CA 122.572 -1.845 . . . . 0.0 112.831 0.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.14 -40.13 21.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.362 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.9 mm -98.76 124.17 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.926 -1.109 . . . . 0.0 109.39 175.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 mt -85.61 168.24 20.88 Favored Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.644 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -68.64 -11.96 33.35 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.126 1.884 . . . . 0.0 111.177 -176.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -91.98 10.82 27.37 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.155 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 68.62 9.59 7.4 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.473 1.909 . . . . 0.0 111.45 172.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.9 m -82.21 150.7 27.21 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.825 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.3 t -91.29 131.0 39.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 126.436 1.894 . . . . 0.0 109.751 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.94 123.56 48.17 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.09 0.948 . . . . 0.0 111.03 173.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.4 t -107.62 147.09 31.11 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.443 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -130.58 140.35 11.69 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -152.86 175.75 12.57 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -86.21 132.78 33.93 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.419 HG21 HD13 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -67.52 -21.96 65.46 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.278 0.561 . . . . 0.0 111.503 -175.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.4 p -65.95 -26.81 67.75 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.916 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.33 21.13 17.46 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.822 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -132.0 -69.46 0.6 Allowed 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -174.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.62 ' HB2' ' OD1' ' A' ' 85' ' ' ASP . . . -81.22 -6.77 59.23 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.548 -174.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.9 t70 72.28 22.63 3.48 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.897 1.679 . . . . 0.0 110.391 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.62 ' OD1' ' HB2' ' A' ' 83' ' ' ALA . 3.6 m-20 -58.9 156.41 11.5 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 114.385 -1.279 . . . . 0.0 108.073 174.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -82.12 75.8 9.03 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 59.74 37.93 21.89 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.901 2.081 . . . . 0.0 109.958 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.0 m 68.42 -76.71 0.05 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.972 1.709 . . . . 0.0 112.095 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.0 p . . . . . 0 C--N 1.305 -1.334 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -175.742 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.097 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 62.62 81.95 0.19 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.363 1.465 . . . . 0.0 112.161 -175.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -107.76 105.38 15.18 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 173.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -79.04 147.55 32.8 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.436 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.0 mt -77.3 158.26 30.3 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.562 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -85.21 78.92 9.72 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 122.052 0.929 . . . . 0.0 109.481 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -82.96 91.98 7.25 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.903 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.22 164.76 20.99 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.516 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.95 -80.75 0.79 Allowed Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -121.4 98.66 6.07 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.376 0.607 . . . . 0.0 110.546 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.3 ptp -115.65 100.07 7.78 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.297 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.47 103.49 14.39 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.636 0.731 . . . . 0.0 109.286 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.513 ' CE3' HG23 ' A' ' 41' ' ' THR . 17.9 m95 -93.29 -175.36 3.8 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.407 ' HB3' ' OD1' ' A' ' 43' ' ' ASN . 61.4 mttp -101.87 -171.35 1.96 Allowed 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.541 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.49 -27.49 58.81 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -173.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.8 m -126.28 142.56 51.48 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.022 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 79' ' ' THR . 12.7 tt -115.22 133.46 61.39 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.402 HD11 ' O ' ' A' ' 27' ' ' ILE . 34.9 mm -127.22 116.94 45.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -173.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.411 ' HB2' ' HB3' ' A' ' 75' ' ' SER . 95.9 mt-30 -105.75 139.12 40.82 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.759 -0.588 . . . . 0.0 110.358 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.471 ' HD2' HG23 ' A' ' 50' ' ' ILE . 24.1 mtp180 -95.82 115.74 27.87 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 121.528 -0.069 . . . . 0.0 110.971 175.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.486 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 29.2 m-85 -95.89 115.87 28.07 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.515 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 11.2 tppt? -142.01 114.4 8.32 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.323 -174.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.383 0.7 OUTLIER 61.43 52.69 3.66 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 112.996 -1.911 . . . . 0.0 116.124 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.8 -4.57 61.41 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 172.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -162.14 174.24 13.21 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-N 119.114 1.457 . . . . 0.0 107.981 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 3.3 p -77.13 115.76 19.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -94.78 -51.78 4.55 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.037 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -119.8 154.25 34.52 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.893 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -121.92 127.26 75.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -133.73 168.99 17.71 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.513 HG23 ' CE3' ' A' ' 23' ' ' TRP . 2.3 t -155.45 139.63 16.55 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.23 152.96 46.38 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.456 -174.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.407 ' OD1' ' HB3' ' A' ' 24' ' ' LYS . 82.2 m-20 -76.69 160.6 29.22 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 120.881 0.372 . . . . 0.0 110.562 175.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.523 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 4.0 ptt180 -60.56 115.59 3.72 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.895 172.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.424 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 82.9 m-20 73.62 65.01 0.09 Allowed 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.969 1.708 . . . . 0.0 109.678 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -145.74 137.46 25.17 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.26 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -107.75 109.5 21.09 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.733 0.778 . . . . 0.0 109.225 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.4 pt -90.59 -177.33 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.812 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.2 m -130.98 134.34 46.63 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.471 HG23 ' HD2' ' A' ' 30' ' ' ARG . 82.1 mt -128.95 110.31 20.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 51.79 38.04 22.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.07 0.938 . . . . 0.0 112.676 177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 69.12 29.05 4.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 113.337 -1.756 . . . . 0.0 112.829 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -118.35 116.82 27.52 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 169.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -82.12 140.9 33.54 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 118.494 -1.283 . . . . 0.0 109.7 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 69.2 t -132.22 125.99 55.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.837 -172.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -96.03 121.01 37.32 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.34 116.99 44.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -70.78 164.72 24.6 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 124.295 0.997 . . . . 0.0 108.374 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.523 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 9.3 pt-20 -62.76 -13.14 29.45 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.39 11.63 29.91 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.009 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.2 m 62.14 69.44 0.62 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.882 0.848 . . . . 0.0 111.937 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -152.01 124.87 4.08 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.49 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 64.0 Cg_endo -87.03 141.2 6.01 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.323 2.682 . . . . 0.0 114.226 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -126.48 129.22 24.18 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 174.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.16 159.68 92.72 Favored 'Cis proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.613 -1.828 . . . . 0.0 112.585 -0.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.8 t -78.94 -44.02 24.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.445 HG21 ' NH2' ' A' ' 71' ' ' ARG . 1.7 mp -94.7 123.69 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 121.597 0.713 . . . . 0.0 109.151 171.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.6 mt -83.19 169.51 17.36 Favored Pre-proline 0 C--N 1.299 -1.596 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.774 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -71.61 -2.51 11.47 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.498 2.132 . . . . 0.0 111.343 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.515 ' OD2' ' HE3' ' A' ' 32' ' ' LYS . 18.3 t70 -97.48 4.72 50.38 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.62 -1.627 . . . . 0.0 109.401 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.445 ' NH2' HG21 ' A' ' 67' ' ' ILE . 0.4 OUTLIER 66.14 21.26 11.16 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.111 1.364 . . . . 0.0 109.323 177.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.2 m -85.5 139.73 31.25 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -90.5 125.48 43.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 125.956 1.702 . . . . 0.0 108.409 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.8 mp -101.56 130.13 47.79 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 122.201 1.001 . . . . 0.0 111.214 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.411 ' HB3' ' HB2' ' A' ' 29' ' ' GLN . 37.6 t -106.02 121.34 43.91 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.49 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -117.69 131.98 9.65 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.293 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -150.12 172.97 14.43 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -80.8 135.44 35.96 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.427 HG21 HD13 ' A' ' 27' ' ' ILE . 2.4 m -70.61 -14.46 62.49 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 121.867 -0.521 . . . . 0.0 111.795 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.538 ' HA ' ' HB2' ' A' ' 84' ' ' ASP . 1.9 t -69.45 -28.93 66.53 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 122.27 1.033 . . . . 0.0 108.879 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.56 16.17 16.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.681 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -130.09 -80.52 0.55 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.172 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.83 -85.9 0.44 Allowed 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.538 ' HB2' ' HA ' ' A' ' 80' ' ' SER . 15.1 t70 62.15 13.93 6.2 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.54 1.136 . . . . 0.0 111.6 174.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -73.81 11.3 0.89 Allowed 'General case' 0 C--O 1.24 0.566 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -171.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -84.38 77.9 9.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 55.45 75.81 0.3 Allowed 'General case' 0 C--O 1.241 0.626 0 CA-C-N 113.503 -1.681 . . . . 0.0 111.28 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.0 m -75.52 100.51 4.56 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.066 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.8 t . . . . . 0 C--N 1.306 -1.291 0 N-CA-C 105.483 -2.044 . . . . 0.0 105.483 -179.372 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.649 ' HA2' ' OXT' ' A' ' 89' ' ' CYS . . . . . . . . 0 CA--C 1.497 -1.071 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -72.0 100.19 2.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.237 0.519 . . . . 0.0 111.41 -176.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 60.6 24.67 14.39 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.755 1.222 . . . . 0.0 112.745 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.588 ' O ' ' HB3' ' A' ' 17' ' ' PHE . 23.0 m120 -74.42 -34.86 63.36 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.445 ' C ' ' H ' ' A' ' 17' ' ' PHE . 87.3 mt 54.34 -157.16 0.2 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.938 1.295 . . . . 0.0 110.917 176.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -95.48 32.44 1.79 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 124.087 1.899 . . . . 0.0 108.747 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.588 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 52.8 t80 -81.89 -25.99 34.52 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 169.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.523 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -91.15 92.42 8.67 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 112.316 -2.22 . . . . 0.0 105.567 173.549 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -130.38 -109.83 1.34 Allowed Glycine 0 C--N 1.297 -1.621 0 N-CA-C 103.575 -3.81 . . . . 0.0 103.575 172.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -85.32 101.88 12.92 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 164.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.523 ' SD ' ' HA ' ' A' ' 18' ' ' GLN . 7.3 tpt -84.89 56.44 3.92 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.226 -166.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.15 88.7 5.99 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.392 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 12.4 m0 -75.73 -172.05 1.77 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.029 177.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.434 ' HB3' ' OD1' ' A' ' 43' ' ' ASN . 10.5 mmpt? -84.93 -174.57 5.34 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.886 0.374 . . . . 0.0 110.229 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.19 -38.38 75.34 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 74.2 m -123.78 145.28 49.15 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.717 -174.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.407 ' C ' HD11 ' A' ' 28' ' ' ILE . 9.8 tt -118.13 127.66 75.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.407 HD11 ' C ' ' A' ' 27' ' ' ILE . 1.6 mp -117.14 114.54 46.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.915 0.864 . . . . 0.0 110.094 -175.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -91.69 124.84 36.14 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.793 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.446 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 63.9 ttt180 -96.51 110.38 22.78 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . 83.1 m-85 -95.67 110.2 22.35 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.459 ' HE2' ' OD2' ' A' ' 70' ' ' ASP . 5.7 tmtt? -99.6 119.19 37.68 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 61.77 30.33 18.31 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 124.069 0.948 . . . . 0.0 112.1 -176.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.3 -12.67 66.48 Favored Glycine 0 N--CA 1.429 -1.778 0 CA-C-N 115.421 -0.809 . . . . 0.0 114.434 176.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -123.27 149.68 44.47 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-N 118.939 1.369 . . . . 0.0 108.738 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 9.0 p -68.37 115.59 6.94 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 CA-C-O 122.694 1.235 . . . . 0.0 112.782 -171.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -96.96 -55.56 2.83 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.918 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.446 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 16.3 m120 -120.12 153.37 36.27 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.477 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 mp -119.2 116.36 50.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.442 ' HH ' HG21 ' A' ' 50' ' ' ILE . 47.0 m-85 -118.72 166.78 12.35 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.0 t -146.84 139.86 25.32 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.2 161.2 38.21 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.165 -1.38 . . . . 0.0 107.771 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.434 ' OD1' ' HB3' ' A' ' 24' ' ' LYS . 90.5 m-20 -87.02 160.99 18.43 Favored 'General case' 0 C--N 1.284 -2.281 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.632 176.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.436 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 3.5 ptt85 -58.68 119.43 7.08 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.956 171.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.1 m120 68.33 64.36 0.35 Allowed 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 125.57 1.548 . . . . 0.0 108.643 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -144.58 133.29 22.3 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 113.755 -1.566 . . . . 0.0 108.403 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 36.4 tt0 -108.13 109.31 20.7 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.753 0.787 . . . . 0.0 109.766 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 32.0 pt -87.8 -178.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.214 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.8 m -136.4 135.63 38.9 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.442 HG21 ' HH ' ' A' ' 40' ' ' TYR . 96.9 mt -127.38 108.34 18.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 53.28 42.88 32.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.356 1.074 . . . . 0.0 112.201 177.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 72.72 8.91 5.6 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.766 2.026 . . . . 0.0 113.865 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -100.12 115.77 30.57 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.63 144.51 33.72 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.702 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.2 t -137.05 117.42 16.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.358 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 64.3 t80 -92.06 123.04 35.12 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.023 0.44 . . . . 0.0 110.841 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.0 t -97.46 123.39 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -76.03 173.87 10.72 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 124.611 1.194 . . . . 0.0 108.822 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.436 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 1.3 pm0 -71.51 -20.73 62.01 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -173.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.5 19.92 11.46 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.559 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.7 m 61.69 79.63 0.25 Allowed 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 124.639 1.212 . . . . 0.0 113.103 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -162.62 128.56 2.29 Favored Pre-proline 0 C--N 1.314 -0.936 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.471 ' CG ' ' HB3' ' A' ' 74' ' ' LEU . 42.6 Cg_endo -88.54 149.93 6.32 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.248 2.632 . . . . 0.0 114.604 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -135.86 134.07 20.34 Favored Pre-proline 0 CA--C 1.498 -1.053 0 C-N-CA 125.167 1.387 . . . . 0.0 110.265 173.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.35 163.63 84.22 Favored 'Cis proline' 0 C--N 1.317 -1.093 0 C-N-CA 122.633 -1.82 . . . . 0.0 112.219 0.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.0 t -82.47 -40.88 17.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.553 -174.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 72' ' ' SER . 1.7 mp -104.16 127.68 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-O 121.45 0.643 . . . . 0.0 110.034 172.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.0 mt -94.77 170.82 7.46 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.193 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -69.94 -12.5 32.67 Favored 'Trans proline' 0 N--CA 1.486 1.086 0 C-N-CA 122.669 2.246 . . . . 0.0 111.56 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.459 ' OD2' ' HE2' ' A' ' 32' ' ' LYS . 29.8 t70 -84.83 -0.22 53.18 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.778 -1.556 . . . . 0.0 108.646 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 59.72 37.79 22.04 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.461 1.904 . . . . 0.0 109.118 -177.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 67' ' ' ILE . 21.5 m -85.92 127.57 34.64 Favored 'General case' 0 N--CA 1.409 -2.485 0 CA-C-N 113.438 -1.71 . . . . 0.0 106.54 172.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.3 t -90.99 116.66 32.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 127.673 2.389 . . . . 0.0 106.748 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.471 ' HB3' ' CG ' ' A' ' 63' ' ' PRO . 6.6 mp -102.09 124.36 47.56 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 122.208 1.004 . . . . 0.0 113.44 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.5 m -117.93 129.11 55.42 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.679 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 27' ' ' ILE . . . -119.84 137.36 12.33 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.397 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -141.8 172.46 12.65 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -77.82 138.41 38.94 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.4 m -66.78 -21.21 66.06 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.418 ' C ' ' H ' ' A' ' 82' ' ' TYR . 8.7 t -71.57 -40.22 70.1 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -174.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.28 9.07 2.26 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.258 1.028 . . . . 0.0 113.296 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.418 ' H ' ' C ' ' A' ' 80' ' ' SER . 8.1 m-85 -125.92 -79.11 0.6 Allowed 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.038 -1.437 . . . . 0.0 109.873 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.41 -65.71 0.95 Allowed 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.691 -174.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.0 t70 66.77 -62.34 0.3 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.807 2.043 . . . . 0.0 107.746 -169.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -152.41 86.07 1.27 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 104.211 -2.514 . . . . 0.0 104.211 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.73 173.36 10.75 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.041 -173.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -117.7 -179.52 3.76 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 122.764 0.425 . . . . 0.0 111.42 -172.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.6 m -79.05 126.22 30.41 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.649 ' OXT' ' HA2' ' A' ' 11' ' ' GLY . 15.2 m . . . . . 0 C--O 1.257 1.454 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.224 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.59 83.89 6.76 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 174.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -114.19 103.05 10.72 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 112.884 -1.962 . . . . 0.0 112.026 -169.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -99.59 159.03 15.34 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.23 163.1 27.38 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -80.99 75.49 7.96 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.455 1.121 . . . . 0.0 109.547 -175.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -75.25 89.53 2.56 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.396 -1.729 . . . . 0.0 107.104 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.511 ' HA ' ' CE ' ' A' ' 21' ' ' MET . 53.5 tp60 -139.27 131.04 27.49 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 113.682 -1.599 . . . . 0.0 108.082 -174.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.06 30.8 13.25 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 119.67 -1.252 . . . . 0.0 111.207 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.6 t60 176.33 105.48 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.511 ' CE ' ' HA ' ' A' ' 18' ' ' GLN . 2.1 mpt? -144.63 178.54 7.9 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -155.3 76.9 0.99 Allowed 'General case' 0 C--N 1.31 -1.118 0 O-C-N 124.217 0.948 . . . . 0.0 109.317 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.492 ' CE3' HG21 ' A' ' 41' ' ' THR . 17.7 m95 -78.46 175.58 10.18 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.777 178.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.437 ' HD2' ' O ' ' A' ' 41' ' ' THR . 95.6 mttt -90.34 -172.57 3.5 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.155 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -74.55 -36.04 63.1 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.841 0.829 . . . . 0.0 111.858 -172.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.0 m -122.1 143.31 49.61 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.222 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.0 tt -115.79 133.05 63.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.0 mm -122.93 119.33 57.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -95.53 127.57 41.68 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -99.25 111.28 23.69 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.466 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 31.5 m-85 -95.83 113.65 25.3 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.486 0.66 . . . . 0.0 109.228 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.34 118.61 36.78 Favored 'General case' 0 N--CA 1.407 -2.61 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.258 45.2 m-20 61.33 30.83 19.26 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.01 -10.97 64.11 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 115.21 -0.905 . . . . 0.0 115.054 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -122.52 151.91 40.87 Favored 'General case' 0 CA--C 1.48 -1.733 0 CA-C-N 118.381 1.09 . . . . 0.0 108.258 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 7.7 p -70.23 110.1 3.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-O 122.493 1.14 . . . . 0.0 109.82 -177.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -85.64 -58.64 2.58 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.518 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -119.91 161.25 21.18 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.938 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.5 tp -115.48 151.04 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 N-CA-C 103.372 -2.825 . . . . 0.0 103.372 171.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.4 ' HH ' HG21 ' A' ' 50' ' ' ILE . 94.0 m-85 -147.06 166.11 27.86 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.492 HG21 ' CE3' ' A' ' 23' ' ' TRP . 2.1 t -151.99 142.74 22.88 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.13 149.73 44.83 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -75.71 156.97 34.19 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -57.13 121.51 10.21 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 121.206 0.526 . . . . 0.0 110.415 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.9 m120 70.32 63.1 0.22 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 112.957 -1.929 . . . . 0.0 108.677 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -141.83 131.68 24.35 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.54 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 33.8 tt0 -95.44 114.18 25.91 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.034 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.0 pt -96.65 -177.24 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.84 138.12 42.2 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 175.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.4 HG21 ' HH ' ' A' ' 40' ' ' TYR . 92.9 mt -129.61 106.96 14.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 50.73 49.37 21.09 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 70.86 1.61 3.83 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 125.042 1.337 . . . . 0.0 114.489 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -95.33 115.82 27.95 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 147.12 30.58 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 119.714 -0.794 . . . . 0.0 108.934 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 96.9 t -139.9 118.34 11.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.881 -174.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 80.4 t80 -93.21 119.41 32.36 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.0 t -98.36 120.87 48.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -73.24 168.51 18.99 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 124.647 1.217 . . . . 0.0 110.199 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -68.35 -8.02 36.4 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 125.771 1.628 . . . . 0.0 114.572 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.89 14.7 27.69 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.8 m 63.84 71.25 0.49 Allowed 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 124.415 1.072 . . . . 0.0 111.455 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -151.05 124.66 4.33 Favored Pre-proline 0 N--CA 1.435 -1.219 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.417 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 88.7 Cg_endo -84.89 143.04 9.22 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.112 2.541 . . . . 0.0 114.964 -177.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -129.63 127.4 22.95 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.038 170.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -81.87 163.49 76.77 Favored 'Cis proline' 0 C--N 1.319 -1.007 0 C-N-CA 122.876 -1.718 . . . . 0.0 112.26 -0.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.436 HG11 ' O ' ' A' ' 74' ' ' LEU . 85.0 t -81.53 -39.83 17.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.708 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.04 128.07 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 121.574 0.702 . . . . 0.0 109.483 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.2 mt -88.0 172.07 8.45 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.757 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -73.99 -13.32 23.88 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.295 1.997 . . . . 0.0 109.703 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -84.82 -6.6 59.35 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.115 -2.311 . . . . 0.0 108.349 177.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.387 12.3 ttm180 52.61 55.92 8.38 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 124.631 2.158 . . . . 0.0 112.224 -176.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.9 m -101.95 135.23 43.87 Favored 'General case' 0 N--CA 1.398 -3.048 0 CA-C-N 111.098 -2.774 . . . . 0.0 104.961 170.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -91.3 117.03 33.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 O-C-N 126.105 2.128 . . . . 0.0 108.395 -176.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.436 ' O ' HG11 ' A' ' 66' ' ' VAL . 5.6 mp -101.49 134.46 44.57 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 122.016 0.912 . . . . 0.0 111.703 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.8 m -120.77 137.12 54.68 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.834 175.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.417 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -129.01 133.67 7.68 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 119.659 -1.258 . . . . 0.0 113.021 -175.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -146.82 171.83 14.59 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -71.91 139.37 48.74 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.2 m -67.2 -18.04 65.08 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 123.093 0.557 . . . . 0.0 111.624 -176.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -69.21 -23.85 63.95 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.362 0.601 . . . . 0.0 111.719 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.6 20.61 15.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.752 0.786 . . . . 0.0 110.824 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -152.81 -161.33 1.27 Allowed 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 125.713 1.605 . . . . 0.0 108.816 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 70.69 136.93 0.04 OUTLIER 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 117.219 2.304 . . . . 0.0 117.219 168.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.4 86.18 1.51 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 111.881 -2.418 . . . . 0.0 105.777 165.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -127.79 155.19 44.47 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 174.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -81.24 89.4 6.04 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.77 0.795 . . . . 0.0 112.09 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -90.4 140.65 29.51 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.673 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.4 p -120.42 162.45 19.49 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.9 p . . . . . 0 C--N 1.304 -1.401 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.705 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.973 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 63.17 75.29 0.4 Allowed 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 123.054 1.407 . . . . 0.0 109.805 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -161.39 104.8 1.27 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 112.591 -2.095 . . . . 0.0 107.367 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -118.29 166.78 12.22 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.3 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -85.52 164.78 17.6 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -77.37 81.92 3.84 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.826 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 49.16 64.95 1.52 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 125.734 1.613 . . . . 0.0 111.746 175.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -76.58 101.7 5.8 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 113.952 -1.477 . . . . 0.0 109.131 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.4 93.89 1.02 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.254 47.7 m80 67.27 154.54 0.09 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 125.067 1.347 . . . . 0.0 114.619 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.41 107.18 8.49 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 113.682 -1.599 . . . . 0.0 110.63 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -105.4 91.62 3.85 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.441 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.5 m95 -112.33 -177.97 3.29 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.717 -174.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -88.95 -172.38 3.67 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.904 178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.413 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 2.8 m-20 -74.76 -34.34 62.48 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -174.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.5 m -121.49 140.87 51.63 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.942 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 79' ' ' THR . 9.7 tt -112.85 128.54 69.51 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -177.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.0 mm -113.39 120.57 63.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.421 ' HA ' HD13 ' A' ' 39' ' ' ILE . 43.5 mt-30 -100.77 116.68 33.23 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 114.236 -1.347 . . . . 0.0 107.678 -172.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -96.44 109.47 22.01 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.524 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 69.2 m-85 -96.14 144.19 26.6 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 37' ' ' ASN . 22.9 tptp -156.22 117.26 3.8 Favored 'General case' 0 N--CA 1.406 -2.653 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 62.44 37.84 13.23 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 125.739 1.615 . . . . 0.0 115.06 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.28 -9.01 64.95 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.342 -0.845 . . . . 0.0 115.208 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -134.87 160.81 37.05 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.899 -0.765 . . . . 0.0 108.996 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 9.6 p -75.87 110.72 11.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 13.9 t-20 -83.8 -45.18 13.58 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.308 -175.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -130.69 153.27 49.15 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.206 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 29' ' ' GLN . 7.8 tp -116.32 153.86 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 173.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -148.63 168.11 23.68 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.441 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.7 t -150.48 145.57 26.09 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.92 155.97 45.5 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -175.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -79.94 161.65 25.38 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.566 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.413 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 8.2 ptt180 -59.12 116.21 3.69 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.744 170.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 75.07 50.07 0.08 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.056 1.743 . . . . 0.0 110.728 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -130.57 134.56 47.11 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.526 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 44.1 tt0 -102.7 109.22 20.74 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.7 pt -90.64 -177.65 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.2 m -135.52 129.1 32.54 Favored 'General case' 0 N--CA 1.401 -2.897 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 173.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 67.5 mt -118.72 105.07 16.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 60.21 36.69 20.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.93 0.871 . . . . 0.0 111.605 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 69.88 17.07 7.64 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.159 1.783 . . . . 0.0 113.221 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -106.49 111.36 23.89 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.44 141.59 41.32 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.448 -177.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.0 t -135.42 114.5 16.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.738 -173.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 64.4 t80 -90.08 118.72 29.84 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.3 t -101.3 116.91 45.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -73.95 166.09 23.98 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.098 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -56.04 -21.4 21.41 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 126.861 2.064 . . . . 0.0 113.454 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.22 11.06 26.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.841 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.8 m 59.37 66.08 1.08 Allowed 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.264 1.03 . . . . 0.0 111.763 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.431 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 9.7 t-80 -149.79 124.91 4.83 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 175.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.431 ' HD2' ' CD2' ' A' ' 62' ' ' HIS . 64.6 Cg_endo -82.59 152.32 15.25 Favored 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 123.463 2.775 . . . . 0.0 114.972 -175.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -134.87 137.11 26.53 Favored Pre-proline 0 CA--C 1.493 -1.231 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.32 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -78.93 168.29 75.09 Favored 'Cis proline' 0 C--N 1.314 -1.287 0 C-N-CA 122.671 -1.804 . . . . 0.0 111.442 -3.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.4 t -86.5 -30.7 6.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.993 -173.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.5 mm -107.44 129.28 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.972 0.891 . . . . 0.0 110.625 175.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.1 mt -88.32 165.74 27.02 Favored Pre-proline 0 C--N 1.305 -1.331 0 CA-C-N 114.383 -1.28 . . . . 0.0 108.907 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -72.5 -4.57 15.53 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.77 2.313 . . . . 0.0 111.839 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -95.78 -1.96 48.67 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.309 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 71' ' ' ARG . 9.0 tpt180 71.7 13.64 6.21 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 126.514 1.926 . . . . 0.0 110.045 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.81 137.05 53.65 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 175.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 3.1 t -90.69 117.97 35.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 125.859 1.663 . . . . 0.0 109.044 -175.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.1 mp -97.29 139.43 33.26 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.06 173.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.6 m -138.93 154.07 48.3 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.2 146.08 17.57 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 118.829 -1.653 . . . . 0.0 111.852 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -141.76 171.78 13.59 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -80.98 134.86 35.77 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.406 HG21 HD13 ' A' ' 27' ' ' ILE . 1.7 m -70.83 -13.99 62.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.419 0.628 . . . . 0.0 110.556 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 p -66.29 -21.96 66.28 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.128 0.971 . . . . 0.0 111.449 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.48 13.69 28.13 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.285 1.041 . . . . 0.0 110.367 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -138.26 -166.74 2.04 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.363 -174.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 68.27 101.92 0.05 Allowed 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 126.557 1.943 . . . . 0.0 113.755 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -148.32 69.94 1.12 Allowed 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 101.961 -3.348 . . . . 0.0 101.961 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -150.33 169.56 21.1 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.758 -1.565 . . . . 0.0 108.766 -174.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -94.31 6.63 48.09 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 123.012 1.387 . . . . 0.0 112.072 -174.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -101.28 174.33 6.04 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.093 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.7 m -161.69 168.59 23.06 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 83.0 m . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 118.83 0.741 . . . . 0.0 109.406 -179.666 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.259 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -123.44 122.23 37.74 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 75.11 84.35 0.1 Allowed 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 125.956 1.702 . . . . 0.0 109.152 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -137.88 154.99 49.41 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.456 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 3.1 mm? -107.78 177.69 4.75 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -77.08 79.46 3.61 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.459 0.647 . . . . 0.0 109.322 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.456 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 80.1 m-85 -99.42 -66.35 0.91 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 175.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -97.83 73.57 2.3 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.76 0.05 12.07 Favored Glycine 0 N--CA 1.435 -1.41 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -83.39 129.54 35.0 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -81.3 76.28 8.24 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.935 1.35 . . . . 0.0 111.464 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.42 75.71 0.93 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 113.615 -1.63 . . . . 0.0 107.114 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.526 ' CE3' HG23 ' A' ' 41' ' ' THR . 11.0 m0 -106.82 -167.38 1.27 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.628 -1.624 . . . . 0.0 108.592 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -86.77 -170.6 3.14 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.165 0.507 . . . . 0.0 109.994 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.454 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 1.1 m-20 -78.57 -25.92 45.44 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.7 m -131.32 152.75 50.28 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.535 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.9 tt -125.08 133.86 68.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.4 mm -120.24 112.3 35.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -173.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -96.62 117.76 31.66 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -176.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -91.62 110.38 21.7 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.488 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 14.5 m-85 -96.18 144.44 26.4 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -134.56 112.07 10.57 Favored 'General case' 0 N--CA 1.401 -2.907 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.284 72.9 m-20 50.6 52.56 14.62 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.05 2.53 88.2 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 115.926 1.13 . . . . 0.0 115.926 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -131.79 154.71 48.82 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.0 p -78.56 131.92 33.43 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -178.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -109.9 -60.09 1.84 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.043 -1.036 . . . . 0.0 111.784 -173.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -127.96 159.94 33.4 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -123.01 130.57 74.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 124.106 0.962 . . . . 0.0 109.264 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -134.34 168.74 18.35 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.526 HG23 ' CE3' ' A' ' 23' ' ' TRP . 1.7 t -150.03 142.36 24.23 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.2 157.91 44.33 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.872 -172.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -81.36 160.21 24.18 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 176.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.454 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 6.8 ptt85 -67.92 108.92 3.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.444 0.64 . . . . 0.0 111.73 175.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.524 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 42.3 m-80 83.7 57.07 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.136 2.575 . . . . 0.0 110.087 -175.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -133.76 129.72 37.04 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.106 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 45.1 tt0 -99.18 108.87 21.57 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 pt -94.12 -176.62 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 6.1 m -133.72 136.28 44.55 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 95.0 mt -132.07 106.65 11.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.05 36.4 25.99 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 122.432 1.111 . . . . 0.0 111.256 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 70.5 16.01 7.1 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 112.687 -2.051 . . . . 0.0 113.994 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -103.64 118.18 36.12 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 172.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -82.14 144.62 30.62 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 118.385 -1.326 . . . . 0.0 108.666 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 88.9 t -135.19 122.35 35.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.609 -173.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 93.9 t80 -93.34 118.16 30.95 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.7 t -96.8 114.02 32.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -73.97 173.28 10.21 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.524 ' HB3' ' ND2' ' A' ' 45' ' ' ASN 0.262 10.3 pt-20 -74.38 0.67 13.74 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -173.32 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.17 12.24 37.95 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.6 m 69.18 33.06 3.44 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.545 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -111.65 117.39 48.88 Favored Pre-proline 0 C--N 1.291 -1.946 0 CA-C-N 113.45 -1.704 . . . . 0.0 108.398 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.513 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 40.8 Cg_endo -88.86 144.69 5.32 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.983 3.122 . . . . 0.0 114.861 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.408 ' HA ' ' C ' ' A' ' 65' ' ' PRO . 26.5 m-85 -130.06 134.76 26.51 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.044 173.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.408 ' C ' ' HA ' ' A' ' 64' ' ' TYR . 42.8 Cg_endo -74.87 157.15 99.77 Favored 'Cis proline' 0 CA--C 1.529 0.246 0 C-N-CA 123.045 -1.648 . . . . 0.0 113.307 0.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.9 t -82.1 -37.37 14.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 17.6 mm -103.18 118.61 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-O 122.008 0.909 . . . . 0.0 108.704 172.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.7 mt -82.36 170.32 15.21 Favored Pre-proline 0 C--N 1.293 -1.867 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.162 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -69.25 -13.06 35.31 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.437 2.092 . . . . 0.0 111.944 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -92.28 1.38 57.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 122.136 0.97 . . . . 0.0 108.42 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 63.7 29.77 14.89 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 124.288 1.995 . . . . 0.0 109.954 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.1 m -75.07 136.42 41.17 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-N 112.457 -2.156 . . . . 0.0 106.309 173.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 6.3 t -91.53 119.11 38.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 125.352 1.461 . . . . 0.0 108.614 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.2 mp -99.72 122.84 43.32 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 122.052 0.929 . . . . 0.0 111.427 175.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.8 m -111.2 123.83 50.98 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.513 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -115.38 124.18 6.21 Favored Glycine 0 N--CA 1.419 -2.443 0 C-N-CA 119.865 -1.16 . . . . 0.0 112.192 -175.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -139.07 172.89 12.17 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -81.65 137.0 35.5 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.01 -21.52 64.95 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 124.24 1.016 . . . . 0.0 112.18 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.8 p -64.84 -31.75 73.13 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.247 1.019 . . . . 0.0 110.881 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.42 16.69 23.71 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.649 0.738 . . . . 0.0 110.765 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -139.86 -165.19 1.84 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.819 -175.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 70.85 -65.07 0.35 Allowed 'General case' 0 C--N 1.347 0.468 0 C-N-CA 127.038 2.135 . . . . 0.0 111.101 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.47 -30.85 67.77 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -122.17 81.02 1.78 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.743 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -135.44 168.24 19.58 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.783 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -76.72 -23.13 53.09 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.163 0.985 . . . . 0.0 112.884 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.2 m -64.67 116.46 6.26 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 60.6 m . . . . . 0 N--CA 1.426 -1.641 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.212 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.915 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -134.79 -73.68 0.47 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.993 0.896 . . . . 0.0 112.318 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -88.83 -48.23 7.63 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 116.866 2.173 . . . . 0.0 116.866 -165.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.479 ' OD1' ' HB2' ' A' ' 17' ' ' PHE . 34.5 t-20 -109.25 -43.75 4.08 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 118.591 -1.243 . . . . 0.0 111.711 -170.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.6 mp 67.91 -167.41 0.2 Allowed 'General case' 0 C--O 1.247 0.97 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.851 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -76.16 96.77 3.95 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 118.08 -1.448 . . . . 0.0 107.45 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.479 ' HB2' ' OD1' ' A' ' 14' ' ' ASN . 80.8 t80 -69.27 106.38 2.86 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.625 174.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -95.5 131.91 41.17 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -156.3 -175.0 26.77 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -68.42 122.16 17.83 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 50.1 ttm -84.82 125.3 32.47 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.467 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.98 89.2 2.46 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.169 175.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.477 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.0 m0 -101.91 -162.67 0.95 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -89.23 -178.62 5.69 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.428 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 1.1 m-20 -71.12 -34.24 70.88 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.573 -175.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.8 m -121.07 143.14 49.23 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.063 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.416 ' O ' ' HA2' ' A' ' 76' ' ' GLY . 6.1 tt -113.69 133.32 60.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.8 mm -121.43 115.31 46.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -173.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -95.17 127.5 41.27 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -98.24 110.83 23.35 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.446 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 7.4 m-85 -94.86 110.76 22.6 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.63 110.28 22.41 Favored 'General case' 0 N--CA 1.411 -2.377 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.381 3.7 m-20 50.93 49.18 21.66 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.099 -1.864 . . . . 0.0 115.909 -172.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.3 -13.18 64.8 Favored Glycine 0 N--CA 1.435 -1.423 0 N-CA-C 116.474 1.35 . . . . 0.0 116.474 173.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -125.77 147.0 49.53 Favored 'General case' 0 CA--C 1.483 -1.624 0 CA-C-N 119.675 1.737 . . . . 0.0 108.959 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.61 110.89 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 O-C-N 124.51 1.131 . . . . 0.0 111.424 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -97.55 -52.71 3.68 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.354 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -121.74 161.76 22.02 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.718 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.7 mm -124.9 128.49 73.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 124.496 1.118 . . . . 0.0 109.118 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -135.14 169.51 17.34 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.477 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.8 t -153.68 144.01 22.3 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.8 152.61 40.59 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -74.16 164.11 27.02 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.592 177.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.432 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 3.4 ptt180 -62.88 116.56 5.38 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 171.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 84.9 m-20 74.4 50.08 0.1 Allowed 'General case' 0 C--O 1.242 0.695 0 C-N-CA 126.237 1.815 . . . . 0.0 110.744 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -128.59 131.34 48.15 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.671 -175.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 44.2 tt0 -101.98 114.62 28.9 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.53 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 pt -98.94 -176.75 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 124.25 1.02 . . . . 0.0 108.49 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.47 131.2 43.32 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 97.5 mt -127.62 106.52 15.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 54.19 43.02 31.23 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.958 0.885 . . . . 0.0 112.001 175.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 75.53 -1.51 3.0 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.14 2.176 . . . . 0.0 115.116 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -95.16 118.22 31.57 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.26 141.57 32.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 118.173 -1.411 . . . . 0.0 108.74 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 92.5 t -133.29 122.41 44.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.406 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -96.54 121.47 38.39 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.336 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 45' ' ' ASN . 90.8 t -100.23 118.78 47.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -68.07 163.7 21.83 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.979 1.712 . . . . 0.0 108.465 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.432 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 1.4 pm0 -66.15 -17.68 64.87 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -171.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.02 14.37 22.06 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.233 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.6 m 65.83 76.82 0.31 Allowed 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 124.64 1.213 . . . . 0.0 112.281 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -157.18 120.54 2.21 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.421 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 73.7 Cg_endo -82.54 143.9 12.41 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 123.391 2.727 . . . . 0.0 114.399 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -130.51 131.16 23.17 Favored Pre-proline 0 CA--C 1.489 -1.391 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.654 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -72.08 162.12 90.49 Favored 'Cis proline' 0 C--N 1.313 -1.301 0 C-N-CA 124.416 -1.077 . . . . 0.0 114.225 -1.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 65.6 t -89.34 -42.68 14.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.075 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mp -99.22 129.49 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.476 0.655 . . . . 0.0 109.533 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.0 mt -97.56 171.12 6.28 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.032 177.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -67.09 -13.78 41.04 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.986 2.457 . . . . 0.0 112.362 -176.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -85.35 -12.28 52.59 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.1 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 71' ' ' ARG . 16.2 tpt180 72.32 31.9 1.76 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-O 123.886 1.803 . . . . 0.0 107.261 -171.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -74.27 127.27 32.55 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -92.46 115.81 32.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 125.492 1.517 . . . . 0.0 108.062 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.404 ' HB3' ' CG ' ' A' ' 63' ' ' PRO . 5.8 mp -97.48 129.07 44.7 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 122.326 1.06 . . . . 0.0 111.805 177.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.1 m -121.9 137.38 54.81 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.421 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -131.72 150.38 19.52 Favored Glycine 0 CA--C 1.474 -2.52 0 C-N-CA 119.331 -1.414 . . . . 0.0 109.672 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.499 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 11.1 t0 -163.4 173.91 12.61 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 174.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -69.95 134.94 48.9 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 118.853 0.751 . . . . 0.0 109.718 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.2 m -65.27 -28.19 69.16 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-O 121.756 0.789 . . . . 0.0 110.857 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 85' ' ' ASP . 3.2 p -67.66 -29.47 68.77 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.679 -176.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.93 11.9 34.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 122.438 1.113 . . . . 0.0 111.199 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.499 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 6.5 m-85 -118.9 -83.15 0.65 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.465 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.87 1.54 52.16 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.939 0.876 . . . . 0.0 111.91 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.9 t70 69.09 39.14 1.8 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.363 -1.744 . . . . 0.0 108.986 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 80' ' ' SER . 13.7 t70 -58.76 116.41 3.72 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 166.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -90.9 78.09 6.08 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 116.801 -1.96 . . . . 0.0 114.207 -169.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -101.66 82.73 2.32 Favored 'General case' 0 N--CA 1.413 -2.289 0 C-N-CA 117.566 -1.653 . . . . 0.0 107.38 166.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.5 p -86.61 100.04 12.14 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 2.0 p . . . . . 0 C--N 1.309 -1.17 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.189 -176.882 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.8 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.451 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 10.6 ptm85 -162.6 178.27 8.69 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 176.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.93 147.31 25.7 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 122.055 0.931 . . . . 0.0 111.073 176.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -161.3 -50.38 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -112.22 157.83 20.42 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 167.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -93.83 79.01 4.18 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.096 -175.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 55.65 81.84 0.11 Allowed 'General case' 0 C--O 1.239 0.511 0 O-C-N 124.853 1.345 . . . . 0.0 110.076 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -131.87 149.16 52.53 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -174.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.27 -54.94 11.24 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.43 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -89.11 141.89 28.11 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.4 ptp -134.3 151.24 51.15 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -166.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.32 99.82 8.08 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.043 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.524 ' CE3' HG21 ' A' ' 41' ' ' THR . 18.6 m95 -110.65 167.6 10.1 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -77.96 -171.94 2.5 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.429 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 1.2 t70 -80.74 -31.38 36.0 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.205 1.002 . . . . 0.0 110.856 -172.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.4 m -120.44 146.63 46.03 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.239 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.446 HD12 HG21 ' A' ' 79' ' ' THR . 11.4 tt -118.01 133.46 64.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 75' ' ' SER . 28.3 mm -124.94 113.25 35.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -173.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.512 ' HB2' ' OG ' ' A' ' 75' ' ' SER . 82.2 mt-30 -96.01 133.22 40.5 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.723 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.489 HH11 ' ND2' ' A' ' 38' ' ' ASN . 27.3 ttt180 -98.87 110.97 23.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.472 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 59.8 m-85 -95.63 141.21 29.4 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -135.84 116.54 13.97 Favored 'General case' 0 N--CA 1.402 -2.838 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.6 t0 60.21 52.27 5.08 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.683 1.23 . . . . 0.0 113.042 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.57 -4.54 42.55 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 113.716 -1.584 . . . . 0.0 116.181 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -127.05 154.93 44.04 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 8.4 p -75.95 116.89 19.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 CA-C-O 122.295 1.045 . . . . 0.0 110.142 -176.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -93.0 -60.68 1.74 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.615 -174.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.489 ' ND2' HH11 ' A' ' 30' ' ' ARG . 97.6 m-20 -122.27 161.72 22.78 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.779 -176.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.451 ' O ' ' HD2' ' A' ' 12' ' ' ARG . 24.8 mm -121.17 137.32 55.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.889 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -142.2 164.52 29.93 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.524 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.6 t -152.66 144.49 23.62 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.24 150.14 45.15 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 123.506 0.504 . . . . 0.0 110.98 -173.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -75.12 156.0 36.47 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.481 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 6.8 ptt180 -60.61 109.82 1.13 Allowed 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 171.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 88.1 m-20 78.65 62.48 0.03 OUTLIER 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.254 1.822 . . . . 0.0 110.37 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -138.9 134.93 33.89 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.987 -178.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -91.84 118.95 31.19 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 172.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.7 pt -98.37 174.08 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.324 0 N-CA-C 105.609 -1.996 . . . . 0.0 105.609 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 m -136.3 117.88 14.88 Favored 'General case' 0 N--CA 1.404 -2.755 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 73.1 mt -108.17 102.04 13.41 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.662 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 58.81 40.27 23.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.387 0.613 . . . . 0.0 112.483 170.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 73.27 9.6 5.18 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.246 1.818 . . . . 0.0 113.803 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -104.42 106.19 16.6 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.05 141.36 33.26 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.534 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.0 t -132.79 119.46 37.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.518 -171.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -93.13 121.72 34.78 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.9 t -102.99 125.11 57.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 174.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -74.58 176.76 6.59 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 124.555 1.16 . . . . 0.0 108.657 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.481 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 9.8 pt-20 -65.44 -20.15 66.24 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.9 106.57 17.12 Favored 'General case' 0 N--CA 1.413 -2.318 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 170.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.4 m -40.42 89.45 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 127.578 2.351 . . . . 0.0 115.344 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -159.72 126.04 2.45 Favored Pre-proline 0 N--CA 1.438 -1.026 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.526 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 56.1 Cg_endo -85.76 146.68 9.34 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.888 2.392 . . . . 0.0 114.333 -175.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -131.02 126.23 21.54 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.513 172.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.95 164.11 75.47 Favored 'Cis proline' 0 C--N 1.323 -0.808 0 C-N-CA 122.742 -1.774 . . . . 0.0 113.173 -0.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.407 HG11 ' O ' ' A' ' 74' ' ' LEU . 92.6 t -82.59 -43.72 19.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.305 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.7 mm -91.89 124.48 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 172.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.2 mt -89.27 168.38 15.43 Favored Pre-proline 0 C--N 1.303 -1.445 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.449 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -73.95 -1.17 10.47 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 123.198 2.598 . . . . 0.0 111.703 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -95.77 -9.06 32.69 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.186 -1.824 . . . . 0.0 109.073 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 60.25 57.22 2.99 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 123.572 1.653 . . . . 0.0 108.2 -169.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 m -102.57 135.05 44.91 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 173.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.6 t -91.61 115.61 31.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 125.496 1.748 . . . . 0.0 107.783 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.407 ' O ' HG11 ' A' ' 66' ' ' VAL . 4.7 mp -101.04 135.82 41.87 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.426 -0.796 . . . . 0.0 111.758 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.512 ' OG ' ' HB2' ' A' ' 29' ' ' GLN . 81.1 p -117.36 142.76 46.71 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.526 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -128.68 132.99 7.46 Favored Glycine 0 CA--C 1.479 -2.173 0 C-N-CA 119.64 -1.267 . . . . 0.0 110.345 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -150.69 172.54 15.4 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -75.56 135.05 40.58 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.446 HG21 HD12 ' A' ' 27' ' ' ILE . 2.8 m -59.93 -19.91 54.45 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -175.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.8 p -66.94 -40.05 87.48 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.594 1.158 . . . . 0.0 110.947 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.24 11.29 6.78 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.397 1.094 . . . . 0.0 112.009 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -130.09 -72.25 0.58 Allowed 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.561 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.22 -60.8 1.56 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.036 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.5 t70 66.53 -66.5 0.18 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.347 1.459 . . . . 0.0 110.618 -174.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -169.24 78.11 0.11 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 102.606 -3.109 . . . . 0.0 102.606 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -73.75 104.44 4.66 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.178 -1.374 . . . . 0.0 113.472 -171.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -86.16 -8.99 57.43 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.348 -1.297 . . . . 0.0 109.18 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.7 m 60.35 -174.24 0.12 Allowed 'General case' 0 C--O 1.242 0.667 0 C-N-CA 125.014 1.326 . . . . 0.0 112.386 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.432 -1.331 0 N-CA-C 105.261 -2.125 . . . . 0.0 105.261 175.183 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.813 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.14 -47.93 4.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.468 1.134 . . . . 0.0 110.573 177.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 54.79 -76.81 0.01 OUTLIER 'General case' 0 C--O 1.241 0.629 0 C-N-CA 126.39 1.876 . . . . 0.0 115.5 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -112.02 162.29 15.53 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 122.902 1.334 . . . . 0.0 114.171 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.7 tp -152.53 174.97 13.26 Favored 'General case' 0 C--N 1.293 -1.863 1 N-CA-C 99.236 -4.357 . . . . 0.0 99.236 177.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -82.64 85.26 7.04 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 116.902 -1.919 . . . . 0.0 110.866 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -79.69 113.19 17.66 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 172.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -78.79 82.71 4.99 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 122.63 1.205 . . . . 0.0 112.297 -173.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -108.12 14.6 36.92 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 114.254 -1.339 . . . . 0.0 112.435 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 86.1 t60 70.24 147.13 0.07 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.539 1.136 . . . . 0.0 111.806 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -81.38 77.51 8.25 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.33 73.44 1.12 Allowed 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 171.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.483 ' CE3' HG23 ' A' ' 41' ' ' THR . 11.2 m95 -100.18 -176.82 3.34 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.21 -1.814 . . . . 0.0 108.422 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -84.59 -172.2 4.04 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.956 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -78.47 -27.39 46.29 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.956 0.884 . . . . 0.0 112.571 -171.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.8 m -124.29 148.54 47.34 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.611 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.43 ' O ' HD13 ' A' ' 28' ' ' ILE . 13.9 tt -120.79 133.62 66.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.43 HD13 ' O ' ' A' ' 27' ' ' ILE . 31.8 mm -128.75 112.29 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -173.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -97.45 131.67 43.88 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.582 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 46.3 ttt180 -97.13 114.17 25.82 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . 21.3 m-85 -95.78 109.26 21.59 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -96.99 115.7 27.9 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -175.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 59.69 30.6 20.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.53 -1.213 . . . . 0.0 112.879 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.75 -11.13 64.6 Favored Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 115.434 -0.803 . . . . 0.0 114.949 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -121.76 152.06 39.88 Favored 'General case' 0 CA--C 1.486 -1.502 0 CA-C-N 118.843 1.322 . . . . 0.0 108.674 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.501 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 9.5 p -73.61 120.54 22.76 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-O 121.656 0.741 . . . . 0.0 112.227 -172.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.68 -50.79 2.97 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.663 0.744 . . . . 0.0 110.483 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.582 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 8.2 m120 -119.22 151.87 37.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.914 -173.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 mp -120.06 122.59 68.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -126.18 167.32 15.58 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.483 HG23 ' CE3' ' A' ' 23' ' ' TRP . 1.4 t -153.45 142.31 21.12 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.73 154.19 43.22 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 124.232 0.958 . . . . 0.0 108.914 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -75.71 161.71 28.84 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.021 0.438 . . . . 0.0 111.045 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -66.14 116.79 7.6 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.454 0.645 . . . . 0.0 110.303 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.582 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 38.8 m-80 72.95 64.79 0.1 Allowed 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 126.826 2.05 . . . . 0.0 109.161 -172.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -142.23 131.16 23.02 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 33.9 tt0 -98.19 113.66 25.65 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.443 177.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.8 pt -94.3 -176.2 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.2 m -135.97 136.69 40.58 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 173.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.3 mt -127.64 108.49 18.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 54.46 40.49 31.84 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.781 0.801 . . . . 0.0 111.695 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.257 36.0 mm-40 70.23 12.91 7.68 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 126.03 1.732 . . . . 0.0 115.068 -178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -103.37 122.2 44.35 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 172.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.77 142.08 29.22 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 118.591 -1.243 . . . . 0.0 109.853 -178.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.1 t -133.29 124.62 49.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.571 -175.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 62.8 t80 -96.08 119.02 33.83 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.0 t -94.97 120.14 43.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -77.16 174.54 10.59 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.582 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 9.7 pt-20 -75.63 -6.27 49.56 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -172.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.66 11.18 36.3 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.816 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 80.3 m 66.2 55.26 0.89 Allowed 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.377 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -136.74 122.59 13.35 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -81.71 146.51 14.98 Favored 'Trans proline' 0 C--N 1.328 -0.512 0 C-N-CA 123.436 2.757 . . . . 0.0 114.098 -177.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -129.84 134.84 26.64 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.651 172.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.87 161.35 79.03 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.158 -2.017 . . . . 0.0 111.495 -2.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.4 t -79.15 -29.78 13.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.274 -176.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.3 mm -103.96 121.83 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-O 121.773 0.797 . . . . 0.0 110.265 173.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.3 mt -85.75 165.57 34.32 Favored Pre-proline 0 C--N 1.3 -1.58 0 CA-C-N 113.899 -1.501 . . . . 0.0 109.135 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.47 -18.11 54.23 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.723 2.282 . . . . 0.0 112.737 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -87.19 -0.18 56.3 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.231 -1.349 . . . . 0.0 109.598 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 64.48 58.33 1.07 Allowed 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 124.725 2.202 . . . . 0.0 108.823 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.1 m -115.29 135.08 54.52 Favored 'General case' 0 N--CA 1.403 -2.821 0 CA-C-N 111.95 -2.386 . . . . 0.0 106.331 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.2 t -91.13 123.8 43.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 127.197 2.199 . . . . 0.0 107.792 -176.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mp -100.72 122.28 43.09 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.922 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.8 t -101.85 118.63 37.33 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -125.66 139.84 11.8 Favored Glycine 0 N--CA 1.424 -2.159 0 C-N-CA 119.015 -1.564 . . . . 0.0 111.647 -177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -159.57 177.39 10.96 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -73.47 139.88 46.08 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.425 HG21 HD13 ' A' ' 27' ' ' ILE . 1.3 m -67.66 -10.55 53.32 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.643 0.735 . . . . 0.0 111.535 -177.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.9 t -67.53 -40.24 85.07 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.46 14.69 12.35 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.486 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -143.5 -170.11 3.22 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.059 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 58.36 92.33 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 125.051 1.34 . . . . 0.0 112.01 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.9 t70 76.11 -43.4 0.47 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 112.986 -1.915 . . . . 0.0 111.139 -174.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -96.49 142.42 28.6 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -116.79 96.31 5.42 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 120.922 0.391 . . . . 0.0 111.123 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -129.65 -179.25 5.07 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.131 0.972 . . . . 0.0 109.911 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.8 t -133.96 -55.52 0.87 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.437 -1.107 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 178.026 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.863 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -90.38 125.35 35.51 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -102.96 -43.33 5.55 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -148.16 -71.1 0.21 Allowed 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.763 0.792 . . . . 0.0 110.36 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.49 ' HG ' ' H ' ' A' ' 16' ' ' TYR 0.26 23.5 tp -179.37 -168.42 0.12 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 -168.652 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.49 ' H ' ' HG ' ' A' ' 15' ' ' LEU . 35.5 t80 -77.0 80.87 3.53 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 168.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -103.53 -23.21 13.52 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.335 -1.757 . . . . 0.0 112.447 -171.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -64.81 134.13 53.45 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.438 0.637 . . . . 0.0 112.059 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.09 -90.19 0.97 Allowed Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -150.9 177.14 10.42 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 124.054 0.942 . . . . 0.0 108.579 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.0 tpt -77.87 79.3 4.34 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.98 90.81 4.76 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.862 0.839 . . . . 0.0 111.011 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.521 ' CE3' HG21 ' A' ' 41' ' ' THR . 16.7 m95 -97.41 -176.67 3.57 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.537 177.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.455 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 70.6 mmtt -91.96 -171.89 2.99 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.464 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -81.28 -33.99 32.32 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 122.069 0.937 . . . . 0.0 110.835 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 70.3 m -120.5 144.31 48.09 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.57 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.445 HD13 HG22 ' A' ' 79' ' ' THR . 14.7 tt -121.09 133.49 67.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-O 121.225 0.536 . . . . 0.0 109.952 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.07 112.77 41.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 122.564 1.173 . . . . 0.0 109.529 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.501 ' OE1' HG22 ' A' ' 36' ' ' VAL . 66.2 mm-40 -91.51 112.33 24.2 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 113.245 -1.798 . . . . 0.0 106.761 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -92.22 110.89 22.29 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.531 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 76.4 m-85 -94.69 128.75 41.58 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -138.7 127.11 23.05 Favored 'General case' 0 N--CA 1.407 -2.61 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 -175.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 61.61 31.1 18.81 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.89 10.73 83.67 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.857 -0.611 . . . . 0.0 114.228 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -141.78 159.73 41.62 Favored 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.501 HG22 ' OE1' ' A' ' 29' ' ' GLN . 7.7 p -77.68 110.77 13.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-O 122.1 0.952 . . . . 0.0 109.385 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -91.25 -48.48 6.9 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.118 0.961 . . . . 0.0 111.027 -174.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -123.26 152.83 40.95 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.694 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.2 mt -128.31 120.77 53.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.717 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -118.69 165.75 13.6 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.521 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.5 t -150.64 143.65 24.72 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.53 153.88 45.15 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.162 -174.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -78.71 160.29 27.54 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.746 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -56.81 118.38 4.86 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.58 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' A' ' 59' ' ' GLU 0.266 58.8 m-80 68.35 68.69 0.32 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.704 1.602 . . . . 0.0 110.488 -173.432 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -146.89 136.28 22.78 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.755 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 42.1 tt0 -104.83 120.38 41.27 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.336 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.7 pt -103.04 -177.54 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.2 m -137.87 139.57 39.95 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.2 mt -134.49 113.21 16.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 53.39 39.04 29.3 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.88 0.848 . . . . 0.0 111.938 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 69.61 17.62 7.82 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 125.494 1.518 . . . . 0.0 112.826 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -103.93 117.77 35.11 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 172.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.95 146.25 33.56 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.984 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.8 t -138.08 115.84 12.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.828 -174.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.437 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 90.7 t80 -94.57 127.11 40.3 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.157 0.503 . . . . 0.0 110.205 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 45' ' ' ASN . 60.8 t -104.25 122.01 56.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -78.7 175.24 10.62 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 123.639 0.587 . . . . 0.0 109.539 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.5 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -64.99 -21.9 66.92 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -171.524 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.75 12.15 28.9 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.664 -177.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 56.4 m 66.29 80.86 0.21 Allowed 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 124.032 0.833 . . . . 0.0 111.535 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -161.44 127.68 2.4 Favored Pre-proline 0 N--CA 1.442 -0.858 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.466 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 28.3 Cg_endo -92.19 149.9 3.1 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.069 2.513 . . . . 0.0 114.985 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -131.21 135.8 27.74 Favored Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.734 169.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -77.06 165.62 84.45 Favored 'Cis proline' 0 C--N 1.326 -0.641 0 C-N-CA 122.865 -1.723 . . . . 0.0 112.479 -1.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.44 HG11 ' O ' ' A' ' 74' ' ' LEU . 57.6 t -87.41 -47.98 15.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -176.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -92.02 121.3 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 121.883 0.849 . . . . 0.0 109.186 170.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.3 mt -85.31 164.78 39.4 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 114.247 -1.342 . . . . 0.0 108.274 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -70.33 -10.56 28.37 Favored 'Trans proline' 0 N--CA 1.483 0.909 0 C-N-CA 122.849 2.366 . . . . 0.0 111.658 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -84.89 -11.05 56.45 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.565 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.404 17.2 ttm180 65.69 58.69 0.78 Allowed 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 124.528 2.109 . . . . 0.0 111.813 -174.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.9 m -114.25 138.27 50.7 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 111.231 -2.713 . . . . 0.0 106.616 172.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -91.42 115.92 31.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 125.408 1.692 . . . . 0.0 107.993 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.44 ' O ' HG11 ' A' ' 66' ' ' VAL . 6.6 mp -99.89 122.76 43.32 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.975 0.893 . . . . 0.0 112.091 177.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.8 m -119.12 118.81 32.39 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.268 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.466 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -101.82 131.39 10.57 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -139.76 168.93 18.7 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -75.61 139.5 42.08 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.445 HG22 HD13 ' A' ' 27' ' ' ILE . 2.4 m -68.54 -20.38 64.55 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.244 0.545 . . . . 0.0 110.966 -177.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.4 t -58.73 -38.58 78.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.157 -177.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.72 21.26 8.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.392 0.615 . . . . 0.0 112.371 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -135.14 -66.23 0.59 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.13 -18.37 43.12 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.001 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.17 39.04 30.35 Favored 'General case' 0 N--CA 1.426 -1.643 0 O-C-N 124.922 1.389 . . . . 0.0 107.667 -175.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 89' ' ' CYS . 2.8 p30 -38.1 130.22 1.21 Allowed 'General case' 0 CA--C 1.507 -0.689 0 O-C-N 126.21 2.194 . . . . 0.0 113.203 -177.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -82.6 72.3 9.68 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.242 -1.345 . . . . 0.0 108.171 -174.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -107.16 -58.4 1.95 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 63.1 m -137.1 10.53 3.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.416 1.103 . . . . 0.0 108.27 173.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 85' ' ' ASP . 37.5 t . . . . . 0 C--O 1.246 0.903 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.709 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -83.72 93.91 8.03 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -134.26 166.76 22.06 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.903 -170.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -139.86 178.13 7.47 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.4 mt -107.76 178.74 4.43 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -84.08 77.65 9.9 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 62.41 -141.21 0.42 Allowed 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.719 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.89 117.32 17.49 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 103.215 -2.883 . . . . 0.0 103.215 174.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.49 68.27 1.21 Allowed Glycine 0 N--CA 1.437 -1.25 0 O-C-N 123.456 0.472 . . . . 0.0 113.199 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -64.37 131.93 48.64 Favored 'General case' 0 C--O 1.252 1.233 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 174.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . 0.267 1.3 pmm? -75.03 83.91 2.27 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 123.498 1.618 . . . . 0.0 114.098 -174.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -128.05 69.56 1.34 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 170.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.55 ' CE3' HG23 ' A' ' 41' ' ' THR . 10.7 m95 -115.1 -167.22 1.2 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 112.633 -2.076 . . . . 0.0 107.481 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.402 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 32.3 mmtp -96.14 -175.63 3.43 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 175.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.462 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 3.6 m-20 -75.24 -33.16 61.28 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.505 0.669 . . . . 0.0 112.592 -176.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.2 m -121.64 140.01 52.82 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.654 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.4 tt -113.36 131.72 64.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -177.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.7 mm -119.57 112.37 36.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-O 121.891 0.853 . . . . 0.0 108.732 -173.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -94.69 125.5 39.38 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.488 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.424 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 52.8 ttt180 -95.09 112.72 24.4 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.516 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 25.8 m-85 -95.69 110.87 22.94 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -136.33 125.03 23.81 Favored 'General case' 0 N--CA 1.397 -3.111 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 -174.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 63.96 33.92 11.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.813 1.292 . . . . 0.0 112.304 -173.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.97 -23.06 37.33 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 113.612 -1.631 . . . . 0.0 114.938 172.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -126.91 162.33 26.18 Favored 'General case' 0 CA--C 1.481 -1.702 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.23 110.43 3.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.846 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -84.99 -50.69 7.26 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.486 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.424 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 16.9 m120 -119.07 149.76 41.12 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.95 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.9 mp -116.51 116.33 51.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.445 ' HH ' HG21 ' A' ' 50' ' ' ILE . 79.9 m-85 -119.07 169.44 9.92 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.55 HG23 ' CE3' ' A' ' 23' ' ' TRP . 3.6 t -154.43 146.86 23.98 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.4 154.51 40.95 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -75.51 157.09 34.45 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.586 176.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.485 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 2.1 ptt180 -59.91 116.4 4.09 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 121.333 0.587 . . . . 0.0 109.986 170.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.6 m120 75.23 67.27 0.07 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.193 -1.822 . . . . 0.0 108.331 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -152.64 128.84 10.47 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.478 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 2.7 mp0 -86.85 135.89 33.16 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.004 173.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.7 pt -113.99 -179.99 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.12 132.09 37.68 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.445 HG21 ' HH ' ' A' ' 40' ' ' TYR . 86.5 mt -125.53 107.01 17.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 177.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 55.06 41.26 31.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.302 1.049 . . . . 0.0 112.65 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 71.51 6.87 5.87 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.943 2.097 . . . . 0.0 112.433 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -93.87 112.34 24.17 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 175.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -83.1 130.61 35.13 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 63.3 t -126.43 120.61 56.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.05 -173.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 56.8 t80 -94.5 121.99 36.62 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.4 t -97.25 125.07 50.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -78.67 175.28 10.56 Favored 'General case' 0 N--CA 1.439 -1.018 0 O-C-N 124.72 1.263 . . . . 0.0 108.002 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.485 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -74.12 -16.52 61.01 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -173.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.63 6.13 21.91 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.089 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 76.7 m 71.49 30.32 2.5 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 122.29 1.043 . . . . 0.0 113.319 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -114.54 124.07 31.22 Favored Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 113.736 -1.575 . . . . 0.0 107.898 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.446 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 60.3 Cg_endo -83.97 147.25 11.81 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 123.469 2.779 . . . . 0.0 114.549 -177.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -132.38 131.25 22.21 Favored Pre-proline 0 CA--C 1.493 -1.229 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.065 172.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -76.65 161.66 93.23 Favored 'Cis proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.644 -1.815 . . . . 0.0 112.948 -0.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 74' ' ' LEU . 57.3 t -82.98 -48.24 17.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.515 HG12 ' NH2' ' A' ' 71' ' ' ARG . 1.7 mp -96.38 122.6 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.261 172.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.434 ' C ' ' H ' ' A' ' 70' ' ' ASP . 54.0 mt -80.19 169.61 19.13 Favored Pre-proline 0 C--N 1.296 -1.76 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.101 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -76.04 5.64 4.36 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.99 2.46 . . . . 0.0 109.72 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 68' ' ' LEU . 27.5 t70 -99.93 -10.52 21.59 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 112.686 -2.052 . . . . 0.0 111.223 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.515 ' NH2' HG12 ' A' ' 67' ' ' ILE . 8.6 tpm_? 75.38 18.28 2.37 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.57 1.148 . . . . 0.0 110.243 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.4 m -82.6 140.52 33.17 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 170.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 7.7 t -90.85 124.76 43.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 126.336 1.854 . . . . 0.0 108.063 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.432 ' O ' HG11 ' A' ' 66' ' ' VAL . 5.4 mp -103.74 122.68 45.58 Favored 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.689 173.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.5 m -117.28 118.2 31.62 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.446 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -114.03 147.38 18.72 Favored Glycine 0 N--CA 1.419 -2.482 0 C-N-CA 118.84 -1.647 . . . . 0.0 110.546 -177.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -150.2 176.51 10.79 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.403 ' HB3' ' OG ' ' A' ' 80' ' ' SER . 52.5 m-85 -78.08 136.55 37.91 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.7 m -69.76 -19.11 63.53 Favored 'General case' 0 C--O 1.242 0.686 0 O-C-N 122.058 -0.401 . . . . 0.0 110.014 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.49 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 12.3 p -56.53 -33.16 65.79 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.33 1.452 . . . . 0.0 111.761 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.54 12.71 31.0 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.648 0.737 . . . . 0.0 112.511 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -122.92 -79.64 0.62 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.57 -13.31 23.04 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.807 0.813 . . . . 0.0 110.38 -177.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.49 ' HB3' ' HA ' ' A' ' 80' ' ' SER . 15.2 t70 -93.16 6.25 48.67 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 175.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -122.77 165.14 17.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.901 -1.5 . . . . 0.0 107.969 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -98.33 108.93 21.74 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -130.86 106.26 8.32 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 166.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.4 m 70.72 -63.32 0.42 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.868 1.267 . . . . 0.0 112.503 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 76.5 m . . . . . 0 C--O 1.251 1.181 0 C-N-CA 124.945 1.298 . . . . 0.0 112.941 -179.549 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.775 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -146.63 -41.08 0.2 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 62.15 -90.97 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.776 1.63 . . . . 0.0 112.44 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 173.46 -60.11 0.01 OUTLIER 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 126.963 2.105 . . . . 0.0 107.45 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.6 mt 70.92 176.46 0.28 Allowed 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.393 -1.276 . . . . 0.0 107.953 -174.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -92.42 80.18 4.92 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 116.515 -2.074 . . . . 0.0 111.443 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.556 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 87.9 m-85 -128.99 88.18 2.68 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 171.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -120.31 122.73 41.48 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -175.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.46 -55.68 0.49 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 107.227 -2.349 . . . . 0.0 107.227 -174.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -133.71 103.98 6.12 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.003 -1.098 . . . . 0.0 109.715 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.556 ' SD ' ' HB2' ' A' ' 17' ' ' PHE . 16.4 tpt -74.07 94.91 2.46 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 170.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.96 95.41 2.99 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.091 -173.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.595 ' CE3' HG23 ' A' ' 41' ' ' THR . 82.2 m95 -88.04 160.23 17.93 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.581 0.705 . . . . 0.0 110.198 175.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -87.0 -170.88 3.25 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.499 178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.523 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 21.2 m-20 -76.02 -28.87 57.92 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.707 0.765 . . . . 0.0 112.298 -174.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.8 m -127.18 147.11 50.2 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.421 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.404 ' O ' ' HA2' ' A' ' 76' ' ' GLY . 10.7 tt -118.42 133.35 65.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.9 mm -123.98 112.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -97.21 125.54 41.81 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -93.26 111.02 22.55 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . 34.7 m-85 -95.63 143.15 27.15 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 123.61 0.764 . . . . 0.0 110.453 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -148.87 120.65 8.1 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.262 79.4 m-20 58.7 36.06 24.73 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.03 -21.38 46.35 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 115.295 0.878 . . . . 0.0 115.295 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -119.08 165.32 14.29 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 118.512 1.156 . . . . 0.0 108.222 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 4.1 p -80.66 116.72 25.39 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-O 122.366 1.079 . . . . 0.0 110.392 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -84.31 -58.74 2.63 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.473 -175.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -121.93 157.67 30.73 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.246 0.546 . . . . 0.0 111.443 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.0 mm -116.35 136.17 54.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.506 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -142.73 164.3 30.49 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.595 HG23 ' CE3' ' A' ' 23' ' ' TRP . 1.6 t -152.15 142.61 22.6 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 176.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.12 155.52 46.95 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.495 -173.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -73.16 154.44 40.31 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.523 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 14.1 ptt180 -66.62 116.22 7.32 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 121.819 -0.551 . . . . 0.0 110.651 172.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.7 m120 76.95 67.33 0.05 Allowed 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 126.059 1.744 . . . . 0.0 108.62 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -146.27 131.25 18.21 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.521 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 42.2 tt0 -97.66 109.0 21.84 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.415 ' CG1' ' HB ' ' A' ' 55' ' ' VAL . 23.6 pt -92.53 -179.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 m -136.89 129.79 30.73 Favored 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 172.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.401 HD11 HD23 ' A' ' 74' ' ' LEU . 68.7 mt -119.43 110.23 28.86 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 57.51 39.37 27.94 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.879 0.847 . . . . 0.0 111.625 172.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 73.67 7.22 5.02 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.411 1.884 . . . . 0.0 113.312 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -102.42 119.57 39.04 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.0 153.38 27.47 Favored 'General case' 0 N--CA 1.435 -1.225 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.849 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.415 ' HB ' ' CG1' ' A' ' 48' ' ' ILE . 95.9 t -146.24 125.08 4.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.993 -175.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 77.7 t80 -98.66 118.9 36.41 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.9 t -97.98 118.08 43.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -81.28 170.86 15.53 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -65.75 -15.58 62.98 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -172.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.13 0.51 31.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.938 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 71.9 m 72.44 26.79 2.53 Favored 'General case' 0 CA--C 1.487 -1.449 0 C-N-CA 124.55 1.14 . . . . 0.0 112.625 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -113.22 121.19 38.54 Favored Pre-proline 0 C--N 1.287 -2.113 0 CA-C-N 112.9 -1.955 . . . . 0.0 108.306 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.504 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 45.7 Cg_endo -85.66 144.19 8.72 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 124.093 3.195 . . . . 0.0 115.26 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -129.58 134.07 25.8 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.729 172.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -79.05 153.52 89.8 Favored 'Cis proline' 0 C--N 1.323 -0.815 0 C-N-CA 122.67 -1.804 . . . . 0.0 112.603 1.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 74' ' ' LEU . 86.2 t -75.05 -35.39 34.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.82 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.0 mm -102.87 125.18 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.359 174.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.1 mt -84.68 165.46 37.55 Favored Pre-proline 0 C--N 1.29 -1.983 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.17 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -70.4 -8.85 24.59 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 C-N-CA 123.038 2.492 . . . . 0.0 112.167 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -88.61 -7.62 56.09 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.587 177.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 67.82 57.76 0.51 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 123.886 1.803 . . . . 0.0 108.817 -173.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.9 m -112.8 140.63 47.43 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-N 112.665 -2.061 . . . . 0.0 107.082 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.7 t -91.81 115.93 31.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 125.233 1.583 . . . . 0.0 108.696 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.43 ' O ' HG11 ' A' ' 66' ' ' VAL . 3.6 mp -96.24 122.68 39.36 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.049 174.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 64.9 m -117.82 117.46 29.36 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.504 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -120.82 137.8 12.25 Favored Glycine 0 N--CA 1.411 -2.993 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.963 -177.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.428 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 9.3 m-20 -145.56 173.73 11.79 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -72.58 138.43 46.83 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.509 HG23 ' CB ' ' A' ' 23' ' ' TRP . 1.8 m -68.84 -18.54 64.17 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.224 0.535 . . . . 0.0 111.802 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 p -63.02 -25.5 68.41 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.368 0.604 . . . . 0.0 111.523 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.71 20.2 18.34 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.026 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 77' ' ' ASP . 7.7 m-85 -144.25 -170.76 3.43 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.794 -174.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 76.16 110.21 0.07 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.764 2.025 . . . . 0.0 113.218 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -69.84 -38.5 76.54 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.074 -1.421 . . . . 0.0 110.061 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -100.42 87.29 3.36 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -92.22 144.12 25.73 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.367 -176.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -79.56 172.07 14.29 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.252 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 89' ' ' CYS . 5.3 m -49.9 -59.4 3.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.36 0.664 . . . . 0.0 109.837 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 88' ' ' SER . 30.3 t . . . . . 0 C--O 1.254 1.32 0 N-CA-C 103.112 -2.921 . . . . 0.0 103.112 174.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.2 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -137.44 150.19 47.43 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -95.69 -173.0 2.75 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 118.629 0.65 . . . . 0.0 110.457 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.2 t30 77.9 -74.67 0.06 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.659 1.584 . . . . 0.0 109.308 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.3 mt 61.69 178.24 0.12 Allowed 'General case' 0 C--O 1.24 0.602 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 176.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -83.8 84.21 7.65 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.123 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -93.97 98.83 11.29 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.469 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -95.01 95.93 8.93 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 175.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.31 -167.19 22.59 Favored Glycine 0 C--N 1.3 -1.44 0 N-CA-C 108.219 -1.953 . . . . 0.0 108.219 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.468 ' CD2' ' HA ' ' A' ' 86' ' ' ASP . 36.7 m80 -140.34 142.56 35.57 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 118.022 0.911 . . . . 0.0 110.144 -177.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 16.4 tpt -69.98 150.54 46.57 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 175.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.84 102.14 14.4 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.96 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.501 ' CE3' HG23 ' A' ' 41' ' ' THR . 71.4 m95 -98.34 155.07 17.39 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.473 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 10.8 mmpt? -88.91 -170.21 2.82 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 123.498 0.719 . . . . 0.0 111.449 -176.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.499 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 4.7 m-20 -69.3 -34.46 74.73 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -173.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.0 m -126.97 147.22 50.12 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.869 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.412 ' O ' HD13 ' A' ' 28' ' ' ILE . 8.2 tt -116.74 133.35 63.66 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 75' ' ' SER . 33.4 mm -125.94 111.61 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -174.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 75' ' ' SER . 25.6 mt-30 -102.51 132.09 48.79 Favored 'General case' 0 C--N 1.282 -2.336 0 O-C-N 121.652 -0.655 . . . . 0.0 109.675 -177.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -92.9 109.85 21.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . 10.2 m-85 -95.53 109.7 21.89 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -89.73 110.76 21.64 Favored 'General case' 0 N--CA 1.398 -3.05 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -177.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 53.88 40.58 31.71 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 113.489 -1.687 . . . . 0.0 114.238 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.16 -18.69 56.72 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 115.038 -0.983 . . . . 0.0 115.048 176.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -108.3 150.23 27.6 Favored 'General case' 0 CA--C 1.477 -1.855 0 CA-C-N 119.075 1.437 . . . . 0.0 107.829 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 31' ' ' TYR 0.253 7.1 p -79.53 115.34 21.7 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 C-N-CA 118.45 -1.3 . . . . 0.0 110.894 -175.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -97.11 -60.67 1.54 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.689 -174.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -119.91 158.38 26.8 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.35 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mp -125.54 121.75 60.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -123.02 169.94 10.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.501 HG23 ' CE3' ' A' ' 23' ' ' TRP . 1.6 t -149.95 142.08 24.04 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.4 160.06 40.49 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.496 -173.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -79.73 158.49 26.9 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.499 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 5.2 ptt180 -64.94 111.89 3.05 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 170.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.544 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 89.4 m-20 76.63 67.53 0.06 Allowed 'General case' 0 C--O 1.243 0.735 0 CA-C-O 123.321 1.534 . . . . 0.0 109.949 -176.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -144.16 123.08 12.74 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 112.581 -2.099 . . . . 0.0 110.46 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 46.6 tt0 -89.4 109.73 20.61 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 173.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.6 pt -92.99 -176.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 177.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 4.5 m -136.32 131.37 34.24 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 176.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 97.5 mt -132.62 108.45 13.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 58.81 35.01 24.08 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 122.91 1.338 . . . . 0.0 110.342 176.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 72.79 5.13 5.16 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 127.847 2.459 . . . . 0.0 113.683 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -92.01 114.27 26.77 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 174.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -80.36 140.54 36.03 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 117.925 -1.51 . . . . 0.0 108.135 178.316 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 86.1 t -133.23 123.18 46.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.011 -170.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 92.7 t80 -91.26 118.69 30.69 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.276 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 45' ' ' ASN . 64.6 t -95.67 119.33 43.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 174.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -77.33 165.03 24.98 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 124.33 1.018 . . . . 0.0 108.738 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.544 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -62.33 -19.98 63.88 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -173.338 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.82 11.36 11.37 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.401 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.6 m 62.65 68.05 0.67 Allowed 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.163 0.982 . . . . 0.0 110.438 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -153.19 120.54 3.01 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.526 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 55.6 Cg_endo -86.24 154.27 9.49 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.768 2.979 . . . . 0.0 114.314 -177.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -135.78 132.09 19.37 Favored Pre-proline 0 CA--C 1.483 -1.634 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.898 172.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.42 168.19 75.97 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.805 -1.748 . . . . 0.0 112.378 -2.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.0 t -88.61 -48.09 15.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.752 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -92.5 124.81 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.683 0.754 . . . . 0.0 109.893 173.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.5 mt -83.82 168.22 23.34 Favored Pre-proline 0 C--N 1.299 -1.593 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.983 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -64.67 -21.24 65.37 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.458 2.105 . . . . 0.0 111.135 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -83.43 -3.55 57.68 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 125.848 1.659 . . . . 0.0 110.934 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.522 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 18.4 tpt180 77.38 6.44 3.0 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.049 1.74 . . . . 0.0 110.747 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.1 m -67.95 134.09 50.19 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 122.134 0.969 . . . . 0.0 109.601 173.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.7 t -91.07 125.32 43.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 C-N-CA 128.493 2.717 . . . . 0.0 107.647 -175.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 mp -98.28 122.35 41.34 Favored 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.964 174.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.489 ' HB3' ' HB2' ' A' ' 29' ' ' GLN . 30.3 t -97.83 118.36 34.22 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.526 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -122.0 126.04 6.31 Favored Glycine 0 N--CA 1.416 -2.686 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.448 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 5.4 t70 -153.71 172.06 17.87 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -73.31 140.87 47.05 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 23' ' ' TRP . 3.7 m -71.68 -16.45 62.24 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.559 0.695 . . . . 0.0 109.632 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . 0.264 1.5 m -59.99 -22.55 62.7 Favored 'General case' 0 N--CA 1.411 -2.417 0 C-N-CA 126.238 1.815 . . . . 0.0 111.627 178.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.8 15.99 16.33 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 122.541 1.162 . . . . 0.0 110.066 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.448 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 31.9 m-85 -138.67 -166.85 2.08 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.202 -176.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 56.17 86.79 0.06 Allowed 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 123.55 1.643 . . . . 0.0 111.598 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -79.61 4.99 14.31 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 111.908 -2.405 . . . . 0.0 113.34 -172.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.62 -46.65 89.5 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 168.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.468 ' HA ' ' CD2' ' A' ' 20' ' ' HIS . 6.6 t70 -83.13 98.33 9.28 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -177.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.8 135.31 33.4 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -176.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.9 m 82.94 99.97 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.08 1.752 . . . . 0.0 112.575 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 59.2 m . . . . . 0 C--N 1.31 -1.149 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 175.833 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.845 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -122.21 -15.93 7.57 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -62.12 -45.54 93.02 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 54.99 -157.8 0.21 Allowed 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.368 1.467 . . . . 0.0 109.412 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -119.03 149.53 41.5 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -89.68 85.49 6.47 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 102.982 -2.97 . . . . 0.0 102.982 175.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . 0.401 4.9 t80 -71.4 104.57 3.24 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -172.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -153.11 -49.27 0.1 Allowed 'General case' 0 C--N 1.29 -2.006 1 N-CA-C 98.854 -4.499 . . . . 0.0 98.854 169.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 10.85 -91.42 0.01 OUTLIER Glycine 0 CA--C 1.498 -1.009 0 C-N-CA 128.167 2.794 . . . . 0.0 118.541 167.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.261 88.1 m-70 63.36 104.82 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 -166.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.67 ' SD ' ' HA ' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -60.69 103.36 0.25 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 112.482 -2.144 . . . . 0.0 115.188 -167.38 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.55 60.75 1.68 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.266 -2.864 . . . . 0.0 103.266 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.547 ' CE3' HG21 ' A' ' 41' ' ' THR . 13.5 m0 -73.65 -162.11 0.12 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 111.833 -2.44 . . . . 0.0 109.919 -177.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.498 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 34.8 mmtp -73.51 -173.47 1.43 Allowed 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.129 0.966 . . . . 0.0 108.675 174.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.558 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 6.7 m-20 -83.5 -33.58 25.52 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.704 -174.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 69.2 m -123.5 140.41 53.03 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.358 -176.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.42 HD13 HG23 ' A' ' 79' ' ' THR . 7.2 tt -113.87 133.26 60.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.4 mm -122.23 112.33 34.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -174.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.611 ' HB2' ' OG ' ' A' ' 75' ' ' SER . 96.8 mt-30 -96.69 127.63 42.86 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.491 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 58.5 ttt180 -95.78 112.33 24.08 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.495 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . 56.9 m-85 -94.71 145.93 24.51 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -149.99 117.68 6.19 Favored 'General case' 0 N--CA 1.404 -2.741 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.256 0.8 OUTLIER 57.86 34.51 24.45 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 177.573 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.54 -1.09 59.98 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.255 -0.974 . . . . 0.0 114.279 175.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -135.55 158.53 44.15 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 10.9 p -80.7 124.0 38.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -99.44 -46.52 5.46 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.316 -173.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.491 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 14.6 m120 -130.18 159.01 38.13 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.841 -176.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.8 mm -118.73 134.11 63.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 123.524 0.73 . . . . 0.0 110.799 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -141.18 165.09 28.48 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.547 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.4 t -157.33 144.35 18.4 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.17 156.43 46.53 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.189 0.596 . . . . 0.0 110.733 -174.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -74.88 157.58 34.82 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.558 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 8.1 ptt180 -62.81 107.86 1.06 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 171.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 83.57 62.09 0.01 OUTLIER 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.95 2.1 . . . . 0.0 110.681 -176.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -144.79 132.28 20.87 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.872 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 3.5 mp0 -87.3 112.45 22.08 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 172.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.1 pt -88.79 179.65 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 172.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.7 m -132.13 133.83 44.73 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 85.8 mt -127.1 106.08 14.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 56.24 38.83 30.18 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.408 1.099 . . . . 0.0 111.821 176.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 64.78 28.7 12.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.742 -1.572 . . . . 0.0 114.335 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -113.42 109.98 19.56 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 169.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.67 136.96 37.59 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 118.005 -1.478 . . . . 0.0 108.827 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 92.4 t -124.4 114.35 40.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.513 -174.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -82.92 115.79 21.93 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.1 t -97.18 118.75 44.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -75.38 173.07 11.41 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 125.162 1.539 . . . . 0.0 108.415 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -20.83 65.99 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -172.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.73 12.19 11.34 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.51 0.671 . . . . 0.0 110.006 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.9 m 68.58 31.1 4.87 Favored 'General case' 0 C--O 1.199 -1.585 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.925 175.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -109.72 119.79 46.79 Favored Pre-proline 0 C--N 1.288 -2.069 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.349 -177.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.482 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 83.7 Cg_endo -83.34 143.16 11.01 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.447 2.765 . . . . 0.0 113.516 -177.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -129.43 132.02 24.0 Favored Pre-proline 0 N--CA 1.432 -1.329 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.691 173.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -80.7 165.97 76.04 Favored 'Cis proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.514 -1.869 . . . . 0.0 112.181 -2.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.3 t -83.44 -39.7 15.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.866 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 mp -96.67 123.55 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 CA-C-O 121.386 0.612 . . . . 0.0 109.503 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.4 mt -84.6 167.44 26.85 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.012 177.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -70.72 -7.3 21.03 Favored 'Trans proline' 0 N--CA 1.484 0.951 0 C-N-CA 122.915 2.41 . . . . 0.0 112.671 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -89.82 -12.01 40.38 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.048 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.38 37.1 ttm180 67.62 58.69 0.5 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 124.032 1.872 . . . . 0.0 110.516 -169.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.7 m -103.48 136.44 43.21 Favored 'General case' 0 N--CA 1.408 -2.527 0 CA-C-N 111.861 -2.427 . . . . 0.0 105.11 172.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.3 t -93.27 115.69 32.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 124.855 1.347 . . . . 0.0 108.29 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.6 mp -97.22 126.87 42.7 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.452 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.611 ' OG ' ' HB2' ' A' ' 29' ' ' GLN . 51.4 p -107.69 129.7 55.0 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.482 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -114.42 118.01 4.26 Favored Glycine 0 N--CA 1.418 -2.534 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.953 -177.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -131.28 169.48 15.92 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -86.84 134.07 33.58 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 177.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.42 HG23 HD13 ' A' ' 27' ' ' ILE . 1.5 m -71.55 -13.85 61.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.954 0.407 . . . . 0.0 111.854 -175.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.4 p -69.69 -31.83 70.08 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.53 0.681 . . . . 0.0 110.765 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.24 17.46 21.27 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 122.437 1.113 . . . . 0.0 110.222 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -142.0 -165.89 2.11 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 125.83 1.652 . . . . 0.0 108.55 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 57.62 90.39 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 124.936 1.398 . . . . 0.0 109.914 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -42.54 -36.86 1.47 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 128.057 2.543 . . . . 0.0 114.931 -170.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.67 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 10.0 t70 56.66 63.58 1.92 Allowed 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 -172.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -41.68 91.22 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 111.523 -2.581 . . . . 0.0 113.109 -170.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -77.5 84.44 3.89 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 123.386 1.565 . . . . 0.0 112.758 -175.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.5 m -151.78 36.31 0.56 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 112.295 -2.23 . . . . 0.0 106.292 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.439 -0.984 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.613 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.847 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . 0.296 6.5 mmt180 68.02 110.67 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -97.77 89.86 4.76 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -77.17 155.36 32.34 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.491 -171.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.4 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 62.6 mt -87.83 168.52 12.85 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 176.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -69.85 85.6 0.5 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.897 0.856 . . . . 0.0 111.746 -176.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.4 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 78.8 m-85 -108.37 69.24 0.72 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.347 174.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -154.37 37.78 0.43 Allowed 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 127.356 2.263 . . . . 0.0 105.184 175.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -139.41 10.11 3.22 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.421 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 68.62 90.45 0.1 Allowed 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 125.835 1.654 . . . . 0.0 112.759 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.4 ttt -88.49 145.53 25.69 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 172.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.87 90.75 5.91 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.573 ' CE3' HG23 ' A' ' 41' ' ' THR . 41.7 m95 -72.17 165.52 24.21 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.094 -177.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.457 ' HB3' ' OD1' ' A' ' 43' ' ' ASN . 9.1 mmpt? -79.47 -173.68 3.85 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.151 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -76.15 -24.38 54.84 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 42' ' ' ALA . 64.5 m -132.52 155.58 48.36 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.43 ' O ' HD13 ' A' ' 28' ' ' ILE . 8.6 tt -125.37 133.68 68.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -178.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.43 HD13 ' O ' ' A' ' 27' ' ' ILE . 25.6 mm -125.08 111.3 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -175.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -103.38 130.33 50.66 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.144 0.497 . . . . 0.0 110.21 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -99.44 115.27 28.89 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.404 -175.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.558 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 27.9 m-85 -96.5 125.73 41.19 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? -131.57 125.63 32.79 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 -178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 60.89 30.16 19.47 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.65 1.18 . . . . 0.0 112.449 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.86 0.68 90.37 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.221 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -122.14 156.98 32.51 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.9 p -77.39 110.11 12.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -91.61 -43.79 9.42 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.217 -171.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -129.72 151.16 50.61 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -119.72 115.06 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.423 ' HH ' HG21 ' A' ' 50' ' ' ILE . 45.5 m-85 -119.17 166.01 13.48 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.573 HG23 ' CE3' ' A' ' 23' ' ' TRP . 1.3 t -150.81 142.72 23.89 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 26' ' ' CYS . . . -147.11 160.91 41.85 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -174.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.457 ' OD1' ' HB3' ' A' ' 24' ' ' LYS . 90.7 m-20 -85.27 164.93 17.73 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 121.769 0.795 . . . . 0.0 112.217 176.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.425 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 5.5 ptt85 -62.26 110.16 1.55 Allowed 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.947 169.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 75.6 67.21 0.07 Allowed 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.719 1.208 . . . . 0.0 109.015 -177.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -152.48 143.71 23.22 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 124.662 1.185 . . . . 0.0 107.932 -178.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -115.56 135.96 53.55 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 121.489 0.661 . . . . 0.0 110.655 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.472 ' CG1' ' HB ' ' A' ' 55' ' ' VAL . 29.1 pt -119.05 -179.99 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.7 m -137.62 135.13 36.3 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.423 HG21 ' HH ' ' A' ' 40' ' ' TYR . 82.6 mt -127.55 108.2 17.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.85 49.54 20.85 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 70.09 5.73 5.43 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.023 1.329 . . . . 0.0 113.277 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -104.16 109.63 21.5 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.1 154.11 38.0 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.991 0.9 . . . . 0.0 112.245 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.472 ' HB ' ' CG1' ' A' ' 48' ' ' ILE . 88.6 t -142.59 118.08 5.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 CA-C-N 113.546 -1.661 . . . . 0.0 109.842 -173.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -102.51 123.7 46.74 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.2 t -97.99 119.38 45.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -80.62 172.0 14.31 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.425 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 9.9 pt-20 -67.27 -5.58 14.67 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -172.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.61 13.68 31.16 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.711 172.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.0 m 69.83 33.96 2.74 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.518 1.152 . . . . 0.0 111.8 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -114.88 119.05 39.91 Favored Pre-proline 0 C--N 1.286 -2.17 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.672 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.463 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 83.6 Cg_endo -83.98 147.95 11.96 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.795 2.997 . . . . 0.0 114.115 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 70.7 m-85 -130.07 129.91 23.02 Favored Pre-proline 0 CA--C 1.488 -1.433 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.227 172.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.27 161.25 81.46 Favored 'Cis proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.923 -1.699 . . . . 0.0 112.354 -2.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.1 t -81.88 -36.76 14.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.265 0.555 . . . . 0.0 109.631 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.9 mm -106.42 127.08 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 173.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 39.4 mt -87.44 171.77 9.2 Favored Pre-proline 0 C--N 1.289 -2.035 0 CA-C-N 114.174 -1.376 . . . . 0.0 109.865 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -71.29 -12.02 29.38 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.551 2.167 . . . . 0.0 110.864 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -87.56 -0.14 56.43 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 125.836 1.654 . . . . 0.0 108.303 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 60.34 26.93 16.47 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 127.849 2.46 . . . . 0.0 109.361 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.13 135.57 47.72 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.558 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 5.5 t -90.89 117.48 34.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 125.704 1.878 . . . . 0.0 108.301 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.45 121.83 42.66 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.586 -1.246 . . . . 0.0 112.265 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.0 m -97.51 118.04 33.12 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 175.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -116.93 111.66 2.35 Favored Glycine 0 N--CA 1.422 -2.262 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.498 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.457 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 19.3 m-20 -142.69 177.21 8.47 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -78.03 139.53 39.11 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.8 -21.77 66.13 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.139 0.975 . . . . 0.0 112.854 -176.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 p -71.49 -24.85 62.06 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.595 0.712 . . . . 0.0 111.32 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.37 14.9 24.62 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.916 0.865 . . . . 0.0 111.178 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 77' ' ' ASP . 37.5 m-85 -146.09 -170.31 3.46 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 124.716 1.206 . . . . 0.0 111.432 -176.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 54.78 99.6 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 126.039 1.735 . . . . 0.0 114.684 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -88.91 70.11 8.58 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.218 -1.355 . . . . 0.0 107.563 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -166.88 -37.46 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 111.838 -2.437 . . . . 0.0 105.608 -174.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.44 129.8 39.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.363 174.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -100.02 142.26 31.74 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.142 0.496 . . . . 0.0 111.676 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.6 m -76.65 -24.04 53.29 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.571 -175.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 6.3 p . . . . . 0 C--N 1.306 -1.295 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 176.877 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.901 0 CA-C-O 118.168 -1.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? 57.08 31.87 20.71 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.515 1.15 . . . . 0.0 108.014 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.487 ' HA ' ' OE1' ' A' ' 13' ' ' GLU . 4.6 tp10 -83.0 113.29 20.47 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.948 -168.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -125.05 -47.48 1.78 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.058 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.3 mt 60.04 -165.78 0.2 Allowed 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.449 -1.251 . . . . 0.0 109.468 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -91.94 76.74 5.49 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -129.63 15.56 5.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.245 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.75 115.42 6.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 174.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.79 -31.07 0.41 Allowed Glycine 0 C--N 1.298 -1.577 0 N-CA-C 107.086 -2.405 . . . . 0.0 107.086 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -114.01 102.26 10.02 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 170.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 49.0 ttm -130.1 114.32 15.6 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.09 84.59 2.11 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.549 ' CE3' HG23 ' A' ' 41' ' ' THR . 12.1 m95 -91.4 -175.29 4.19 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.513 177.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -92.37 -173.74 3.49 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.87 -33.86 64.23 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.935 -178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.6 m -122.16 145.21 48.4 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.787 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 79' ' ' THR . 9.2 tt -114.8 133.31 61.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.8 mm -124.36 112.51 32.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -174.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -95.92 127.53 42.02 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 28.1 ttt180 -95.24 110.93 22.85 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.479 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 30.3 m-85 -95.77 137.06 35.36 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -153.13 123.33 7.05 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 63.0 29.58 16.42 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.963 1.705 . . . . 0.0 114.122 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.98 -4.85 75.44 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.901 176.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -124.72 160.63 28.17 Favored 'General case' 0 CA--C 1.482 -1.635 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 5.6 p -84.9 110.22 18.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -88.98 -45.98 9.24 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.588 -171.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.424 ' HB2' ' HB3' ' A' ' 30' ' ' ARG . 18.6 m120 -122.03 157.48 31.27 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.676 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.4 mm -121.42 134.87 63.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.671 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -141.49 166.64 24.19 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.549 HG23 ' CE3' ' A' ' 23' ' ' TRP . 1.8 t -158.13 141.49 15.2 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.34 156.84 45.27 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -173.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -79.72 157.98 27.03 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.898 175.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.421 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 4.1 ptt180 -59.06 115.78 3.39 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 169.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 75.49 59.34 0.06 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 126.163 1.785 . . . . 0.0 109.173 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -141.65 136.12 30.62 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.114 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 45.3 tt0 -101.67 109.94 21.82 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.7 pt -91.6 -178.11 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.5 m -136.36 126.78 26.74 Favored 'General case' 0 N--CA 1.405 -2.712 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 68.4 mt -118.34 104.15 15.71 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 56.3 43.49 26.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 122.108 0.956 . . . . 0.0 112.154 170.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 71.96 8.92 6.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.242 1.817 . . . . 0.0 114.512 -178.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -103.3 118.13 36.06 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 104.411 -2.441 . . . . 0.0 104.411 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 139.96 30.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 117.665 -1.614 . . . . 0.0 109.038 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.0 t -131.81 124.1 52.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.463 -173.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 75.5 t80 -96.7 121.76 38.89 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.1 t -100.74 124.28 54.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 175.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -83.41 -175.46 5.83 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.421 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 4.3 pm0 -70.59 -17.93 62.9 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -173.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.48 14.79 13.82 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.08 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 84.7 m 66.27 36.61 5.31 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.849 1.309 . . . . 0.0 112.355 174.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -116.48 120.4 34.73 Favored Pre-proline 0 C--N 1.293 -1.861 0 CA-C-N 113.223 -1.808 . . . . 0.0 108.169 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 63.9 Cg_endo -84.79 144.9 10.02 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.672 2.915 . . . . 0.0 114.422 -177.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -131.1 129.92 22.61 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.646 172.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.57 164.94 81.11 Favored 'Cis proline' 0 C--N 1.325 -0.67 0 C-N-CA 122.965 -1.681 . . . . 0.0 112.93 0.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.01 -36.59 10.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.638 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.7 mm -101.13 127.95 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.92 173.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.5 mt -86.42 169.86 14.08 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.608 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -72.09 -11.21 26.97 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.342 2.028 . . . . 0.0 111.329 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -99.15 12.94 34.66 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.196 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 71' ' ' ARG . 9.8 tpt180 61.76 27.6 16.9 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 123.274 1.511 . . . . 0.0 110.102 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.35 139.82 32.8 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 3.0 t -91.35 124.43 43.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 125.996 1.719 . . . . 0.0 108.843 -177.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mp -101.79 125.99 48.57 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.566 173.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.5 m -116.64 118.62 33.08 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.265 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.406 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -110.55 142.0 16.53 Favored Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 120.503 -0.855 . . . . 0.0 112.78 -176.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -156.26 177.35 11.54 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -80.33 136.02 36.32 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.412 HG21 HD13 ' A' ' 27' ' ' ILE . 2.3 m -61.78 -25.61 67.58 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 p -64.44 -40.64 96.12 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.42 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.35 13.17 10.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.988 0.899 . . . . 0.0 111.654 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -124.85 -79.12 0.61 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.815 -1.084 . . . . 0.0 113.505 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 84' ' ' ASP . . . -85.71 -3.13 58.81 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.947 -173.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 83' ' ' ALA . 9.2 t70 81.82 -56.96 0.24 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.912 1.685 . . . . 0.0 109.031 -177.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.0 t70 48.45 83.03 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.472 1.509 . . . . 0.0 112.488 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -79.27 117.59 20.41 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.453 -1.249 . . . . 0.0 112.422 -176.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -96.12 -11.91 25.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 173.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.5 m 76.76 -46.59 0.51 Allowed 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 126.472 1.909 . . . . 0.0 110.291 -175.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 31.5 t . . . . . 0 N--CA 1.433 -1.324 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 177.09 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.836 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -148.12 82.13 1.49 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -116.96 105.05 11.91 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.778 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -101.71 160.84 14.12 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 171.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 mp -128.47 171.93 11.62 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.911 -174.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -81.13 77.09 8.06 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -77.93 -51.58 10.18 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -119.51 143.98 47.28 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.05 20.57 50.29 Favored Glycine 0 CA--C 1.497 -1.08 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -142.54 173.86 11.16 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.506 ' HG3' ' O ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -118.35 101.71 8.39 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.458 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -128.65 78.34 1.84 Allowed 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 113.413 -1.721 . . . . 0.0 106.81 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.473 ' CE3' HG21 ' A' ' 41' ' ' THR . 14.8 m0 -92.93 -164.06 1.13 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 113.389 -1.732 . . . . 0.0 108.559 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -84.2 -171.48 3.63 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.451 ' CG ' ' HE ' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -81.8 -28.39 33.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -172.737 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.6 m -123.5 144.26 49.65 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.044 -177.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 79' ' ' THR . 11.0 tt -117.31 133.08 65.19 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.7 mm -125.48 112.77 32.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -172.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -101.05 136.26 41.18 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -99.58 111.02 23.41 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.476 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 29.6 m-85 -95.41 136.57 35.62 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 123.223 0.609 . . . . 0.0 109.861 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.44 123.57 15.55 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -176.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.29 15.6 m-20 50.9 31.37 6.08 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.44 -15.84 61.52 Favored Glycine 0 N--CA 1.432 -1.583 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.809 177.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -104.26 152.84 21.72 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 p -83.02 109.5 16.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -89.17 -43.46 11.0 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.85 -168.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -129.12 148.97 51.12 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -118.0 120.74 65.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -126.6 169.22 13.32 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.473 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.5 t -149.76 145.34 26.58 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.33 154.02 44.33 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 123.673 0.789 . . . . 0.0 110.016 -174.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -75.05 151.05 38.72 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 122.026 -0.421 . . . . 0.0 110.049 173.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.451 ' HE ' ' CG ' ' A' ' 25' ' ' ASP . 8.6 ptt85 -57.55 114.83 2.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 171.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 74.67 67.74 0.08 Allowed 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 125.477 1.511 . . . . 0.0 109.553 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -151.46 139.6 20.19 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.764 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -97.13 121.88 39.51 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.2 pt -102.08 177.06 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 172.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.4 m -136.62 124.6 22.8 Favored 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 98.8 mt -114.88 105.59 18.94 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 57.26 46.75 18.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.605 0.717 . . . . 0.0 112.564 174.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 71.65 3.01 4.51 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.861 1.665 . . . . 0.0 112.897 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -99.36 109.36 21.97 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.45 143.52 34.89 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 117.959 -1.496 . . . . 0.0 109.707 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -133.74 121.21 39.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.113 -174.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -91.56 128.81 37.53 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.4 t -108.83 121.71 62.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -78.14 169.09 18.84 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 124.407 1.083 . . . . 0.0 108.223 178.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.437 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 10.5 pt-20 -72.35 -4.0 27.28 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.86 7.42 45.02 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 172.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 70.8 m 64.83 35.59 8.46 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.097 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -123.01 129.07 25.11 Favored Pre-proline 0 C--N 1.29 -2.013 0 CA-C-N 114.308 -1.314 . . . . 0.0 107.789 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -84.73 159.43 12.19 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.038 2.492 . . . . 0.0 116.01 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -134.7 131.03 20.0 Favored Pre-proline 0 C--N 1.312 -1.064 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.101 171.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.85 161.06 70.84 Favored 'Cis proline' 0 C--N 1.319 -1.022 0 C-N-CA 122.907 -1.705 . . . . 0.0 111.425 -2.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 74' ' ' LEU . 90.7 t -81.17 -38.44 16.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.695 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 8.3 mm -97.44 116.61 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-O 122.106 0.955 . . . . 0.0 109.932 173.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.9 mt -76.87 165.77 49.88 Favored Pre-proline 0 C--N 1.297 -1.701 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.935 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.07 -3.41 13.6 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.428 2.085 . . . . 0.0 111.366 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -93.17 -12.15 31.02 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.019 -1.901 . . . . 0.0 110.462 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.278 40.0 ttm180 66.88 59.05 0.57 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 123.819 1.771 . . . . 0.0 109.763 -171.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.3 m -120.7 139.55 52.89 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 112.269 -2.241 . . . . 0.0 106.743 172.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.7 t -90.62 115.78 30.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 125.439 1.712 . . . . 0.0 108.975 -175.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.442 ' O ' HG11 ' A' ' 66' ' ' VAL . 4.0 mp -92.92 122.64 35.5 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 118.693 -1.203 . . . . 0.0 109.794 173.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.6 m -118.67 118.71 32.37 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.85 152.72 17.41 Favored Glycine 0 N--CA 1.415 -2.763 0 C-N-CA 119.763 -1.208 . . . . 0.0 111.405 -177.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 61' ' ' CYS . 2.9 t70 -157.53 177.1 11.79 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 174.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -82.91 137.05 34.37 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.419 HG21 HD13 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -68.19 -25.31 65.17 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 118.213 0.461 . . . . 0.0 111.867 -175.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 84' ' ' ASP . 12.2 t -67.91 -38.15 82.58 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -176.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.19 17.41 4.32 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.434 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.04 -68.59 0.63 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.573 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . . . -87.84 -7.13 57.66 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 80' ' ' SER . 30.5 t70 77.6 21.86 0.95 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.701 2.0 . . . . 0.0 110.483 175.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.573 ' OD1' ' HB3' ' A' ' 83' ' ' ALA . 3.0 m-20 -46.86 114.83 0.91 Allowed 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 114.025 -1.443 . . . . 0.0 112.143 176.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -93.7 95.98 9.51 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.799 0.809 . . . . 0.0 108.978 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -101.31 33.44 2.9 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.0 m 68.98 18.76 8.37 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-O 123.242 1.496 . . . . 0.0 108.173 -170.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 59.2 m . . . . . 0 N--CA 1.421 -1.922 0 N-CA-C 102.113 -3.292 . . . . 0.0 102.113 179.043 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.527 ' CE3' HG21 ' A' ' 41' ' ' THR . 12.1 m95 . . . . . 0 N--CA 1.44 -0.96 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.524 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 34.4 mmtp -83.34 -173.87 4.96 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.513 0.673 . . . . 0.0 110.102 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.97 -37.47 55.14 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.775 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.2 m -122.02 144.32 48.97 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.87 -176.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.511 HD12 HG23 ' A' ' 79' ' ' THR . 7.1 tt -118.89 133.24 66.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.3 mm -121.97 112.72 36.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -92.91 128.72 38.87 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.074 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -98.31 114.28 26.52 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.45 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 35.5 m-85 . . . . . 0 N--CA 1.421 -1.896 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.437 -1.114 0 CA-C-O 122.442 1.115 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -97.16 -60.49 1.57 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.445 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -121.92 156.83 32.53 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.512 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 mp -120.05 118.04 55.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -119.93 169.12 10.46 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.527 HG21 ' CE3' ' A' ' 23' ' ' TRP . 4.2 t -155.37 147.95 24.1 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.76 157.85 43.61 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.582 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -72.64 155.35 40.11 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -57.65 121.11 9.59 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 166.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 74.9 55.05 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 126.464 1.906 . . . . 0.0 110.054 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -139.54 139.54 36.9 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.803 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 5.8 mp0 -95.85 125.8 40.66 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.4 pt -105.47 -176.94 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 172.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 m -136.93 134.67 37.01 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.413 HD12 HD21 ' A' ' 74' ' ' LEU . 80.1 mt -126.77 105.05 13.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 54.26 46.08 25.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.721 0.772 . . . . 0.0 111.841 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 69.7 9.42 7.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -103.92 115.26 30.14 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.45 142.62 31.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.003 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.1 t -134.33 125.04 46.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.768 -172.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 82.9 t80 -94.74 122.03 36.93 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.0 t -97.53 121.75 48.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.427 ' OD1' ' HG2' ' A' ' 59' ' ' GLU . 40.1 t30 -71.53 165.77 23.18 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 124.923 1.389 . . . . 0.0 109.3 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.427 ' HG2' ' OD1' ' A' ' 58' ' ' ASN . 10.7 pt-20 -58.28 -24.3 59.01 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 126.012 1.725 . . . . 0.0 114.1 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.12 16.6 22.2 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.2 m 64.85 69.45 0.49 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.341 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.403 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 4.3 t-80 -148.07 124.42 5.4 Favored Pre-proline 0 C--N 1.313 -0.981 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.477 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 52.2 Cg_endo -83.58 140.49 9.43 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.252 2.635 . . . . 0.0 114.033 -176.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -129.41 131.68 23.78 Favored Pre-proline 0 CA--C 1.494 -1.183 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.148 174.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.28 166.62 81.63 Favored 'Cis proline' 0 C--N 1.325 -0.704 0 C-N-CA 122.726 -1.781 . . . . 0.0 112.74 -1.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.33 -28.43 5.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.565 0.698 . . . . 0.0 110.344 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.554 HG23 ' HA ' ' A' ' 71' ' ' ARG . 32.4 mm -108.75 132.56 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-O 121.525 0.679 . . . . 0.0 109.936 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.41 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 45.3 mt -91.15 171.87 7.5 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.582 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.41 ' CD ' ' HB3' ' A' ' 68' ' ' LEU . 25.5 Cg_exo -67.99 -15.33 43.27 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.593 2.195 . . . . 0.0 111.85 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -86.41 -12.29 49.56 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.55 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.554 ' HA ' HG23 ' A' ' 67' ' ' ILE . 23.7 ttm180 72.17 31.11 1.99 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 124.081 1.896 . . . . 0.0 109.013 -173.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 m -70.24 138.85 52.01 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 169.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 1.4 t -96.8 125.58 49.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 O-C-N 125.01 1.444 . . . . 0.0 109.571 -175.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.413 HD21 HD12 ' A' ' 50' ' ' ILE . 3.0 mp -103.96 138.66 40.2 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 121.438 0.637 . . . . 0.0 109.63 174.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.9 m -136.34 122.06 19.79 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.505 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.477 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -107.12 142.81 15.78 Favored Glycine 0 N--CA 1.428 -1.899 0 C-N-CA 120.247 -0.977 . . . . 0.0 110.973 -177.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -147.05 173.01 12.86 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -79.69 138.45 37.36 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.511 HG23 HD12 ' A' ' 27' ' ' ILE . 1.9 m -68.49 -15.36 63.51 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.465 0.65 . . . . 0.0 110.437 -177.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.5 t -56.59 -42.23 78.33 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 126.079 1.752 . . . . 0.0 108.903 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.15 21.33 11.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.555 0.693 . . . . 0.0 112.107 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 . . . . . 0 C--N 1.303 -1.445 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.826 -179.366 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.55 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.3 m95 . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 120.809 0.338 . . . . 0.0 111.632 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.538 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 50.8 mmtt -85.15 -171.91 3.89 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.423 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 2.0 m-20 -82.26 -29.85 31.0 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.453 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 71.9 m -127.21 141.99 51.6 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.173 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.581 HD12 HG23 ' A' ' 79' ' ' THR . 11.0 tt -119.17 133.06 67.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.6 mm -123.56 111.92 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -95.48 125.99 40.46 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.577 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -94.76 113.75 25.56 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.636 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 11.3 m-85 . . . . . 0 C--N 1.293 -1.855 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.433 -1.321 0 CA-C-O 122.599 1.19 . . . . 0.0 107.824 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -87.15 -50.96 6.27 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.439 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -128.97 155.32 45.54 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.202 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -119.14 119.04 59.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -120.25 167.83 11.87 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.55 HG21 ' CE3' ' A' ' 23' ' ' TRP . 4.3 t -154.55 147.33 24.36 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.11 160.74 43.08 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -82.06 162.34 22.6 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.794 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.423 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 6.5 ptt85 -60.86 113.48 2.53 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.297 174.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.447 ' OD1' ' HB3' ' A' ' 59' ' ' GLU . 23.5 m120 73.46 67.79 0.11 Allowed 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 126.489 1.916 . . . . 0.0 109.102 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -147.38 130.02 15.99 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.069 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 43.0 tt0 -97.62 116.84 30.62 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.501 0.667 . . . . 0.0 109.868 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.0 pt -98.26 -178.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 3.0 m -137.06 136.22 38.19 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 92.1 mt -128.01 107.96 17.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 56.8 34.78 25.27 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 74.7 14.56 3.37 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 127.015 2.126 . . . . 0.0 112.719 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -102.64 110.31 22.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 172.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.518 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -78.67 145.31 34.66 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.72 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -137.23 118.99 18.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.663 -173.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 69.2 t80 -89.89 118.71 29.67 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.2 t -94.11 117.97 38.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -71.98 168.29 18.34 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.447 ' HB3' ' OD1' ' A' ' 45' ' ' ASN . 13.5 pt-20 -64.38 -15.48 60.55 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.653 1.181 . . . . 0.0 113.663 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.13 6.18 43.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.8 m 69.48 36.55 2.2 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.595 1.158 . . . . 0.0 112.127 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -122.39 124.3 26.85 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 113.632 -1.622 . . . . 0.0 107.52 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.416 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 72.2 Cg_endo -81.72 153.62 17.57 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.218 2.612 . . . . 0.0 115.047 -176.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -136.39 131.45 18.51 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.174 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.07 161.69 88.06 Favored 'Cis proline' 0 C--N 1.322 -0.843 0 C-N-CA 122.526 -1.864 . . . . 0.0 111.513 -3.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.3 t -78.92 -36.68 19.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.373 0.606 . . . . 0.0 110.125 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.29 126.74 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 121.614 0.721 . . . . 0.0 110.782 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.62 170.7 10.07 Favored Pre-proline 0 C--N 1.305 -1.336 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.017 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -69.3 -9.48 26.39 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.551 2.167 . . . . 0.0 112.456 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.69 -11.07 54.66 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.463 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.411 ' HD2' ' HA ' ' A' ' 71' ' ' ARG . 11.5 tpt180 76.16 22.58 1.35 Allowed 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 126.375 1.87 . . . . 0.0 107.925 -172.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.4 m -67.45 134.68 51.83 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.379 -1.282 . . . . 0.0 107.657 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -92.93 116.74 34.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 126.002 1.721 . . . . 0.0 108.796 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 mp -96.84 122.55 39.93 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.117 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.9 m -114.36 118.7 34.59 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.416 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -117.27 134.99 11.55 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 119.933 -1.127 . . . . 0.0 112.551 -175.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -141.35 168.37 19.94 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -72.6 139.98 47.75 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.581 HG23 HD12 ' A' ' 27' ' ' ILE . 1.7 m -71.93 -15.71 62.09 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.798 0.808 . . . . 0.0 109.709 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . 0.276 0.7 OUTLIER -56.82 -32.64 65.93 Favored 'General case' 0 N--CA 1.414 -2.244 0 C-N-CA 126.399 1.88 . . . . 0.0 111.015 179.01 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.69 19.41 20.52 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.1 0.952 . . . . 0.0 109.851 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 . . . . . 0 C--N 1.299 -1.591 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.236 -176.346 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.534 ' HB2' HG21 ' A' ' 79' ' ' THR . 14.3 m0 . . . . . 0 N--CA 1.441 -0.896 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -88.51 -170.75 3.06 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -77.96 -29.87 50.05 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.075 0.941 . . . . 0.0 111.116 -171.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.2 m -124.55 143.22 50.8 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.709 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.596 HD12 HG23 ' A' ' 79' ' ' THR . 13.5 tt -117.89 133.05 65.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.41 HG23 ' HG3' ' A' ' 63' ' ' PRO . 30.8 mm -126.45 114.24 37.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -172.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -98.92 135.14 40.78 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.505 ' HG3' HD11 ' A' ' 74' ' ' LEU . 4.7 ttp180 -103.8 112.88 26.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.642 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 33.7 m-85 . . . . . 0 C--N 1.293 -1.863 0 C-N-CA 124.367 1.067 . . . . 0.0 110.016 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 N--CA 1.445 -0.693 0 CA-C-O 121.72 0.771 . . . . 0.0 111.604 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -111.4 -62.68 1.51 Allowed 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 125.016 1.326 . . . . 0.0 112.537 -174.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.403 ' O ' HD12 ' A' ' 39' ' ' ILE . 6.9 m-80 -121.61 167.32 13.03 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 122.764 0.426 . . . . 0.0 111.041 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.403 HD12 ' O ' ' A' ' 38' ' ' ASN . 1.7 mp -131.71 135.88 58.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 125.118 1.367 . . . . 0.0 108.426 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -141.79 163.83 31.84 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.444 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.7 t -149.14 139.53 22.41 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.72 163.77 31.71 Favored 'General case' 0 C--N 1.311 -1.068 0 O-C-N 124.003 0.815 . . . . 0.0 109.272 -173.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -77.56 159.73 29.08 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 120.467 -0.493 . . . . 0.0 109.836 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -67.75 116.37 8.36 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 120.924 0.392 . . . . 0.0 110.029 173.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.581 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 26.3 m-80 75.36 67.63 0.07 Allowed 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 126.901 2.08 . . . . 0.0 109.332 -174.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -149.68 134.57 17.86 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.609 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 44.3 tt0 -101.19 119.46 38.79 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-O 121.839 0.828 . . . . 0.0 110.209 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.5 pt -100.01 179.27 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.789 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 m -136.9 134.25 36.62 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.417 HD12 HG21 ' A' ' 55' ' ' VAL . 95.2 mt -124.88 106.63 16.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 59.05 34.9 23.71 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.119 0.961 . . . . 0.0 111.193 176.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.26 42.9 mm-40 67.39 21.19 9.79 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.625 1.57 . . . . 0.0 113.523 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -104.2 111.28 23.82 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 169.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -81.45 133.64 35.43 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.649 0.737 . . . . 0.0 109.241 -176.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.417 HG21 HD12 ' A' ' 50' ' ' ILE . 94.1 t -127.38 119.12 51.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.744 -173.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 79.4 t80 -92.89 121.52 34.33 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.9 t -94.01 114.62 31.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -69.03 165.03 21.04 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.581 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 9.1 pt-20 -70.14 -7.81 44.66 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 123.768 0.827 . . . . 0.0 112.428 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.41 -2.37 52.9 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 79.1 m 69.35 32.81 3.4 Favored 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.917 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -122.05 128.37 25.56 Favored Pre-proline 0 C--N 1.293 -1.85 0 CA-C-N 113.027 -1.897 . . . . 0.0 106.708 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.41 ' HG3' HG23 ' A' ' 28' ' ' ILE . 42.6 Cg_endo -85.01 156.07 11.35 Favored 'Trans proline' 0 C--N 1.329 -0.447 0 C-N-CA 123.267 2.645 . . . . 0.0 115.4 -175.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -135.17 131.32 19.66 Favored Pre-proline 0 N--CA 1.441 -0.906 0 C-N-CA 124.678 1.191 . . . . 0.0 111.571 172.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.5 169.7 70.17 Favored 'Cis proline' 0 C--N 1.322 -0.82 0 C-N-CA 122.435 -1.902 . . . . 0.0 112.306 -1.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.8 t -86.79 -42.17 15.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.093 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.447 HG12 ' NH2' ' A' ' 71' ' ' ARG . 1.7 mp -98.3 128.02 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.71 0.767 . . . . 0.0 110.49 173.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.6 mt -88.41 169.11 14.31 Favored Pre-proline 0 C--N 1.306 -1.298 0 CA-C-N 114.297 -1.319 . . . . 0.0 108.243 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.35 -9.18 25.34 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.281 1.988 . . . . 0.0 110.904 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -88.7 1.2 55.54 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.687 -1.597 . . . . 0.0 109.492 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.447 ' NH2' HG12 ' A' ' 67' ' ' ILE . 8.3 tpm_? 74.93 9.43 4.0 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 125.253 1.421 . . . . 0.0 109.671 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 67' ' ' ILE . 0.9 OUTLIER -70.86 138.15 50.0 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.703 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.642 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.3 t -92.1 124.07 44.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 125.614 1.566 . . . . 0.0 109.479 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.505 HD11 ' HG3' ' A' ' 30' ' ' ARG . 7.6 mp -100.23 122.74 43.51 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.959 0.885 . . . . 0.0 110.307 172.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 52.3 m -118.03 117.74 30.04 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -118.07 152.28 17.6 Favored Glycine 0 N--CA 1.422 -2.279 0 C-N-CA 119.395 -1.383 . . . . 0.0 111.38 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -155.84 177.13 11.75 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -79.65 139.2 37.49 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.596 HG23 HD12 ' A' ' 27' ' ' ILE . 1.6 m -72.11 -10.9 60.4 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.568 0.699 . . . . 0.0 110.409 -178.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.4 p -69.09 -22.93 63.97 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.425 0.631 . . . . 0.0 111.034 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.36 17.14 24.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 122.07 0.938 . . . . 0.0 109.909 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 . . . . . 0 C--N 1.3 -1.578 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.955 -175.426 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.441 ' CB ' HG21 ' A' ' 79' ' ' THR . 11.5 m0 . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . 11.2 mmpt? -88.55 -170.58 2.99 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 121.923 -0.485 . . . . 0.0 110.759 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -29.18 54.7 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.091 0.472 . . . . 0.0 112.013 -175.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 68.1 m -122.34 144.81 48.79 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.884 0.85 . . . . 0.0 110.766 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.623 HD12 HG23 ' A' ' 79' ' ' THR . 8.6 tt -119.48 133.66 65.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.4 mm -119.01 133.07 67.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -174.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -117.23 132.56 56.6 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -174.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -94.6 112.98 24.74 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.641 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 23.2 m-85 . . . . . 0 C--N 1.301 -1.539 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.433 -1.312 0 CA-C-O 122.524 1.154 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -88.19 -57.54 2.89 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.801 -173.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -121.09 159.88 24.82 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.876 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.6 tp -122.73 155.85 28.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -151.02 167.88 26.3 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.424 HG21 ' CE3' ' A' ' 23' ' ' TRP . 2.0 t -149.63 146.82 27.49 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.374 0.606 . . . . 0.0 110.029 177.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.85 158.87 44.25 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -80.99 158.82 25.04 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.483 ' HB2' ' HA ' ' A' ' 59' ' ' GLU . 6.8 ptt85 -61.58 114.42 3.25 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 171.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.467 HD21 ' HB3' ' A' ' 59' ' ' GLU . 9.4 m-80 76.52 67.15 0.06 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 127.112 2.165 . . . . 0.0 108.914 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -146.72 128.5 15.29 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.561 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -89.86 109.93 20.9 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.368 0.604 . . . . 0.0 109.696 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.9 pt -96.7 -178.97 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.9 m -133.24 130.68 39.34 Favored 'General case' 0 N--CA 1.403 -2.789 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 174.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.44 HD12 HG21 ' A' ' 55' ' ' VAL . 87.7 mt -122.75 101.82 10.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 61.14 36.96 17.95 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.947 0.879 . . . . 0.0 111.251 172.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 70.64 18.94 6.25 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 113.751 -1.568 . . . . 0.0 113.798 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -112.52 107.66 16.48 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 172.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 49' ' ' THR 0.31 0.0 OUTLIER -78.78 152.92 31.16 Favored 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 117.654 -1.618 . . . . 0.0 111.81 -179.534 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 50' ' ' ILE . 91.8 t -142.72 129.83 18.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.299 -170.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -100.34 120.8 40.5 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 66.2 t -98.32 117.68 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -71.76 167.65 19.47 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 124.586 1.179 . . . . 0.0 109.336 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.483 ' HA ' ' HB2' ' A' ' 44' ' ' ARG . 9.5 pt-20 -58.65 -20.8 51.05 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 126.0 1.72 . . . . 0.0 114.851 -174.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.56 19.89 18.16 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 120.953 0.406 . . . . 0.0 109.965 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.9 m 62.33 69.97 0.59 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.403 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -148.0 121.79 4.84 Favored Pre-proline 0 N--CA 1.439 -0.997 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.515 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 48.7 Cg_endo -87.73 142.74 5.9 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.564 2.843 . . . . 0.0 114.912 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -131.79 134.61 25.56 Favored Pre-proline 0 C--N 1.309 -1.165 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.491 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.01 158.08 96.84 Favored 'Cis proline' 0 C--N 1.332 -0.342 0 C-N-CA 122.572 -1.845 . . . . 0.0 112.831 0.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.14 -40.13 21.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.362 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.9 mm -98.76 124.17 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.926 -1.109 . . . . 0.0 109.39 175.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 mt -85.61 168.24 20.88 Favored Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.644 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -68.64 -11.96 33.35 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.126 1.884 . . . . 0.0 111.177 -176.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -91.98 10.82 27.37 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.155 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 68.62 9.59 7.4 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.473 1.909 . . . . 0.0 111.45 172.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.9 m -82.21 150.7 27.21 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.825 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.3 t -91.29 131.0 39.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 126.436 1.894 . . . . 0.0 109.751 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.94 123.56 48.17 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.09 0.948 . . . . 0.0 111.03 173.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.4 t -107.62 147.09 31.11 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.515 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -130.58 140.35 11.69 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -152.86 175.75 12.57 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -86.21 132.78 33.93 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.623 HG23 HD12 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -67.52 -21.96 65.46 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.278 0.561 . . . . 0.0 111.503 -175.845 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.4 p -65.95 -26.81 67.75 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.916 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.33 21.13 17.46 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.822 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.312 -1.05 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -174.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.509 ' CE3' HG21 ' A' ' 41' ' ' THR . 17.9 m95 . . . . . 0 N--CA 1.43 -1.472 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -101.87 -171.35 1.96 Allowed 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.541 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.49 -27.49 58.81 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -173.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.8 m -126.28 142.56 51.48 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.022 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.647 HD12 HG23 ' A' ' 79' ' ' THR . 12.7 tt -115.22 133.46 61.39 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.41 HD13 ' O ' ' A' ' 27' ' ' ILE . 34.9 mm -127.22 116.94 45.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -173.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 75' ' ' SER . 95.9 mt-30 -105.75 139.12 40.82 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.759 -0.588 . . . . 0.0 110.358 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.536 ' HD2' HG21 ' A' ' 50' ' ' ILE . 24.1 mtp180 -95.82 115.74 27.87 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 121.528 -0.069 . . . . 0.0 110.971 175.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.648 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 29.2 m-85 . . . . . 0 C--N 1.295 -1.761 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.431 -1.375 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -94.78 -51.78 4.55 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.037 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -119.8 154.25 34.52 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.893 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -121.92 127.26 75.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -133.73 168.99 17.71 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.509 HG21 ' CE3' ' A' ' 23' ' ' TRP . 2.3 t -155.45 139.63 16.55 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.23 152.96 46.38 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.456 -174.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -76.69 160.6 29.22 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 120.881 0.372 . . . . 0.0 110.562 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.53 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 4.0 ptt180 -60.56 115.59 3.72 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.895 172.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.426 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 82.9 m-20 73.62 65.01 0.09 Allowed 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.969 1.708 . . . . 0.0 109.678 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -145.74 137.46 25.17 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.26 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 39.2 tt0 -107.75 109.5 21.09 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.733 0.778 . . . . 0.0 109.225 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.4 pt -90.59 -177.33 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.812 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.2 m -130.98 134.34 46.63 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.536 HG21 ' HD2' ' A' ' 30' ' ' ARG . 82.1 mt -128.95 110.31 20.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 51.79 38.04 22.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.07 0.938 . . . . 0.0 112.676 177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 69.12 29.05 4.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 113.337 -1.756 . . . . 0.0 112.829 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -118.35 116.82 27.52 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 169.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -82.12 140.9 33.54 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 118.494 -1.283 . . . . 0.0 109.7 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.452 HG21 HD12 ' A' ' 50' ' ' ILE . 69.2 t -132.22 125.99 55.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.837 -172.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 54.6 t80 -96.03 121.01 37.32 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -178.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.34 116.99 44.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -70.78 164.72 24.6 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 124.295 0.997 . . . . 0.0 108.374 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.53 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 9.3 pt-20 -62.76 -13.14 29.45 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.39 11.63 29.91 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.009 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.2 m 62.14 69.44 0.62 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.882 0.848 . . . . 0.0 111.937 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -152.01 124.87 4.08 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.578 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 64.0 Cg_endo -87.03 141.2 6.01 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.323 2.682 . . . . 0.0 114.226 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -126.48 129.22 24.18 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 174.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.16 159.68 92.72 Favored 'Cis proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.613 -1.828 . . . . 0.0 112.585 -0.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.8 t -78.94 -44.02 24.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.458 HG21 ' NH2' ' A' ' 71' ' ' ARG . 1.7 mp -94.7 123.69 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 121.597 0.713 . . . . 0.0 109.151 171.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.6 mt -83.19 169.51 17.36 Favored Pre-proline 0 C--N 1.299 -1.596 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.774 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -71.61 -2.51 11.47 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.498 2.132 . . . . 0.0 111.343 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -97.48 4.72 50.38 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.62 -1.627 . . . . 0.0 109.401 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.458 ' NH2' HG21 ' A' ' 67' ' ' ILE . 0.4 OUTLIER 66.14 21.26 11.16 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.111 1.364 . . . . 0.0 109.323 177.92 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.2 m -85.5 139.73 31.25 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.648 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -90.5 125.48 43.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 125.956 1.702 . . . . 0.0 108.409 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.8 mp -101.56 130.13 47.79 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 122.201 1.001 . . . . 0.0 111.214 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.435 ' HB3' ' HB2' ' A' ' 29' ' ' GLN . 37.6 t -106.02 121.34 43.91 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.578 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -117.69 131.98 9.65 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.293 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -150.12 172.97 14.43 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -80.8 135.44 35.96 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.647 HG23 HD12 ' A' ' 27' ' ' ILE . 2.4 m -70.61 -14.46 62.49 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 121.867 -0.521 . . . . 0.0 111.795 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.9 t -69.45 -28.93 66.53 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 122.27 1.033 . . . . 0.0 108.879 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.56 16.17 16.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.681 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 C--N 1.305 -1.367 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.172 -177.662 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.432 ' CB ' HG21 ' A' ' 79' ' ' THR . 12.4 m0 . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 120.917 0.389 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.488 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . 10.5 mmpt? -84.93 -174.57 5.34 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.886 0.374 . . . . 0.0 110.229 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.406 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 5.4 m-20 -70.19 -38.38 75.34 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 74.2 m -123.78 145.28 49.15 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.717 -174.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.544 HD12 HG23 ' A' ' 79' ' ' THR . 9.8 tt -118.13 127.66 75.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.405 HD12 ' C ' ' A' ' 27' ' ' ILE . 1.6 mp -117.14 114.54 46.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.915 0.864 . . . . 0.0 110.094 -175.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -91.69 124.84 36.14 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.793 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.462 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 63.9 ttt180 -96.51 110.38 22.78 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.655 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 83.1 m-85 . . . . . 0 C--N 1.301 -1.523 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 9.0 p . . . . . 0 N--CA 1.431 -1.386 0 CA-C-O 122.694 1.235 . . . . 0.0 112.782 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -96.96 -55.56 2.83 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.918 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.462 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 16.3 m120 -120.12 153.37 36.27 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.477 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 mp -119.2 116.36 50.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -118.72 166.78 12.35 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 24' ' ' LYS . 4.0 t -146.84 139.86 25.32 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 173.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.2 161.2 38.21 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.165 -1.38 . . . . 0.0 107.771 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 24' ' ' LYS . 90.5 m-20 -87.02 160.99 18.43 Favored 'General case' 0 C--N 1.284 -2.281 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.632 176.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.422 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 3.5 ptt85 -58.68 119.43 7.08 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.956 171.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.1 m120 68.33 64.36 0.35 Allowed 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 125.57 1.548 . . . . 0.0 108.643 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -144.58 133.29 22.3 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 113.755 -1.566 . . . . 0.0 108.403 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 36.4 tt0 -108.13 109.31 20.7 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.753 0.787 . . . . 0.0 109.766 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 32.0 pt -87.8 -178.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.214 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.8 m -136.4 135.63 38.9 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.9 mt -127.38 108.34 18.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 53.28 42.88 32.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.356 1.074 . . . . 0.0 112.201 177.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 72.72 8.91 5.6 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.766 2.026 . . . . 0.0 113.865 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -100.12 115.77 30.57 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.63 144.51 33.72 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.702 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.2 t -137.05 117.42 16.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.358 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 64.3 t80 -92.06 123.04 35.12 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.023 0.44 . . . . 0.0 110.841 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.0 t -97.46 123.39 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -76.03 173.87 10.72 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 124.611 1.194 . . . . 0.0 108.822 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.422 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 1.3 pm0 -71.51 -20.73 62.01 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -173.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.5 19.92 11.46 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.559 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.7 m 61.69 79.63 0.25 Allowed 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 124.639 1.212 . . . . 0.0 113.103 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -162.62 128.56 2.29 Favored Pre-proline 0 C--N 1.314 -0.936 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.497 ' CG ' ' HB3' ' A' ' 74' ' ' LEU . 42.6 Cg_endo -88.54 149.93 6.32 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.248 2.632 . . . . 0.0 114.604 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -135.86 134.07 20.34 Favored Pre-proline 0 CA--C 1.498 -1.053 0 C-N-CA 125.167 1.387 . . . . 0.0 110.265 173.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.35 163.63 84.22 Favored 'Cis proline' 0 C--N 1.317 -1.093 0 C-N-CA 122.633 -1.82 . . . . 0.0 112.219 0.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.0 t -82.47 -40.88 17.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.553 -174.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 72' ' ' SER . 1.7 mp -104.16 127.68 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-O 121.45 0.643 . . . . 0.0 110.034 172.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.0 mt -94.77 170.82 7.46 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.193 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -69.94 -12.5 32.67 Favored 'Trans proline' 0 N--CA 1.486 1.086 0 C-N-CA 122.669 2.246 . . . . 0.0 111.56 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -84.83 -0.22 53.18 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.778 -1.556 . . . . 0.0 108.646 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 59.72 37.79 22.04 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.461 1.904 . . . . 0.0 109.118 -177.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 67' ' ' ILE . 21.5 m -85.92 127.57 34.64 Favored 'General case' 0 N--CA 1.409 -2.485 0 CA-C-N 113.438 -1.71 . . . . 0.0 106.54 172.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.655 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.3 t -90.99 116.66 32.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 127.673 2.389 . . . . 0.0 106.748 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.497 ' HB3' ' CG ' ' A' ' 63' ' ' PRO . 6.6 mp -102.09 124.36 47.56 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 122.208 1.004 . . . . 0.0 113.44 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.5 m -117.93 129.11 55.42 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.679 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 27' ' ' ILE . . . -119.84 137.36 12.33 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.397 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -141.8 172.46 12.65 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -77.82 138.41 38.94 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.544 HG23 HD12 ' A' ' 27' ' ' ILE . 3.4 m -66.78 -21.21 66.06 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -174.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.7 t -71.57 -40.22 70.1 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -174.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.28 9.07 2.26 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.258 1.028 . . . . 0.0 113.296 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 . . . . . 0 C--N 1.291 -1.936 0 CA-C-N 114.038 -1.437 . . . . 0.0 109.873 179.604 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.504 ' CE3' HG21 ' A' ' 41' ' ' THR . 17.7 m95 . . . . . 0 N--CA 1.443 -0.792 0 CA-C-O 121.254 0.549 . . . . 0.0 109.777 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 41' ' ' THR . 95.6 mttt -90.34 -172.57 3.5 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.155 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -74.55 -36.04 63.1 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.841 0.829 . . . . 0.0 111.858 -172.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.0 m -122.1 143.31 49.61 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.222 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.499 HD12 HG23 ' A' ' 79' ' ' THR . 4.0 tt -115.79 133.05 63.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.0 mm -122.93 119.33 57.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.4 ' HG2' ' CD1' ' A' ' 39' ' ' ILE . 95.4 mt-30 -95.53 127.57 41.68 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -99.25 111.28 23.69 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.619 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 31.5 m-85 . . . . . 0 C--N 1.301 -1.509 0 CA-C-O 121.486 0.66 . . . . 0.0 109.228 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 7.7 p . . . . . 0 N--CA 1.432 -1.368 0 CA-C-O 122.493 1.14 . . . . 0.0 109.82 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -85.64 -58.64 2.58 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.518 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -119.91 161.25 21.18 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.938 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.4 ' CD1' ' HG2' ' A' ' 29' ' ' GLN . 7.5 tp -115.48 151.04 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 N-CA-C 103.372 -2.825 . . . . 0.0 103.372 171.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -147.06 166.11 27.86 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.504 HG21 ' CE3' ' A' ' 23' ' ' TRP . 2.1 t -151.99 142.74 22.88 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.13 149.73 44.83 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -75.71 156.97 34.19 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -57.13 121.51 10.21 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 121.206 0.526 . . . . 0.0 110.415 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.9 m120 70.32 63.1 0.22 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 112.957 -1.929 . . . . 0.0 108.677 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -141.83 131.68 24.35 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.54 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 33.8 tt0 -95.44 114.18 25.91 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.034 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.0 pt -96.65 -177.24 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.84 138.12 42.2 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 175.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 92.9 mt -129.61 106.96 14.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 50.73 49.37 21.09 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 70.86 1.61 3.83 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 125.042 1.337 . . . . 0.0 114.489 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -95.33 115.82 27.95 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 147.12 30.58 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 119.714 -0.794 . . . . 0.0 108.934 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 96.9 t -139.9 118.34 11.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.881 -174.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 80.4 t80 -93.21 119.41 32.36 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.0 t -98.36 120.87 48.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -73.24 168.51 18.99 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 124.647 1.217 . . . . 0.0 110.199 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -68.35 -8.02 36.4 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 125.771 1.628 . . . . 0.0 114.572 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.89 14.7 27.69 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.8 m 63.84 71.25 0.49 Allowed 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 124.415 1.072 . . . . 0.0 111.455 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -151.05 124.66 4.33 Favored Pre-proline 0 N--CA 1.435 -1.219 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.479 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 88.7 Cg_endo -84.89 143.04 9.22 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.112 2.541 . . . . 0.0 114.964 -177.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 32.9 m-85 -129.63 127.4 22.95 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.038 170.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 73.5 Cg_endo -81.87 163.49 76.77 Favored 'Cis proline' 0 C--N 1.319 -1.007 0 C-N-CA 122.876 -1.718 . . . . 0.0 112.26 -0.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 74' ' ' LEU . 85.0 t -81.53 -39.83 17.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.708 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.04 128.07 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 121.574 0.702 . . . . 0.0 109.483 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.2 mt -88.0 172.07 8.45 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.757 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -73.99 -13.32 23.88 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.295 1.997 . . . . 0.0 109.703 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -84.82 -6.6 59.35 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.115 -2.311 . . . . 0.0 108.349 177.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.387 12.3 ttm180 52.61 55.92 8.38 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 124.631 2.158 . . . . 0.0 112.224 -176.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.9 m -101.95 135.23 43.87 Favored 'General case' 0 N--CA 1.398 -3.048 0 CA-C-N 111.098 -2.774 . . . . 0.0 104.961 170.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.619 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -91.3 117.03 33.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 O-C-N 126.105 2.128 . . . . 0.0 108.395 -176.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.445 ' O ' HG13 ' A' ' 66' ' ' VAL . 5.6 mp -101.49 134.46 44.57 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 122.016 0.912 . . . . 0.0 111.703 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.8 m -120.77 137.12 54.68 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.834 175.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.479 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -129.01 133.67 7.68 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 119.659 -1.258 . . . . 0.0 113.021 -175.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -146.82 171.83 14.59 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -71.91 139.37 48.74 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.499 HG23 HD12 ' A' ' 27' ' ' ILE . 3.2 m -67.2 -18.04 65.08 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 123.093 0.557 . . . . 0.0 111.624 -176.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -69.21 -23.85 63.95 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.362 0.601 . . . . 0.0 111.719 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.6 20.61 15.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.752 0.786 . . . . 0.0 110.824 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 . . . . . 0 C--N 1.307 -1.252 0 C-N-CA 125.713 1.605 . . . . 0.0 108.816 -177.495 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.454 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.5 m95 . . . . . 0 N--CA 1.446 -0.627 0 CA-C-O 120.709 0.29 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 50.7 mttm -88.95 -172.38 3.67 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.904 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.42 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 2.8 m-20 -74.76 -34.34 62.48 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -174.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.5 m -121.49 140.87 51.63 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.942 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.588 HD12 HG23 ' A' ' 79' ' ' THR . 9.7 tt -112.85 128.54 69.51 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -177.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.0 mm -113.39 120.57 63.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.427 ' HA ' HD12 ' A' ' 39' ' ' ILE . 43.5 mt-30 -100.77 116.68 33.23 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 114.236 -1.347 . . . . 0.0 107.678 -172.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -96.44 109.47 22.01 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.692 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 69.2 m-85 . . . . . 0 C--N 1.298 -1.661 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 9.6 p . . . . . 0 N--CA 1.43 -1.445 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -83.8 -45.18 13.58 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.308 -175.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -130.69 153.27 49.15 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.206 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 29' ' ' GLN . 7.8 tp -116.32 153.86 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 173.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -148.63 168.11 23.68 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.454 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.7 t -150.48 145.57 26.09 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 24' ' ' LYS . . . -141.92 155.97 45.5 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -175.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -79.94 161.65 25.38 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.566 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.42 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 8.2 ptt180 -59.12 116.21 3.69 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.744 170.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 75.07 50.07 0.08 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.056 1.743 . . . . 0.0 110.728 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -130.57 134.56 47.11 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.526 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 44.1 tt0 -102.7 109.22 20.74 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.7 pt -90.64 -177.65 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.2 m -135.52 129.1 32.54 Favored 'General case' 0 N--CA 1.401 -2.897 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 173.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.411 HD12 HD21 ' A' ' 74' ' ' LEU . 67.5 mt -118.72 105.07 16.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 60.21 36.69 20.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.93 0.871 . . . . 0.0 111.605 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 69.88 17.07 7.64 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.159 1.783 . . . . 0.0 113.221 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -106.49 111.36 23.89 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.44 141.59 41.32 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.448 -177.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 88.0 t -135.42 114.5 16.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.738 -173.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 64.4 t80 -90.08 118.72 29.84 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.3 t -101.3 116.91 45.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -73.95 166.09 23.98 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.098 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 17.1 pt-20 -56.04 -21.4 21.41 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 126.861 2.064 . . . . 0.0 113.454 -175.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.22 11.06 26.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.841 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.8 m 59.37 66.08 1.08 Allowed 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.264 1.03 . . . . 0.0 111.763 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -149.79 124.91 4.83 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -82.59 152.32 15.25 Favored 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 123.463 2.775 . . . . 0.0 114.972 -175.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -134.87 137.11 26.53 Favored Pre-proline 0 CA--C 1.493 -1.231 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.32 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -78.93 168.29 75.09 Favored 'Cis proline' 0 C--N 1.314 -1.287 0 C-N-CA 122.671 -1.804 . . . . 0.0 111.442 -3.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 74' ' ' LEU . 64.4 t -86.5 -30.7 6.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.993 -173.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 67' ' ' ILE . 18.5 mm -107.44 129.28 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.972 0.891 . . . . 0.0 110.625 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.1 mt -88.32 165.74 27.02 Favored Pre-proline 0 C--N 1.305 -1.331 0 CA-C-N 114.383 -1.28 . . . . 0.0 108.907 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -72.5 -4.57 15.53 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.77 2.313 . . . . 0.0 111.839 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -95.78 -1.96 48.67 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.309 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 71.7 13.64 6.21 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 126.514 1.926 . . . . 0.0 110.045 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.81 137.05 53.65 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 175.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.692 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 3.1 t -90.69 117.97 35.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 125.859 1.663 . . . . 0.0 109.044 -175.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.411 HD21 HD12 ' A' ' 50' ' ' ILE . 6.1 mp -97.29 139.43 33.26 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.06 173.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.6 m -138.93 154.07 48.3 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.2 146.08 17.57 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 118.829 -1.653 . . . . 0.0 111.852 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -141.76 171.78 13.59 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -80.98 134.86 35.77 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.588 HG23 HD12 ' A' ' 27' ' ' ILE . 1.7 m -70.83 -13.99 62.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.419 0.628 . . . . 0.0 110.556 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 p -66.29 -21.96 66.28 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.128 0.971 . . . . 0.0 111.449 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.48 13.69 28.13 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.285 1.041 . . . . 0.0 110.367 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 C--N 1.301 -1.515 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.363 -174.205 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.518 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.0 m0 . . . . . 0 N--CA 1.438 -1.073 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -86.77 -170.6 3.14 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.165 0.507 . . . . 0.0 109.994 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.45 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 1.1 m-20 -78.57 -25.92 45.44 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.7 m -131.32 152.75 50.28 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.535 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.411 ' HB ' HG23 ' A' ' 79' ' ' THR . 11.9 tt -125.08 133.86 68.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.4 mm -120.24 112.3 35.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -173.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -96.62 117.76 31.66 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -176.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.411 ' HG3' HD11 ' A' ' 74' ' ' LEU . 8.7 ttp180 -91.62 110.38 21.7 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.687 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 14.5 m-85 . . . . . 0 C--N 1.289 -2.023 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.437 -1.089 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -109.9 -60.09 1.84 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.043 -1.036 . . . . 0.0 111.784 -173.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -127.96 159.94 33.4 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -123.01 130.57 74.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 124.106 0.962 . . . . 0.0 109.264 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -134.34 168.74 18.35 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.518 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.7 t -150.03 142.36 24.23 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.2 157.91 44.33 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.872 -172.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -81.36 160.21 24.18 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 176.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.45 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 6.8 ptt85 -67.92 108.92 3.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.444 0.64 . . . . 0.0 111.73 175.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.531 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 42.3 m-80 83.7 57.07 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.136 2.575 . . . . 0.0 110.087 -175.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -133.76 129.72 37.04 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.106 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 45.1 tt0 -99.18 108.87 21.57 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 pt -94.12 -176.62 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 6.1 m -133.72 136.28 44.55 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.436 HD12 HG21 ' A' ' 55' ' ' VAL . 95.0 mt -132.07 106.65 11.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.05 36.4 25.99 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 122.432 1.111 . . . . 0.0 111.256 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 70.5 16.01 7.1 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 112.687 -2.051 . . . . 0.0 113.994 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -103.64 118.18 36.12 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 172.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -82.14 144.62 30.62 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 118.385 -1.326 . . . . 0.0 108.666 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 88.9 t -135.19 122.35 35.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.609 -173.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 93.9 t80 -93.34 118.16 30.95 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.7 t -96.8 114.02 32.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -73.97 173.28 10.21 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.531 ' HB3' ' ND2' ' A' ' 45' ' ' ASN 0.262 10.3 pt-20 -74.38 0.67 13.74 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -173.32 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.17 12.24 37.95 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.6 m 69.18 33.06 3.44 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.545 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -111.65 117.39 48.88 Favored Pre-proline 0 C--N 1.291 -1.946 0 CA-C-N 113.45 -1.704 . . . . 0.0 108.398 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.587 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 40.8 Cg_endo -88.86 144.69 5.32 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.983 3.122 . . . . 0.0 114.861 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -130.06 134.76 26.51 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.044 173.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -74.87 157.15 99.77 Favored 'Cis proline' 0 CA--C 1.529 0.246 0 C-N-CA 123.045 -1.648 . . . . 0.0 113.307 0.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.9 t -82.1 -37.37 14.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.449 HG23 ' HA ' ' A' ' 71' ' ' ARG . 17.6 mm -103.18 118.61 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-O 122.008 0.909 . . . . 0.0 108.704 172.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.7 mt -82.36 170.32 15.21 Favored Pre-proline 0 C--N 1.293 -1.867 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.162 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -69.25 -13.06 35.31 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.437 2.092 . . . . 0.0 111.944 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -92.28 1.38 57.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 122.136 0.97 . . . . 0.0 108.42 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.449 ' HA ' HG23 ' A' ' 67' ' ' ILE . 16.6 ttm180 63.7 29.77 14.89 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 124.288 1.995 . . . . 0.0 109.954 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.1 m -75.07 136.42 41.17 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-N 112.457 -2.156 . . . . 0.0 106.309 173.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.687 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 6.3 t -91.53 119.11 38.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 125.352 1.461 . . . . 0.0 108.614 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.411 HD11 ' HG3' ' A' ' 30' ' ' ARG . 5.2 mp -99.72 122.84 43.32 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 122.052 0.929 . . . . 0.0 111.427 175.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.8 m -111.2 123.83 50.98 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.587 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -115.38 124.18 6.21 Favored Glycine 0 N--CA 1.419 -2.443 0 C-N-CA 119.865 -1.16 . . . . 0.0 112.192 -175.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -139.07 172.89 12.17 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -81.65 137.0 35.5 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.411 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -62.01 -21.52 64.95 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 124.24 1.016 . . . . 0.0 112.18 -176.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.8 p -64.84 -31.75 73.13 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.247 1.019 . . . . 0.0 110.881 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.42 16.69 23.71 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.649 0.738 . . . . 0.0 110.765 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 . . . . . 0 C--N 1.31 -1.144 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.819 -175.824 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.479 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.0 m0 . . . . . 0 N--CA 1.441 -0.918 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HD2' ' CG ' ' A' ' 43' ' ' ASN . 34.6 mmtp -89.23 -178.62 5.69 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.445 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 1.1 m-20 -71.12 -34.24 70.88 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.573 -175.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.8 m -121.07 143.14 49.23 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.063 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.578 HD12 HG23 ' A' ' 79' ' ' THR . 6.1 tt -113.69 133.32 60.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.8 mm -121.43 115.31 46.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -173.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -95.17 127.5 41.27 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -98.24 110.83 23.35 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.626 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 7.4 m-85 . . . . . 0 C--N 1.299 -1.609 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.444 -0.744 0 CA-C-O 122.372 1.082 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -97.55 -52.71 3.68 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.354 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -121.74 161.76 22.02 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.718 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 39' ' ' ILE . 13.7 mm -124.9 128.49 73.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 124.496 1.118 . . . . 0.0 109.118 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -135.14 169.51 17.34 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.479 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.8 t -153.68 144.01 22.3 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.8 152.61 40.59 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.438 ' CG ' ' HD2' ' A' ' 24' ' ' LYS . 61.2 m-20 -74.16 164.11 27.02 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.592 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.445 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 3.4 ptt180 -62.88 116.56 5.38 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 171.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 74.4 50.08 0.1 Allowed 'General case' 0 C--O 1.242 0.695 0 C-N-CA 126.237 1.815 . . . . 0.0 110.744 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -128.59 131.34 48.15 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.671 -175.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 44.2 tt0 -101.98 114.62 28.9 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.53 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 pt -98.94 -176.75 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 124.25 1.02 . . . . 0.0 108.49 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.47 131.2 43.32 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.475 HD12 HG21 ' A' ' 55' ' ' VAL . 97.5 mt -127.62 106.52 15.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 54.19 43.02 31.23 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.958 0.885 . . . . 0.0 112.001 175.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 75.53 -1.51 3.0 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.14 2.176 . . . . 0.0 115.116 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -95.16 118.22 31.57 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.26 141.57 32.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 118.173 -1.411 . . . . 0.0 108.74 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 92.5 t -133.29 122.41 44.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.406 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -96.54 121.47 38.39 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.336 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.8 t -100.23 118.78 47.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -68.07 163.7 21.83 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.979 1.712 . . . . 0.0 108.465 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.402 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 1.4 pm0 -66.15 -17.68 64.87 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -171.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.02 14.37 22.06 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.233 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.6 m 65.83 76.82 0.31 Allowed 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 124.64 1.213 . . . . 0.0 112.281 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -157.18 120.54 2.21 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.485 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 73.7 Cg_endo -82.54 143.9 12.41 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 123.391 2.727 . . . . 0.0 114.399 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -130.51 131.16 23.17 Favored Pre-proline 0 CA--C 1.489 -1.391 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.654 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -72.08 162.12 90.49 Favored 'Cis proline' 0 C--N 1.313 -1.301 0 C-N-CA 124.416 -1.077 . . . . 0.0 114.225 -1.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 74' ' ' LEU . 65.6 t -89.34 -42.68 14.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.075 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mp -99.22 129.49 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.476 0.655 . . . . 0.0 109.533 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.4 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 51.0 mt -97.56 171.12 6.28 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.032 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.4 ' CD ' ' HB3' ' A' ' 68' ' ' LEU . 31.0 Cg_exo -67.09 -13.78 41.04 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.986 2.457 . . . . 0.0 112.362 -176.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -85.35 -12.28 52.59 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.1 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 71' ' ' ARG . 16.2 tpt180 72.32 31.9 1.76 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-O 123.886 1.803 . . . . 0.0 107.261 -171.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -74.27 127.27 32.55 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.626 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -92.46 115.81 32.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 125.492 1.517 . . . . 0.0 108.062 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.446 ' HB3' ' CG ' ' A' ' 63' ' ' PRO . 5.8 mp -97.48 129.07 44.7 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 122.326 1.06 . . . . 0.0 111.805 177.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.1 m -121.9 137.38 54.81 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.485 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -131.72 150.38 19.52 Favored Glycine 0 CA--C 1.474 -2.52 0 C-N-CA 119.331 -1.414 . . . . 0.0 109.672 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.511 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 11.1 t0 -163.4 173.91 12.61 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 174.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -69.95 134.94 48.9 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 118.853 0.751 . . . . 0.0 109.718 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.578 HG23 HD12 ' A' ' 27' ' ' ILE . 3.2 m -65.27 -28.19 69.16 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-O 121.756 0.789 . . . . 0.0 110.857 -177.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 p -67.66 -29.47 68.77 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.679 -176.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.93 11.9 34.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 122.438 1.113 . . . . 0.0 111.199 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.511 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 6.5 m-85 . . . . . 0 C--N 1.301 -1.508 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.465 -178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.523 ' CE3' HG21 ' A' ' 41' ' ' THR . 18.6 m95 . . . . . 0 N--CA 1.44 -0.936 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HD2' ' CG ' ' A' ' 43' ' ' ASN . 34.8 mmtp -77.96 -171.94 2.5 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.436 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 1.2 t70 -80.74 -31.38 36.0 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.205 1.002 . . . . 0.0 110.856 -172.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.4 m -120.44 146.63 46.03 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.239 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.572 HD12 HG23 ' A' ' 79' ' ' THR . 11.4 tt -118.01 133.46 64.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 75' ' ' SER . 28.3 mm -124.94 113.25 35.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -173.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.505 ' HB2' ' OG ' ' A' ' 75' ' ' SER . 82.2 mt-30 -96.01 133.22 40.5 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.723 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -98.87 110.97 23.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.638 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 59.8 m-85 . . . . . 0 C--N 1.296 -1.719 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 8.4 p . . . . . 0 N--CA 1.435 -1.183 0 CA-C-O 122.295 1.045 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -93.0 -60.68 1.74 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.615 -174.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -122.27 161.72 22.78 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.779 -176.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.8 mm -121.17 137.32 55.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.889 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -142.2 164.52 29.93 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.523 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.6 t -152.66 144.49 23.62 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.24 150.14 45.15 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 123.506 0.504 . . . . 0.0 110.98 -173.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.405 ' CG ' ' HD2' ' A' ' 24' ' ' LYS . 48.1 m-20 -75.12 156.0 36.47 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.514 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 6.8 ptt180 -60.61 109.82 1.13 Allowed 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 171.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 88.1 m-20 78.65 62.48 0.03 OUTLIER 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.254 1.822 . . . . 0.0 110.37 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -138.9 134.93 33.89 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.987 -178.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 2.6 mp0 -91.84 118.95 31.19 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 172.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.7 pt -98.37 174.08 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.324 0 N-CA-C 105.609 -1.996 . . . . 0.0 105.609 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 1.3 m -136.3 117.88 14.88 Favored 'General case' 0 N--CA 1.404 -2.755 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 176.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.434 HD12 HD21 ' A' ' 74' ' ' LEU . 73.1 mt -108.17 102.04 13.41 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.662 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 58.81 40.27 23.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.387 0.613 . . . . 0.0 112.483 170.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 73.27 9.6 5.18 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.246 1.818 . . . . 0.0 113.803 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -104.42 106.19 16.6 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -82.05 141.36 33.26 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.534 -178.784 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.0 t -132.79 119.46 37.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.518 -171.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 63.6 t80 -93.13 121.72 34.78 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.9 t -102.99 125.11 57.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 174.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -74.58 176.76 6.59 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 124.555 1.16 . . . . 0.0 108.657 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.514 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 9.8 pt-20 -65.44 -20.15 66.24 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.9 106.57 17.12 Favored 'General case' 0 N--CA 1.413 -2.318 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 170.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.4 m -40.42 89.45 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 127.578 2.351 . . . . 0.0 115.344 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -159.72 126.04 2.45 Favored Pre-proline 0 N--CA 1.438 -1.026 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.61 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 56.1 Cg_endo -85.76 146.68 9.34 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.888 2.392 . . . . 0.0 114.333 -175.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 54.9 m-85 -131.02 126.23 21.54 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.513 172.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 72.5 Cg_endo -81.95 164.11 75.47 Favored 'Cis proline' 0 C--N 1.323 -0.808 0 C-N-CA 122.742 -1.774 . . . . 0.0 113.173 -0.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 74' ' ' LEU . 92.6 t -82.59 -43.72 19.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.305 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 67' ' ' ILE . 4.7 mm -91.89 124.48 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 172.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.2 mt -89.27 168.38 15.43 Favored Pre-proline 0 C--N 1.303 -1.445 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.449 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -73.95 -1.17 10.47 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 123.198 2.598 . . . . 0.0 111.703 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -95.77 -9.06 32.69 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.186 -1.824 . . . . 0.0 109.073 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 60.25 57.22 2.99 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 123.572 1.653 . . . . 0.0 108.2 -169.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 m -102.57 135.05 44.91 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 173.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.638 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.6 t -91.61 115.61 31.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 125.496 1.748 . . . . 0.0 107.783 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.434 HD21 HD12 ' A' ' 50' ' ' ILE . 4.7 mp -101.04 135.82 41.87 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.426 -0.796 . . . . 0.0 111.758 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.505 ' OG ' ' HB2' ' A' ' 29' ' ' GLN . 81.1 p -117.36 142.76 46.71 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.61 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -128.68 132.99 7.46 Favored Glycine 0 CA--C 1.479 -2.173 0 C-N-CA 119.64 -1.267 . . . . 0.0 110.345 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -150.69 172.54 15.4 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -75.56 135.05 40.58 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.572 HG23 HD12 ' A' ' 27' ' ' ILE . 2.8 m -59.93 -19.91 54.45 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -175.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.8 p -66.94 -40.05 87.48 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.594 1.158 . . . . 0.0 110.947 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.24 11.29 6.78 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.397 1.094 . . . . 0.0 112.009 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 . . . . . 0 C--N 1.298 -1.665 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.561 -178.645 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.488 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.2 m95 . . . . . 0 N--CA 1.437 -1.1 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -84.59 -172.2 4.04 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.956 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -78.47 -27.39 46.29 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.956 0.884 . . . . 0.0 112.571 -171.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.8 m -124.29 148.54 47.34 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.611 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.586 HD12 HG23 ' A' ' 79' ' ' THR . 13.9 tt -120.79 133.62 66.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 27' ' ' ILE . 31.8 mm -128.75 112.29 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -173.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 75' ' ' SER . 96.9 mt-30 -97.45 131.67 43.88 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.589 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 46.3 ttt180 -97.13 114.17 25.82 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.642 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 21.3 m-85 . . . . . 0 N--CA 1.427 -1.617 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 9.5 p . . . . . 0 N--CA 1.447 -0.602 0 CA-C-O 121.656 0.741 . . . . 0.0 112.227 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.68 -50.79 2.97 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.663 0.744 . . . . 0.0 110.483 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.589 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 8.2 m120 -119.22 151.87 37.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.914 -173.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 mp -120.06 122.59 68.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -126.18 167.32 15.58 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.488 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.4 t -153.45 142.31 21.12 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.73 154.19 43.22 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 124.232 0.958 . . . . 0.0 108.914 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -75.71 161.71 28.84 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.021 0.438 . . . . 0.0 111.045 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -66.14 116.79 7.6 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.454 0.645 . . . . 0.0 110.303 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.587 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 38.8 m-80 72.95 64.79 0.1 Allowed 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 126.826 2.05 . . . . 0.0 109.161 -172.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -142.23 131.16 23.02 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 33.9 tt0 -98.19 113.66 25.65 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.443 177.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.8 pt -94.3 -176.2 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.2 m -135.97 136.69 40.58 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.3 mt -127.64 108.49 18.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 54.46 40.49 31.84 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.781 0.801 . . . . 0.0 111.695 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.257 36.0 mm-40 70.23 12.91 7.68 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 126.03 1.732 . . . . 0.0 115.068 -178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -103.37 122.2 44.35 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 172.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -85.77 142.08 29.22 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 118.591 -1.243 . . . . 0.0 109.853 -178.446 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 86.1 t -133.29 124.62 49.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.571 -175.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 62.8 t80 -96.08 119.02 33.83 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 61.0 t -94.97 120.14 43.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -77.16 174.54 10.59 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.587 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 9.7 pt-20 -75.63 -6.27 49.56 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -172.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.66 11.18 36.3 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.816 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 80.3 m 66.2 55.26 0.89 Allowed 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.377 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -136.74 122.59 13.35 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.463 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 98.2 Cg_endo -81.71 146.51 14.98 Favored 'Trans proline' 0 C--N 1.328 -0.512 0 C-N-CA 123.436 2.757 . . . . 0.0 114.098 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -129.84 134.84 26.64 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.651 172.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.87 161.35 79.03 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.158 -2.017 . . . . 0.0 111.495 -2.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.4 t -79.15 -29.78 13.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.274 -176.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 67' ' ' ILE . 8.3 mm -103.96 121.83 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-O 121.773 0.797 . . . . 0.0 110.265 173.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.3 mt -85.75 165.57 34.32 Favored Pre-proline 0 C--N 1.3 -1.58 0 CA-C-N 113.899 -1.501 . . . . 0.0 109.135 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.47 -18.11 54.23 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.723 2.282 . . . . 0.0 112.737 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -87.19 -0.18 56.3 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.231 -1.349 . . . . 0.0 109.598 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 64.48 58.33 1.07 Allowed 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 124.725 2.202 . . . . 0.0 108.823 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.1 m -115.29 135.08 54.52 Favored 'General case' 0 N--CA 1.403 -2.821 0 CA-C-N 111.95 -2.386 . . . . 0.0 106.331 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.642 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.2 t -91.13 123.8 43.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 127.197 2.199 . . . . 0.0 107.792 -176.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mp -100.72 122.28 43.09 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.922 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.408 ' HB3' ' HB2' ' A' ' 29' ' ' GLN . 42.8 t -101.85 118.63 37.33 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -125.66 139.84 11.8 Favored Glycine 0 N--CA 1.424 -2.159 0 C-N-CA 119.015 -1.564 . . . . 0.0 111.647 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -159.57 177.39 10.96 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -73.47 139.88 46.08 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.586 HG23 HD12 ' A' ' 27' ' ' ILE . 1.3 m -67.66 -10.55 53.32 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.643 0.735 . . . . 0.0 111.535 -177.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.9 t -67.53 -40.24 85.07 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.46 14.69 12.35 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.486 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 . . . . . 0 C--N 1.293 -1.863 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.059 -177.201 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.521 ' CE3' HG21 ' A' ' 41' ' ' THR . 16.7 m95 . . . . . 0 N--CA 1.44 -0.974 0 CA-C-O 121.119 0.485 . . . . 0.0 111.537 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.487 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 70.6 mmtt -91.96 -171.89 2.99 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.464 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -81.28 -33.99 32.32 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 122.069 0.937 . . . . 0.0 110.835 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 70.3 m -120.5 144.31 48.09 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.57 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.668 HD12 HG23 ' A' ' 79' ' ' THR . 14.7 tt -121.09 133.49 67.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-O 121.225 0.536 . . . . 0.0 109.952 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.401 HD12 ' C ' ' A' ' 27' ' ' ILE . 1.7 mp -113.07 112.77 41.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 122.564 1.173 . . . . 0.0 109.529 -178.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.51 ' OE1' HG21 ' A' ' 36' ' ' VAL . 66.2 mm-40 -91.51 112.33 24.2 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 113.245 -1.798 . . . . 0.0 106.761 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.401 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 56.1 ttt180 -92.22 110.89 22.29 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.664 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 76.4 m-85 . . . . . 0 C--N 1.304 -1.398 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.51 HG21 ' OE1' ' A' ' 29' ' ' GLN . 7.7 p . . . . . 0 N--CA 1.439 -0.989 0 CA-C-O 122.1 0.952 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -91.25 -48.48 6.9 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.118 0.961 . . . . 0.0 111.027 -174.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 30' ' ' ARG . 15.6 m120 -123.26 152.83 40.95 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.694 -177.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.2 mt -128.31 120.77 53.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.717 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -118.69 165.75 13.6 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.521 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.5 t -150.64 143.65 24.72 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.53 153.88 45.15 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.162 -174.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -78.71 160.29 27.54 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.746 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 44' ' ' ARG . 4.2 ptt180 -56.81 118.38 4.86 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.58 173.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.51 ' ND2' ' HB3' ' A' ' 59' ' ' GLU 0.266 58.8 m-80 68.35 68.69 0.32 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.704 1.602 . . . . 0.0 110.488 -173.432 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -146.89 136.28 22.78 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.755 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 42.1 tt0 -104.83 120.38 41.27 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.336 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.7 pt -103.04 -177.54 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.2 m -137.87 139.57 39.95 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.2 mt -134.49 113.21 16.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 53.39 39.04 29.3 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.88 0.848 . . . . 0.0 111.938 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 69.61 17.62 7.82 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 125.494 1.518 . . . . 0.0 112.826 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -103.93 117.77 35.11 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 172.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.447 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -78.95 146.25 33.56 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.984 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.8 t -138.08 115.84 12.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.828 -174.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 90.7 t80 -94.57 127.11 40.3 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.157 0.503 . . . . 0.0 110.205 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.8 t -104.25 122.01 56.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -78.7 175.24 10.62 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 123.639 0.587 . . . . 0.0 109.539 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.51 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -64.99 -21.9 66.92 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -171.524 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.75 12.15 28.9 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.664 -177.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 56.4 m 66.29 80.86 0.21 Allowed 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 124.032 0.833 . . . . 0.0 111.535 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -161.44 127.68 2.4 Favored Pre-proline 0 N--CA 1.442 -0.858 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.535 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 28.3 Cg_endo -92.19 149.9 3.1 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.069 2.513 . . . . 0.0 114.985 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -131.21 135.8 27.74 Favored Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.734 169.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -77.06 165.62 84.45 Favored 'Cis proline' 0 C--N 1.326 -0.641 0 C-N-CA 122.865 -1.723 . . . . 0.0 112.479 -1.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 74' ' ' LEU . 57.6 t -87.41 -47.98 15.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -176.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -92.02 121.3 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 121.883 0.849 . . . . 0.0 109.186 170.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.3 mt -85.31 164.78 39.4 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 114.247 -1.342 . . . . 0.0 108.274 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -70.33 -10.56 28.37 Favored 'Trans proline' 0 N--CA 1.483 0.909 0 C-N-CA 122.849 2.366 . . . . 0.0 111.658 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -84.89 -11.05 56.45 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.565 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.404 17.2 ttm180 65.69 58.69 0.78 Allowed 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 124.528 2.109 . . . . 0.0 111.813 -174.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.9 m -114.25 138.27 50.7 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 111.231 -2.713 . . . . 0.0 106.616 172.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.664 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -91.42 115.92 31.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 125.408 1.692 . . . . 0.0 107.993 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.452 ' O ' HG13 ' A' ' 66' ' ' VAL . 6.6 mp -99.89 122.76 43.32 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.975 0.893 . . . . 0.0 112.091 177.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.8 m -119.12 118.81 32.39 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.268 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.535 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -101.82 131.39 10.57 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -139.76 168.93 18.7 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -75.61 139.5 42.08 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.668 HG23 HD12 ' A' ' 27' ' ' ILE . 2.4 m -68.54 -20.38 64.55 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.244 0.545 . . . . 0.0 110.966 -177.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.4 t -58.73 -38.58 78.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.157 -177.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.72 21.26 8.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.392 0.615 . . . . 0.0 112.371 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 . . . . . 0 C--N 1.302 -1.461 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -178.236 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.559 ' CE3' HG21 ' A' ' 41' ' ' THR . 10.7 m95 . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.45 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 32.3 mmtp -96.14 -175.63 3.43 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 175.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.486 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 3.6 m-20 -75.24 -33.16 61.28 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.505 0.669 . . . . 0.0 112.592 -176.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.2 m -121.64 140.01 52.82 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.654 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.52 HD12 HG23 ' A' ' 79' ' ' THR . 5.4 tt -113.36 131.72 64.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -177.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.7 mm -119.57 112.37 36.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-O 121.891 0.853 . . . . 0.0 108.732 -173.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -94.69 125.5 39.38 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.488 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.433 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 52.8 ttt180 -95.09 112.72 24.4 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.695 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 25.8 m-85 . . . . . 0 CA--C 1.484 -1.569 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.432 -1.361 0 CA-C-O 121.979 0.895 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -84.99 -50.69 7.26 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.486 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.433 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 16.9 m120 -119.07 149.76 41.12 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.95 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.9 mp -116.51 116.33 51.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -119.07 169.44 9.92 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.559 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.6 t -154.43 146.86 23.98 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.4 154.51 40.95 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -75.51 157.09 34.45 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.586 176.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.486 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 2.1 ptt180 -59.91 116.4 4.09 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 121.333 0.587 . . . . 0.0 109.986 170.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.6 m120 75.23 67.27 0.07 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.193 -1.822 . . . . 0.0 108.331 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -152.64 128.84 10.47 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.478 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 2.7 mp0 -86.85 135.89 33.16 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.004 173.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.7 pt -113.99 -179.99 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.12 132.09 37.68 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 86.5 mt -125.53 107.01 17.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 55.06 41.26 31.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.302 1.049 . . . . 0.0 112.65 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 71.51 6.87 5.87 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.943 2.097 . . . . 0.0 112.433 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -93.87 112.34 24.17 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 175.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -83.1 130.61 35.13 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 63.3 t -126.43 120.61 56.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.05 -173.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 56.8 t80 -94.5 121.99 36.62 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.4 t -97.25 125.07 50.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -78.67 175.28 10.56 Favored 'General case' 0 N--CA 1.439 -1.018 0 O-C-N 124.72 1.263 . . . . 0.0 108.002 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.486 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -74.12 -16.52 61.01 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -173.726 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.63 6.13 21.91 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.089 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 76.7 m 71.49 30.32 2.5 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 122.29 1.043 . . . . 0.0 113.319 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -114.54 124.07 31.22 Favored Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 113.736 -1.575 . . . . 0.0 107.898 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.507 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 60.3 Cg_endo -83.97 147.25 11.81 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 123.469 2.779 . . . . 0.0 114.549 -177.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -132.38 131.25 22.21 Favored Pre-proline 0 CA--C 1.493 -1.229 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.065 172.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -76.65 161.66 93.23 Favored 'Cis proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.644 -1.815 . . . . 0.0 112.948 -0.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 74' ' ' LEU . 57.3 t -82.98 -48.24 17.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.539 HG12 ' NH2' ' A' ' 71' ' ' ARG . 1.7 mp -96.38 122.6 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.261 172.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.426 ' C ' ' H ' ' A' ' 70' ' ' ASP . 54.0 mt -80.19 169.61 19.13 Favored Pre-proline 0 C--N 1.296 -1.76 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.101 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -76.04 5.64 4.36 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.99 2.46 . . . . 0.0 109.72 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 68' ' ' LEU . 27.5 t70 -99.93 -10.52 21.59 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 112.686 -2.052 . . . . 0.0 111.223 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.539 ' NH2' HG12 ' A' ' 67' ' ' ILE . 8.6 tpm_? 75.38 18.28 2.37 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.57 1.148 . . . . 0.0 110.243 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.4 m -82.6 140.52 33.17 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 170.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.695 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 7.7 t -90.85 124.76 43.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 126.336 1.854 . . . . 0.0 108.063 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 66' ' ' VAL . 5.4 mp -103.74 122.68 45.58 Favored 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.689 173.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.5 m -117.28 118.2 31.62 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.507 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -114.03 147.38 18.72 Favored Glycine 0 N--CA 1.419 -2.482 0 C-N-CA 118.84 -1.647 . . . . 0.0 110.546 -177.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -150.2 176.51 10.79 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -78.08 136.55 37.91 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.52 HG23 HD12 ' A' ' 27' ' ' ILE . 3.7 m -69.76 -19.11 63.53 Favored 'General case' 0 C--O 1.242 0.686 0 O-C-N 122.058 -0.401 . . . . 0.0 110.014 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.3 p -56.53 -33.16 65.79 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.33 1.452 . . . . 0.0 111.761 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.54 12.71 31.0 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.648 0.737 . . . . 0.0 112.511 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 C--N 1.302 -1.459 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -175.818 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.681 ' HB3' HG21 ' A' ' 79' ' ' THR . 82.2 m95 . . . . . 0 N--CA 1.427 -1.614 0 CA-C-O 121.581 0.705 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.413 ' HD2' ' OD1' ' A' ' 43' ' ' ASN . 43.9 mmtm -87.0 -170.88 3.25 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.499 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.516 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 21.2 m-20 -76.02 -28.87 57.92 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.707 0.765 . . . . 0.0 112.298 -174.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.8 m -127.18 147.11 50.2 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.421 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.555 HD12 HG23 ' A' ' 79' ' ' THR . 10.7 tt -118.42 133.35 65.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.9 mm -123.98 112.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -97.21 125.54 41.81 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -93.26 111.02 22.55 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.658 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 34.7 m-85 . . . . . 0 C--N 1.303 -1.456 0 C-N-CA 123.61 0.764 . . . . 0.0 110.453 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 4.1 p . . . . . 0 N--CA 1.429 -1.522 0 CA-C-O 122.366 1.079 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -84.31 -58.74 2.63 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.473 -175.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -121.93 157.67 30.73 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.246 0.546 . . . . 0.0 111.443 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.0 mm -116.35 136.17 54.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.506 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -142.73 164.3 30.49 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.6 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.6 t -152.15 142.61 22.6 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 176.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.12 155.52 46.95 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.495 -173.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.413 ' OD1' ' HD2' ' A' ' 24' ' ' LYS . 83.3 m-20 -73.16 154.44 40.31 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.516 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 14.1 ptt180 -66.62 116.22 7.32 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 121.819 -0.551 . . . . 0.0 110.651 172.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 76.95 67.33 0.05 Allowed 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 126.059 1.744 . . . . 0.0 108.62 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -146.27 131.25 18.21 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.521 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 42.2 tt0 -97.66 109.0 21.84 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.425 ' CG1' ' HB ' ' A' ' 55' ' ' VAL . 23.6 pt -92.53 -179.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 3.1 m -136.89 129.79 30.73 Favored 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 172.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.444 HD12 HD21 ' A' ' 74' ' ' LEU . 68.7 mt -119.43 110.23 28.86 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 57.51 39.37 27.94 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.879 0.847 . . . . 0.0 111.625 172.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 73.67 7.22 5.02 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.411 1.884 . . . . 0.0 113.312 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -102.42 119.57 39.04 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -81.0 153.38 27.47 Favored 'General case' 0 N--CA 1.435 -1.225 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.849 -178.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 95.9 t -146.24 125.08 4.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.993 -175.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 77.7 t80 -98.66 118.9 36.41 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.9 t -97.98 118.08 43.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -81.28 170.86 15.53 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -65.75 -15.58 62.98 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -172.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.13 0.51 31.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.938 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 71.9 m 72.44 26.79 2.53 Favored 'General case' 0 CA--C 1.487 -1.449 0 C-N-CA 124.55 1.14 . . . . 0.0 112.625 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -113.22 121.19 38.54 Favored Pre-proline 0 C--N 1.287 -2.113 0 CA-C-N 112.9 -1.955 . . . . 0.0 108.306 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.556 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 45.7 Cg_endo -85.66 144.19 8.72 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 124.093 3.195 . . . . 0.0 115.26 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -129.58 134.07 25.8 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.729 172.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -79.05 153.52 89.8 Favored 'Cis proline' 0 C--N 1.323 -0.815 0 C-N-CA 122.67 -1.804 . . . . 0.0 112.603 1.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 74' ' ' LEU . 86.2 t -75.05 -35.39 34.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.82 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.0 mm -102.87 125.18 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.359 174.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.1 mt -84.68 165.46 37.55 Favored Pre-proline 0 C--N 1.29 -1.983 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.17 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -70.4 -8.85 24.59 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 C-N-CA 123.038 2.492 . . . . 0.0 112.167 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -88.61 -7.62 56.09 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.587 177.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 67.82 57.76 0.51 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 123.886 1.803 . . . . 0.0 108.817 -173.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.9 m -112.8 140.63 47.43 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-N 112.665 -2.061 . . . . 0.0 107.082 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.658 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.7 t -91.81 115.93 31.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 125.233 1.583 . . . . 0.0 108.696 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.444 HD21 HD12 ' A' ' 50' ' ' ILE . 3.6 mp -96.24 122.68 39.36 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.049 174.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 64.9 m -117.82 117.46 29.36 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.556 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -120.82 137.8 12.25 Favored Glycine 0 N--CA 1.411 -2.993 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.963 -177.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.436 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 9.3 m-20 -145.56 173.73 11.79 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -72.58 138.43 46.83 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.681 HG21 ' HB3' ' A' ' 23' ' ' TRP . 1.8 m -68.84 -18.54 64.17 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.224 0.535 . . . . 0.0 111.802 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 p -63.02 -25.5 68.41 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.368 0.604 . . . . 0.0 111.523 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.71 20.2 18.34 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.026 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.436 ' CE1' ' HB2' ' A' ' 77' ' ' ASP . 7.7 m-85 . . . . . 0 C--N 1.308 -1.224 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.794 -174.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.596 ' HB3' HG21 ' A' ' 79' ' ' THR . 71.4 m95 . . . . . 0 N--CA 1.429 -1.506 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.553 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 10.8 mmpt? -88.91 -170.21 2.82 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 123.498 0.719 . . . . 0.0 111.449 -176.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.495 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 4.7 m-20 -69.3 -34.46 74.73 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -173.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.0 m -126.97 147.22 50.12 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.869 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.553 HD12 HG23 ' A' ' 79' ' ' THR . 8.2 tt -116.74 133.35 63.66 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 75' ' ' SER . 33.4 mm -125.94 111.61 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -174.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.535 ' HB2' ' HB3' ' A' ' 75' ' ' SER . 97.6 mt-30 -102.51 132.09 48.79 Favored 'General case' 0 C--N 1.282 -2.336 0 O-C-N 121.652 -0.655 . . . . 0.0 109.675 -177.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -92.9 109.85 21.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.587 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 10.2 m-85 . . . . . 0 C--N 1.297 -1.696 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 31' ' ' TYR 0.253 7.1 p . . . . . 0 N--CA 1.432 -1.361 0 CA-C-O 122.108 0.956 . . . . 0.0 110.894 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -97.11 -60.67 1.54 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.689 -174.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.402 ' C ' HD12 ' A' ' 39' ' ' ILE . 96.5 m-20 -119.91 158.38 26.8 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.35 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.402 HD12 ' C ' ' A' ' 38' ' ' ASN . 2.9 mp -125.54 121.75 60.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -123.02 169.94 10.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.489 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.6 t -149.95 142.08 24.04 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.4 160.06 40.49 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.496 -173.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -79.73 158.49 26.9 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.495 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 5.2 ptt180 -64.94 111.89 3.05 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 170.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.554 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 89.4 m-20 76.63 67.53 0.06 Allowed 'General case' 0 C--O 1.243 0.735 0 CA-C-O 123.321 1.534 . . . . 0.0 109.949 -176.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -144.16 123.08 12.74 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 112.581 -2.099 . . . . 0.0 110.46 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 46.6 tt0 -89.4 109.73 20.61 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 173.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.6 pt -92.99 -176.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 177.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 4.5 m -136.32 131.37 34.24 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 176.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 97.5 mt -132.62 108.45 13.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 58.81 35.01 24.08 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 122.91 1.338 . . . . 0.0 110.342 176.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 72.79 5.13 5.16 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 127.847 2.459 . . . . 0.0 113.683 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -92.01 114.27 26.77 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 174.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -80.36 140.54 36.03 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 117.925 -1.51 . . . . 0.0 108.135 178.316 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 86.1 t -133.23 123.18 46.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.011 -170.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 92.7 t80 -91.26 118.69 30.69 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.276 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 45' ' ' ASN . 64.6 t -95.67 119.33 43.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 174.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -77.33 165.03 24.98 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 124.33 1.018 . . . . 0.0 108.738 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.554 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -62.33 -19.98 63.88 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -173.338 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.82 11.36 11.37 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.401 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.6 m 62.65 68.05 0.67 Allowed 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.163 0.982 . . . . 0.0 110.438 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -153.19 120.54 3.01 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.608 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 55.6 Cg_endo -86.24 154.27 9.49 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.768 2.979 . . . . 0.0 114.314 -177.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -135.78 132.09 19.37 Favored Pre-proline 0 CA--C 1.483 -1.634 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.898 172.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.42 168.19 75.97 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.805 -1.748 . . . . 0.0 112.378 -2.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.0 t -88.61 -48.09 15.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.752 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -92.5 124.81 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.683 0.754 . . . . 0.0 109.893 173.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.5 mt -83.82 168.22 23.34 Favored Pre-proline 0 C--N 1.299 -1.593 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.983 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -64.67 -21.24 65.37 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.458 2.105 . . . . 0.0 111.135 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -83.43 -3.55 57.68 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 125.848 1.659 . . . . 0.0 110.934 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 18.4 tpt180 77.38 6.44 3.0 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.049 1.74 . . . . 0.0 110.747 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.1 m -67.95 134.09 50.19 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 122.134 0.969 . . . . 0.0 109.601 173.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.7 t -91.07 125.32 43.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 C-N-CA 128.493 2.717 . . . . 0.0 107.647 -175.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 mp -98.28 122.35 41.34 Favored 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.964 174.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' ' 29' ' ' GLN . 30.3 t -97.83 118.36 34.22 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.608 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -122.0 126.04 6.31 Favored Glycine 0 N--CA 1.416 -2.686 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.457 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 5.4 t70 -153.71 172.06 17.87 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -73.31 140.87 47.05 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.596 HG21 ' HB3' ' A' ' 23' ' ' TRP . 3.7 m -71.68 -16.45 62.24 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.559 0.695 . . . . 0.0 109.632 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . 0.264 1.5 m -59.99 -22.55 62.7 Favored 'General case' 0 N--CA 1.411 -2.417 0 C-N-CA 126.238 1.815 . . . . 0.0 111.627 178.036 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.8 15.99 16.33 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 122.541 1.162 . . . . 0.0 110.066 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.457 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 31.9 m-85 . . . . . 0 C--N 1.296 -1.732 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.202 -176.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.55 ' CE3' HG21 ' A' ' 41' ' ' THR . 13.5 m0 . . . . . 0 N--CA 1.445 -0.676 0 CA-C-O 121.518 0.675 . . . . 0.0 109.919 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.526 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 34.8 mmtp -73.51 -173.47 1.43 Allowed 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.129 0.966 . . . . 0.0 108.675 174.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.553 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 6.7 m-20 -83.5 -33.58 25.52 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.704 -174.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 69.2 m -123.5 140.41 53.03 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.358 -176.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.64 HD12 HG23 ' A' ' 79' ' ' THR . 7.2 tt -113.87 133.26 60.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.4 mm -122.23 112.33 34.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -174.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.614 ' HB2' ' OG ' ' A' ' 75' ' ' SER . 96.8 mt-30 -96.69 127.63 42.86 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.5 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 58.5 ttt180 -95.78 112.33 24.08 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.529 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 56.9 m-85 . . . . . 0 C--N 1.3 -1.549 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 10.9 p . . . . . 0 N--CA 1.433 -1.319 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -99.44 -46.52 5.46 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.316 -173.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.5 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 14.6 m120 -130.18 159.01 38.13 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.841 -176.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.8 mm -118.73 134.11 63.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 123.524 0.73 . . . . 0.0 110.799 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -141.18 165.09 28.48 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.55 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.4 t -157.33 144.35 18.4 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.445 ' HB2' HG23 ' A' ' 48' ' ' ILE . . . -140.17 156.43 46.53 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.189 0.596 . . . . 0.0 110.733 -174.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -74.88 157.58 34.82 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.553 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 8.1 ptt180 -62.81 107.86 1.06 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 171.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 83.57 62.09 0.01 OUTLIER 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.95 2.1 . . . . 0.0 110.681 -176.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -144.79 132.28 20.87 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.872 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 3.5 mp0 -87.3 112.45 22.08 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 172.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.445 HG23 ' HB2' ' A' ' 42' ' ' ALA . 23.1 pt -88.79 179.65 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 172.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.7 m -132.13 133.83 44.73 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 85.8 mt -127.1 106.08 14.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 56.24 38.83 30.18 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.408 1.099 . . . . 0.0 111.821 176.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 64.78 28.7 12.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.742 -1.572 . . . . 0.0 114.335 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -113.42 109.98 19.56 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 169.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.67 136.96 37.59 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 118.005 -1.478 . . . . 0.0 108.827 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.4 t -124.4 114.35 40.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.513 -174.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 79.1 t80 -82.92 115.79 21.93 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.1 t -97.18 118.75 44.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -75.38 173.07 11.41 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 125.162 1.539 . . . . 0.0 108.415 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -20.83 65.99 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -172.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.73 12.19 11.34 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.51 0.671 . . . . 0.0 110.006 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.9 m 68.58 31.1 4.87 Favored 'General case' 0 C--O 1.199 -1.585 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.925 175.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -109.72 119.79 46.79 Favored Pre-proline 0 C--N 1.288 -2.069 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.349 -177.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.604 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 83.7 Cg_endo -83.34 143.16 11.01 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.447 2.765 . . . . 0.0 113.516 -177.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 86.9 m-85 -129.43 132.02 24.0 Favored Pre-proline 0 N--CA 1.432 -1.329 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.691 173.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 62.9 Cg_endo -80.7 165.97 76.04 Favored 'Cis proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.514 -1.869 . . . . 0.0 112.181 -2.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.3 t -83.44 -39.7 15.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.866 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 mp -96.67 123.55 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 CA-C-O 121.386 0.612 . . . . 0.0 109.503 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.4 mt -84.6 167.44 26.85 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.012 177.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -70.72 -7.3 21.03 Favored 'Trans proline' 0 N--CA 1.484 0.951 0 C-N-CA 122.915 2.41 . . . . 0.0 112.671 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -89.82 -12.01 40.38 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.048 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.38 37.1 ttm180 67.62 58.69 0.5 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 124.032 1.872 . . . . 0.0 110.516 -169.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.7 m -103.48 136.44 43.21 Favored 'General case' 0 N--CA 1.408 -2.527 0 CA-C-N 111.861 -2.427 . . . . 0.0 105.11 172.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.3 t -93.27 115.69 32.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 124.855 1.347 . . . . 0.0 108.29 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.6 mp -97.22 126.87 42.7 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.452 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 29' ' ' GLN . 51.4 p -107.69 129.7 55.0 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.604 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -114.42 118.01 4.26 Favored Glycine 0 N--CA 1.418 -2.534 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.953 -177.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -131.28 169.48 15.92 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -86.84 134.07 33.58 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 177.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.64 HG23 HD12 ' A' ' 27' ' ' ILE . 1.5 m -71.55 -13.85 61.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.954 0.407 . . . . 0.0 111.854 -175.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.4 p -69.69 -31.83 70.08 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.53 0.681 . . . . 0.0 110.765 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.24 17.46 21.27 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 122.437 1.113 . . . . 0.0 110.222 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 . . . . . 0 C--N 1.302 -1.489 0 C-N-CA 125.83 1.652 . . . . 0.0 108.55 -178.422 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.562 ' HB3' HG21 ' A' ' 79' ' ' THR . 41.7 m95 . . . . . 0 N--CA 1.435 -1.215 0 CA-C-O 121.283 0.564 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.517 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . 9.1 mmpt? -79.47 -173.68 3.85 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.151 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -76.15 -24.38 54.84 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.5 m -132.52 155.58 48.36 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.462 HD12 HG23 ' A' ' 79' ' ' THR . 8.6 tt -125.37 133.68 68.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -178.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.438 HD13 ' O ' ' A' ' 27' ' ' ILE . 25.6 mm -125.08 111.3 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -175.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -103.38 130.33 50.66 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.144 0.497 . . . . 0.0 110.21 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -99.44 115.27 28.89 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.404 -175.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.743 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 27.9 m-85 . . . . . 0 C--N 1.294 -1.847 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.435 -1.176 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -91.61 -43.79 9.42 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.217 -171.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -129.72 151.16 50.61 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -119.72 115.06 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -119.17 166.01 13.48 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.56 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.3 t -150.81 142.72 23.89 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.11 160.91 41.85 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -174.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.436 ' OD1' ' HB3' ' A' ' 24' ' ' LYS . 90.7 m-20 -85.27 164.93 17.73 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 121.769 0.795 . . . . 0.0 112.217 176.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.423 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 5.5 ptt85 -62.26 110.16 1.55 Allowed 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.947 169.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 75.6 67.21 0.07 Allowed 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.719 1.208 . . . . 0.0 109.015 -177.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -152.48 143.71 23.22 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 124.662 1.185 . . . . 0.0 107.932 -178.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -115.56 135.96 53.55 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 121.489 0.661 . . . . 0.0 110.655 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.478 ' CG1' ' HB ' ' A' ' 55' ' ' VAL . 29.1 pt -119.05 -179.99 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 1.7 m -137.62 135.13 36.3 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.6 mt -127.55 108.2 17.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.85 49.54 20.85 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 70.09 5.73 5.43 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.023 1.329 . . . . 0.0 113.277 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -104.16 109.63 21.5 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -75.1 154.11 38.0 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.991 0.9 . . . . 0.0 112.245 178.619 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.478 ' HB ' ' CG1' ' A' ' 48' ' ' ILE . 88.6 t -142.59 118.08 5.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 CA-C-N 113.546 -1.661 . . . . 0.0 109.842 -173.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -102.51 123.7 46.74 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.2 t -97.99 119.38 45.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -80.62 172.0 14.31 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.423 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 9.9 pt-20 -67.27 -5.58 14.67 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -172.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.61 13.68 31.16 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.711 172.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.0 m 69.83 33.96 2.74 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.518 1.152 . . . . 0.0 111.8 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -114.88 119.05 39.91 Favored Pre-proline 0 C--N 1.286 -2.17 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.672 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.577 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 83.6 Cg_endo -83.98 147.95 11.96 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.795 2.997 . . . . 0.0 114.115 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 70.7 m-85 -130.07 129.91 23.02 Favored Pre-proline 0 CA--C 1.488 -1.433 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.227 172.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.27 161.25 81.46 Favored 'Cis proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.923 -1.699 . . . . 0.0 112.354 -2.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.1 t -81.88 -36.76 14.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.265 0.555 . . . . 0.0 109.631 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.9 mm -106.42 127.08 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 173.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 39.4 mt -87.44 171.77 9.2 Favored Pre-proline 0 C--N 1.289 -2.035 0 CA-C-N 114.174 -1.376 . . . . 0.0 109.865 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -71.29 -12.02 29.38 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.551 2.167 . . . . 0.0 110.864 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -87.56 -0.14 56.43 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 125.836 1.654 . . . . 0.0 108.303 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 60.34 26.93 16.47 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 127.849 2.46 . . . . 0.0 109.361 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.13 135.57 47.72 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.743 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 5.5 t -90.89 117.48 34.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 125.704 1.878 . . . . 0.0 108.301 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.45 121.83 42.66 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.586 -1.246 . . . . 0.0 112.265 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.0 m -97.51 118.04 33.12 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 175.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.577 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -116.93 111.66 2.35 Favored Glycine 0 N--CA 1.422 -2.262 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.498 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.474 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 19.3 m-20 -142.69 177.21 8.47 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -78.03 139.53 39.11 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.562 HG21 ' HB3' ' A' ' 23' ' ' TRP . 0.2 OUTLIER -62.8 -21.77 66.13 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.139 0.975 . . . . 0.0 112.854 -176.272 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 p -71.49 -24.85 62.06 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.595 0.712 . . . . 0.0 111.32 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.37 14.9 24.62 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.916 0.865 . . . . 0.0 111.178 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.474 ' CE1' ' HB2' ' A' ' 77' ' ' ASP . 37.5 m-85 . . . . . 0 C--N 1.305 -1.354 0 C-N-CA 124.716 1.206 . . . . 0.0 111.432 -176.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.543 ' CE3' HG21 ' A' ' 41' ' ' THR . 12.1 m95 . . . . . 0 N--CA 1.438 -1.056 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -92.37 -173.74 3.49 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.403 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 1.3 m-20 -73.87 -33.86 64.23 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.935 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.6 m -122.16 145.21 48.4 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.787 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.571 HD12 HG23 ' A' ' 79' ' ' THR . 9.2 tt -114.8 133.31 61.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.8 mm -124.36 112.51 32.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -174.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -95.92 127.53 42.02 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.463 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 28.1 ttt180 -95.24 110.93 22.85 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.647 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 30.3 m-85 . . . . . 0 CA--C 1.483 -1.612 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 5.6 p . . . . . 0 N--CA 1.432 -1.371 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -88.98 -45.98 9.24 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.588 -171.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.463 ' HB2' ' HB3' ' A' ' 30' ' ' ARG . 18.6 m120 -122.03 157.48 31.27 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.676 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.4 mm -121.42 134.87 63.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.671 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -141.49 166.64 24.19 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.543 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.8 t -158.13 141.49 15.2 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.34 156.84 45.27 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -173.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -79.72 157.98 27.03 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.898 175.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.41 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 4.1 ptt180 -59.06 115.78 3.39 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 169.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 75.49 59.34 0.06 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 126.163 1.785 . . . . 0.0 109.173 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -141.65 136.12 30.62 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.114 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 45.3 tt0 -101.67 109.94 21.82 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.7 pt -91.6 -178.11 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.5 m -136.36 126.78 26.74 Favored 'General case' 0 N--CA 1.405 -2.712 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 68.4 mt -118.34 104.15 15.71 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 56.3 43.49 26.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 122.108 0.956 . . . . 0.0 112.154 170.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 71.96 8.92 6.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.242 1.817 . . . . 0.0 114.512 -178.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -103.3 118.13 36.06 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 104.411 -2.441 . . . . 0.0 104.411 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 139.96 30.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 117.665 -1.614 . . . . 0.0 109.038 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 93.0 t -131.81 124.1 52.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.463 -173.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 75.5 t80 -96.7 121.76 38.89 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.1 t -100.74 124.28 54.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 175.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -83.41 -175.46 5.83 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.41 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 4.3 pm0 -70.59 -17.93 62.9 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -173.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.48 14.79 13.82 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.08 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 84.7 m 66.27 36.61 5.31 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.849 1.309 . . . . 0.0 112.355 174.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -116.48 120.4 34.73 Favored Pre-proline 0 C--N 1.293 -1.861 0 CA-C-N 113.223 -1.808 . . . . 0.0 108.169 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.474 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 63.9 Cg_endo -84.79 144.9 10.02 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.672 2.915 . . . . 0.0 114.422 -177.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -131.1 129.92 22.61 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.646 172.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.57 164.94 81.11 Favored 'Cis proline' 0 C--N 1.325 -0.67 0 C-N-CA 122.965 -1.681 . . . . 0.0 112.93 0.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.01 -36.59 10.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.638 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 67' ' ' ILE . 20.7 mm -101.13 127.95 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.92 173.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.5 mt -86.42 169.86 14.08 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.608 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -72.09 -11.21 26.97 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.342 2.028 . . . . 0.0 111.329 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -99.15 12.94 34.66 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.196 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 71' ' ' ARG . 9.8 tpt180 61.76 27.6 16.9 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 123.274 1.511 . . . . 0.0 110.102 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.35 139.82 32.8 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.647 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 3.0 t -91.35 124.43 43.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 125.996 1.719 . . . . 0.0 108.843 -177.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mp -101.79 125.99 48.57 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.566 173.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.5 m -116.64 118.62 33.08 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.265 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.474 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -110.55 142.0 16.53 Favored Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 120.503 -0.855 . . . . 0.0 112.78 -176.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -156.26 177.35 11.54 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -80.33 136.02 36.32 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.571 HG23 HD12 ' A' ' 27' ' ' ILE . 2.3 m -61.78 -25.61 67.58 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 p -64.44 -40.64 96.12 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.42 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.35 13.17 10.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.988 0.899 . . . . 0.0 111.654 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 C--N 1.298 -1.649 0 CA-C-N 114.815 -1.084 . . . . 0.0 113.505 -178.079 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.464 ' CE3' HG21 ' A' ' 41' ' ' THR . 14.8 m0 . . . . . 0 N--CA 1.441 -0.922 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -84.2 -171.48 3.63 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.431 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -81.8 -28.39 33.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -172.737 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.6 m -123.5 144.26 49.65 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.044 -177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.612 HD12 HG23 ' A' ' 79' ' ' THR . 11.0 tt -117.31 133.08 65.19 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.7 mm -125.48 112.77 32.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -172.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -101.05 136.26 41.18 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.413 ' HG3' HD11 ' A' ' 74' ' ' LEU . 3.6 ttp180 -99.58 111.02 23.41 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.677 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 29.6 m-85 . . . . . 0 C--N 1.296 -1.76 0 C-N-CA 123.223 0.609 . . . . 0.0 109.861 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.424 -1.754 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -89.17 -43.46 11.0 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.85 -168.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -129.12 148.97 51.12 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -118.0 120.74 65.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -126.6 169.22 13.32 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.464 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.5 t -149.76 145.34 26.58 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.33 154.02 44.33 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 123.673 0.789 . . . . 0.0 110.016 -174.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -75.05 151.05 38.72 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 122.026 -0.421 . . . . 0.0 110.049 173.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.449 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 8.6 ptt85 -57.55 114.83 2.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 171.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 74.67 67.74 0.08 Allowed 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 125.477 1.511 . . . . 0.0 109.553 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -151.46 139.6 20.19 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.764 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -97.13 121.88 39.51 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.2 pt -102.08 177.06 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 172.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.4 m -136.62 124.6 22.8 Favored 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.434 HD12 HD21 ' A' ' 74' ' ' LEU . 98.8 mt -114.88 105.59 18.94 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 57.26 46.75 18.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.605 0.717 . . . . 0.0 112.564 174.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 71.65 3.01 4.51 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.861 1.665 . . . . 0.0 112.897 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -99.36 109.36 21.97 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.45 143.52 34.89 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 117.959 -1.496 . . . . 0.0 109.707 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -133.74 121.21 39.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.113 -174.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -91.56 128.81 37.53 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.4 t -108.83 121.71 62.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -78.14 169.09 18.84 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 124.407 1.083 . . . . 0.0 108.223 178.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.449 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 10.5 pt-20 -72.35 -4.0 27.28 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.86 7.42 45.02 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 172.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 70.8 m 64.83 35.59 8.46 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.097 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -123.01 129.07 25.11 Favored Pre-proline 0 C--N 1.29 -2.013 0 CA-C-N 114.308 -1.314 . . . . 0.0 107.789 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.422 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 46.6 Cg_endo -84.73 159.43 12.19 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.038 2.492 . . . . 0.0 116.01 -175.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 40.8 m-85 -134.7 131.03 20.0 Favored Pre-proline 0 C--N 1.312 -1.064 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.101 171.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 91.4 Cg_endo -83.85 161.06 70.84 Favored 'Cis proline' 0 C--N 1.319 -1.022 0 C-N-CA 122.907 -1.705 . . . . 0.0 111.425 -2.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 74' ' ' LEU . 90.7 t -81.17 -38.44 16.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.695 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 67' ' ' ILE . 8.3 mm -97.44 116.61 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-O 122.106 0.955 . . . . 0.0 109.932 173.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.9 mt -76.87 165.77 49.88 Favored Pre-proline 0 C--N 1.297 -1.701 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.935 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.07 -3.41 13.6 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.428 2.085 . . . . 0.0 111.366 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -93.17 -12.15 31.02 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.019 -1.901 . . . . 0.0 110.462 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.278 40.0 ttm180 66.88 59.05 0.57 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 123.819 1.771 . . . . 0.0 109.763 -171.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.3 m -120.7 139.55 52.89 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 112.269 -2.241 . . . . 0.0 106.743 172.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.677 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.7 t -90.62 115.78 30.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 125.439 1.712 . . . . 0.0 108.975 -175.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.452 ' O ' HG13 ' A' ' 66' ' ' VAL . 4.0 mp -92.92 122.64 35.5 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 118.693 -1.203 . . . . 0.0 109.794 173.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.6 m -118.67 118.71 32.37 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.422 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -110.85 152.72 17.41 Favored Glycine 0 N--CA 1.415 -2.763 0 C-N-CA 119.763 -1.208 . . . . 0.0 111.405 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 61' ' ' CYS . 2.9 t70 -157.53 177.1 11.79 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 174.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -82.91 137.05 34.37 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.612 HG23 HD12 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -68.19 -25.31 65.17 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 118.213 0.461 . . . . 0.0 111.867 -175.0 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.2 t -67.91 -38.15 82.58 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.19 17.41 4.32 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.434 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.303 -1.442 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.939 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -143.32 176.24 9.3 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -94.91 113.41 25.14 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.955 1.359 . . . . 0.0 113.238 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -134.29 -59.04 0.83 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 171.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.92 159.21 27.36 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 172.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -83.37 79.25 9.47 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.685 0.755 . . . . 0.0 110.495 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -143.68 91.42 2.24 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.329 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -138.6 132.04 30.38 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.98 -71.46 0.23 Allowed Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -136.9 148.48 47.05 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.424 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -152.97 88.3 1.32 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.865 0.841 . . . . 0.0 111.373 -173.081 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.24 95.6 1.02 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.03 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.527 ' CE3' HG21 ' A' ' 41' ' ' THR . 12.1 m95 -99.33 -177.83 3.72 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.391 173.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.524 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 34.4 mmtp -83.34 -173.87 4.96 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.513 0.673 . . . . 0.0 110.102 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.97 -37.47 55.14 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.775 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.2 m -122.02 144.32 48.97 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.87 -176.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.511 HD12 HG23 ' A' ' 79' ' ' THR . 7.1 tt -118.89 133.24 66.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.3 mm -121.97 112.72 36.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -92.91 128.72 38.87 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.074 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -98.31 114.28 26.52 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.45 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 35.5 m-85 -96.41 130.72 43.49 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 177.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -122.64 119.27 30.26 Favored 'General case' 0 N--CA 1.4 -2.965 0 N-CA-C 105.326 -2.102 . . . . 0.0 105.326 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 60.99 30.85 19.85 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.41 5.66 65.08 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.895 -0.593 . . . . 0.0 114.473 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -135.25 151.13 50.3 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.67 114.04 12.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-O 122.442 1.115 . . . . 0.0 109.523 -175.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -97.16 -60.49 1.57 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.445 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -121.92 156.83 32.53 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.512 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 mp -120.05 118.04 55.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -119.93 169.12 10.46 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.527 HG21 ' CE3' ' A' ' 23' ' ' TRP . 4.2 t -155.37 147.95 24.1 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.76 157.85 43.61 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.582 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -72.64 155.35 40.11 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -57.65 121.11 9.59 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 166.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 74.9 55.05 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 126.464 1.906 . . . . 0.0 110.054 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -139.54 139.54 36.9 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.803 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 5.8 mp0 -95.85 125.8 40.66 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.4 pt -105.47 -176.94 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 172.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 m -136.93 134.67 37.01 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.413 HD12 HD21 ' A' ' 74' ' ' LEU . 80.1 mt -126.77 105.05 13.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 54.26 46.08 25.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.721 0.772 . . . . 0.0 111.841 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 69.7 9.42 7.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -103.92 115.26 30.14 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.45 142.62 31.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.003 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.1 t -134.33 125.04 46.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.768 -172.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 82.9 t80 -94.74 122.03 36.93 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.0 t -97.53 121.75 48.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.427 ' OD1' ' HG2' ' A' ' 59' ' ' GLU . 40.1 t30 -71.53 165.77 23.18 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 124.923 1.389 . . . . 0.0 109.3 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.427 ' HG2' ' OD1' ' A' ' 58' ' ' ASN . 10.7 pt-20 -58.28 -24.3 59.01 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 126.012 1.725 . . . . 0.0 114.1 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.12 16.6 22.2 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.2 m 64.85 69.45 0.49 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.341 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.403 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 4.3 t-80 -148.07 124.42 5.4 Favored Pre-proline 0 C--N 1.313 -0.981 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.477 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 52.2 Cg_endo -83.58 140.49 9.43 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.252 2.635 . . . . 0.0 114.033 -176.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -129.41 131.68 23.78 Favored Pre-proline 0 CA--C 1.494 -1.183 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.148 174.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.28 166.62 81.63 Favored 'Cis proline' 0 C--N 1.325 -0.704 0 C-N-CA 122.726 -1.781 . . . . 0.0 112.74 -1.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.33 -28.43 5.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.565 0.698 . . . . 0.0 110.344 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.554 HG23 ' HA ' ' A' ' 71' ' ' ARG . 32.4 mm -108.75 132.56 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-O 121.525 0.679 . . . . 0.0 109.936 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.41 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 45.3 mt -91.15 171.87 7.5 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.582 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.41 ' CD ' ' HB3' ' A' ' 68' ' ' LEU . 25.5 Cg_exo -67.99 -15.33 43.27 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.593 2.195 . . . . 0.0 111.85 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -86.41 -12.29 49.56 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.55 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.554 ' HA ' HG23 ' A' ' 67' ' ' ILE . 23.7 ttm180 72.17 31.11 1.99 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 124.081 1.896 . . . . 0.0 109.013 -173.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 m -70.24 138.85 52.01 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 169.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 1.4 t -96.8 125.58 49.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 O-C-N 125.01 1.444 . . . . 0.0 109.571 -175.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.413 HD21 HD12 ' A' ' 50' ' ' ILE . 3.0 mp -103.96 138.66 40.2 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 121.438 0.637 . . . . 0.0 109.63 174.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.9 m -136.34 122.06 19.79 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.505 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.477 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -107.12 142.81 15.78 Favored Glycine 0 N--CA 1.428 -1.899 0 C-N-CA 120.247 -0.977 . . . . 0.0 110.973 -177.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -147.05 173.01 12.86 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -79.69 138.45 37.36 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.511 HG23 HD12 ' A' ' 27' ' ' ILE . 1.9 m -68.49 -15.36 63.51 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.465 0.65 . . . . 0.0 110.437 -177.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.5 t -56.59 -42.23 78.33 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 126.079 1.752 . . . . 0.0 108.903 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.15 21.33 11.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.555 0.693 . . . . 0.0 112.107 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -129.45 -78.84 0.55 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.826 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.23 -30.48 34.18 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.5 t70 73.16 -56.84 0.65 Allowed 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 125.328 1.451 . . . . 0.0 114.368 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 21' ' ' MET . 25.8 t70 63.16 99.11 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 124.828 1.33 . . . . 0.0 108.168 -172.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.21 111.36 1.32 Allowed 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -81.65 129.51 34.72 Favored 'General case' 0 N--CA 1.425 -1.7 0 C-N-CA 119.509 -0.876 . . . . 0.0 113.223 -173.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -63.41 130.52 44.81 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.341 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 61.6 m . . . . . 0 C--N 1.301 -1.508 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 179.405 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.925 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -83.75 117.92 23.56 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.43 -61.57 2.35 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 124.219 1.008 . . . . 0.0 110.618 -169.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -126.17 -58.41 1.37 Allowed 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -163.2 177.63 8.89 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 175.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.43 ' HE2' ' O ' ' A' ' 22' ' ' ALA . 68.1 t80 -82.8 85.42 7.09 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 65.91 -99.43 0.06 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.618 1.567 . . . . 0.0 108.881 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -146.9 77.93 1.48 Allowed 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 169.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.28 153.17 20.75 Favored Glycine 0 N--CA 1.417 -2.632 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -71.58 -39.29 70.68 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 176.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -161.18 136.0 7.4 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.693 1.997 . . . . 0.0 105.854 171.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.43 ' O ' ' HE2' ' A' ' 16' ' ' TYR . . . -153.21 90.02 1.4 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.55 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.3 m95 -115.36 -167.73 1.29 Allowed 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.632 -174.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.538 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 50.8 mmtt -85.15 -171.91 3.89 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.423 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 2.0 m-20 -82.26 -29.85 31.0 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.453 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 71.9 m -127.21 141.99 51.6 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.173 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.581 HD12 HG23 ' A' ' 79' ' ' THR . 11.0 tt -119.17 133.06 67.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.6 mm -123.56 111.92 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -95.48 125.99 40.46 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.577 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -94.76 113.75 25.56 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.636 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 11.3 m-85 -95.37 136.28 35.93 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.632 ' HB3' ' HB2' ' A' ' 37' ' ' ASN . 11.5 tmtt? -155.31 128.38 8.19 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 -173.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.8 29.8 18.1 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.79 -0.63 76.99 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 114.588 0.595 . . . . 0.0 114.588 174.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -140.7 161.19 38.36 Favored 'General case' 0 CA--C 1.486 -1.515 0 CA-C-N 117.993 0.896 . . . . 0.0 109.045 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.2 p -70.68 110.63 3.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 122.599 1.19 . . . . 0.0 107.824 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.632 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 27.1 t-20 -87.15 -50.96 6.27 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.439 -174.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -128.97 155.32 45.54 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.202 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -119.14 119.04 59.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -120.25 167.83 11.87 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.55 HG21 ' CE3' ' A' ' 23' ' ' TRP . 4.3 t -154.55 147.33 24.36 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.11 160.74 43.08 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -82.06 162.34 22.6 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.794 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.423 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 6.5 ptt85 -60.86 113.48 2.53 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.297 174.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.447 ' OD1' ' HB3' ' A' ' 59' ' ' GLU . 23.5 m120 73.46 67.79 0.11 Allowed 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 126.489 1.916 . . . . 0.0 109.102 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -147.38 130.02 15.99 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.069 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 43.0 tt0 -97.62 116.84 30.62 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.501 0.667 . . . . 0.0 109.868 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.0 pt -98.26 -178.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 3.0 m -137.06 136.22 38.19 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 92.1 mt -128.01 107.96 17.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 56.8 34.78 25.27 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 74.7 14.56 3.37 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 127.015 2.126 . . . . 0.0 112.719 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -102.64 110.31 22.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 172.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.518 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -78.67 145.31 34.66 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.72 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -137.23 118.99 18.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.663 -173.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 69.2 t80 -89.89 118.71 29.67 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.2 t -94.11 117.97 38.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -71.98 168.29 18.34 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.447 ' HB3' ' OD1' ' A' ' 45' ' ' ASN . 13.5 pt-20 -64.38 -15.48 60.55 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.653 1.181 . . . . 0.0 113.663 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.13 6.18 43.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.8 m 69.48 36.55 2.2 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.595 1.158 . . . . 0.0 112.127 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -122.39 124.3 26.85 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 113.632 -1.622 . . . . 0.0 107.52 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.416 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 72.2 Cg_endo -81.72 153.62 17.57 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.218 2.612 . . . . 0.0 115.047 -176.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -136.39 131.45 18.51 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.174 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.07 161.69 88.06 Favored 'Cis proline' 0 C--N 1.322 -0.843 0 C-N-CA 122.526 -1.864 . . . . 0.0 111.513 -3.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.3 t -78.92 -36.68 19.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.373 0.606 . . . . 0.0 110.125 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.29 126.74 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 121.614 0.721 . . . . 0.0 110.782 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.62 170.7 10.07 Favored Pre-proline 0 C--N 1.305 -1.336 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.017 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -69.3 -9.48 26.39 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.551 2.167 . . . . 0.0 112.456 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.69 -11.07 54.66 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.463 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.411 ' HD2' ' HA ' ' A' ' 71' ' ' ARG . 11.5 tpt180 76.16 22.58 1.35 Allowed 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 126.375 1.87 . . . . 0.0 107.925 -172.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.4 m -67.45 134.68 51.83 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.379 -1.282 . . . . 0.0 107.657 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -92.93 116.74 34.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 126.002 1.721 . . . . 0.0 108.796 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 mp -96.84 122.55 39.93 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.117 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.9 m -114.36 118.7 34.59 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.416 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -117.27 134.99 11.55 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 119.933 -1.127 . . . . 0.0 112.551 -175.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -141.35 168.37 19.94 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -72.6 139.98 47.75 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.581 HG23 HD12 ' A' ' 27' ' ' ILE . 1.7 m -71.93 -15.71 62.09 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.798 0.808 . . . . 0.0 109.709 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . 0.276 0.7 OUTLIER -56.82 -32.64 65.93 Favored 'General case' 0 N--CA 1.414 -2.244 0 C-N-CA 126.399 1.88 . . . . 0.0 111.015 179.01 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.69 19.41 20.52 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.1 0.952 . . . . 0.0 109.851 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -141.74 -174.72 4.14 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.236 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 58.01 9.27 0.89 Allowed 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 125.781 1.632 . . . . 0.0 115.356 171.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -77.43 64.86 2.87 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.8 t70 42.68 56.03 4.03 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 127.175 2.19 . . . . 0.0 108.867 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -133.41 116.89 16.59 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 112.757 -2.019 . . . . 0.0 110.852 -171.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -101.84 154.27 19.08 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.0 m -81.82 90.55 6.41 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.32 0.581 . . . . 0.0 110.412 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 67.3 m . . . . . 0 C--O 1.25 1.114 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.159 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 37' ' ' ASN . . . . . . . . 0 CA--C 1.498 -0.982 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.505 ' HD3' ' O ' ' A' ' 39' ' ' ILE . 67.8 ttt180 79.44 85.47 0.06 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 125.625 1.57 . . . . 0.0 112.771 -177.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -96.6 109.22 21.87 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 172.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -64.85 -59.16 4.51 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.604 0.716 . . . . 0.0 110.383 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.5 mt -151.19 176.7 10.95 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -80.82 83.95 6.45 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 172.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.458 ' CE2' ' HG2' ' A' ' 87' ' ' GLU . 38.6 p90 -96.64 99.37 10.99 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.225 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -92.57 103.8 16.16 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -157.66 -171.17 23.32 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 119.558 -1.306 . . . . 0.0 111.838 -176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -95.13 148.74 22.05 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.599 ' HG3' ' O ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -70.85 118.9 14.22 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.911 0.862 . . . . 0.0 111.686 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.24 77.94 1.5 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 174.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.534 ' HB2' HG21 ' A' ' 79' ' ' THR . 14.3 m0 -94.89 -165.52 1.32 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 113.235 -1.802 . . . . 0.0 109.876 -175.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -88.51 -170.75 3.06 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -77.96 -29.87 50.05 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.075 0.941 . . . . 0.0 111.116 -171.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.2 m -124.55 143.22 50.8 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.709 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.596 HD12 HG23 ' A' ' 79' ' ' THR . 13.5 tt -117.89 133.05 65.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.41 HG23 ' HG3' ' A' ' 63' ' ' PRO . 30.8 mm -126.45 114.24 37.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -172.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -98.92 135.14 40.78 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.505 ' HG3' HD11 ' A' ' 74' ' ' LEU . 4.7 ttp180 -103.8 112.88 26.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.642 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 33.7 m-85 -96.45 147.88 23.38 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 124.367 1.067 . . . . 0.0 110.016 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -144.9 120.0 10.09 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 60.9 30.6 19.73 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.57 -13.37 64.21 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.851 -0.69 . . . . 0.0 114.449 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -123.59 159.07 30.02 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.2 p -73.23 135.21 28.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-O 121.72 0.771 . . . . 0.0 111.604 -175.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.477 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 16.1 t-20 -111.4 -62.68 1.51 Allowed 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 125.016 1.326 . . . . 0.0 112.537 -174.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.403 ' O ' HD12 ' A' ' 39' ' ' ILE . 6.9 m-80 -121.61 167.32 13.03 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 122.764 0.426 . . . . 0.0 111.041 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.505 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 1.7 mp -131.71 135.88 58.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 125.118 1.367 . . . . 0.0 108.426 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -141.79 163.83 31.84 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.444 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.7 t -149.14 139.53 22.41 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.72 163.77 31.71 Favored 'General case' 0 C--N 1.311 -1.068 0 O-C-N 124.003 0.815 . . . . 0.0 109.272 -173.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -77.56 159.73 29.08 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 120.467 -0.493 . . . . 0.0 109.836 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -67.75 116.37 8.36 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 120.924 0.392 . . . . 0.0 110.029 173.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.581 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 26.3 m-80 75.36 67.63 0.07 Allowed 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 126.901 2.08 . . . . 0.0 109.332 -174.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -149.68 134.57 17.86 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.609 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 44.3 tt0 -101.19 119.46 38.79 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-O 121.839 0.828 . . . . 0.0 110.209 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.5 pt -100.01 179.27 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.789 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 m -136.9 134.25 36.62 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.417 HD12 HG21 ' A' ' 55' ' ' VAL . 95.2 mt -124.88 106.63 16.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 59.05 34.9 23.71 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.119 0.961 . . . . 0.0 111.193 176.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.26 42.9 mm-40 67.39 21.19 9.79 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.625 1.57 . . . . 0.0 113.523 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -104.2 111.28 23.82 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 169.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -81.45 133.64 35.43 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.649 0.737 . . . . 0.0 109.241 -176.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.417 HG21 HD12 ' A' ' 50' ' ' ILE . 94.1 t -127.38 119.12 51.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.744 -173.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 79.4 t80 -92.89 121.52 34.33 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.9 t -94.01 114.62 31.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -69.03 165.03 21.04 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.581 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 9.1 pt-20 -70.14 -7.81 44.66 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 123.768 0.827 . . . . 0.0 112.428 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.41 -2.37 52.9 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 79.1 m 69.35 32.81 3.4 Favored 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.917 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -122.05 128.37 25.56 Favored Pre-proline 0 C--N 1.293 -1.85 0 CA-C-N 113.027 -1.897 . . . . 0.0 106.708 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.41 ' HG3' HG23 ' A' ' 28' ' ' ILE . 42.6 Cg_endo -85.01 156.07 11.35 Favored 'Trans proline' 0 C--N 1.329 -0.447 0 C-N-CA 123.267 2.645 . . . . 0.0 115.4 -175.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -135.17 131.32 19.66 Favored Pre-proline 0 N--CA 1.441 -0.906 0 C-N-CA 124.678 1.191 . . . . 0.0 111.571 172.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.5 169.7 70.17 Favored 'Cis proline' 0 C--N 1.322 -0.82 0 C-N-CA 122.435 -1.902 . . . . 0.0 112.306 -1.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.8 t -86.79 -42.17 15.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.093 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.447 HG12 ' NH2' ' A' ' 71' ' ' ARG . 1.7 mp -98.3 128.02 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.71 0.767 . . . . 0.0 110.49 173.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.6 mt -88.41 169.11 14.31 Favored Pre-proline 0 C--N 1.306 -1.298 0 CA-C-N 114.297 -1.319 . . . . 0.0 108.243 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.35 -9.18 25.34 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.281 1.988 . . . . 0.0 110.904 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -88.7 1.2 55.54 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.687 -1.597 . . . . 0.0 109.492 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.447 ' NH2' HG12 ' A' ' 67' ' ' ILE . 8.3 tpm_? 74.93 9.43 4.0 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 125.253 1.421 . . . . 0.0 109.671 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 67' ' ' ILE . 0.9 OUTLIER -70.86 138.15 50.0 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.703 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.642 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.3 t -92.1 124.07 44.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 125.614 1.566 . . . . 0.0 109.479 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.505 HD11 ' HG3' ' A' ' 30' ' ' ARG . 7.6 mp -100.23 122.74 43.51 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.959 0.885 . . . . 0.0 110.307 172.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 52.3 m -118.03 117.74 30.04 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -118.07 152.28 17.6 Favored Glycine 0 N--CA 1.422 -2.279 0 C-N-CA 119.395 -1.383 . . . . 0.0 111.38 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -155.84 177.13 11.75 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -79.65 139.2 37.49 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.596 HG23 HD12 ' A' ' 27' ' ' ILE . 1.6 m -72.11 -10.9 60.4 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.568 0.699 . . . . 0.0 110.409 -178.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.4 p -69.09 -22.93 63.97 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.425 0.631 . . . . 0.0 111.034 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.36 17.14 24.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 122.07 0.938 . . . . 0.0 109.909 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -145.1 -169.3 3.16 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.955 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.599 ' O ' ' HG3' ' A' ' 21' ' ' MET 0.284 . . 60.49 87.55 0.09 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 126.084 1.754 . . . . 0.0 114.459 175.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -151.47 29.88 0.61 Allowed 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 110.566 -3.015 . . . . 0.0 102.954 173.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.16 154.42 27.3 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 111.857 -2.429 . . . . 0.0 113.13 -175.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -97.79 74.41 2.35 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.327 -172.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.458 ' HG2' ' CE2' ' A' ' 17' ' ' PHE . 3.2 mp0 -96.16 -43.49 7.71 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.0 m -82.02 81.17 8.07 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 3.8 p . . . . . 0 C--N 1.307 -1.266 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.814 -175.616 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.8 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -71.36 -28.99 64.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.608 0.718 . . . . 0.0 110.371 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -170.73 96.5 0.22 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 102.792 -3.04 . . . . 0.0 102.792 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -120.3 167.7 12.03 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.49 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.6 mt -87.2 168.32 13.33 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 123.889 0.743 . . . . 0.0 110.504 -174.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.427 ' HE1' ' SD ' ' A' ' 21' ' ' MET . 83.6 t80 -78.2 81.53 4.57 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 171.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -86.04 -45.28 11.57 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.539 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.405 ' H ' ' HG2' ' A' ' 18' ' ' GLN . 15.1 pt20 -101.11 150.49 22.88 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.308 -174.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.75 -39.25 93.57 Favored Glycine 0 C--N 1.331 0.263 0 O-C-N 124.247 0.967 . . . . 0.0 111.481 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.3 m170 -97.37 87.9 4.27 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.427 ' SD ' ' HE1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -65.45 147.76 52.88 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.056 175.739 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.48 90.94 2.93 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.186 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.441 ' CB ' HG21 ' A' ' 79' ' ' THR . 11.5 m0 -93.43 -171.63 2.69 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.41 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . 11.2 mmpt? -88.55 -170.58 2.99 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 121.923 -0.485 . . . . 0.0 110.759 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -29.18 54.7 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.091 0.472 . . . . 0.0 112.013 -175.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 68.1 m -122.34 144.81 48.79 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.884 0.85 . . . . 0.0 110.766 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.623 HD12 HG23 ' A' ' 79' ' ' THR . 8.6 tt -119.48 133.66 65.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.4 mm -119.01 133.07 67.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -174.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -117.23 132.56 56.6 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -174.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -94.6 112.98 24.74 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.641 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 23.2 m-85 -95.54 110.82 22.84 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.58 ' HB3' ' HB2' ' A' ' 37' ' ' ASN . 11.8 tmtt? -121.07 126.32 49.54 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 -175.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 61.04 29.59 19.05 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 124.913 1.285 . . . . 0.0 111.765 -175.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.71 -10.0 76.02 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 114.646 0.618 . . . . 0.0 114.646 177.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -123.73 155.12 38.45 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.7 p -73.12 110.29 6.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-O 122.524 1.154 . . . . 0.0 109.53 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.58 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 61.8 t30 -88.19 -57.54 2.89 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.801 -173.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -121.09 159.88 24.82 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.876 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.6 tp -122.73 155.85 28.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -151.02 167.88 26.3 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.424 HG21 ' CE3' ' A' ' 23' ' ' TRP . 2.0 t -149.63 146.82 27.49 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.374 0.606 . . . . 0.0 110.029 177.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.85 158.87 44.25 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -80.99 158.82 25.04 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.483 ' HB2' ' HA ' ' A' ' 59' ' ' GLU . 6.8 ptt85 -61.58 114.42 3.25 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 171.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.467 HD21 ' HB3' ' A' ' 59' ' ' GLU . 9.4 m-80 76.52 67.15 0.06 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 127.112 2.165 . . . . 0.0 108.914 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -146.72 128.5 15.29 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.561 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -89.86 109.93 20.9 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.368 0.604 . . . . 0.0 109.696 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.9 pt -96.7 -178.97 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.9 m -133.24 130.68 39.34 Favored 'General case' 0 N--CA 1.403 -2.789 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 174.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.44 HD12 HG21 ' A' ' 55' ' ' VAL . 87.7 mt -122.75 101.82 10.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 61.14 36.96 17.95 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.947 0.879 . . . . 0.0 111.251 172.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 70.64 18.94 6.25 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 113.751 -1.568 . . . . 0.0 113.798 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -112.52 107.66 16.48 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 172.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 49' ' ' THR 0.31 0.0 OUTLIER -78.78 152.92 31.16 Favored 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 117.654 -1.618 . . . . 0.0 111.81 -179.534 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 50' ' ' ILE . 91.8 t -142.72 129.83 18.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.299 -170.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -100.34 120.8 40.5 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 66.2 t -98.32 117.68 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -71.76 167.65 19.47 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 124.586 1.179 . . . . 0.0 109.336 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.483 ' HA ' ' HB2' ' A' ' 44' ' ' ARG . 9.5 pt-20 -58.65 -20.8 51.05 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 126.0 1.72 . . . . 0.0 114.851 -174.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.56 19.89 18.16 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 120.953 0.406 . . . . 0.0 109.965 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.9 m 62.33 69.97 0.59 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.403 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -148.0 121.79 4.84 Favored Pre-proline 0 N--CA 1.439 -0.997 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.515 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 48.7 Cg_endo -87.73 142.74 5.9 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.564 2.843 . . . . 0.0 114.912 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -131.79 134.61 25.56 Favored Pre-proline 0 C--N 1.309 -1.165 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.491 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.01 158.08 96.84 Favored 'Cis proline' 0 C--N 1.332 -0.342 0 C-N-CA 122.572 -1.845 . . . . 0.0 112.831 0.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.14 -40.13 21.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.362 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.9 mm -98.76 124.17 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.926 -1.109 . . . . 0.0 109.39 175.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 mt -85.61 168.24 20.88 Favored Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.644 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -68.64 -11.96 33.35 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.126 1.884 . . . . 0.0 111.177 -176.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -91.98 10.82 27.37 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.155 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 68.62 9.59 7.4 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.473 1.909 . . . . 0.0 111.45 172.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.9 m -82.21 150.7 27.21 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.825 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.3 t -91.29 131.0 39.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 126.436 1.894 . . . . 0.0 109.751 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.94 123.56 48.17 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.09 0.948 . . . . 0.0 111.03 173.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.4 t -107.62 147.09 31.11 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.515 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -130.58 140.35 11.69 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -152.86 175.75 12.57 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -86.21 132.78 33.93 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.623 HG23 HD12 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -67.52 -21.96 65.46 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.278 0.561 . . . . 0.0 111.503 -175.845 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.4 p -65.95 -26.81 67.75 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.916 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.33 21.13 17.46 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.822 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -132.0 -69.46 0.6 Allowed 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -174.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.596 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . . . -81.22 -6.77 59.23 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.548 -174.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.9 t70 72.28 22.63 3.48 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.897 1.679 . . . . 0.0 110.391 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.596 ' OD1' ' HB3' ' A' ' 83' ' ' ALA . 3.6 m-20 -58.9 156.41 11.5 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 114.385 -1.279 . . . . 0.0 108.073 174.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -82.12 75.8 9.03 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 59.74 37.93 21.89 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.901 2.081 . . . . 0.0 109.958 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.0 m 68.42 -76.71 0.05 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.972 1.709 . . . . 0.0 112.095 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.0 p . . . . . 0 C--N 1.305 -1.334 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -175.742 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.097 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 62.62 81.95 0.19 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.363 1.465 . . . . 0.0 112.161 -175.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -107.76 105.38 15.18 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 173.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -79.04 147.55 32.8 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.436 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.0 mt -77.3 158.26 30.3 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.562 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -85.21 78.92 9.72 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 122.052 0.929 . . . . 0.0 109.481 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.41 ' O ' ' HB3' ' A' ' 21' ' ' MET . 71.9 m-85 -82.96 91.98 7.25 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.903 178.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.22 164.76 20.99 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.516 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.95 -80.75 0.79 Allowed Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -121.4 98.66 6.07 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.376 0.607 . . . . 0.0 110.546 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.41 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 20.3 ptp -115.65 100.07 7.78 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.297 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.47 103.49 14.39 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.636 0.731 . . . . 0.0 109.286 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.509 ' CE3' HG21 ' A' ' 41' ' ' THR . 17.9 m95 -93.29 -175.36 3.8 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -101.87 -171.35 1.96 Allowed 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.541 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.49 -27.49 58.81 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -173.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.8 m -126.28 142.56 51.48 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.022 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.647 HD12 HG23 ' A' ' 79' ' ' THR . 12.7 tt -115.22 133.46 61.39 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.41 HD13 ' O ' ' A' ' 27' ' ' ILE . 34.9 mm -127.22 116.94 45.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -173.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 75' ' ' SER . 95.9 mt-30 -105.75 139.12 40.82 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.759 -0.588 . . . . 0.0 110.358 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.536 ' HD2' HG21 ' A' ' 50' ' ' ILE . 24.1 mtp180 -95.82 115.74 27.87 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 121.528 -0.069 . . . . 0.0 110.971 175.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.648 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 29.2 m-85 -95.89 115.87 28.07 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.511 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 11.2 tppt? -142.01 114.4 8.32 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.323 -174.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.383 0.7 OUTLIER 61.43 52.69 3.66 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 112.996 -1.911 . . . . 0.0 116.124 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.8 -4.57 61.41 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 172.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -162.14 174.24 13.21 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-N 119.114 1.457 . . . . 0.0 107.981 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 p -77.13 115.76 19.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -94.78 -51.78 4.55 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.037 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -119.8 154.25 34.52 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.893 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -121.92 127.26 75.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -133.73 168.99 17.71 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.509 HG21 ' CE3' ' A' ' 23' ' ' TRP . 2.3 t -155.45 139.63 16.55 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.23 152.96 46.38 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.456 -174.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -76.69 160.6 29.22 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 120.881 0.372 . . . . 0.0 110.562 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.53 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 4.0 ptt180 -60.56 115.59 3.72 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.895 172.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.426 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 82.9 m-20 73.62 65.01 0.09 Allowed 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.969 1.708 . . . . 0.0 109.678 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -145.74 137.46 25.17 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.26 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 39.2 tt0 -107.75 109.5 21.09 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.733 0.778 . . . . 0.0 109.225 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.4 pt -90.59 -177.33 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.812 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.2 m -130.98 134.34 46.63 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.536 HG21 ' HD2' ' A' ' 30' ' ' ARG . 82.1 mt -128.95 110.31 20.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 51.79 38.04 22.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.07 0.938 . . . . 0.0 112.676 177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 69.12 29.05 4.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 113.337 -1.756 . . . . 0.0 112.829 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -118.35 116.82 27.52 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 169.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -82.12 140.9 33.54 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 118.494 -1.283 . . . . 0.0 109.7 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.452 HG21 HD12 ' A' ' 50' ' ' ILE . 69.2 t -132.22 125.99 55.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.837 -172.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 54.6 t80 -96.03 121.01 37.32 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -178.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.34 116.99 44.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -70.78 164.72 24.6 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 124.295 0.997 . . . . 0.0 108.374 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.53 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 9.3 pt-20 -62.76 -13.14 29.45 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.39 11.63 29.91 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.009 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.2 m 62.14 69.44 0.62 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.882 0.848 . . . . 0.0 111.937 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -152.01 124.87 4.08 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.578 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 64.0 Cg_endo -87.03 141.2 6.01 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.323 2.682 . . . . 0.0 114.226 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -126.48 129.22 24.18 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 174.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.16 159.68 92.72 Favored 'Cis proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.613 -1.828 . . . . 0.0 112.585 -0.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.8 t -78.94 -44.02 24.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.458 HG21 ' NH2' ' A' ' 71' ' ' ARG . 1.7 mp -94.7 123.69 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 121.597 0.713 . . . . 0.0 109.151 171.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.6 mt -83.19 169.51 17.36 Favored Pre-proline 0 C--N 1.299 -1.596 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.774 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -71.61 -2.51 11.47 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.498 2.132 . . . . 0.0 111.343 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.511 ' OD2' ' HE3' ' A' ' 32' ' ' LYS . 18.3 t70 -97.48 4.72 50.38 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.62 -1.627 . . . . 0.0 109.401 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.458 ' NH2' HG21 ' A' ' 67' ' ' ILE . 0.4 OUTLIER 66.14 21.26 11.16 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.111 1.364 . . . . 0.0 109.323 177.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.2 m -85.5 139.73 31.25 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.648 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -90.5 125.48 43.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 125.956 1.702 . . . . 0.0 108.409 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.8 mp -101.56 130.13 47.79 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 122.201 1.001 . . . . 0.0 111.214 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.435 ' HB3' ' HB2' ' A' ' 29' ' ' GLN . 37.6 t -106.02 121.34 43.91 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.578 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -117.69 131.98 9.65 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.293 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -150.12 172.97 14.43 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -80.8 135.44 35.96 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.647 HG23 HD12 ' A' ' 27' ' ' ILE . 2.4 m -70.61 -14.46 62.49 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 121.867 -0.521 . . . . 0.0 111.795 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.584 ' HA ' ' HB2' ' A' ' 84' ' ' ASP . 1.9 t -69.45 -28.93 66.53 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 122.27 1.033 . . . . 0.0 108.879 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.56 16.17 16.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.681 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -130.09 -80.52 0.55 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.172 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.83 -85.9 0.44 Allowed 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.584 ' HB2' ' HA ' ' A' ' 80' ' ' SER . 15.1 t70 62.15 13.93 6.2 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.54 1.136 . . . . 0.0 111.6 174.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -73.81 11.3 0.89 Allowed 'General case' 0 C--O 1.24 0.566 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -171.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -84.38 77.9 9.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 55.45 75.81 0.3 Allowed 'General case' 0 C--O 1.241 0.626 0 CA-C-N 113.503 -1.681 . . . . 0.0 111.28 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.0 m -75.52 100.51 4.56 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.066 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.8 t . . . . . 0 C--N 1.306 -1.291 0 N-CA-C 105.483 -2.044 . . . . 0.0 105.483 -179.372 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.656 ' HA2' ' OXT' ' A' ' 89' ' ' CYS . . . . . . . . 0 CA--C 1.497 -1.071 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -72.0 100.19 2.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.237 0.519 . . . . 0.0 111.41 -176.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 60.6 24.67 14.39 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.755 1.222 . . . . 0.0 112.745 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.596 ' O ' ' HB3' ' A' ' 17' ' ' PHE . 23.0 m120 -74.42 -34.86 63.36 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.3 mt 54.34 -157.16 0.2 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.938 1.295 . . . . 0.0 110.917 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -95.48 32.44 1.79 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 124.087 1.899 . . . . 0.0 108.747 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.596 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 52.8 t80 -81.89 -25.99 34.52 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 169.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.535 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 0.2 OUTLIER -91.15 92.42 8.67 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 112.316 -2.22 . . . . 0.0 105.567 173.549 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -130.38 -109.83 1.34 Allowed Glycine 0 C--N 1.297 -1.621 0 N-CA-C 103.575 -3.81 . . . . 0.0 103.575 172.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -85.32 101.88 12.92 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 164.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.535 ' SD ' ' HA ' ' A' ' 18' ' ' GLN . 7.3 tpt -84.89 56.44 3.92 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.226 -166.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.15 88.7 5.99 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.392 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.432 ' CB ' HG21 ' A' ' 79' ' ' THR . 12.4 m0 -75.73 -172.05 1.77 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.029 177.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.488 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 10.5 mmpt? -84.93 -174.57 5.34 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.886 0.374 . . . . 0.0 110.229 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.406 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 5.4 m-20 -70.19 -38.38 75.34 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 74.2 m -123.78 145.28 49.15 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.717 -174.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.544 HD12 HG23 ' A' ' 79' ' ' THR . 9.8 tt -118.13 127.66 75.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.405 HD12 ' C ' ' A' ' 27' ' ' ILE . 1.6 mp -117.14 114.54 46.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.915 0.864 . . . . 0.0 110.094 -175.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -91.69 124.84 36.14 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.793 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.462 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 63.9 ttt180 -96.51 110.38 22.78 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.655 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 83.1 m-85 -95.67 110.2 22.35 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.473 ' HE2' ' OD2' ' A' ' 70' ' ' ASP . 5.7 tmtt? -99.6 119.19 37.68 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 61.77 30.33 18.31 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 124.069 0.948 . . . . 0.0 112.1 -176.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.3 -12.67 66.48 Favored Glycine 0 N--CA 1.429 -1.778 0 CA-C-N 115.421 -0.809 . . . . 0.0 114.434 176.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -123.27 149.68 44.47 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-N 118.939 1.369 . . . . 0.0 108.738 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 9.0 p -68.37 115.59 6.94 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 CA-C-O 122.694 1.235 . . . . 0.0 112.782 -171.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -96.96 -55.56 2.83 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.918 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.462 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 16.3 m120 -120.12 153.37 36.27 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.477 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 mp -119.2 116.36 50.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -118.72 166.78 12.35 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 24' ' ' LYS . 4.0 t -146.84 139.86 25.32 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 173.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.2 161.2 38.21 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.165 -1.38 . . . . 0.0 107.771 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 24' ' ' LYS . 90.5 m-20 -87.02 160.99 18.43 Favored 'General case' 0 C--N 1.284 -2.281 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.632 176.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.422 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 3.5 ptt85 -58.68 119.43 7.08 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.956 171.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.1 m120 68.33 64.36 0.35 Allowed 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 125.57 1.548 . . . . 0.0 108.643 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -144.58 133.29 22.3 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 113.755 -1.566 . . . . 0.0 108.403 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 36.4 tt0 -108.13 109.31 20.7 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.753 0.787 . . . . 0.0 109.766 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 32.0 pt -87.8 -178.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.214 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.8 m -136.4 135.63 38.9 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.9 mt -127.38 108.34 18.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 53.28 42.88 32.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.356 1.074 . . . . 0.0 112.201 177.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 72.72 8.91 5.6 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.766 2.026 . . . . 0.0 113.865 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -100.12 115.77 30.57 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.63 144.51 33.72 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.702 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.2 t -137.05 117.42 16.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.358 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 64.3 t80 -92.06 123.04 35.12 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.023 0.44 . . . . 0.0 110.841 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.0 t -97.46 123.39 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -76.03 173.87 10.72 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 124.611 1.194 . . . . 0.0 108.822 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.422 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 1.3 pm0 -71.51 -20.73 62.01 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -173.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.5 19.92 11.46 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.559 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.7 m 61.69 79.63 0.25 Allowed 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 124.639 1.212 . . . . 0.0 113.103 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -162.62 128.56 2.29 Favored Pre-proline 0 C--N 1.314 -0.936 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.497 ' CG ' ' HB3' ' A' ' 74' ' ' LEU . 42.6 Cg_endo -88.54 149.93 6.32 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.248 2.632 . . . . 0.0 114.604 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -135.86 134.07 20.34 Favored Pre-proline 0 CA--C 1.498 -1.053 0 C-N-CA 125.167 1.387 . . . . 0.0 110.265 173.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.35 163.63 84.22 Favored 'Cis proline' 0 C--N 1.317 -1.093 0 C-N-CA 122.633 -1.82 . . . . 0.0 112.219 0.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.0 t -82.47 -40.88 17.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.553 -174.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 72' ' ' SER . 1.7 mp -104.16 127.68 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-O 121.45 0.643 . . . . 0.0 110.034 172.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.0 mt -94.77 170.82 7.46 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.193 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -69.94 -12.5 32.67 Favored 'Trans proline' 0 N--CA 1.486 1.086 0 C-N-CA 122.669 2.246 . . . . 0.0 111.56 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.473 ' OD2' ' HE2' ' A' ' 32' ' ' LYS . 29.8 t70 -84.83 -0.22 53.18 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.778 -1.556 . . . . 0.0 108.646 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 59.72 37.79 22.04 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.461 1.904 . . . . 0.0 109.118 -177.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 67' ' ' ILE . 21.5 m -85.92 127.57 34.64 Favored 'General case' 0 N--CA 1.409 -2.485 0 CA-C-N 113.438 -1.71 . . . . 0.0 106.54 172.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.655 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.3 t -90.99 116.66 32.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 127.673 2.389 . . . . 0.0 106.748 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.497 ' HB3' ' CG ' ' A' ' 63' ' ' PRO . 6.6 mp -102.09 124.36 47.56 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 122.208 1.004 . . . . 0.0 113.44 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.5 m -117.93 129.11 55.42 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.679 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 27' ' ' ILE . . . -119.84 137.36 12.33 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.397 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -141.8 172.46 12.65 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -77.82 138.41 38.94 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.544 HG23 HD12 ' A' ' 27' ' ' ILE . 3.4 m -66.78 -21.21 66.06 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -174.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.7 t -71.57 -40.22 70.1 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -174.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.28 9.07 2.26 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.258 1.028 . . . . 0.0 113.296 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -125.92 -79.11 0.6 Allowed 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.038 -1.437 . . . . 0.0 109.873 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.53 ' HB1' ' HB2' ' A' ' 86' ' ' ASP . . . -98.41 -65.71 0.95 Allowed 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.691 -174.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.0 t70 66.77 -62.34 0.3 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.807 2.043 . . . . 0.0 107.746 -169.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.48 ' HA ' ' HB3' ' A' ' 21' ' ' MET . 25.4 t70 -152.41 86.07 1.27 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 104.211 -2.514 . . . . 0.0 104.211 175.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.53 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 5.2 t70 -84.73 173.36 10.75 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.041 -173.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -117.7 -179.52 3.76 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 122.764 0.425 . . . . 0.0 111.42 -172.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.6 m -79.05 126.22 30.41 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.656 ' OXT' ' HA2' ' A' ' 11' ' ' GLY . 15.2 m . . . . . 0 C--O 1.257 1.454 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.224 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.59 83.89 6.76 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 174.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -114.19 103.05 10.72 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 112.884 -1.962 . . . . 0.0 112.026 -169.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -99.59 159.03 15.34 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.23 163.1 27.38 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -80.99 75.49 7.96 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.455 1.121 . . . . 0.0 109.547 -175.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -75.25 89.53 2.56 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.396 -1.729 . . . . 0.0 107.104 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.524 ' HA ' ' CE ' ' A' ' 21' ' ' MET . 53.5 tp60 -139.27 131.04 27.49 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 113.682 -1.599 . . . . 0.0 108.082 -174.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.06 30.8 13.25 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 119.67 -1.252 . . . . 0.0 111.207 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.6 t60 176.33 105.48 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.524 ' CE ' ' HA ' ' A' ' 18' ' ' GLN . 2.1 mpt? -144.63 178.54 7.9 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -155.3 76.9 0.99 Allowed 'General case' 0 C--N 1.31 -1.118 0 O-C-N 124.217 0.948 . . . . 0.0 109.317 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.504 ' CE3' HG21 ' A' ' 41' ' ' THR . 17.7 m95 -78.46 175.58 10.18 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.777 178.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 41' ' ' THR . 95.6 mttt -90.34 -172.57 3.5 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.155 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -74.55 -36.04 63.1 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.841 0.829 . . . . 0.0 111.858 -172.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.0 m -122.1 143.31 49.61 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.222 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.499 HD12 HG23 ' A' ' 79' ' ' THR . 4.0 tt -115.79 133.05 63.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.0 mm -122.93 119.33 57.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.4 ' HG2' ' CD1' ' A' ' 39' ' ' ILE . 95.4 mt-30 -95.53 127.57 41.68 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -99.25 111.28 23.69 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.619 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 31.5 m-85 -95.83 113.65 25.3 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.486 0.66 . . . . 0.0 109.228 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.34 118.61 36.78 Favored 'General case' 0 N--CA 1.407 -2.61 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.258 45.2 m-20 61.33 30.83 19.26 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.01 -10.97 64.11 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 115.21 -0.905 . . . . 0.0 115.054 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -122.52 151.91 40.87 Favored 'General case' 0 CA--C 1.48 -1.733 0 CA-C-N 118.381 1.09 . . . . 0.0 108.258 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 7.7 p -70.23 110.1 3.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-O 122.493 1.14 . . . . 0.0 109.82 -177.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -85.64 -58.64 2.58 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.518 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -119.91 161.25 21.18 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.938 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.4 ' CD1' ' HG2' ' A' ' 29' ' ' GLN . 7.5 tp -115.48 151.04 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 N-CA-C 103.372 -2.825 . . . . 0.0 103.372 171.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -147.06 166.11 27.86 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.504 HG21 ' CE3' ' A' ' 23' ' ' TRP . 2.1 t -151.99 142.74 22.88 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.13 149.73 44.83 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -75.71 156.97 34.19 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -57.13 121.51 10.21 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 121.206 0.526 . . . . 0.0 110.415 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.9 m120 70.32 63.1 0.22 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 112.957 -1.929 . . . . 0.0 108.677 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -141.83 131.68 24.35 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.54 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 33.8 tt0 -95.44 114.18 25.91 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.034 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.0 pt -96.65 -177.24 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.84 138.12 42.2 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 175.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 92.9 mt -129.61 106.96 14.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 50.73 49.37 21.09 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 70.86 1.61 3.83 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 125.042 1.337 . . . . 0.0 114.489 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -95.33 115.82 27.95 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 147.12 30.58 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 119.714 -0.794 . . . . 0.0 108.934 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 96.9 t -139.9 118.34 11.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.881 -174.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 80.4 t80 -93.21 119.41 32.36 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.0 t -98.36 120.87 48.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -73.24 168.51 18.99 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 124.647 1.217 . . . . 0.0 110.199 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -68.35 -8.02 36.4 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 125.771 1.628 . . . . 0.0 114.572 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.89 14.7 27.69 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.8 m 63.84 71.25 0.49 Allowed 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 124.415 1.072 . . . . 0.0 111.455 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -151.05 124.66 4.33 Favored Pre-proline 0 N--CA 1.435 -1.219 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.479 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 88.7 Cg_endo -84.89 143.04 9.22 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.112 2.541 . . . . 0.0 114.964 -177.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 32.9 m-85 -129.63 127.4 22.95 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.038 170.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 73.5 Cg_endo -81.87 163.49 76.77 Favored 'Cis proline' 0 C--N 1.319 -1.007 0 C-N-CA 122.876 -1.718 . . . . 0.0 112.26 -0.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 74' ' ' LEU . 85.0 t -81.53 -39.83 17.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.708 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.04 128.07 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 121.574 0.702 . . . . 0.0 109.483 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.2 mt -88.0 172.07 8.45 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.757 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -73.99 -13.32 23.88 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.295 1.997 . . . . 0.0 109.703 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -84.82 -6.6 59.35 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.115 -2.311 . . . . 0.0 108.349 177.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.387 12.3 ttm180 52.61 55.92 8.38 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 124.631 2.158 . . . . 0.0 112.224 -176.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.9 m -101.95 135.23 43.87 Favored 'General case' 0 N--CA 1.398 -3.048 0 CA-C-N 111.098 -2.774 . . . . 0.0 104.961 170.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.619 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -91.3 117.03 33.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 O-C-N 126.105 2.128 . . . . 0.0 108.395 -176.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.445 ' O ' HG13 ' A' ' 66' ' ' VAL . 5.6 mp -101.49 134.46 44.57 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 122.016 0.912 . . . . 0.0 111.703 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.8 m -120.77 137.12 54.68 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.834 175.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.479 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -129.01 133.67 7.68 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 119.659 -1.258 . . . . 0.0 113.021 -175.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -146.82 171.83 14.59 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -71.91 139.37 48.74 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.499 HG23 HD12 ' A' ' 27' ' ' ILE . 3.2 m -67.2 -18.04 65.08 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 123.093 0.557 . . . . 0.0 111.624 -176.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -69.21 -23.85 63.95 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.362 0.601 . . . . 0.0 111.719 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.6 20.61 15.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.752 0.786 . . . . 0.0 110.824 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -152.81 -161.33 1.27 Allowed 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 125.713 1.605 . . . . 0.0 108.816 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 70.69 136.93 0.04 OUTLIER 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 117.219 2.304 . . . . 0.0 117.219 168.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.4 86.18 1.51 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 111.881 -2.418 . . . . 0.0 105.777 165.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -127.79 155.19 44.47 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 174.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -81.24 89.4 6.04 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.77 0.795 . . . . 0.0 112.09 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -90.4 140.65 29.51 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.673 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.4 p -120.42 162.45 19.49 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.9 p . . . . . 0 C--N 1.304 -1.401 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.705 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.973 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 63.17 75.29 0.4 Allowed 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 123.054 1.407 . . . . 0.0 109.805 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -161.39 104.8 1.27 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 112.591 -2.095 . . . . 0.0 107.367 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -118.29 166.78 12.22 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.3 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -85.52 164.78 17.6 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -77.37 81.92 3.84 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.826 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 49.16 64.95 1.52 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 125.734 1.613 . . . . 0.0 111.746 175.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -76.58 101.7 5.8 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 113.952 -1.477 . . . . 0.0 109.131 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.4 93.89 1.02 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.254 47.7 m80 67.27 154.54 0.09 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 125.067 1.347 . . . . 0.0 114.619 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.41 107.18 8.49 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 113.682 -1.599 . . . . 0.0 110.63 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -105.4 91.62 3.85 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.454 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.5 m95 -112.33 -177.97 3.29 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.717 -174.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 50.7 mttm -88.95 -172.38 3.67 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.904 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.42 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 2.8 m-20 -74.76 -34.34 62.48 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -174.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.5 m -121.49 140.87 51.63 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.942 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.588 HD12 HG23 ' A' ' 79' ' ' THR . 9.7 tt -112.85 128.54 69.51 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -177.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.0 mm -113.39 120.57 63.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.427 ' HA ' HD12 ' A' ' 39' ' ' ILE . 43.5 mt-30 -100.77 116.68 33.23 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 114.236 -1.347 . . . . 0.0 107.678 -172.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -96.44 109.47 22.01 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.692 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 69.2 m-85 -96.14 144.19 26.6 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 37' ' ' ASN . 22.9 tptp -156.22 117.26 3.8 Favored 'General case' 0 N--CA 1.406 -2.653 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 62.44 37.84 13.23 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 125.739 1.615 . . . . 0.0 115.06 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.28 -9.01 64.95 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.342 -0.845 . . . . 0.0 115.208 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -134.87 160.81 37.05 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.899 -0.765 . . . . 0.0 108.996 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 9.6 p -75.87 110.72 11.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 5.9 t30 -83.8 -45.18 13.58 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.308 -175.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -130.69 153.27 49.15 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.206 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 29' ' ' GLN . 7.8 tp -116.32 153.86 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 173.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -148.63 168.11 23.68 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.454 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.7 t -150.48 145.57 26.09 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 24' ' ' LYS . . . -141.92 155.97 45.5 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -175.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -79.94 161.65 25.38 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.566 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.42 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 8.2 ptt180 -59.12 116.21 3.69 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.744 170.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 75.07 50.07 0.08 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.056 1.743 . . . . 0.0 110.728 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -130.57 134.56 47.11 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.526 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 44.1 tt0 -102.7 109.22 20.74 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.7 pt -90.64 -177.65 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.2 m -135.52 129.1 32.54 Favored 'General case' 0 N--CA 1.401 -2.897 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 173.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.411 HD12 HD21 ' A' ' 74' ' ' LEU . 67.5 mt -118.72 105.07 16.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 60.21 36.69 20.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.93 0.871 . . . . 0.0 111.605 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 69.88 17.07 7.64 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.159 1.783 . . . . 0.0 113.221 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -106.49 111.36 23.89 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.44 141.59 41.32 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.448 -177.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 88.0 t -135.42 114.5 16.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.738 -173.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 64.4 t80 -90.08 118.72 29.84 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.3 t -101.3 116.91 45.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -73.95 166.09 23.98 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.098 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 17.1 pt-20 -56.04 -21.4 21.41 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 126.861 2.064 . . . . 0.0 113.454 -175.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.22 11.06 26.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.841 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.8 m 59.37 66.08 1.08 Allowed 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.264 1.03 . . . . 0.0 111.763 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -149.79 124.91 4.83 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -82.59 152.32 15.25 Favored 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 123.463 2.775 . . . . 0.0 114.972 -175.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -134.87 137.11 26.53 Favored Pre-proline 0 CA--C 1.493 -1.231 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.32 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -78.93 168.29 75.09 Favored 'Cis proline' 0 C--N 1.314 -1.287 0 C-N-CA 122.671 -1.804 . . . . 0.0 111.442 -3.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 74' ' ' LEU . 64.4 t -86.5 -30.7 6.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.993 -173.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 67' ' ' ILE . 18.5 mm -107.44 129.28 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.972 0.891 . . . . 0.0 110.625 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.1 mt -88.32 165.74 27.02 Favored Pre-proline 0 C--N 1.305 -1.331 0 CA-C-N 114.383 -1.28 . . . . 0.0 108.907 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -72.5 -4.57 15.53 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.77 2.313 . . . . 0.0 111.839 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -95.78 -1.96 48.67 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.309 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 71.7 13.64 6.21 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 126.514 1.926 . . . . 0.0 110.045 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.81 137.05 53.65 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 175.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.692 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 3.1 t -90.69 117.97 35.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 125.859 1.663 . . . . 0.0 109.044 -175.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.411 HD21 HD12 ' A' ' 50' ' ' ILE . 6.1 mp -97.29 139.43 33.26 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.06 173.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.6 m -138.93 154.07 48.3 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.2 146.08 17.57 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 118.829 -1.653 . . . . 0.0 111.852 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -141.76 171.78 13.59 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -80.98 134.86 35.77 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.588 HG23 HD12 ' A' ' 27' ' ' ILE . 1.7 m -70.83 -13.99 62.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.419 0.628 . . . . 0.0 110.556 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 p -66.29 -21.96 66.28 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.128 0.971 . . . . 0.0 111.449 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.48 13.69 28.13 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.285 1.041 . . . . 0.0 110.367 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -138.26 -166.74 2.04 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.363 -174.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 68.27 101.92 0.05 Allowed 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 126.557 1.943 . . . . 0.0 113.755 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -148.32 69.94 1.12 Allowed 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 101.961 -3.348 . . . . 0.0 101.961 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -150.33 169.56 21.1 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.758 -1.565 . . . . 0.0 108.766 -174.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -94.31 6.63 48.09 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 123.012 1.387 . . . . 0.0 112.072 -174.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -101.28 174.33 6.04 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.093 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.7 m -161.69 168.59 23.06 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 83.0 m . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 118.83 0.741 . . . . 0.0 109.406 -179.666 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.259 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -123.44 122.23 37.74 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 75.11 84.35 0.1 Allowed 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 125.956 1.702 . . . . 0.0 109.152 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -137.88 154.99 49.41 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.463 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 3.1 mm? -107.78 177.69 4.75 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -77.08 79.46 3.61 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.459 0.647 . . . . 0.0 109.322 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.463 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 80.1 m-85 -99.42 -66.35 0.91 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 175.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -97.83 73.57 2.3 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.76 0.05 12.07 Favored Glycine 0 N--CA 1.435 -1.41 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -83.39 129.54 35.0 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -81.3 76.28 8.24 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.935 1.35 . . . . 0.0 111.464 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.42 75.71 0.93 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 113.615 -1.63 . . . . 0.0 107.114 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.518 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.0 m0 -106.82 -167.38 1.27 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.628 -1.624 . . . . 0.0 108.592 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -86.77 -170.6 3.14 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.165 0.507 . . . . 0.0 109.994 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.45 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 1.1 m-20 -78.57 -25.92 45.44 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.7 m -131.32 152.75 50.28 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.535 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.411 ' HB ' HG23 ' A' ' 79' ' ' THR . 11.9 tt -125.08 133.86 68.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.4 mm -120.24 112.3 35.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -173.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -96.62 117.76 31.66 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -176.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.411 ' HG3' HD11 ' A' ' 74' ' ' LEU . 8.7 ttp180 -91.62 110.38 21.7 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.687 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 14.5 m-85 -96.18 144.44 26.4 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -134.56 112.07 10.57 Favored 'General case' 0 N--CA 1.401 -2.907 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.284 72.9 m-20 50.6 52.56 14.62 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.05 2.53 88.2 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 115.926 1.13 . . . . 0.0 115.926 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -131.79 154.71 48.82 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.0 p -78.56 131.92 33.43 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -178.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -109.9 -60.09 1.84 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.043 -1.036 . . . . 0.0 111.784 -173.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -127.96 159.94 33.4 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -123.01 130.57 74.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 124.106 0.962 . . . . 0.0 109.264 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -134.34 168.74 18.35 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.518 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.7 t -150.03 142.36 24.23 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.2 157.91 44.33 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.872 -172.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -81.36 160.21 24.18 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 176.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.45 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 6.8 ptt85 -67.92 108.92 3.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.444 0.64 . . . . 0.0 111.73 175.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.531 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 42.3 m-80 83.7 57.07 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.136 2.575 . . . . 0.0 110.087 -175.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -133.76 129.72 37.04 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.106 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 45.1 tt0 -99.18 108.87 21.57 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 pt -94.12 -176.62 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 6.1 m -133.72 136.28 44.55 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.436 HD12 HG21 ' A' ' 55' ' ' VAL . 95.0 mt -132.07 106.65 11.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.05 36.4 25.99 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 122.432 1.111 . . . . 0.0 111.256 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 70.5 16.01 7.1 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 112.687 -2.051 . . . . 0.0 113.994 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -103.64 118.18 36.12 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 172.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -82.14 144.62 30.62 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 118.385 -1.326 . . . . 0.0 108.666 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 88.9 t -135.19 122.35 35.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.609 -173.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 93.9 t80 -93.34 118.16 30.95 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.7 t -96.8 114.02 32.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -73.97 173.28 10.21 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.531 ' HB3' ' ND2' ' A' ' 45' ' ' ASN 0.262 10.3 pt-20 -74.38 0.67 13.74 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -173.32 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.17 12.24 37.95 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.6 m 69.18 33.06 3.44 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.545 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -111.65 117.39 48.88 Favored Pre-proline 0 C--N 1.291 -1.946 0 CA-C-N 113.45 -1.704 . . . . 0.0 108.398 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.587 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 40.8 Cg_endo -88.86 144.69 5.32 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.983 3.122 . . . . 0.0 114.861 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -130.06 134.76 26.51 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.044 173.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -74.87 157.15 99.77 Favored 'Cis proline' 0 CA--C 1.529 0.246 0 C-N-CA 123.045 -1.648 . . . . 0.0 113.307 0.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.9 t -82.1 -37.37 14.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.449 HG23 ' HA ' ' A' ' 71' ' ' ARG . 17.6 mm -103.18 118.61 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-O 122.008 0.909 . . . . 0.0 108.704 172.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.7 mt -82.36 170.32 15.21 Favored Pre-proline 0 C--N 1.293 -1.867 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.162 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -69.25 -13.06 35.31 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.437 2.092 . . . . 0.0 111.944 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -92.28 1.38 57.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 122.136 0.97 . . . . 0.0 108.42 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.449 ' HA ' HG23 ' A' ' 67' ' ' ILE . 16.6 ttm180 63.7 29.77 14.89 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 124.288 1.995 . . . . 0.0 109.954 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.1 m -75.07 136.42 41.17 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-N 112.457 -2.156 . . . . 0.0 106.309 173.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.687 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 6.3 t -91.53 119.11 38.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 125.352 1.461 . . . . 0.0 108.614 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.411 HD11 ' HG3' ' A' ' 30' ' ' ARG . 5.2 mp -99.72 122.84 43.32 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 122.052 0.929 . . . . 0.0 111.427 175.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.8 m -111.2 123.83 50.98 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.587 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -115.38 124.18 6.21 Favored Glycine 0 N--CA 1.419 -2.443 0 C-N-CA 119.865 -1.16 . . . . 0.0 112.192 -175.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -139.07 172.89 12.17 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -81.65 137.0 35.5 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.411 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -62.01 -21.52 64.95 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 124.24 1.016 . . . . 0.0 112.18 -176.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.8 p -64.84 -31.75 73.13 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.247 1.019 . . . . 0.0 110.881 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.42 16.69 23.71 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.649 0.738 . . . . 0.0 110.765 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -139.86 -165.19 1.84 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.819 -175.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 70.85 -65.07 0.35 Allowed 'General case' 0 C--N 1.347 0.468 0 C-N-CA 127.038 2.135 . . . . 0.0 111.101 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.47 -30.85 67.77 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -122.17 81.02 1.78 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.743 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -135.44 168.24 19.58 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.783 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -76.72 -23.13 53.09 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.163 0.985 . . . . 0.0 112.884 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.2 m -64.67 116.46 6.26 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 60.6 m . . . . . 0 N--CA 1.426 -1.641 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.212 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.915 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -134.79 -73.68 0.47 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.993 0.896 . . . . 0.0 112.318 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -88.83 -48.23 7.63 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 116.866 2.173 . . . . 0.0 116.866 -165.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.49 ' OD1' ' HB2' ' A' ' 17' ' ' PHE . 34.5 t-20 -109.25 -43.75 4.08 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 118.591 -1.243 . . . . 0.0 111.711 -170.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.6 mp 67.91 -167.41 0.2 Allowed 'General case' 0 C--O 1.247 0.97 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.851 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -76.16 96.77 3.95 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 118.08 -1.448 . . . . 0.0 107.45 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.49 ' HB2' ' OD1' ' A' ' 14' ' ' ASN . 80.8 t80 -69.27 106.38 2.86 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.625 174.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -95.5 131.91 41.17 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -156.3 -175.0 26.77 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -68.42 122.16 17.83 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 50.1 ttm -84.82 125.3 32.47 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.467 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.98 89.2 2.46 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.169 175.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.479 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.0 m0 -101.91 -162.67 0.95 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HD2' ' CG ' ' A' ' 43' ' ' ASN . 34.6 mmtp -89.23 -178.62 5.69 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.445 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 1.1 m-20 -71.12 -34.24 70.88 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.573 -175.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.8 m -121.07 143.14 49.23 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.063 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.578 HD12 HG23 ' A' ' 79' ' ' THR . 6.1 tt -113.69 133.32 60.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.8 mm -121.43 115.31 46.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -173.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -95.17 127.5 41.27 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -98.24 110.83 23.35 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.626 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 7.4 m-85 -94.86 110.76 22.6 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.401 ' C ' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -95.63 110.28 22.41 Favored 'General case' 0 N--CA 1.411 -2.377 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 -177.683 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.381 3.7 m-20 50.93 49.18 21.66 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.099 -1.864 . . . . 0.0 115.909 -172.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.3 -13.18 64.8 Favored Glycine 0 N--CA 1.435 -1.423 0 N-CA-C 116.474 1.35 . . . . 0.0 116.474 173.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -125.77 147.0 49.53 Favored 'General case' 0 CA--C 1.483 -1.624 0 CA-C-N 119.675 1.737 . . . . 0.0 108.959 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.61 110.89 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 O-C-N 124.51 1.131 . . . . 0.0 111.424 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -97.55 -52.71 3.68 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.354 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -121.74 161.76 22.02 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.718 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 39' ' ' ILE . 13.7 mm -124.9 128.49 73.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 124.496 1.118 . . . . 0.0 109.118 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -135.14 169.51 17.34 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.479 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.8 t -153.68 144.01 22.3 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.8 152.61 40.59 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.438 ' CG ' ' HD2' ' A' ' 24' ' ' LYS . 61.2 m-20 -74.16 164.11 27.02 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.592 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.445 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 3.4 ptt180 -62.88 116.56 5.38 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 171.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 74.4 50.08 0.1 Allowed 'General case' 0 C--O 1.242 0.695 0 C-N-CA 126.237 1.815 . . . . 0.0 110.744 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -128.59 131.34 48.15 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.671 -175.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 44.2 tt0 -101.98 114.62 28.9 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.53 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 pt -98.94 -176.75 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 124.25 1.02 . . . . 0.0 108.49 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.47 131.2 43.32 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.475 HD12 HG21 ' A' ' 55' ' ' VAL . 97.5 mt -127.62 106.52 15.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 54.19 43.02 31.23 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.958 0.885 . . . . 0.0 112.001 175.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 75.53 -1.51 3.0 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.14 2.176 . . . . 0.0 115.116 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -95.16 118.22 31.57 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.26 141.57 32.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 118.173 -1.411 . . . . 0.0 108.74 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 92.5 t -133.29 122.41 44.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.406 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -96.54 121.47 38.39 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.336 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.8 t -100.23 118.78 47.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -68.07 163.7 21.83 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.979 1.712 . . . . 0.0 108.465 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.402 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 1.4 pm0 -66.15 -17.68 64.87 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -171.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.02 14.37 22.06 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.233 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.6 m 65.83 76.82 0.31 Allowed 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 124.64 1.213 . . . . 0.0 112.281 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -157.18 120.54 2.21 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.485 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 73.7 Cg_endo -82.54 143.9 12.41 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 123.391 2.727 . . . . 0.0 114.399 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -130.51 131.16 23.17 Favored Pre-proline 0 CA--C 1.489 -1.391 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.654 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -72.08 162.12 90.49 Favored 'Cis proline' 0 C--N 1.313 -1.301 0 C-N-CA 124.416 -1.077 . . . . 0.0 114.225 -1.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 74' ' ' LEU . 65.6 t -89.34 -42.68 14.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.075 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mp -99.22 129.49 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.476 0.655 . . . . 0.0 109.533 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.4 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 51.0 mt -97.56 171.12 6.28 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.032 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.4 ' CD ' ' HB3' ' A' ' 68' ' ' LEU . 31.0 Cg_exo -67.09 -13.78 41.04 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.986 2.457 . . . . 0.0 112.362 -176.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -85.35 -12.28 52.59 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.1 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 71' ' ' ARG . 16.2 tpt180 72.32 31.9 1.76 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-O 123.886 1.803 . . . . 0.0 107.261 -171.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -74.27 127.27 32.55 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.626 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -92.46 115.81 32.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 125.492 1.517 . . . . 0.0 108.062 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.446 ' HB3' ' CG ' ' A' ' 63' ' ' PRO . 5.8 mp -97.48 129.07 44.7 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 122.326 1.06 . . . . 0.0 111.805 177.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.1 m -121.9 137.38 54.81 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.485 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -131.72 150.38 19.52 Favored Glycine 0 CA--C 1.474 -2.52 0 C-N-CA 119.331 -1.414 . . . . 0.0 109.672 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.511 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 11.1 t0 -163.4 173.91 12.61 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 174.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -69.95 134.94 48.9 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 118.853 0.751 . . . . 0.0 109.718 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.578 HG23 HD12 ' A' ' 27' ' ' ILE . 3.2 m -65.27 -28.19 69.16 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-O 121.756 0.789 . . . . 0.0 110.857 -177.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 85' ' ' ASP . 3.2 p -67.66 -29.47 68.77 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.679 -176.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.93 11.9 34.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 122.438 1.113 . . . . 0.0 111.199 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.511 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 6.5 m-85 -118.9 -83.15 0.65 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.465 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.87 1.54 52.16 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.939 0.876 . . . . 0.0 111.91 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.9 t70 69.09 39.14 1.8 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.363 -1.744 . . . . 0.0 108.986 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 80' ' ' SER . 13.7 t70 -58.76 116.41 3.72 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 166.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -90.9 78.09 6.08 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 116.801 -1.96 . . . . 0.0 114.207 -169.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -101.66 82.73 2.32 Favored 'General case' 0 N--CA 1.413 -2.289 0 C-N-CA 117.566 -1.653 . . . . 0.0 107.38 166.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.5 p -86.61 100.04 12.14 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 2.0 p . . . . . 0 C--N 1.309 -1.17 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.189 -176.882 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.8 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.453 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 10.6 ptm85 -162.6 178.27 8.69 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 176.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.93 147.31 25.7 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 122.055 0.931 . . . . 0.0 111.073 176.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -161.3 -50.38 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -112.22 157.83 20.42 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 167.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -93.83 79.01 4.18 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.096 -175.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 55.65 81.84 0.11 Allowed 'General case' 0 C--O 1.239 0.511 0 O-C-N 124.853 1.345 . . . . 0.0 110.076 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -131.87 149.16 52.53 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -174.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.27 -54.94 11.24 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.43 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -89.11 141.89 28.11 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.4 ptp -134.3 151.24 51.15 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -166.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.32 99.82 8.08 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.043 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.523 ' CE3' HG21 ' A' ' 41' ' ' THR . 18.6 m95 -110.65 167.6 10.1 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HD2' ' CG ' ' A' ' 43' ' ' ASN . 34.8 mmtp -77.96 -171.94 2.5 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.436 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 1.2 t70 -80.74 -31.38 36.0 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.205 1.002 . . . . 0.0 110.856 -172.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.4 m -120.44 146.63 46.03 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.239 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.572 HD12 HG23 ' A' ' 79' ' ' THR . 11.4 tt -118.01 133.46 64.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 75' ' ' SER . 28.3 mm -124.94 113.25 35.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -173.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.505 ' HB2' ' OG ' ' A' ' 75' ' ' SER . 82.2 mt-30 -96.01 133.22 40.5 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.723 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -98.87 110.97 23.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.638 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 59.8 m-85 -95.63 141.21 29.4 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -135.84 116.54 13.97 Favored 'General case' 0 N--CA 1.402 -2.838 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.6 t0 60.21 52.27 5.08 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.683 1.23 . . . . 0.0 113.042 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.57 -4.54 42.55 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 113.716 -1.584 . . . . 0.0 116.181 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -127.05 154.93 44.04 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 8.4 p -75.95 116.89 19.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 CA-C-O 122.295 1.045 . . . . 0.0 110.142 -176.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -93.0 -60.68 1.74 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.615 -174.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -122.27 161.72 22.78 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.779 -176.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.453 ' O ' ' HD2' ' A' ' 12' ' ' ARG . 24.8 mm -121.17 137.32 55.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.889 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -142.2 164.52 29.93 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.523 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.6 t -152.66 144.49 23.62 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.24 150.14 45.15 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 123.506 0.504 . . . . 0.0 110.98 -173.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.405 ' CG ' ' HD2' ' A' ' 24' ' ' LYS . 48.1 m-20 -75.12 156.0 36.47 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.514 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 6.8 ptt180 -60.61 109.82 1.13 Allowed 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 171.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 88.1 m-20 78.65 62.48 0.03 OUTLIER 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.254 1.822 . . . . 0.0 110.37 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -138.9 134.93 33.89 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.987 -178.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 2.6 mp0 -91.84 118.95 31.19 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 172.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.7 pt -98.37 174.08 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.324 0 N-CA-C 105.609 -1.996 . . . . 0.0 105.609 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 1.3 m -136.3 117.88 14.88 Favored 'General case' 0 N--CA 1.404 -2.755 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 176.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.434 HD12 HD21 ' A' ' 74' ' ' LEU . 73.1 mt -108.17 102.04 13.41 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.662 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 58.81 40.27 23.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.387 0.613 . . . . 0.0 112.483 170.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 73.27 9.6 5.18 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.246 1.818 . . . . 0.0 113.803 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -104.42 106.19 16.6 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -82.05 141.36 33.26 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.534 -178.784 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.0 t -132.79 119.46 37.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.518 -171.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 63.6 t80 -93.13 121.72 34.78 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.9 t -102.99 125.11 57.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 174.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -74.58 176.76 6.59 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 124.555 1.16 . . . . 0.0 108.657 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.514 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 9.8 pt-20 -65.44 -20.15 66.24 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.9 106.57 17.12 Favored 'General case' 0 N--CA 1.413 -2.318 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 170.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.4 m -40.42 89.45 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 127.578 2.351 . . . . 0.0 115.344 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -159.72 126.04 2.45 Favored Pre-proline 0 N--CA 1.438 -1.026 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.61 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 56.1 Cg_endo -85.76 146.68 9.34 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.888 2.392 . . . . 0.0 114.333 -175.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 54.9 m-85 -131.02 126.23 21.54 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.513 172.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 72.5 Cg_endo -81.95 164.11 75.47 Favored 'Cis proline' 0 C--N 1.323 -0.808 0 C-N-CA 122.742 -1.774 . . . . 0.0 113.173 -0.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 74' ' ' LEU . 92.6 t -82.59 -43.72 19.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.305 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 67' ' ' ILE . 4.7 mm -91.89 124.48 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 172.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.2 mt -89.27 168.38 15.43 Favored Pre-proline 0 C--N 1.303 -1.445 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.449 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -73.95 -1.17 10.47 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 123.198 2.598 . . . . 0.0 111.703 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -95.77 -9.06 32.69 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.186 -1.824 . . . . 0.0 109.073 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 60.25 57.22 2.99 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 123.572 1.653 . . . . 0.0 108.2 -169.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 m -102.57 135.05 44.91 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 173.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.638 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.6 t -91.61 115.61 31.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 125.496 1.748 . . . . 0.0 107.783 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.434 HD21 HD12 ' A' ' 50' ' ' ILE . 4.7 mp -101.04 135.82 41.87 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.426 -0.796 . . . . 0.0 111.758 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.505 ' OG ' ' HB2' ' A' ' 29' ' ' GLN . 81.1 p -117.36 142.76 46.71 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.61 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -128.68 132.99 7.46 Favored Glycine 0 CA--C 1.479 -2.173 0 C-N-CA 119.64 -1.267 . . . . 0.0 110.345 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -150.69 172.54 15.4 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -75.56 135.05 40.58 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.572 HG23 HD12 ' A' ' 27' ' ' ILE . 2.8 m -59.93 -19.91 54.45 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -175.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.8 p -66.94 -40.05 87.48 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.594 1.158 . . . . 0.0 110.947 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.24 11.29 6.78 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.397 1.094 . . . . 0.0 112.009 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -130.09 -72.25 0.58 Allowed 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.561 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.22 -60.8 1.56 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.036 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.5 t70 66.53 -66.5 0.18 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.347 1.459 . . . . 0.0 110.618 -174.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -169.24 78.11 0.11 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 102.606 -3.109 . . . . 0.0 102.606 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -73.75 104.44 4.66 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.178 -1.374 . . . . 0.0 113.472 -171.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -86.16 -8.99 57.43 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.348 -1.297 . . . . 0.0 109.18 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.7 m 60.35 -174.24 0.12 Allowed 'General case' 0 C--O 1.242 0.667 0 C-N-CA 125.014 1.326 . . . . 0.0 112.386 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.432 -1.331 0 N-CA-C 105.261 -2.125 . . . . 0.0 105.261 175.183 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.813 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.454 ' H ' ' HD3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -101.14 -47.93 4.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.468 1.134 . . . . 0.0 110.573 177.608 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 54.79 -76.81 0.01 OUTLIER 'General case' 0 C--O 1.241 0.629 0 C-N-CA 126.39 1.876 . . . . 0.0 115.5 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -112.02 162.29 15.53 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 122.902 1.334 . . . . 0.0 114.171 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.7 tp -152.53 174.97 13.26 Favored 'General case' 0 C--N 1.293 -1.863 1 N-CA-C 99.236 -4.357 . . . . 0.0 99.236 177.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -82.64 85.26 7.04 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 116.902 -1.919 . . . . 0.0 110.866 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -79.69 113.19 17.66 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 172.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -78.79 82.71 4.99 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 122.63 1.205 . . . . 0.0 112.297 -173.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -108.12 14.6 36.92 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 114.254 -1.339 . . . . 0.0 112.435 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 86.1 t60 70.24 147.13 0.07 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.539 1.136 . . . . 0.0 111.806 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.473 ' HG2' ' HB1' ' A' ' 83' ' ' ALA . 1.1 mpt? -81.38 77.51 8.25 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.33 73.44 1.12 Allowed 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 171.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.488 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.2 m95 -100.18 -176.82 3.34 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.21 -1.814 . . . . 0.0 108.422 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -84.59 -172.2 4.04 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.956 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -78.47 -27.39 46.29 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.956 0.884 . . . . 0.0 112.571 -171.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.8 m -124.29 148.54 47.34 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.611 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.586 HD12 HG23 ' A' ' 79' ' ' THR . 13.9 tt -120.79 133.62 66.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 27' ' ' ILE . 31.8 mm -128.75 112.29 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -173.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 75' ' ' SER . 96.9 mt-30 -97.45 131.67 43.88 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.589 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 46.3 ttt180 -97.13 114.17 25.82 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.642 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 21.3 m-85 -95.78 109.26 21.59 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -96.99 115.7 27.9 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -175.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 59.69 30.6 20.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.53 -1.213 . . . . 0.0 112.879 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.75 -11.13 64.6 Favored Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 115.434 -0.803 . . . . 0.0 114.949 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -121.76 152.06 39.88 Favored 'General case' 0 CA--C 1.486 -1.502 0 CA-C-N 118.843 1.322 . . . . 0.0 108.674 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 9.5 p -73.61 120.54 22.76 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-O 121.656 0.741 . . . . 0.0 112.227 -172.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.68 -50.79 2.97 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.663 0.744 . . . . 0.0 110.483 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.589 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 8.2 m120 -119.22 151.87 37.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.914 -173.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 mp -120.06 122.59 68.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -126.18 167.32 15.58 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.488 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.4 t -153.45 142.31 21.12 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.73 154.19 43.22 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 124.232 0.958 . . . . 0.0 108.914 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -75.71 161.71 28.84 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.021 0.438 . . . . 0.0 111.045 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -66.14 116.79 7.6 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.454 0.645 . . . . 0.0 110.303 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.587 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 38.8 m-80 72.95 64.79 0.1 Allowed 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 126.826 2.05 . . . . 0.0 109.161 -172.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -142.23 131.16 23.02 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 33.9 tt0 -98.19 113.66 25.65 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.443 177.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.8 pt -94.3 -176.2 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.2 m -135.97 136.69 40.58 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.3 mt -127.64 108.49 18.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 54.46 40.49 31.84 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.781 0.801 . . . . 0.0 111.695 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.257 36.0 mm-40 70.23 12.91 7.68 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 126.03 1.732 . . . . 0.0 115.068 -178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -103.37 122.2 44.35 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 172.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -85.77 142.08 29.22 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 118.591 -1.243 . . . . 0.0 109.853 -178.446 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 86.1 t -133.29 124.62 49.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.571 -175.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 62.8 t80 -96.08 119.02 33.83 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 61.0 t -94.97 120.14 43.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -77.16 174.54 10.59 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.587 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 9.7 pt-20 -75.63 -6.27 49.56 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -172.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.66 11.18 36.3 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.816 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 80.3 m 66.2 55.26 0.89 Allowed 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.377 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -136.74 122.59 13.35 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.463 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 98.2 Cg_endo -81.71 146.51 14.98 Favored 'Trans proline' 0 C--N 1.328 -0.512 0 C-N-CA 123.436 2.757 . . . . 0.0 114.098 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -129.84 134.84 26.64 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.651 172.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.87 161.35 79.03 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.158 -2.017 . . . . 0.0 111.495 -2.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.4 t -79.15 -29.78 13.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.274 -176.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 67' ' ' ILE . 8.3 mm -103.96 121.83 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-O 121.773 0.797 . . . . 0.0 110.265 173.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.3 mt -85.75 165.57 34.32 Favored Pre-proline 0 C--N 1.3 -1.58 0 CA-C-N 113.899 -1.501 . . . . 0.0 109.135 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.47 -18.11 54.23 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.723 2.282 . . . . 0.0 112.737 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -87.19 -0.18 56.3 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.231 -1.349 . . . . 0.0 109.598 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 64.48 58.33 1.07 Allowed 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 124.725 2.202 . . . . 0.0 108.823 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.1 m -115.29 135.08 54.52 Favored 'General case' 0 N--CA 1.403 -2.821 0 CA-C-N 111.95 -2.386 . . . . 0.0 106.331 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.642 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.2 t -91.13 123.8 43.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 127.197 2.199 . . . . 0.0 107.792 -176.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mp -100.72 122.28 43.09 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.922 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.408 ' HB3' ' HB2' ' A' ' 29' ' ' GLN . 42.8 t -101.85 118.63 37.33 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -125.66 139.84 11.8 Favored Glycine 0 N--CA 1.424 -2.159 0 C-N-CA 119.015 -1.564 . . . . 0.0 111.647 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -159.57 177.39 10.96 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -73.47 139.88 46.08 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.586 HG23 HD12 ' A' ' 27' ' ' ILE . 1.3 m -67.66 -10.55 53.32 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.643 0.735 . . . . 0.0 111.535 -177.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.9 t -67.53 -40.24 85.07 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.46 14.69 12.35 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.486 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -143.5 -170.11 3.22 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.059 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.473 ' HB1' ' HG2' ' A' ' 21' ' ' MET . . . 58.36 92.33 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 125.051 1.34 . . . . 0.0 112.01 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.9 t70 76.11 -43.4 0.47 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 112.986 -1.915 . . . . 0.0 111.139 -174.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -96.49 142.42 28.6 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -116.79 96.31 5.42 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 120.922 0.391 . . . . 0.0 111.123 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -129.65 -179.25 5.07 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.131 0.972 . . . . 0.0 109.911 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.8 t -133.96 -55.52 0.87 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.437 -1.107 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 178.026 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.863 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -90.38 125.35 35.51 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -102.96 -43.33 5.55 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -148.16 -71.1 0.21 Allowed 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.763 0.792 . . . . 0.0 110.36 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.502 ' HG ' ' H ' ' A' ' 16' ' ' TYR 0.26 23.5 tp -179.37 -168.42 0.12 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 -168.652 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.502 ' H ' ' HG ' ' A' ' 15' ' ' LEU . 35.5 t80 -77.0 80.87 3.53 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 168.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -103.53 -23.21 13.52 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.335 -1.757 . . . . 0.0 112.447 -171.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -64.81 134.13 53.45 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.438 0.637 . . . . 0.0 112.059 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.09 -90.19 0.97 Allowed Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -150.9 177.14 10.42 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 124.054 0.942 . . . . 0.0 108.579 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.0 tpt -77.87 79.3 4.34 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.98 90.81 4.76 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.862 0.839 . . . . 0.0 111.011 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.521 ' CE3' HG21 ' A' ' 41' ' ' THR . 16.7 m95 -97.41 -176.67 3.57 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.537 177.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.487 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 70.6 mmtt -91.96 -171.89 2.99 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.464 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -81.28 -33.99 32.32 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 122.069 0.937 . . . . 0.0 110.835 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 70.3 m -120.5 144.31 48.09 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.57 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.668 HD12 HG23 ' A' ' 79' ' ' THR . 14.7 tt -121.09 133.49 67.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-O 121.225 0.536 . . . . 0.0 109.952 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.401 HD12 ' C ' ' A' ' 27' ' ' ILE . 1.7 mp -113.07 112.77 41.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 122.564 1.173 . . . . 0.0 109.529 -178.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.51 ' OE1' HG21 ' A' ' 36' ' ' VAL . 66.2 mm-40 -91.51 112.33 24.2 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 113.245 -1.798 . . . . 0.0 106.761 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.401 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 56.1 ttt180 -92.22 110.89 22.29 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.664 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 76.4 m-85 -94.69 128.75 41.58 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -138.7 127.11 23.05 Favored 'General case' 0 N--CA 1.407 -2.61 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 -175.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 61.61 31.1 18.81 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.89 10.73 83.67 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.857 -0.611 . . . . 0.0 114.228 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -141.78 159.73 41.62 Favored 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.51 HG21 ' OE1' ' A' ' 29' ' ' GLN . 7.7 p -77.68 110.77 13.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-O 122.1 0.952 . . . . 0.0 109.385 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -91.25 -48.48 6.9 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.118 0.961 . . . . 0.0 111.027 -174.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 30' ' ' ARG . 15.6 m120 -123.26 152.83 40.95 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.694 -177.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.2 mt -128.31 120.77 53.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.717 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -118.69 165.75 13.6 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.521 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.5 t -150.64 143.65 24.72 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.53 153.88 45.15 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.162 -174.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -78.71 160.29 27.54 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.746 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 44' ' ' ARG . 4.2 ptt180 -56.81 118.38 4.86 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.58 173.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.51 ' ND2' ' HB3' ' A' ' 59' ' ' GLU 0.266 58.8 m-80 68.35 68.69 0.32 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.704 1.602 . . . . 0.0 110.488 -173.432 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -146.89 136.28 22.78 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.755 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 42.1 tt0 -104.83 120.38 41.27 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.336 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.7 pt -103.04 -177.54 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.2 m -137.87 139.57 39.95 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.2 mt -134.49 113.21 16.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 53.39 39.04 29.3 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.88 0.848 . . . . 0.0 111.938 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 69.61 17.62 7.82 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 125.494 1.518 . . . . 0.0 112.826 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -103.93 117.77 35.11 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 172.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.447 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -78.95 146.25 33.56 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.984 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.8 t -138.08 115.84 12.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.828 -174.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 90.7 t80 -94.57 127.11 40.3 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.157 0.503 . . . . 0.0 110.205 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.8 t -104.25 122.01 56.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -78.7 175.24 10.62 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 123.639 0.587 . . . . 0.0 109.539 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.51 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -64.99 -21.9 66.92 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -171.524 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.75 12.15 28.9 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.664 -177.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 56.4 m 66.29 80.86 0.21 Allowed 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 124.032 0.833 . . . . 0.0 111.535 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -161.44 127.68 2.4 Favored Pre-proline 0 N--CA 1.442 -0.858 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.535 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 28.3 Cg_endo -92.19 149.9 3.1 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.069 2.513 . . . . 0.0 114.985 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -131.21 135.8 27.74 Favored Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.734 169.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -77.06 165.62 84.45 Favored 'Cis proline' 0 C--N 1.326 -0.641 0 C-N-CA 122.865 -1.723 . . . . 0.0 112.479 -1.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 74' ' ' LEU . 57.6 t -87.41 -47.98 15.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -176.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -92.02 121.3 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 121.883 0.849 . . . . 0.0 109.186 170.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.3 mt -85.31 164.78 39.4 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 114.247 -1.342 . . . . 0.0 108.274 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -70.33 -10.56 28.37 Favored 'Trans proline' 0 N--CA 1.483 0.909 0 C-N-CA 122.849 2.366 . . . . 0.0 111.658 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -84.89 -11.05 56.45 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.565 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.404 17.2 ttm180 65.69 58.69 0.78 Allowed 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 124.528 2.109 . . . . 0.0 111.813 -174.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.9 m -114.25 138.27 50.7 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 111.231 -2.713 . . . . 0.0 106.616 172.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.664 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -91.42 115.92 31.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 125.408 1.692 . . . . 0.0 107.993 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.452 ' O ' HG13 ' A' ' 66' ' ' VAL . 6.6 mp -99.89 122.76 43.32 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.975 0.893 . . . . 0.0 112.091 177.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.8 m -119.12 118.81 32.39 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.268 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.535 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -101.82 131.39 10.57 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -139.76 168.93 18.7 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -75.61 139.5 42.08 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.668 HG23 HD12 ' A' ' 27' ' ' ILE . 2.4 m -68.54 -20.38 64.55 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.244 0.545 . . . . 0.0 110.966 -177.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.4 t -58.73 -38.58 78.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.157 -177.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.72 21.26 8.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.392 0.615 . . . . 0.0 112.371 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -135.14 -66.23 0.59 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -178.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.13 -18.37 43.12 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.001 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.17 39.04 30.35 Favored 'General case' 0 N--CA 1.426 -1.643 0 O-C-N 124.922 1.389 . . . . 0.0 107.667 -175.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 89' ' ' CYS . 2.8 p30 -38.1 130.22 1.21 Allowed 'General case' 0 CA--C 1.507 -0.689 0 O-C-N 126.21 2.194 . . . . 0.0 113.203 -177.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -82.6 72.3 9.68 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.242 -1.345 . . . . 0.0 108.171 -174.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -107.16 -58.4 1.95 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 63.1 m -137.1 10.53 3.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.416 1.103 . . . . 0.0 108.27 173.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 85' ' ' ASP . 37.5 t . . . . . 0 C--O 1.246 0.903 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.709 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -83.72 93.91 8.03 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -134.26 166.76 22.06 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.903 -170.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -139.86 178.13 7.47 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.4 mt -107.76 178.74 4.43 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -84.08 77.65 9.9 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 62.41 -141.21 0.42 Allowed 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.719 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.89 117.32 17.49 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 103.215 -2.883 . . . . 0.0 103.215 174.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.49 68.27 1.21 Allowed Glycine 0 N--CA 1.437 -1.25 0 O-C-N 123.456 0.472 . . . . 0.0 113.199 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -64.37 131.93 48.64 Favored 'General case' 0 C--O 1.252 1.233 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 174.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . 0.267 1.3 pmm? -75.03 83.91 2.27 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 123.498 1.618 . . . . 0.0 114.098 -174.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -128.05 69.56 1.34 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 170.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.559 ' CE3' HG21 ' A' ' 41' ' ' THR . 10.7 m95 -115.1 -167.22 1.2 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 112.633 -2.076 . . . . 0.0 107.481 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.45 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 32.3 mmtp -96.14 -175.63 3.43 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 175.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.486 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 3.6 m-20 -75.24 -33.16 61.28 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.505 0.669 . . . . 0.0 112.592 -176.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.2 m -121.64 140.01 52.82 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.654 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.52 HD12 HG23 ' A' ' 79' ' ' THR . 5.4 tt -113.36 131.72 64.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -177.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.7 mm -119.57 112.37 36.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-O 121.891 0.853 . . . . 0.0 108.732 -173.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -94.69 125.5 39.38 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.488 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.433 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 52.8 ttt180 -95.09 112.72 24.4 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.695 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 25.8 m-85 -95.69 110.87 22.94 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -136.33 125.03 23.81 Favored 'General case' 0 N--CA 1.397 -3.111 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 -174.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 63.96 33.92 11.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.813 1.292 . . . . 0.0 112.304 -173.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.97 -23.06 37.33 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 113.612 -1.631 . . . . 0.0 114.938 172.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -126.91 162.33 26.18 Favored 'General case' 0 CA--C 1.481 -1.702 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.23 110.43 3.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.846 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -84.99 -50.69 7.26 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.486 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.433 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 16.9 m120 -119.07 149.76 41.12 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.95 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.9 mp -116.51 116.33 51.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -119.07 169.44 9.92 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.559 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.6 t -154.43 146.86 23.98 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.4 154.51 40.95 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -75.51 157.09 34.45 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.586 176.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.486 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 2.1 ptt180 -59.91 116.4 4.09 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 121.333 0.587 . . . . 0.0 109.986 170.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.6 m120 75.23 67.27 0.07 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.193 -1.822 . . . . 0.0 108.331 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -152.64 128.84 10.47 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.478 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 2.7 mp0 -86.85 135.89 33.16 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.004 173.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.7 pt -113.99 -179.99 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.12 132.09 37.68 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 86.5 mt -125.53 107.01 17.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 55.06 41.26 31.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.302 1.049 . . . . 0.0 112.65 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 71.51 6.87 5.87 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.943 2.097 . . . . 0.0 112.433 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -93.87 112.34 24.17 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 175.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -83.1 130.61 35.13 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 63.3 t -126.43 120.61 56.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.05 -173.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 56.8 t80 -94.5 121.99 36.62 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.4 t -97.25 125.07 50.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -78.67 175.28 10.56 Favored 'General case' 0 N--CA 1.439 -1.018 0 O-C-N 124.72 1.263 . . . . 0.0 108.002 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.486 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -74.12 -16.52 61.01 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -173.726 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.63 6.13 21.91 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.089 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 76.7 m 71.49 30.32 2.5 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 122.29 1.043 . . . . 0.0 113.319 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -114.54 124.07 31.22 Favored Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 113.736 -1.575 . . . . 0.0 107.898 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.507 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 60.3 Cg_endo -83.97 147.25 11.81 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 123.469 2.779 . . . . 0.0 114.549 -177.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -132.38 131.25 22.21 Favored Pre-proline 0 CA--C 1.493 -1.229 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.065 172.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -76.65 161.66 93.23 Favored 'Cis proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.644 -1.815 . . . . 0.0 112.948 -0.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 74' ' ' LEU . 57.3 t -82.98 -48.24 17.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.539 HG12 ' NH2' ' A' ' 71' ' ' ARG . 1.7 mp -96.38 122.6 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.261 172.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.426 ' C ' ' H ' ' A' ' 70' ' ' ASP . 54.0 mt -80.19 169.61 19.13 Favored Pre-proline 0 C--N 1.296 -1.76 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.101 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -76.04 5.64 4.36 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.99 2.46 . . . . 0.0 109.72 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 68' ' ' LEU . 27.5 t70 -99.93 -10.52 21.59 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 112.686 -2.052 . . . . 0.0 111.223 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.539 ' NH2' HG12 ' A' ' 67' ' ' ILE . 8.6 tpm_? 75.38 18.28 2.37 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.57 1.148 . . . . 0.0 110.243 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.4 m -82.6 140.52 33.17 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 170.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.695 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 7.7 t -90.85 124.76 43.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 126.336 1.854 . . . . 0.0 108.063 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 66' ' ' VAL . 5.4 mp -103.74 122.68 45.58 Favored 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.689 173.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.5 m -117.28 118.2 31.62 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.507 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -114.03 147.38 18.72 Favored Glycine 0 N--CA 1.419 -2.482 0 C-N-CA 118.84 -1.647 . . . . 0.0 110.546 -177.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -150.2 176.51 10.79 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -78.08 136.55 37.91 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.52 HG23 HD12 ' A' ' 27' ' ' ILE . 3.7 m -69.76 -19.11 63.53 Favored 'General case' 0 C--O 1.242 0.686 0 O-C-N 122.058 -0.401 . . . . 0.0 110.014 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.639 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 12.3 p -56.53 -33.16 65.79 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.33 1.452 . . . . 0.0 111.761 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.54 12.71 31.0 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.648 0.737 . . . . 0.0 112.511 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -122.92 -79.64 0.62 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.57 -13.31 23.04 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.807 0.813 . . . . 0.0 110.38 -177.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.639 ' HB3' ' HA ' ' A' ' 80' ' ' SER . 15.2 t70 -93.16 6.25 48.67 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 175.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -122.77 165.14 17.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.901 -1.5 . . . . 0.0 107.969 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -98.33 108.93 21.74 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -130.86 106.26 8.32 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 166.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.4 m 70.72 -63.32 0.42 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.868 1.267 . . . . 0.0 112.503 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 76.5 m . . . . . 0 C--O 1.251 1.181 0 C-N-CA 124.945 1.298 . . . . 0.0 112.941 -179.549 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.775 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 12' ' ' ARG . 18.7 ptt180 -146.63 -41.08 0.2 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 62.15 -90.97 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.776 1.63 . . . . 0.0 112.44 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 173.46 -60.11 0.01 OUTLIER 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 126.963 2.105 . . . . 0.0 107.45 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.6 mt 70.92 176.46 0.28 Allowed 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.393 -1.276 . . . . 0.0 107.953 -174.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -92.42 80.18 4.92 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 116.515 -2.074 . . . . 0.0 111.443 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.549 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 87.9 m-85 -128.99 88.18 2.68 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 171.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -120.31 122.73 41.48 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -175.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.46 -55.68 0.49 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 107.227 -2.349 . . . . 0.0 107.227 -174.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -133.71 103.98 6.12 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.003 -1.098 . . . . 0.0 109.715 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.549 ' SD ' ' HB2' ' A' ' 17' ' ' PHE . 16.4 tpt -74.07 94.91 2.46 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 170.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.96 95.41 2.99 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.091 -173.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.681 ' HB3' HG21 ' A' ' 79' ' ' THR . 82.2 m95 -88.04 160.23 17.93 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.581 0.705 . . . . 0.0 110.198 175.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.413 ' HD2' ' OD1' ' A' ' 43' ' ' ASN . 43.9 mmtm -87.0 -170.88 3.25 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.499 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.516 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 21.2 m-20 -76.02 -28.87 57.92 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.707 0.765 . . . . 0.0 112.298 -174.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.8 m -127.18 147.11 50.2 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.421 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.555 HD12 HG23 ' A' ' 79' ' ' THR . 10.7 tt -118.42 133.35 65.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.9 mm -123.98 112.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -97.21 125.54 41.81 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -93.26 111.02 22.55 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.658 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 34.7 m-85 -95.63 143.15 27.15 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 123.61 0.764 . . . . 0.0 110.453 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -148.87 120.65 8.1 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.262 79.4 m-20 58.7 36.06 24.73 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.03 -21.38 46.35 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 115.295 0.878 . . . . 0.0 115.295 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -119.08 165.32 14.29 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 118.512 1.156 . . . . 0.0 108.222 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 4.1 p -80.66 116.72 25.39 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-O 122.366 1.079 . . . . 0.0 110.392 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -84.31 -58.74 2.63 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.473 -175.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -121.93 157.67 30.73 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.246 0.546 . . . . 0.0 111.443 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.0 mm -116.35 136.17 54.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.506 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -142.73 164.3 30.49 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.6 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.6 t -152.15 142.61 22.6 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 176.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.12 155.52 46.95 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.495 -173.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.413 ' OD1' ' HD2' ' A' ' 24' ' ' LYS . 83.3 m-20 -73.16 154.44 40.31 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.516 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 14.1 ptt180 -66.62 116.22 7.32 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 121.819 -0.551 . . . . 0.0 110.651 172.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 76.95 67.33 0.05 Allowed 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 126.059 1.744 . . . . 0.0 108.62 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -146.27 131.25 18.21 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.521 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 42.2 tt0 -97.66 109.0 21.84 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.425 ' CG1' ' HB ' ' A' ' 55' ' ' VAL . 23.6 pt -92.53 -179.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 3.1 m -136.89 129.79 30.73 Favored 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 172.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.444 HD12 HD21 ' A' ' 74' ' ' LEU . 68.7 mt -119.43 110.23 28.86 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 57.51 39.37 27.94 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.879 0.847 . . . . 0.0 111.625 172.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 73.67 7.22 5.02 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.411 1.884 . . . . 0.0 113.312 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -102.42 119.57 39.04 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -81.0 153.38 27.47 Favored 'General case' 0 N--CA 1.435 -1.225 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.849 -178.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 95.9 t -146.24 125.08 4.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.993 -175.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 77.7 t80 -98.66 118.9 36.41 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.9 t -97.98 118.08 43.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -81.28 170.86 15.53 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -65.75 -15.58 62.98 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -172.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.13 0.51 31.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.938 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 71.9 m 72.44 26.79 2.53 Favored 'General case' 0 CA--C 1.487 -1.449 0 C-N-CA 124.55 1.14 . . . . 0.0 112.625 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -113.22 121.19 38.54 Favored Pre-proline 0 C--N 1.287 -2.113 0 CA-C-N 112.9 -1.955 . . . . 0.0 108.306 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.556 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 45.7 Cg_endo -85.66 144.19 8.72 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 124.093 3.195 . . . . 0.0 115.26 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -129.58 134.07 25.8 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.729 172.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -79.05 153.52 89.8 Favored 'Cis proline' 0 C--N 1.323 -0.815 0 C-N-CA 122.67 -1.804 . . . . 0.0 112.603 1.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 74' ' ' LEU . 86.2 t -75.05 -35.39 34.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.82 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.0 mm -102.87 125.18 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.359 174.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.1 mt -84.68 165.46 37.55 Favored Pre-proline 0 C--N 1.29 -1.983 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.17 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -70.4 -8.85 24.59 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 C-N-CA 123.038 2.492 . . . . 0.0 112.167 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -88.61 -7.62 56.09 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.587 177.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 67.82 57.76 0.51 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 123.886 1.803 . . . . 0.0 108.817 -173.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.9 m -112.8 140.63 47.43 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-N 112.665 -2.061 . . . . 0.0 107.082 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.658 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.7 t -91.81 115.93 31.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 125.233 1.583 . . . . 0.0 108.696 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.444 HD21 HD12 ' A' ' 50' ' ' ILE . 3.6 mp -96.24 122.68 39.36 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.049 174.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 64.9 m -117.82 117.46 29.36 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.556 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -120.82 137.8 12.25 Favored Glycine 0 N--CA 1.411 -2.993 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.963 -177.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.436 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 9.3 m-20 -145.56 173.73 11.79 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -72.58 138.43 46.83 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.681 HG21 ' HB3' ' A' ' 23' ' ' TRP . 1.8 m -68.84 -18.54 64.17 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.224 0.535 . . . . 0.0 111.802 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 p -63.02 -25.5 68.41 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.368 0.604 . . . . 0.0 111.523 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.71 20.2 18.34 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.026 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.436 ' CE1' ' HB2' ' A' ' 77' ' ' ASP . 7.7 m-85 -144.25 -170.76 3.43 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.794 -174.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 76.16 110.21 0.07 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.764 2.025 . . . . 0.0 113.218 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -69.84 -38.5 76.54 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.074 -1.421 . . . . 0.0 110.061 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -100.42 87.29 3.36 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -92.22 144.12 25.73 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.367 -176.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -79.56 172.07 14.29 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.252 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 89' ' ' CYS . 5.3 m -49.9 -59.4 3.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.36 0.664 . . . . 0.0 109.837 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 88' ' ' SER . 30.3 t . . . . . 0 C--O 1.254 1.32 0 N-CA-C 103.112 -2.921 . . . . 0.0 103.112 174.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.2 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -137.44 150.19 47.43 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -95.69 -173.0 2.75 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 118.629 0.65 . . . . 0.0 110.457 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.2 t30 77.9 -74.67 0.06 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.659 1.584 . . . . 0.0 109.308 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.3 mt 61.69 178.24 0.12 Allowed 'General case' 0 C--O 1.24 0.602 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 176.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -83.8 84.21 7.65 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.123 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -93.97 98.83 11.29 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.469 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -95.01 95.93 8.93 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 175.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.31 -167.19 22.59 Favored Glycine 0 C--N 1.3 -1.44 0 N-CA-C 108.219 -1.953 . . . . 0.0 108.219 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -140.34 142.56 35.57 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 118.022 0.911 . . . . 0.0 110.144 -177.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.408 ' HB3' ' HE1' ' A' ' 23' ' ' TRP . 16.4 tpt -69.98 150.54 46.57 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 175.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.84 102.14 14.4 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.96 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.596 ' HB3' HG21 ' A' ' 79' ' ' THR . 71.4 m95 -98.34 155.07 17.39 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.553 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 10.8 mmpt? -88.91 -170.21 2.82 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 123.498 0.719 . . . . 0.0 111.449 -176.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.495 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 4.7 m-20 -69.3 -34.46 74.73 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -173.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.0 m -126.97 147.22 50.12 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.869 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.553 HD12 HG23 ' A' ' 79' ' ' THR . 8.2 tt -116.74 133.35 63.66 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 75' ' ' SER . 33.4 mm -125.94 111.61 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -174.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.535 ' HB2' ' HB3' ' A' ' 75' ' ' SER . 97.6 mt-30 -102.51 132.09 48.79 Favored 'General case' 0 C--N 1.282 -2.336 0 O-C-N 121.652 -0.655 . . . . 0.0 109.675 -177.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -92.9 109.85 21.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.587 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 10.2 m-85 -95.53 109.7 21.89 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -89.73 110.76 21.64 Favored 'General case' 0 N--CA 1.398 -3.05 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -177.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 53.88 40.58 31.71 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 113.489 -1.687 . . . . 0.0 114.238 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.16 -18.69 56.72 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 115.038 -0.983 . . . . 0.0 115.048 176.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -108.3 150.23 27.6 Favored 'General case' 0 CA--C 1.477 -1.855 0 CA-C-N 119.075 1.437 . . . . 0.0 107.829 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 31' ' ' TYR 0.253 7.1 p -79.53 115.34 21.7 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 C-N-CA 118.45 -1.3 . . . . 0.0 110.894 -175.567 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -97.11 -60.67 1.54 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.689 -174.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.402 ' C ' HD12 ' A' ' 39' ' ' ILE . 96.5 m-20 -119.91 158.38 26.8 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.35 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.402 HD12 ' C ' ' A' ' 38' ' ' ASN . 2.9 mp -125.54 121.75 60.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -123.02 169.94 10.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.489 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.6 t -149.95 142.08 24.04 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.4 160.06 40.49 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.496 -173.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -79.73 158.49 26.9 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.495 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 5.2 ptt180 -64.94 111.89 3.05 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 170.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.554 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 89.4 m-20 76.63 67.53 0.06 Allowed 'General case' 0 C--O 1.243 0.735 0 CA-C-O 123.321 1.534 . . . . 0.0 109.949 -176.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -144.16 123.08 12.74 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 112.581 -2.099 . . . . 0.0 110.46 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 46.6 tt0 -89.4 109.73 20.61 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 173.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.6 pt -92.99 -176.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 177.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 4.5 m -136.32 131.37 34.24 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 176.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 97.5 mt -132.62 108.45 13.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 58.81 35.01 24.08 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 122.91 1.338 . . . . 0.0 110.342 176.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 72.79 5.13 5.16 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 127.847 2.459 . . . . 0.0 113.683 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -92.01 114.27 26.77 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 174.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -80.36 140.54 36.03 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 117.925 -1.51 . . . . 0.0 108.135 178.316 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 86.1 t -133.23 123.18 46.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.011 -170.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 92.7 t80 -91.26 118.69 30.69 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.276 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 45' ' ' ASN . 64.6 t -95.67 119.33 43.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 174.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -77.33 165.03 24.98 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 124.33 1.018 . . . . 0.0 108.738 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.554 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -62.33 -19.98 63.88 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -173.338 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.82 11.36 11.37 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.401 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.6 m 62.65 68.05 0.67 Allowed 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.163 0.982 . . . . 0.0 110.438 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -153.19 120.54 3.01 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.608 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 55.6 Cg_endo -86.24 154.27 9.49 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.768 2.979 . . . . 0.0 114.314 -177.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -135.78 132.09 19.37 Favored Pre-proline 0 CA--C 1.483 -1.634 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.898 172.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.42 168.19 75.97 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.805 -1.748 . . . . 0.0 112.378 -2.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.0 t -88.61 -48.09 15.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.752 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -92.5 124.81 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.683 0.754 . . . . 0.0 109.893 173.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.5 mt -83.82 168.22 23.34 Favored Pre-proline 0 C--N 1.299 -1.593 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.983 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -64.67 -21.24 65.37 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.458 2.105 . . . . 0.0 111.135 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -83.43 -3.55 57.68 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 125.848 1.659 . . . . 0.0 110.934 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 18.4 tpt180 77.38 6.44 3.0 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.049 1.74 . . . . 0.0 110.747 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.1 m -67.95 134.09 50.19 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 122.134 0.969 . . . . 0.0 109.601 173.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.7 t -91.07 125.32 43.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 C-N-CA 128.493 2.717 . . . . 0.0 107.647 -175.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 mp -98.28 122.35 41.34 Favored 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.964 174.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' ' 29' ' ' GLN . 30.3 t -97.83 118.36 34.22 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.608 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -122.0 126.04 6.31 Favored Glycine 0 N--CA 1.416 -2.686 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.457 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 5.4 t70 -153.71 172.06 17.87 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -73.31 140.87 47.05 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.596 HG21 ' HB3' ' A' ' 23' ' ' TRP . 3.7 m -71.68 -16.45 62.24 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.559 0.695 . . . . 0.0 109.632 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . 0.264 1.5 m -59.99 -22.55 62.7 Favored 'General case' 0 N--CA 1.411 -2.417 0 C-N-CA 126.238 1.815 . . . . 0.0 111.627 178.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.8 15.99 16.33 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 122.541 1.162 . . . . 0.0 110.066 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.457 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 31.9 m-85 -138.67 -166.85 2.08 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.202 -176.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 56.17 86.79 0.06 Allowed 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 123.55 1.643 . . . . 0.0 111.598 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -79.61 4.99 14.31 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 111.908 -2.405 . . . . 0.0 113.34 -172.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.62 -46.65 89.5 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 168.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -83.13 98.33 9.28 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.8 135.31 33.4 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -176.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.9 m 82.94 99.97 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.08 1.752 . . . . 0.0 112.575 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 59.2 m . . . . . 0 C--N 1.31 -1.149 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 175.833 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.845 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -122.21 -15.93 7.57 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -62.12 -45.54 93.02 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 54.99 -157.8 0.21 Allowed 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.368 1.467 . . . . 0.0 109.412 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -119.03 149.53 41.5 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -89.68 85.49 6.47 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 102.982 -2.97 . . . . 0.0 102.982 175.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . 0.401 4.9 t80 -71.4 104.57 3.24 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -172.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.442 ' OE1' ' HA ' ' A' ' 18' ' ' GLN . 7.9 mm-40 -153.11 -49.27 0.1 Allowed 'General case' 0 C--N 1.29 -2.006 1 N-CA-C 98.854 -4.499 . . . . 0.0 98.854 169.71 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 10.85 -91.42 0.01 OUTLIER Glycine 0 CA--C 1.498 -1.009 0 C-N-CA 128.167 2.794 . . . . 0.0 118.541 167.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.261 88.1 m-70 63.36 104.82 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 -166.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.635 ' SD ' ' HA ' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -60.69 103.36 0.25 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 112.482 -2.144 . . . . 0.0 115.188 -167.38 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.55 60.75 1.68 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.266 -2.864 . . . . 0.0 103.266 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.55 ' CE3' HG21 ' A' ' 41' ' ' THR . 13.5 m0 -73.65 -162.11 0.12 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 111.833 -2.44 . . . . 0.0 109.919 -177.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.526 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 34.8 mmtp -73.51 -173.47 1.43 Allowed 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.129 0.966 . . . . 0.0 108.675 174.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.553 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 6.7 m-20 -83.5 -33.58 25.52 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.704 -174.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 69.2 m -123.5 140.41 53.03 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.358 -176.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.64 HD12 HG23 ' A' ' 79' ' ' THR . 7.2 tt -113.87 133.26 60.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.4 mm -122.23 112.33 34.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -174.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.614 ' HB2' ' OG ' ' A' ' 75' ' ' SER . 96.8 mt-30 -96.69 127.63 42.86 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.5 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 58.5 ttt180 -95.78 112.33 24.08 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.529 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 56.9 m-85 -94.71 145.93 24.51 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -149.99 117.68 6.19 Favored 'General case' 0 N--CA 1.404 -2.741 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.256 0.8 OUTLIER 57.86 34.51 24.45 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 177.573 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.54 -1.09 59.98 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.255 -0.974 . . . . 0.0 114.279 175.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -135.55 158.53 44.15 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 10.9 p -80.7 124.0 38.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -99.44 -46.52 5.46 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.316 -173.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.5 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 14.6 m120 -130.18 159.01 38.13 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.841 -176.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.8 mm -118.73 134.11 63.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 123.524 0.73 . . . . 0.0 110.799 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -141.18 165.09 28.48 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.55 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.4 t -157.33 144.35 18.4 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.445 ' HB2' HG23 ' A' ' 48' ' ' ILE . . . -140.17 156.43 46.53 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.189 0.596 . . . . 0.0 110.733 -174.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -74.88 157.58 34.82 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.553 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 8.1 ptt180 -62.81 107.86 1.06 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 171.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 83.57 62.09 0.01 OUTLIER 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.95 2.1 . . . . 0.0 110.681 -176.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -144.79 132.28 20.87 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.872 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 3.5 mp0 -87.3 112.45 22.08 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 172.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.445 HG23 ' HB2' ' A' ' 42' ' ' ALA . 23.1 pt -88.79 179.65 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 172.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.7 m -132.13 133.83 44.73 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 85.8 mt -127.1 106.08 14.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 56.24 38.83 30.18 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.408 1.099 . . . . 0.0 111.821 176.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 64.78 28.7 12.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.742 -1.572 . . . . 0.0 114.335 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -113.42 109.98 19.56 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 169.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.67 136.96 37.59 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 118.005 -1.478 . . . . 0.0 108.827 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.4 t -124.4 114.35 40.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.513 -174.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 79.1 t80 -82.92 115.79 21.93 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.1 t -97.18 118.75 44.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -75.38 173.07 11.41 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 125.162 1.539 . . . . 0.0 108.415 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -20.83 65.99 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -172.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.73 12.19 11.34 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.51 0.671 . . . . 0.0 110.006 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.9 m 68.58 31.1 4.87 Favored 'General case' 0 C--O 1.199 -1.585 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.925 175.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -109.72 119.79 46.79 Favored Pre-proline 0 C--N 1.288 -2.069 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.349 -177.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.604 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 83.7 Cg_endo -83.34 143.16 11.01 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.447 2.765 . . . . 0.0 113.516 -177.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 86.9 m-85 -129.43 132.02 24.0 Favored Pre-proline 0 N--CA 1.432 -1.329 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.691 173.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 62.9 Cg_endo -80.7 165.97 76.04 Favored 'Cis proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.514 -1.869 . . . . 0.0 112.181 -2.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.3 t -83.44 -39.7 15.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.866 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 mp -96.67 123.55 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 CA-C-O 121.386 0.612 . . . . 0.0 109.503 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.4 mt -84.6 167.44 26.85 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.012 177.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -70.72 -7.3 21.03 Favored 'Trans proline' 0 N--CA 1.484 0.951 0 C-N-CA 122.915 2.41 . . . . 0.0 112.671 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -89.82 -12.01 40.38 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.048 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.38 37.1 ttm180 67.62 58.69 0.5 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 124.032 1.872 . . . . 0.0 110.516 -169.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.7 m -103.48 136.44 43.21 Favored 'General case' 0 N--CA 1.408 -2.527 0 CA-C-N 111.861 -2.427 . . . . 0.0 105.11 172.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.3 t -93.27 115.69 32.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 124.855 1.347 . . . . 0.0 108.29 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.6 mp -97.22 126.87 42.7 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.452 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 29' ' ' GLN . 51.4 p -107.69 129.7 55.0 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.604 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -114.42 118.01 4.26 Favored Glycine 0 N--CA 1.418 -2.534 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.953 -177.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -131.28 169.48 15.92 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -86.84 134.07 33.58 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 177.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.64 HG23 HD12 ' A' ' 27' ' ' ILE . 1.5 m -71.55 -13.85 61.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.954 0.407 . . . . 0.0 111.854 -175.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.4 p -69.69 -31.83 70.08 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.53 0.681 . . . . 0.0 110.765 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.24 17.46 21.27 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 122.437 1.113 . . . . 0.0 110.222 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -142.0 -165.89 2.11 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 125.83 1.652 . . . . 0.0 108.55 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 57.62 90.39 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 124.936 1.398 . . . . 0.0 109.914 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -42.54 -36.86 1.47 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 128.057 2.543 . . . . 0.0 114.931 -170.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.635 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 10.0 t70 56.66 63.58 1.92 Allowed 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 -172.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -41.68 91.22 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 111.523 -2.581 . . . . 0.0 113.109 -170.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -77.5 84.44 3.89 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 123.386 1.565 . . . . 0.0 112.758 -175.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.5 m -151.78 36.31 0.56 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 112.295 -2.23 . . . . 0.0 106.292 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.439 -0.984 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.613 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.847 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . 0.296 6.5 mmt180 68.02 110.67 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -97.77 89.86 4.76 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -77.17 155.36 32.34 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.491 -171.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.409 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 62.6 mt -87.83 168.52 12.85 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 176.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -69.85 85.6 0.5 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.897 0.856 . . . . 0.0 111.746 -176.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.409 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 78.8 m-85 -108.37 69.24 0.72 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.347 174.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -154.37 37.78 0.43 Allowed 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 127.356 2.263 . . . . 0.0 105.184 175.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -139.41 10.11 3.22 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.421 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 68.62 90.45 0.1 Allowed 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 125.835 1.654 . . . . 0.0 112.759 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.4 ttt -88.49 145.53 25.69 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 172.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.87 90.75 5.91 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.562 ' HB3' HG21 ' A' ' 79' ' ' THR . 41.7 m95 -72.17 165.52 24.21 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.094 -177.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.517 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . 9.1 mmpt? -79.47 -173.68 3.85 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.151 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -76.15 -24.38 54.84 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.5 m -132.52 155.58 48.36 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.462 HD12 HG23 ' A' ' 79' ' ' THR . 8.6 tt -125.37 133.68 68.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -178.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.438 HD13 ' O ' ' A' ' 27' ' ' ILE . 25.6 mm -125.08 111.3 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -175.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -103.38 130.33 50.66 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.144 0.497 . . . . 0.0 110.21 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -99.44 115.27 28.89 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.404 -175.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.743 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 27.9 m-85 -96.5 125.73 41.19 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 37' ' ' ASN . 10.2 tmtt? -131.57 125.63 32.79 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 -178.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 60.89 30.16 19.47 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.65 1.18 . . . . 0.0 112.449 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.86 0.68 90.37 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.221 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -122.14 156.98 32.51 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.9 p -77.39 110.11 12.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.485 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 64.8 t30 -91.61 -43.79 9.42 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.217 -171.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -129.72 151.16 50.61 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -119.72 115.06 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -119.17 166.01 13.48 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.56 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.3 t -150.81 142.72 23.89 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.11 160.91 41.85 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -174.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.436 ' OD1' ' HB3' ' A' ' 24' ' ' LYS . 90.7 m-20 -85.27 164.93 17.73 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 121.769 0.795 . . . . 0.0 112.217 176.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.423 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 5.5 ptt85 -62.26 110.16 1.55 Allowed 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.947 169.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 75.6 67.21 0.07 Allowed 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.719 1.208 . . . . 0.0 109.015 -177.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -152.48 143.71 23.22 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 124.662 1.185 . . . . 0.0 107.932 -178.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -115.56 135.96 53.55 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 121.489 0.661 . . . . 0.0 110.655 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.478 ' CG1' ' HB ' ' A' ' 55' ' ' VAL . 29.1 pt -119.05 -179.99 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 1.7 m -137.62 135.13 36.3 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.6 mt -127.55 108.2 17.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.85 49.54 20.85 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 70.09 5.73 5.43 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.023 1.329 . . . . 0.0 113.277 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -104.16 109.63 21.5 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -75.1 154.11 38.0 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.991 0.9 . . . . 0.0 112.245 178.619 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.478 ' HB ' ' CG1' ' A' ' 48' ' ' ILE . 88.6 t -142.59 118.08 5.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 CA-C-N 113.546 -1.661 . . . . 0.0 109.842 -173.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -102.51 123.7 46.74 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.2 t -97.99 119.38 45.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -80.62 172.0 14.31 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.423 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 9.9 pt-20 -67.27 -5.58 14.67 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -172.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.61 13.68 31.16 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.711 172.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.0 m 69.83 33.96 2.74 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.518 1.152 . . . . 0.0 111.8 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -114.88 119.05 39.91 Favored Pre-proline 0 C--N 1.286 -2.17 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.672 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.577 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 83.6 Cg_endo -83.98 147.95 11.96 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.795 2.997 . . . . 0.0 114.115 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 70.7 m-85 -130.07 129.91 23.02 Favored Pre-proline 0 CA--C 1.488 -1.433 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.227 172.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.27 161.25 81.46 Favored 'Cis proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.923 -1.699 . . . . 0.0 112.354 -2.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.1 t -81.88 -36.76 14.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.265 0.555 . . . . 0.0 109.631 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.9 mm -106.42 127.08 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 173.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 39.4 mt -87.44 171.77 9.2 Favored Pre-proline 0 C--N 1.289 -2.035 0 CA-C-N 114.174 -1.376 . . . . 0.0 109.865 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -71.29 -12.02 29.38 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.551 2.167 . . . . 0.0 110.864 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -87.56 -0.14 56.43 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 125.836 1.654 . . . . 0.0 108.303 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 60.34 26.93 16.47 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 127.849 2.46 . . . . 0.0 109.361 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.13 135.57 47.72 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.743 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 5.5 t -90.89 117.48 34.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 125.704 1.878 . . . . 0.0 108.301 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.45 121.83 42.66 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.586 -1.246 . . . . 0.0 112.265 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.0 m -97.51 118.04 33.12 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 175.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.577 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -116.93 111.66 2.35 Favored Glycine 0 N--CA 1.422 -2.262 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.498 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.474 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 19.3 m-20 -142.69 177.21 8.47 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -78.03 139.53 39.11 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.562 HG21 ' HB3' ' A' ' 23' ' ' TRP . 0.2 OUTLIER -62.8 -21.77 66.13 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.139 0.975 . . . . 0.0 112.854 -176.272 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 p -71.49 -24.85 62.06 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.595 0.712 . . . . 0.0 111.32 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.37 14.9 24.62 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.916 0.865 . . . . 0.0 111.178 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.474 ' CE1' ' HB2' ' A' ' 77' ' ' ASP . 37.5 m-85 -146.09 -170.31 3.46 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 124.716 1.206 . . . . 0.0 111.432 -176.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 54.78 99.6 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 126.039 1.735 . . . . 0.0 114.684 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -88.91 70.11 8.58 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.218 -1.355 . . . . 0.0 107.563 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -166.88 -37.46 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 111.838 -2.437 . . . . 0.0 105.608 -174.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.44 129.8 39.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.363 174.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -100.02 142.26 31.74 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.142 0.496 . . . . 0.0 111.676 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.6 m -76.65 -24.04 53.29 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.571 -175.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 6.3 p . . . . . 0 C--N 1.306 -1.295 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 176.877 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.901 0 CA-C-O 118.168 -1.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? 57.08 31.87 20.71 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.515 1.15 . . . . 0.0 108.014 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.485 ' HA ' ' OE1' ' A' ' 13' ' ' GLU . 4.6 tp10 -83.0 113.29 20.47 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.948 -168.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -125.05 -47.48 1.78 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.058 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.3 mt 60.04 -165.78 0.2 Allowed 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.449 -1.251 . . . . 0.0 109.468 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -91.94 76.74 5.49 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -129.63 15.56 5.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.245 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.75 115.42 6.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 174.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.79 -31.07 0.41 Allowed Glycine 0 C--N 1.298 -1.577 0 N-CA-C 107.086 -2.405 . . . . 0.0 107.086 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -114.01 102.26 10.02 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 170.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 49.0 ttm -130.1 114.32 15.6 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.09 84.59 2.11 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.543 ' CE3' HG21 ' A' ' 41' ' ' THR . 12.1 m95 -91.4 -175.29 4.19 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.513 177.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -92.37 -173.74 3.49 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.403 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 1.3 m-20 -73.87 -33.86 64.23 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.935 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.6 m -122.16 145.21 48.4 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.787 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.571 HD12 HG23 ' A' ' 79' ' ' THR . 9.2 tt -114.8 133.31 61.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.8 mm -124.36 112.51 32.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -174.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -95.92 127.53 42.02 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.463 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 28.1 ttt180 -95.24 110.93 22.85 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.647 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 30.3 m-85 -95.77 137.06 35.36 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -153.13 123.33 7.05 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 63.0 29.58 16.42 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.963 1.705 . . . . 0.0 114.122 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.98 -4.85 75.44 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.901 176.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -124.72 160.63 28.17 Favored 'General case' 0 CA--C 1.482 -1.635 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 5.6 p -84.9 110.22 18.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -88.98 -45.98 9.24 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.588 -171.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.463 ' HB2' ' HB3' ' A' ' 30' ' ' ARG . 18.6 m120 -122.03 157.48 31.27 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.676 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.4 mm -121.42 134.87 63.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.671 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -141.49 166.64 24.19 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.543 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.8 t -158.13 141.49 15.2 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.34 156.84 45.27 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -173.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -79.72 157.98 27.03 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.898 175.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.41 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 4.1 ptt180 -59.06 115.78 3.39 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 169.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 75.49 59.34 0.06 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 126.163 1.785 . . . . 0.0 109.173 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -141.65 136.12 30.62 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.114 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 45.3 tt0 -101.67 109.94 21.82 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.7 pt -91.6 -178.11 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.5 m -136.36 126.78 26.74 Favored 'General case' 0 N--CA 1.405 -2.712 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 68.4 mt -118.34 104.15 15.71 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 56.3 43.49 26.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 122.108 0.956 . . . . 0.0 112.154 170.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 71.96 8.92 6.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.242 1.817 . . . . 0.0 114.512 -178.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -103.3 118.13 36.06 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 104.411 -2.441 . . . . 0.0 104.411 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 139.96 30.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 117.665 -1.614 . . . . 0.0 109.038 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 93.0 t -131.81 124.1 52.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.463 -173.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 75.5 t80 -96.7 121.76 38.89 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.1 t -100.74 124.28 54.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 175.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -83.41 -175.46 5.83 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.41 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 4.3 pm0 -70.59 -17.93 62.9 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -173.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.48 14.79 13.82 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.08 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 84.7 m 66.27 36.61 5.31 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.849 1.309 . . . . 0.0 112.355 174.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -116.48 120.4 34.73 Favored Pre-proline 0 C--N 1.293 -1.861 0 CA-C-N 113.223 -1.808 . . . . 0.0 108.169 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.474 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 63.9 Cg_endo -84.79 144.9 10.02 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.672 2.915 . . . . 0.0 114.422 -177.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -131.1 129.92 22.61 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.646 172.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.57 164.94 81.11 Favored 'Cis proline' 0 C--N 1.325 -0.67 0 C-N-CA 122.965 -1.681 . . . . 0.0 112.93 0.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.01 -36.59 10.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.638 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 67' ' ' ILE . 20.7 mm -101.13 127.95 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.92 173.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.5 mt -86.42 169.86 14.08 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.608 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -72.09 -11.21 26.97 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.342 2.028 . . . . 0.0 111.329 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -99.15 12.94 34.66 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.196 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 71' ' ' ARG . 9.8 tpt180 61.76 27.6 16.9 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 123.274 1.511 . . . . 0.0 110.102 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.35 139.82 32.8 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.647 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 3.0 t -91.35 124.43 43.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 125.996 1.719 . . . . 0.0 108.843 -177.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mp -101.79 125.99 48.57 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.566 173.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.5 m -116.64 118.62 33.08 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.265 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.474 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -110.55 142.0 16.53 Favored Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 120.503 -0.855 . . . . 0.0 112.78 -176.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -156.26 177.35 11.54 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -80.33 136.02 36.32 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.571 HG23 HD12 ' A' ' 27' ' ' ILE . 2.3 m -61.78 -25.61 67.58 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 p -64.44 -40.64 96.12 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.42 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.35 13.17 10.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.988 0.899 . . . . 0.0 111.654 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -124.85 -79.12 0.61 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.815 -1.084 . . . . 0.0 113.505 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 84' ' ' ASP . . . -85.71 -3.13 58.81 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.947 -173.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 83' ' ' ALA . 9.2 t70 81.82 -56.96 0.24 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.912 1.685 . . . . 0.0 109.031 -177.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.0 t70 48.45 83.03 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.472 1.509 . . . . 0.0 112.488 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -79.27 117.59 20.41 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.453 -1.249 . . . . 0.0 112.422 -176.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -96.12 -11.91 25.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 173.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.5 m 76.76 -46.59 0.51 Allowed 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 126.472 1.909 . . . . 0.0 110.291 -175.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 31.5 t . . . . . 0 N--CA 1.433 -1.324 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 177.09 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.836 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -148.12 82.13 1.49 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -116.96 105.05 11.91 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.778 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -101.71 160.84 14.12 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 171.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 mp -128.47 171.93 11.62 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.911 -174.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -81.13 77.09 8.06 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -77.93 -51.58 10.18 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.412 ' HG2' ' H ' ' A' ' 20' ' ' HIS . 36.1 tt0 -119.51 143.98 47.28 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.05 20.57 50.29 Favored Glycine 0 CA--C 1.497 -1.08 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.412 ' H ' ' HG2' ' A' ' 18' ' ' GLN . 85.4 m-70 -142.54 173.86 11.16 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.515 ' HG3' ' O ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -118.35 101.71 8.39 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.458 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -128.65 78.34 1.84 Allowed 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 113.413 -1.721 . . . . 0.0 106.81 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.464 ' CE3' HG21 ' A' ' 41' ' ' THR . 14.8 m0 -92.93 -164.06 1.13 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 113.389 -1.732 . . . . 0.0 108.559 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -84.2 -171.48 3.63 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.431 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -81.8 -28.39 33.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -172.737 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.6 m -123.5 144.26 49.65 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.044 -177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.612 HD12 HG23 ' A' ' 79' ' ' THR . 11.0 tt -117.31 133.08 65.19 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.7 mm -125.48 112.77 32.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -172.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -101.05 136.26 41.18 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.413 ' HG3' HD11 ' A' ' 74' ' ' LEU . 3.6 ttp180 -99.58 111.02 23.41 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.677 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 29.6 m-85 -95.41 136.57 35.62 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 123.223 0.609 . . . . 0.0 109.861 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.44 123.57 15.55 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -176.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.29 15.6 m-20 50.9 31.37 6.08 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.44 -15.84 61.52 Favored Glycine 0 N--CA 1.432 -1.583 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.809 177.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -104.26 152.84 21.72 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 p -83.02 109.5 16.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -89.17 -43.46 11.0 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.85 -168.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -129.12 148.97 51.12 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -118.0 120.74 65.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -126.6 169.22 13.32 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.464 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.5 t -149.76 145.34 26.58 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.33 154.02 44.33 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 123.673 0.789 . . . . 0.0 110.016 -174.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -75.05 151.05 38.72 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 122.026 -0.421 . . . . 0.0 110.049 173.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.449 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 8.6 ptt85 -57.55 114.83 2.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 171.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 74.67 67.74 0.08 Allowed 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 125.477 1.511 . . . . 0.0 109.553 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -151.46 139.6 20.19 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.764 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -97.13 121.88 39.51 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.2 pt -102.08 177.06 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 172.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.4 m -136.62 124.6 22.8 Favored 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.434 HD12 HD21 ' A' ' 74' ' ' LEU . 98.8 mt -114.88 105.59 18.94 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 57.26 46.75 18.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.605 0.717 . . . . 0.0 112.564 174.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 71.65 3.01 4.51 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.861 1.665 . . . . 0.0 112.897 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -99.36 109.36 21.97 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.45 143.52 34.89 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 117.959 -1.496 . . . . 0.0 109.707 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -133.74 121.21 39.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.113 -174.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -91.56 128.81 37.53 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.4 t -108.83 121.71 62.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -78.14 169.09 18.84 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 124.407 1.083 . . . . 0.0 108.223 178.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.449 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 10.5 pt-20 -72.35 -4.0 27.28 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.86 7.42 45.02 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 172.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 70.8 m 64.83 35.59 8.46 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.097 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -123.01 129.07 25.11 Favored Pre-proline 0 C--N 1.29 -2.013 0 CA-C-N 114.308 -1.314 . . . . 0.0 107.789 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.422 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 46.6 Cg_endo -84.73 159.43 12.19 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.038 2.492 . . . . 0.0 116.01 -175.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 40.8 m-85 -134.7 131.03 20.0 Favored Pre-proline 0 C--N 1.312 -1.064 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.101 171.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 91.4 Cg_endo -83.85 161.06 70.84 Favored 'Cis proline' 0 C--N 1.319 -1.022 0 C-N-CA 122.907 -1.705 . . . . 0.0 111.425 -2.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 74' ' ' LEU . 90.7 t -81.17 -38.44 16.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.695 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 67' ' ' ILE . 8.3 mm -97.44 116.61 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-O 122.106 0.955 . . . . 0.0 109.932 173.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.9 mt -76.87 165.77 49.88 Favored Pre-proline 0 C--N 1.297 -1.701 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.935 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.07 -3.41 13.6 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.428 2.085 . . . . 0.0 111.366 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -93.17 -12.15 31.02 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.019 -1.901 . . . . 0.0 110.462 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.278 40.0 ttm180 66.88 59.05 0.57 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 123.819 1.771 . . . . 0.0 109.763 -171.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.3 m -120.7 139.55 52.89 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 112.269 -2.241 . . . . 0.0 106.743 172.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.677 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.7 t -90.62 115.78 30.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 125.439 1.712 . . . . 0.0 108.975 -175.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.452 ' O ' HG13 ' A' ' 66' ' ' VAL . 4.0 mp -92.92 122.64 35.5 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 118.693 -1.203 . . . . 0.0 109.794 173.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.6 m -118.67 118.71 32.37 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.422 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -110.85 152.72 17.41 Favored Glycine 0 N--CA 1.415 -2.763 0 C-N-CA 119.763 -1.208 . . . . 0.0 111.405 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 61' ' ' CYS . 2.9 t70 -157.53 177.1 11.79 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 174.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -82.91 137.05 34.37 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.612 HG23 HD12 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -68.19 -25.31 65.17 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 118.213 0.461 . . . . 0.0 111.867 -175.0 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.2 t -67.91 -38.15 82.58 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.19 17.41 4.32 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.434 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.04 -68.59 0.63 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.556 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . . . -87.84 -7.13 57.66 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.5 t70 77.6 21.86 0.95 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.701 2.0 . . . . 0.0 110.483 175.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.556 ' OD1' ' HB3' ' A' ' 83' ' ' ALA . 3.0 m-20 -46.86 114.83 0.91 Allowed 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 114.025 -1.443 . . . . 0.0 112.143 176.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -93.7 95.98 9.51 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.799 0.809 . . . . 0.0 108.978 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -101.31 33.44 2.9 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.0 m 68.98 18.76 8.37 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-O 123.242 1.496 . . . . 0.0 108.173 -170.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 59.2 m . . . . . 0 N--CA 1.421 -1.922 0 N-CA-C 102.113 -3.292 . . . . 0.0 102.113 179.043 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.527 ' CE3' HG21 ' A' ' 41' ' ' THR . 12.1 m95 . . . . . 0 N--CA 1.44 -0.96 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.524 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 34.4 mmtp -83.34 -173.87 4.96 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.513 0.673 . . . . 0.0 110.102 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.97 -37.47 55.14 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.775 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.2 m -122.02 144.32 48.97 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.87 -176.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.511 HD12 HG23 ' A' ' 79' ' ' THR . 7.1 tt -118.89 133.24 66.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.3 mm -121.97 112.72 36.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -92.91 128.72 38.87 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.074 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -98.31 114.28 26.52 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.45 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 35.5 m-85 . . . . . 0 N--CA 1.421 -1.896 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.437 -1.114 0 CA-C-O 122.442 1.115 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -97.16 -60.49 1.57 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.445 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -121.92 156.83 32.53 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.512 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 mp -120.05 118.04 55.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -119.93 169.12 10.46 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.527 HG21 ' CE3' ' A' ' 23' ' ' TRP . 4.2 t -155.37 147.95 24.1 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.76 157.85 43.61 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.582 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -72.64 155.35 40.11 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -57.65 121.11 9.59 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 166.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.56 HD21 ' HB3' ' A' ' 59' ' ' GLU . 2.0 m120 74.9 55.05 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 126.464 1.906 . . . . 0.0 110.054 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -139.54 139.54 36.9 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.803 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 5.8 mp0 -95.85 125.8 40.66 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.4 pt -105.47 -176.94 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 172.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 m -136.93 134.67 37.01 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.413 HD12 HD21 ' A' ' 74' ' ' LEU . 80.1 mt -126.77 105.05 13.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 54.26 46.08 25.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.721 0.772 . . . . 0.0 111.841 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 69.7 9.42 7.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -103.92 115.26 30.14 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.45 142.62 31.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.003 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.1 t -134.33 125.04 46.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.768 -172.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 82.9 t80 -94.74 122.03 36.93 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.0 t -97.53 121.75 48.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.427 ' OD1' ' HG2' ' A' ' 59' ' ' GLU . 40.1 t30 -71.53 165.77 23.18 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 124.923 1.389 . . . . 0.0 109.3 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.56 ' HB3' HD21 ' A' ' 45' ' ' ASN . 10.7 pt-20 -58.28 -24.3 59.01 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 126.012 1.725 . . . . 0.0 114.1 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.12 16.6 22.2 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.2 m 64.85 69.45 0.49 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.341 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.403 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 4.3 t-80 -148.07 124.42 5.4 Favored Pre-proline 0 C--N 1.313 -0.981 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.477 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 52.2 Cg_endo -83.58 140.49 9.43 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.252 2.635 . . . . 0.0 114.033 -176.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -129.41 131.68 23.78 Favored Pre-proline 0 CA--C 1.494 -1.183 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.148 174.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.28 166.62 81.63 Favored 'Cis proline' 0 C--N 1.325 -0.704 0 C-N-CA 122.726 -1.781 . . . . 0.0 112.74 -1.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.33 -28.43 5.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.565 0.698 . . . . 0.0 110.344 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.554 HG23 ' HA ' ' A' ' 71' ' ' ARG . 32.4 mm -108.75 132.56 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-O 121.525 0.679 . . . . 0.0 109.936 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.41 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 45.3 mt -91.15 171.87 7.5 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.582 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.41 ' CD ' ' HB3' ' A' ' 68' ' ' LEU . 25.5 Cg_exo -67.99 -15.33 43.27 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.593 2.195 . . . . 0.0 111.85 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -86.41 -12.29 49.56 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.55 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.554 ' HA ' HG23 ' A' ' 67' ' ' ILE . 23.7 ttm180 72.17 31.11 1.99 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 124.081 1.896 . . . . 0.0 109.013 -173.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 m -70.24 138.85 52.01 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 169.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 1.4 t -96.8 125.58 49.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 O-C-N 125.01 1.444 . . . . 0.0 109.571 -175.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.413 HD21 HD12 ' A' ' 50' ' ' ILE . 3.0 mp -103.96 138.66 40.2 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 121.438 0.637 . . . . 0.0 109.63 174.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.9 m -136.34 122.06 19.79 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.505 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.477 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -107.12 142.81 15.78 Favored Glycine 0 N--CA 1.428 -1.899 0 C-N-CA 120.247 -0.977 . . . . 0.0 110.973 -177.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -147.05 173.01 12.86 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -79.69 138.45 37.36 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.511 HG23 HD12 ' A' ' 27' ' ' ILE . 1.9 m -68.49 -15.36 63.51 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.465 0.65 . . . . 0.0 110.437 -177.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.5 t -56.59 -42.23 78.33 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 126.079 1.752 . . . . 0.0 108.903 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.15 21.33 11.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.555 0.693 . . . . 0.0 112.107 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 . . . . . 0 C--N 1.303 -1.445 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.826 -179.366 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.55 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.3 m95 . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 120.809 0.338 . . . . 0.0 111.632 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.538 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 50.8 mmtt -85.15 -171.91 3.89 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.423 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 2.0 m-20 -82.26 -29.85 31.0 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.453 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 71.9 m -127.21 141.99 51.6 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.173 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.581 HD12 HG23 ' A' ' 79' ' ' THR . 11.0 tt -119.17 133.06 67.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.6 mm -123.56 111.92 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -95.48 125.99 40.46 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.577 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -94.76 113.75 25.56 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.636 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 11.3 m-85 . . . . . 0 C--N 1.293 -1.855 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 N--CA 1.433 -1.321 0 CA-C-O 122.599 1.19 . . . . 0.0 107.824 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -87.15 -50.96 6.27 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.439 -174.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -128.97 155.32 45.54 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.202 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -119.14 119.04 59.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -120.25 167.83 11.87 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.55 HG21 ' CE3' ' A' ' 23' ' ' TRP . 4.3 t -154.55 147.33 24.36 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.11 160.74 43.08 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -82.06 162.34 22.6 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.794 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.423 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 6.5 ptt85 -60.86 113.48 2.53 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.297 174.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.605 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 32.1 m-80 73.46 67.79 0.11 Allowed 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 126.489 1.916 . . . . 0.0 109.102 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -147.38 130.02 15.99 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.069 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 43.0 tt0 -97.62 116.84 30.62 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.501 0.667 . . . . 0.0 109.868 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.0 pt -98.26 -178.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 3.0 m -137.06 136.22 38.19 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 92.1 mt -128.01 107.96 17.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 56.8 34.78 25.27 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 74.7 14.56 3.37 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 127.015 2.126 . . . . 0.0 112.719 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -102.64 110.31 22.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 172.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.518 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -78.67 145.31 34.66 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.72 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -137.23 118.99 18.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.663 -173.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 69.2 t80 -89.89 118.71 29.67 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.2 t -94.11 117.97 38.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -71.98 168.29 18.34 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.605 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 13.5 pt-20 -64.38 -15.48 60.55 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.653 1.181 . . . . 0.0 113.663 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.13 6.18 43.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.8 m 69.48 36.55 2.2 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.595 1.158 . . . . 0.0 112.127 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -122.39 124.3 26.85 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 113.632 -1.622 . . . . 0.0 107.52 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.416 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 72.2 Cg_endo -81.72 153.62 17.57 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.218 2.612 . . . . 0.0 115.047 -176.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -136.39 131.45 18.51 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.174 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.07 161.69 88.06 Favored 'Cis proline' 0 C--N 1.322 -0.843 0 C-N-CA 122.526 -1.864 . . . . 0.0 111.513 -3.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.3 t -78.92 -36.68 19.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.373 0.606 . . . . 0.0 110.125 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.29 126.74 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 121.614 0.721 . . . . 0.0 110.782 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.62 170.7 10.07 Favored Pre-proline 0 C--N 1.305 -1.336 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.017 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -69.3 -9.48 26.39 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.551 2.167 . . . . 0.0 112.456 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.69 -11.07 54.66 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.463 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.411 ' HD2' ' HA ' ' A' ' 71' ' ' ARG . 11.5 tpt180 76.16 22.58 1.35 Allowed 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 126.375 1.87 . . . . 0.0 107.925 -172.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.4 m -67.45 134.68 51.83 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.379 -1.282 . . . . 0.0 107.657 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -92.93 116.74 34.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 126.002 1.721 . . . . 0.0 108.796 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 mp -96.84 122.55 39.93 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.117 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.9 m -114.36 118.7 34.59 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.416 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -117.27 134.99 11.55 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 119.933 -1.127 . . . . 0.0 112.551 -175.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -141.35 168.37 19.94 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -72.6 139.98 47.75 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.581 HG23 HD12 ' A' ' 27' ' ' ILE . 1.7 m -71.93 -15.71 62.09 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.798 0.808 . . . . 0.0 109.709 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . 0.276 0.7 OUTLIER -56.82 -32.64 65.93 Favored 'General case' 0 N--CA 1.414 -2.244 0 C-N-CA 126.399 1.88 . . . . 0.0 111.015 179.01 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.69 19.41 20.52 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.1 0.952 . . . . 0.0 109.851 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 . . . . . 0 C--N 1.299 -1.591 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.236 -176.346 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.534 ' HB2' HG21 ' A' ' 79' ' ' THR . 14.3 m0 . . . . . 0 N--CA 1.441 -0.896 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -88.51 -170.75 3.06 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -77.96 -29.87 50.05 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.075 0.941 . . . . 0.0 111.116 -171.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.2 m -124.55 143.22 50.8 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.709 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.596 HD12 HG23 ' A' ' 79' ' ' THR . 13.5 tt -117.89 133.05 65.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.41 HG23 ' HG3' ' A' ' 63' ' ' PRO . 30.8 mm -126.45 114.24 37.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -172.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -98.92 135.14 40.78 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.505 ' HG3' HD11 ' A' ' 74' ' ' LEU . 4.7 ttp180 -103.8 112.88 26.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.642 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 33.7 m-85 . . . . . 0 C--N 1.293 -1.863 0 C-N-CA 124.367 1.067 . . . . 0.0 110.016 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 N--CA 1.445 -0.693 0 CA-C-O 121.72 0.771 . . . . 0.0 111.604 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -111.4 -62.68 1.51 Allowed 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 125.016 1.326 . . . . 0.0 112.537 -174.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.403 ' O ' HD12 ' A' ' 39' ' ' ILE . 6.9 m-80 -121.61 167.32 13.03 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 122.764 0.426 . . . . 0.0 111.041 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.403 HD12 ' O ' ' A' ' 38' ' ' ASN . 1.7 mp -131.71 135.88 58.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 125.118 1.367 . . . . 0.0 108.426 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -141.79 163.83 31.84 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.444 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.7 t -149.14 139.53 22.41 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.72 163.77 31.71 Favored 'General case' 0 C--N 1.311 -1.068 0 O-C-N 124.003 0.815 . . . . 0.0 109.272 -173.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -77.56 159.73 29.08 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 120.467 -0.493 . . . . 0.0 109.836 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -67.75 116.37 8.36 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 120.924 0.392 . . . . 0.0 110.029 173.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.581 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 26.3 m-80 75.36 67.63 0.07 Allowed 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 126.901 2.08 . . . . 0.0 109.332 -174.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -149.68 134.57 17.86 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.609 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 44.3 tt0 -101.19 119.46 38.79 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-O 121.839 0.828 . . . . 0.0 110.209 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.5 pt -100.01 179.27 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.789 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 m -136.9 134.25 36.62 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.417 HD12 HG21 ' A' ' 55' ' ' VAL . 95.2 mt -124.88 106.63 16.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 59.05 34.9 23.71 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.119 0.961 . . . . 0.0 111.193 176.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.26 42.9 mm-40 67.39 21.19 9.79 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.625 1.57 . . . . 0.0 113.523 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -104.2 111.28 23.82 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 169.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -81.45 133.64 35.43 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.649 0.737 . . . . 0.0 109.241 -176.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.417 HG21 HD12 ' A' ' 50' ' ' ILE . 94.1 t -127.38 119.12 51.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.744 -173.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 79.4 t80 -92.89 121.52 34.33 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.9 t -94.01 114.62 31.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -69.03 165.03 21.04 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.581 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 9.1 pt-20 -70.14 -7.81 44.66 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 123.768 0.827 . . . . 0.0 112.428 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.41 -2.37 52.9 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 79.1 m 69.35 32.81 3.4 Favored 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.917 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -122.05 128.37 25.56 Favored Pre-proline 0 C--N 1.293 -1.85 0 CA-C-N 113.027 -1.897 . . . . 0.0 106.708 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.41 ' HG3' HG23 ' A' ' 28' ' ' ILE . 42.6 Cg_endo -85.01 156.07 11.35 Favored 'Trans proline' 0 C--N 1.329 -0.447 0 C-N-CA 123.267 2.645 . . . . 0.0 115.4 -175.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -135.17 131.32 19.66 Favored Pre-proline 0 N--CA 1.441 -0.906 0 C-N-CA 124.678 1.191 . . . . 0.0 111.571 172.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.5 169.7 70.17 Favored 'Cis proline' 0 C--N 1.322 -0.82 0 C-N-CA 122.435 -1.902 . . . . 0.0 112.306 -1.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.8 t -86.79 -42.17 15.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.093 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.447 HG12 ' NH2' ' A' ' 71' ' ' ARG . 1.7 mp -98.3 128.02 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.71 0.767 . . . . 0.0 110.49 173.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.6 mt -88.41 169.11 14.31 Favored Pre-proline 0 C--N 1.306 -1.298 0 CA-C-N 114.297 -1.319 . . . . 0.0 108.243 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.35 -9.18 25.34 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.281 1.988 . . . . 0.0 110.904 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -88.7 1.2 55.54 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.687 -1.597 . . . . 0.0 109.492 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.447 ' NH2' HG12 ' A' ' 67' ' ' ILE . 8.3 tpm_? 74.93 9.43 4.0 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 125.253 1.421 . . . . 0.0 109.671 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 67' ' ' ILE . 0.9 OUTLIER -70.86 138.15 50.0 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.703 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.642 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.3 t -92.1 124.07 44.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 125.614 1.566 . . . . 0.0 109.479 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.505 HD11 ' HG3' ' A' ' 30' ' ' ARG . 7.6 mp -100.23 122.74 43.51 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.959 0.885 . . . . 0.0 110.307 172.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 52.3 m -118.03 117.74 30.04 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -118.07 152.28 17.6 Favored Glycine 0 N--CA 1.422 -2.279 0 C-N-CA 119.395 -1.383 . . . . 0.0 111.38 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -155.84 177.13 11.75 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -79.65 139.2 37.49 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.596 HG23 HD12 ' A' ' 27' ' ' ILE . 1.6 m -72.11 -10.9 60.4 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.568 0.699 . . . . 0.0 110.409 -178.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.4 p -69.09 -22.93 63.97 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.425 0.631 . . . . 0.0 111.034 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.36 17.14 24.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 122.07 0.938 . . . . 0.0 109.909 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 . . . . . 0 C--N 1.3 -1.578 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.955 -175.426 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.441 ' CB ' HG21 ' A' ' 79' ' ' THR . 11.5 m0 . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . 11.2 mmpt? -88.55 -170.58 2.99 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 121.923 -0.485 . . . . 0.0 110.759 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -29.18 54.7 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.091 0.472 . . . . 0.0 112.013 -175.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 68.1 m -122.34 144.81 48.79 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.884 0.85 . . . . 0.0 110.766 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.623 HD12 HG23 ' A' ' 79' ' ' THR . 8.6 tt -119.48 133.66 65.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.4 mm -119.01 133.07 67.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -174.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -117.23 132.56 56.6 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -174.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -94.6 112.98 24.74 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.641 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 23.2 m-85 . . . . . 0 C--N 1.301 -1.539 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.433 -1.312 0 CA-C-O 122.524 1.154 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -88.19 -57.54 2.89 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.801 -173.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -121.09 159.88 24.82 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.876 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.6 tp -122.73 155.85 28.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -151.02 167.88 26.3 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.424 HG21 ' CE3' ' A' ' 23' ' ' TRP . 2.0 t -149.63 146.82 27.49 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.374 0.606 . . . . 0.0 110.029 177.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.85 158.87 44.25 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -80.99 158.82 25.04 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.483 ' HB2' ' HA ' ' A' ' 59' ' ' GLU . 6.8 ptt85 -61.58 114.42 3.25 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 171.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.467 HD21 ' HB3' ' A' ' 59' ' ' GLU . 9.4 m-80 76.52 67.15 0.06 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 127.112 2.165 . . . . 0.0 108.914 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -146.72 128.5 15.29 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.561 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -89.86 109.93 20.9 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.368 0.604 . . . . 0.0 109.696 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.9 pt -96.7 -178.97 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.9 m -133.24 130.68 39.34 Favored 'General case' 0 N--CA 1.403 -2.789 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 174.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.44 HD12 HG21 ' A' ' 55' ' ' VAL . 87.7 mt -122.75 101.82 10.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 61.14 36.96 17.95 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.947 0.879 . . . . 0.0 111.251 172.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 70.64 18.94 6.25 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 113.751 -1.568 . . . . 0.0 113.798 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -112.52 107.66 16.48 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 172.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 49' ' ' THR 0.31 0.0 OUTLIER -78.78 152.92 31.16 Favored 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 117.654 -1.618 . . . . 0.0 111.81 -179.534 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 50' ' ' ILE . 91.8 t -142.72 129.83 18.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.299 -170.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -100.34 120.8 40.5 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 66.2 t -98.32 117.68 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -71.76 167.65 19.47 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 124.586 1.179 . . . . 0.0 109.336 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.483 ' HA ' ' HB2' ' A' ' 44' ' ' ARG . 9.5 pt-20 -58.65 -20.8 51.05 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 126.0 1.72 . . . . 0.0 114.851 -174.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.56 19.89 18.16 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 120.953 0.406 . . . . 0.0 109.965 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.9 m 62.33 69.97 0.59 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.403 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -148.0 121.79 4.84 Favored Pre-proline 0 N--CA 1.439 -0.997 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.515 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 48.7 Cg_endo -87.73 142.74 5.9 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.564 2.843 . . . . 0.0 114.912 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -131.79 134.61 25.56 Favored Pre-proline 0 C--N 1.309 -1.165 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.491 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.01 158.08 96.84 Favored 'Cis proline' 0 C--N 1.332 -0.342 0 C-N-CA 122.572 -1.845 . . . . 0.0 112.831 0.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.14 -40.13 21.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.362 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.9 mm -98.76 124.17 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.926 -1.109 . . . . 0.0 109.39 175.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 mt -85.61 168.24 20.88 Favored Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.644 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -68.64 -11.96 33.35 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.126 1.884 . . . . 0.0 111.177 -176.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -91.98 10.82 27.37 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.155 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 68.62 9.59 7.4 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.473 1.909 . . . . 0.0 111.45 172.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.9 m -82.21 150.7 27.21 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.825 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.3 t -91.29 131.0 39.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 126.436 1.894 . . . . 0.0 109.751 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.94 123.56 48.17 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.09 0.948 . . . . 0.0 111.03 173.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.4 t -107.62 147.09 31.11 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.515 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -130.58 140.35 11.69 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -152.86 175.75 12.57 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -86.21 132.78 33.93 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.623 HG23 HD12 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -67.52 -21.96 65.46 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.278 0.561 . . . . 0.0 111.503 -175.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.4 p -65.95 -26.81 67.75 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.916 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.33 21.13 17.46 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.822 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.312 -1.05 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -174.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.509 ' CE3' HG21 ' A' ' 41' ' ' THR . 17.9 m95 . . . . . 0 N--CA 1.43 -1.472 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -101.87 -171.35 1.96 Allowed 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.541 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.49 -27.49 58.81 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -173.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.8 m -126.28 142.56 51.48 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.022 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.647 HD12 HG23 ' A' ' 79' ' ' THR . 12.7 tt -115.22 133.46 61.39 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.41 HD13 ' O ' ' A' ' 27' ' ' ILE . 34.9 mm -127.22 116.94 45.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -173.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 75' ' ' SER . 95.9 mt-30 -105.75 139.12 40.82 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.759 -0.588 . . . . 0.0 110.358 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.536 ' HD2' HG21 ' A' ' 50' ' ' ILE . 24.1 mtp180 -95.82 115.74 27.87 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 121.528 -0.069 . . . . 0.0 110.971 175.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.648 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 29.2 m-85 . . . . . 0 C--N 1.295 -1.761 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.431 -1.375 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -94.78 -51.78 4.55 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.037 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -119.8 154.25 34.52 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.893 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -121.92 127.26 75.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -133.73 168.99 17.71 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.509 HG21 ' CE3' ' A' ' 23' ' ' TRP . 2.3 t -155.45 139.63 16.55 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.23 152.96 46.38 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.456 -174.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -76.69 160.6 29.22 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 120.881 0.372 . . . . 0.0 110.562 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.53 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 4.0 ptt180 -60.56 115.59 3.72 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.895 172.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.426 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 82.9 m-20 73.62 65.01 0.09 Allowed 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.969 1.708 . . . . 0.0 109.678 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -145.74 137.46 25.17 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.26 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 39.2 tt0 -107.75 109.5 21.09 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.733 0.778 . . . . 0.0 109.225 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.4 pt -90.59 -177.33 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.812 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.2 m -130.98 134.34 46.63 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.536 HG21 ' HD2' ' A' ' 30' ' ' ARG . 82.1 mt -128.95 110.31 20.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 51.79 38.04 22.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.07 0.938 . . . . 0.0 112.676 177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 69.12 29.05 4.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 113.337 -1.756 . . . . 0.0 112.829 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -118.35 116.82 27.52 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 169.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -82.12 140.9 33.54 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 118.494 -1.283 . . . . 0.0 109.7 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.452 HG21 HD12 ' A' ' 50' ' ' ILE . 69.2 t -132.22 125.99 55.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.837 -172.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 54.6 t80 -96.03 121.01 37.32 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -178.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.34 116.99 44.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -70.78 164.72 24.6 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 124.295 0.997 . . . . 0.0 108.374 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.53 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 9.3 pt-20 -62.76 -13.14 29.45 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.39 11.63 29.91 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.009 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.2 m 62.14 69.44 0.62 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.882 0.848 . . . . 0.0 111.937 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -152.01 124.87 4.08 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.578 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 64.0 Cg_endo -87.03 141.2 6.01 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.323 2.682 . . . . 0.0 114.226 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -126.48 129.22 24.18 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 174.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.16 159.68 92.72 Favored 'Cis proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.613 -1.828 . . . . 0.0 112.585 -0.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.8 t -78.94 -44.02 24.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.458 HG21 ' NH2' ' A' ' 71' ' ' ARG . 1.7 mp -94.7 123.69 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 121.597 0.713 . . . . 0.0 109.151 171.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.6 mt -83.19 169.51 17.36 Favored Pre-proline 0 C--N 1.299 -1.596 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.774 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -71.61 -2.51 11.47 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.498 2.132 . . . . 0.0 111.343 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -97.48 4.72 50.38 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.62 -1.627 . . . . 0.0 109.401 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.458 ' NH2' HG21 ' A' ' 67' ' ' ILE . 0.4 OUTLIER 66.14 21.26 11.16 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.111 1.364 . . . . 0.0 109.323 177.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.2 m -85.5 139.73 31.25 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.648 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -90.5 125.48 43.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 125.956 1.702 . . . . 0.0 108.409 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.8 mp -101.56 130.13 47.79 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 122.201 1.001 . . . . 0.0 111.214 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.435 ' HB3' ' HB2' ' A' ' 29' ' ' GLN . 37.6 t -106.02 121.34 43.91 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.578 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -117.69 131.98 9.65 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.293 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -150.12 172.97 14.43 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -80.8 135.44 35.96 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.647 HG23 HD12 ' A' ' 27' ' ' ILE . 2.4 m -70.61 -14.46 62.49 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 121.867 -0.521 . . . . 0.0 111.795 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.9 t -69.45 -28.93 66.53 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 122.27 1.033 . . . . 0.0 108.879 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.56 16.17 16.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.681 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 C--N 1.305 -1.367 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.172 -177.662 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.432 ' CB ' HG21 ' A' ' 79' ' ' THR . 12.4 m0 . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 120.917 0.389 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.488 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . 10.5 mmpt? -84.93 -174.57 5.34 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.886 0.374 . . . . 0.0 110.229 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.406 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 5.4 m-20 -70.19 -38.38 75.34 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 74.2 m -123.78 145.28 49.15 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.717 -174.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.544 HD12 HG23 ' A' ' 79' ' ' THR . 9.8 tt -118.13 127.66 75.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.405 HD12 ' C ' ' A' ' 27' ' ' ILE . 1.6 mp -117.14 114.54 46.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.915 0.864 . . . . 0.0 110.094 -175.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -91.69 124.84 36.14 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.793 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.462 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 63.9 ttt180 -96.51 110.38 22.78 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.655 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 83.1 m-85 . . . . . 0 C--N 1.301 -1.523 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 9.0 p . . . . . 0 N--CA 1.431 -1.386 0 CA-C-O 122.694 1.235 . . . . 0.0 112.782 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -96.96 -55.56 2.83 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.918 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.462 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 16.3 m120 -120.12 153.37 36.27 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.477 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 mp -119.2 116.36 50.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -118.72 166.78 12.35 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 24' ' ' LYS . 4.0 t -146.84 139.86 25.32 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 173.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.2 161.2 38.21 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.165 -1.38 . . . . 0.0 107.771 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 24' ' ' LYS . 90.5 m-20 -87.02 160.99 18.43 Favored 'General case' 0 C--N 1.284 -2.281 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.632 176.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.422 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 3.5 ptt85 -58.68 119.43 7.08 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.956 171.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.1 m120 68.33 64.36 0.35 Allowed 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 125.57 1.548 . . . . 0.0 108.643 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -144.58 133.29 22.3 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 113.755 -1.566 . . . . 0.0 108.403 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 36.4 tt0 -108.13 109.31 20.7 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.753 0.787 . . . . 0.0 109.766 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 32.0 pt -87.8 -178.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.214 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.8 m -136.4 135.63 38.9 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.9 mt -127.38 108.34 18.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 53.28 42.88 32.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.356 1.074 . . . . 0.0 112.201 177.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 72.72 8.91 5.6 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.766 2.026 . . . . 0.0 113.865 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -100.12 115.77 30.57 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.63 144.51 33.72 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.702 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.2 t -137.05 117.42 16.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.358 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 64.3 t80 -92.06 123.04 35.12 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.023 0.44 . . . . 0.0 110.841 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.0 t -97.46 123.39 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -76.03 173.87 10.72 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 124.611 1.194 . . . . 0.0 108.822 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.422 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 1.3 pm0 -71.51 -20.73 62.01 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -173.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.5 19.92 11.46 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.559 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.7 m 61.69 79.63 0.25 Allowed 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 124.639 1.212 . . . . 0.0 113.103 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -162.62 128.56 2.29 Favored Pre-proline 0 C--N 1.314 -0.936 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.497 ' CG ' ' HB3' ' A' ' 74' ' ' LEU . 42.6 Cg_endo -88.54 149.93 6.32 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.248 2.632 . . . . 0.0 114.604 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -135.86 134.07 20.34 Favored Pre-proline 0 CA--C 1.498 -1.053 0 C-N-CA 125.167 1.387 . . . . 0.0 110.265 173.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.35 163.63 84.22 Favored 'Cis proline' 0 C--N 1.317 -1.093 0 C-N-CA 122.633 -1.82 . . . . 0.0 112.219 0.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.0 t -82.47 -40.88 17.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.553 -174.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 72' ' ' SER . 1.7 mp -104.16 127.68 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-O 121.45 0.643 . . . . 0.0 110.034 172.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.0 mt -94.77 170.82 7.46 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.193 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -69.94 -12.5 32.67 Favored 'Trans proline' 0 N--CA 1.486 1.086 0 C-N-CA 122.669 2.246 . . . . 0.0 111.56 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -84.83 -0.22 53.18 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.778 -1.556 . . . . 0.0 108.646 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 59.72 37.79 22.04 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.461 1.904 . . . . 0.0 109.118 -177.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 67' ' ' ILE . 21.5 m -85.92 127.57 34.64 Favored 'General case' 0 N--CA 1.409 -2.485 0 CA-C-N 113.438 -1.71 . . . . 0.0 106.54 172.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.655 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.3 t -90.99 116.66 32.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 127.673 2.389 . . . . 0.0 106.748 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.497 ' HB3' ' CG ' ' A' ' 63' ' ' PRO . 6.6 mp -102.09 124.36 47.56 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 122.208 1.004 . . . . 0.0 113.44 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.5 m -117.93 129.11 55.42 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.679 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 27' ' ' ILE . . . -119.84 137.36 12.33 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.397 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -141.8 172.46 12.65 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -77.82 138.41 38.94 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.544 HG23 HD12 ' A' ' 27' ' ' ILE . 3.4 m -66.78 -21.21 66.06 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -174.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.7 t -71.57 -40.22 70.1 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -174.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.28 9.07 2.26 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.258 1.028 . . . . 0.0 113.296 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 . . . . . 0 C--N 1.291 -1.936 0 CA-C-N 114.038 -1.437 . . . . 0.0 109.873 179.604 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.504 ' CE3' HG21 ' A' ' 41' ' ' THR . 17.7 m95 . . . . . 0 N--CA 1.443 -0.792 0 CA-C-O 121.254 0.549 . . . . 0.0 109.777 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 41' ' ' THR . 95.6 mttt -90.34 -172.57 3.5 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.155 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -74.55 -36.04 63.1 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.841 0.829 . . . . 0.0 111.858 -172.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.0 m -122.1 143.31 49.61 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.222 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.499 HD12 HG23 ' A' ' 79' ' ' THR . 4.0 tt -115.79 133.05 63.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.0 mm -122.93 119.33 57.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.4 ' HG2' ' CD1' ' A' ' 39' ' ' ILE . 95.4 mt-30 -95.53 127.57 41.68 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -99.25 111.28 23.69 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.619 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 31.5 m-85 . . . . . 0 C--N 1.301 -1.509 0 CA-C-O 121.486 0.66 . . . . 0.0 109.228 178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 7.7 p . . . . . 0 N--CA 1.432 -1.368 0 CA-C-O 122.493 1.14 . . . . 0.0 109.82 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -85.64 -58.64 2.58 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.518 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -119.91 161.25 21.18 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.938 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.4 ' CD1' ' HG2' ' A' ' 29' ' ' GLN . 7.5 tp -115.48 151.04 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 N-CA-C 103.372 -2.825 . . . . 0.0 103.372 171.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -147.06 166.11 27.86 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.504 HG21 ' CE3' ' A' ' 23' ' ' TRP . 2.1 t -151.99 142.74 22.88 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.13 149.73 44.83 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -75.71 156.97 34.19 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -57.13 121.51 10.21 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 121.206 0.526 . . . . 0.0 110.415 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.9 m120 70.32 63.1 0.22 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 112.957 -1.929 . . . . 0.0 108.677 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -141.83 131.68 24.35 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.54 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 33.8 tt0 -95.44 114.18 25.91 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.034 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.0 pt -96.65 -177.24 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.84 138.12 42.2 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 175.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 92.9 mt -129.61 106.96 14.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 50.73 49.37 21.09 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 70.86 1.61 3.83 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 125.042 1.337 . . . . 0.0 114.489 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -95.33 115.82 27.95 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 147.12 30.58 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 119.714 -0.794 . . . . 0.0 108.934 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 96.9 t -139.9 118.34 11.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.881 -174.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 80.4 t80 -93.21 119.41 32.36 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.0 t -98.36 120.87 48.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -73.24 168.51 18.99 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 124.647 1.217 . . . . 0.0 110.199 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -68.35 -8.02 36.4 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 125.771 1.628 . . . . 0.0 114.572 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.89 14.7 27.69 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.8 m 63.84 71.25 0.49 Allowed 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 124.415 1.072 . . . . 0.0 111.455 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -151.05 124.66 4.33 Favored Pre-proline 0 N--CA 1.435 -1.219 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.479 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 88.7 Cg_endo -84.89 143.04 9.22 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.112 2.541 . . . . 0.0 114.964 -177.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 32.9 m-85 -129.63 127.4 22.95 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.038 170.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 73.5 Cg_endo -81.87 163.49 76.77 Favored 'Cis proline' 0 C--N 1.319 -1.007 0 C-N-CA 122.876 -1.718 . . . . 0.0 112.26 -0.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 74' ' ' LEU . 85.0 t -81.53 -39.83 17.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.708 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.04 128.07 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 121.574 0.702 . . . . 0.0 109.483 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.2 mt -88.0 172.07 8.45 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.757 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -73.99 -13.32 23.88 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.295 1.997 . . . . 0.0 109.703 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -84.82 -6.6 59.35 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.115 -2.311 . . . . 0.0 108.349 177.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.387 12.3 ttm180 52.61 55.92 8.38 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 124.631 2.158 . . . . 0.0 112.224 -176.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.9 m -101.95 135.23 43.87 Favored 'General case' 0 N--CA 1.398 -3.048 0 CA-C-N 111.098 -2.774 . . . . 0.0 104.961 170.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.619 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -91.3 117.03 33.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 O-C-N 126.105 2.128 . . . . 0.0 108.395 -176.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.445 ' O ' HG13 ' A' ' 66' ' ' VAL . 5.6 mp -101.49 134.46 44.57 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 122.016 0.912 . . . . 0.0 111.703 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.8 m -120.77 137.12 54.68 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.834 175.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.479 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -129.01 133.67 7.68 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 119.659 -1.258 . . . . 0.0 113.021 -175.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -146.82 171.83 14.59 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -71.91 139.37 48.74 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.499 HG23 HD12 ' A' ' 27' ' ' ILE . 3.2 m -67.2 -18.04 65.08 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 123.093 0.557 . . . . 0.0 111.624 -176.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -69.21 -23.85 63.95 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.362 0.601 . . . . 0.0 111.719 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.6 20.61 15.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.752 0.786 . . . . 0.0 110.824 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 . . . . . 0 C--N 1.307 -1.252 0 C-N-CA 125.713 1.605 . . . . 0.0 108.816 -177.495 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.454 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.5 m95 . . . . . 0 N--CA 1.446 -0.627 0 CA-C-O 120.709 0.29 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 50.7 mttm -88.95 -172.38 3.67 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.904 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.42 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 2.8 m-20 -74.76 -34.34 62.48 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -174.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.5 m -121.49 140.87 51.63 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.942 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.588 HD12 HG23 ' A' ' 79' ' ' THR . 9.7 tt -112.85 128.54 69.51 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -177.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.0 mm -113.39 120.57 63.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.427 ' HA ' HD12 ' A' ' 39' ' ' ILE . 43.5 mt-30 -100.77 116.68 33.23 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 114.236 -1.347 . . . . 0.0 107.678 -172.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -96.44 109.47 22.01 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.692 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 69.2 m-85 . . . . . 0 C--N 1.298 -1.661 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 9.6 p . . . . . 0 N--CA 1.43 -1.445 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -83.8 -45.18 13.58 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.308 -175.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -130.69 153.27 49.15 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.206 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 29' ' ' GLN . 7.8 tp -116.32 153.86 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 173.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -148.63 168.11 23.68 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.454 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.7 t -150.48 145.57 26.09 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 24' ' ' LYS . . . -141.92 155.97 45.5 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -175.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -79.94 161.65 25.38 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.566 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.42 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 8.2 ptt180 -59.12 116.21 3.69 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.744 170.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 75.07 50.07 0.08 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.056 1.743 . . . . 0.0 110.728 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -130.57 134.56 47.11 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.526 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 44.1 tt0 -102.7 109.22 20.74 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.7 pt -90.64 -177.65 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.2 m -135.52 129.1 32.54 Favored 'General case' 0 N--CA 1.401 -2.897 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 173.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.411 HD12 HD21 ' A' ' 74' ' ' LEU . 67.5 mt -118.72 105.07 16.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 60.21 36.69 20.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.93 0.871 . . . . 0.0 111.605 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 69.88 17.07 7.64 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.159 1.783 . . . . 0.0 113.221 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -106.49 111.36 23.89 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.44 141.59 41.32 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.448 -177.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 88.0 t -135.42 114.5 16.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.738 -173.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 64.4 t80 -90.08 118.72 29.84 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.3 t -101.3 116.91 45.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -73.95 166.09 23.98 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.098 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 17.1 pt-20 -56.04 -21.4 21.41 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 126.861 2.064 . . . . 0.0 113.454 -175.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.22 11.06 26.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.841 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.8 m 59.37 66.08 1.08 Allowed 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.264 1.03 . . . . 0.0 111.763 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.442 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 9.7 t-80 -149.79 124.91 4.83 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 175.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.442 ' HD2' ' CD2' ' A' ' 62' ' ' HIS . 64.6 Cg_endo -82.59 152.32 15.25 Favored 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 123.463 2.775 . . . . 0.0 114.972 -175.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -134.87 137.11 26.53 Favored Pre-proline 0 CA--C 1.493 -1.231 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.32 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -78.93 168.29 75.09 Favored 'Cis proline' 0 C--N 1.314 -1.287 0 C-N-CA 122.671 -1.804 . . . . 0.0 111.442 -3.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 74' ' ' LEU . 64.4 t -86.5 -30.7 6.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.993 -173.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 67' ' ' ILE . 18.5 mm -107.44 129.28 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.972 0.891 . . . . 0.0 110.625 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.1 mt -88.32 165.74 27.02 Favored Pre-proline 0 C--N 1.305 -1.331 0 CA-C-N 114.383 -1.28 . . . . 0.0 108.907 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -72.5 -4.57 15.53 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.77 2.313 . . . . 0.0 111.839 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -95.78 -1.96 48.67 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.309 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 71.7 13.64 6.21 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 126.514 1.926 . . . . 0.0 110.045 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.81 137.05 53.65 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 175.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.692 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 3.1 t -90.69 117.97 35.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 125.859 1.663 . . . . 0.0 109.044 -175.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.411 HD21 HD12 ' A' ' 50' ' ' ILE . 6.1 mp -97.29 139.43 33.26 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.06 173.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.6 m -138.93 154.07 48.3 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.2 146.08 17.57 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 118.829 -1.653 . . . . 0.0 111.852 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -141.76 171.78 13.59 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -80.98 134.86 35.77 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.588 HG23 HD12 ' A' ' 27' ' ' ILE . 1.7 m -70.83 -13.99 62.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.419 0.628 . . . . 0.0 110.556 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 p -66.29 -21.96 66.28 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.128 0.971 . . . . 0.0 111.449 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.48 13.69 28.13 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.285 1.041 . . . . 0.0 110.367 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 C--N 1.301 -1.515 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.363 -174.205 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.518 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.0 m0 . . . . . 0 N--CA 1.438 -1.073 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -86.77 -170.6 3.14 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.165 0.507 . . . . 0.0 109.994 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.45 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 1.1 m-20 -78.57 -25.92 45.44 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.7 m -131.32 152.75 50.28 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.535 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.411 ' HB ' HG23 ' A' ' 79' ' ' THR . 11.9 tt -125.08 133.86 68.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.4 mm -120.24 112.3 35.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -173.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -96.62 117.76 31.66 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -176.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.411 ' HG3' HD11 ' A' ' 74' ' ' LEU . 8.7 ttp180 -91.62 110.38 21.7 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.687 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 14.5 m-85 . . . . . 0 C--N 1.289 -2.023 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.437 -1.089 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -109.9 -60.09 1.84 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.043 -1.036 . . . . 0.0 111.784 -173.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -127.96 159.94 33.4 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -123.01 130.57 74.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 124.106 0.962 . . . . 0.0 109.264 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -134.34 168.74 18.35 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.518 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.7 t -150.03 142.36 24.23 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.2 157.91 44.33 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.872 -172.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -81.36 160.21 24.18 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 176.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.45 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 6.8 ptt85 -67.92 108.92 3.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.444 0.64 . . . . 0.0 111.73 175.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.531 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 42.3 m-80 83.7 57.07 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.136 2.575 . . . . 0.0 110.087 -175.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -133.76 129.72 37.04 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.106 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 45.1 tt0 -99.18 108.87 21.57 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 pt -94.12 -176.62 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 6.1 m -133.72 136.28 44.55 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.436 HD12 HG21 ' A' ' 55' ' ' VAL . 95.0 mt -132.07 106.65 11.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.05 36.4 25.99 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 122.432 1.111 . . . . 0.0 111.256 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 70.5 16.01 7.1 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 112.687 -2.051 . . . . 0.0 113.994 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -103.64 118.18 36.12 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 172.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -82.14 144.62 30.62 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 118.385 -1.326 . . . . 0.0 108.666 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 88.9 t -135.19 122.35 35.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.609 -173.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 93.9 t80 -93.34 118.16 30.95 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.7 t -96.8 114.02 32.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -73.97 173.28 10.21 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.531 ' HB3' ' ND2' ' A' ' 45' ' ' ASN 0.262 10.3 pt-20 -74.38 0.67 13.74 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -173.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.17 12.24 37.95 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.6 m 69.18 33.06 3.44 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.545 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -111.65 117.39 48.88 Favored Pre-proline 0 C--N 1.291 -1.946 0 CA-C-N 113.45 -1.704 . . . . 0.0 108.398 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.587 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 40.8 Cg_endo -88.86 144.69 5.32 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.983 3.122 . . . . 0.0 114.861 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -130.06 134.76 26.51 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.044 173.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -74.87 157.15 99.77 Favored 'Cis proline' 0 CA--C 1.529 0.246 0 C-N-CA 123.045 -1.648 . . . . 0.0 113.307 0.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.9 t -82.1 -37.37 14.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.449 HG23 ' HA ' ' A' ' 71' ' ' ARG . 17.6 mm -103.18 118.61 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-O 122.008 0.909 . . . . 0.0 108.704 172.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.7 mt -82.36 170.32 15.21 Favored Pre-proline 0 C--N 1.293 -1.867 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.162 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -69.25 -13.06 35.31 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.437 2.092 . . . . 0.0 111.944 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -92.28 1.38 57.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 122.136 0.97 . . . . 0.0 108.42 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.449 ' HA ' HG23 ' A' ' 67' ' ' ILE . 16.6 ttm180 63.7 29.77 14.89 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 124.288 1.995 . . . . 0.0 109.954 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.1 m -75.07 136.42 41.17 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-N 112.457 -2.156 . . . . 0.0 106.309 173.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.687 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 6.3 t -91.53 119.11 38.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 125.352 1.461 . . . . 0.0 108.614 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.411 HD11 ' HG3' ' A' ' 30' ' ' ARG . 5.2 mp -99.72 122.84 43.32 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 122.052 0.929 . . . . 0.0 111.427 175.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.8 m -111.2 123.83 50.98 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.587 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -115.38 124.18 6.21 Favored Glycine 0 N--CA 1.419 -2.443 0 C-N-CA 119.865 -1.16 . . . . 0.0 112.192 -175.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -139.07 172.89 12.17 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -81.65 137.0 35.5 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.411 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -62.01 -21.52 64.95 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 124.24 1.016 . . . . 0.0 112.18 -176.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.8 p -64.84 -31.75 73.13 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.247 1.019 . . . . 0.0 110.881 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.42 16.69 23.71 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.649 0.738 . . . . 0.0 110.765 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 . . . . . 0 C--N 1.31 -1.144 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.819 -175.824 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.479 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.0 m0 . . . . . 0 N--CA 1.441 -0.918 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HD2' ' CG ' ' A' ' 43' ' ' ASN . 34.6 mmtp -89.23 -178.62 5.69 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.445 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 1.1 m-20 -71.12 -34.24 70.88 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.573 -175.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.8 m -121.07 143.14 49.23 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.063 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.578 HD12 HG23 ' A' ' 79' ' ' THR . 6.1 tt -113.69 133.32 60.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.8 mm -121.43 115.31 46.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -173.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -95.17 127.5 41.27 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -98.24 110.83 23.35 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.626 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 7.4 m-85 . . . . . 0 C--N 1.299 -1.609 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.444 -0.744 0 CA-C-O 122.372 1.082 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -97.55 -52.71 3.68 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.354 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -121.74 161.76 22.02 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.718 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 39' ' ' ILE . 13.7 mm -124.9 128.49 73.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 124.496 1.118 . . . . 0.0 109.118 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -135.14 169.51 17.34 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.479 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.8 t -153.68 144.01 22.3 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.8 152.61 40.59 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.438 ' CG ' ' HD2' ' A' ' 24' ' ' LYS . 61.2 m-20 -74.16 164.11 27.02 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.592 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.445 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 3.4 ptt180 -62.88 116.56 5.38 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 171.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 74.4 50.08 0.1 Allowed 'General case' 0 C--O 1.242 0.695 0 C-N-CA 126.237 1.815 . . . . 0.0 110.744 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -128.59 131.34 48.15 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.671 -175.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 44.2 tt0 -101.98 114.62 28.9 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.53 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 pt -98.94 -176.75 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 124.25 1.02 . . . . 0.0 108.49 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.47 131.2 43.32 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.475 HD12 HG21 ' A' ' 55' ' ' VAL . 97.5 mt -127.62 106.52 15.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 54.19 43.02 31.23 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.958 0.885 . . . . 0.0 112.001 175.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 75.53 -1.51 3.0 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.14 2.176 . . . . 0.0 115.116 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -95.16 118.22 31.57 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 177.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.26 141.57 32.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 118.173 -1.411 . . . . 0.0 108.74 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 92.5 t -133.29 122.41 44.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.406 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -96.54 121.47 38.39 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.336 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.8 t -100.23 118.78 47.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -68.07 163.7 21.83 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.979 1.712 . . . . 0.0 108.465 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.402 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 1.4 pm0 -66.15 -17.68 64.87 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -171.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.02 14.37 22.06 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.233 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.6 m 65.83 76.82 0.31 Allowed 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 124.64 1.213 . . . . 0.0 112.281 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -157.18 120.54 2.21 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.485 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 73.7 Cg_endo -82.54 143.9 12.41 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 123.391 2.727 . . . . 0.0 114.399 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -130.51 131.16 23.17 Favored Pre-proline 0 CA--C 1.489 -1.391 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.654 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -72.08 162.12 90.49 Favored 'Cis proline' 0 C--N 1.313 -1.301 0 C-N-CA 124.416 -1.077 . . . . 0.0 114.225 -1.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 74' ' ' LEU . 65.6 t -89.34 -42.68 14.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.075 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mp -99.22 129.49 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.476 0.655 . . . . 0.0 109.533 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.4 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 51.0 mt -97.56 171.12 6.28 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.032 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.4 ' CD ' ' HB3' ' A' ' 68' ' ' LEU . 31.0 Cg_exo -67.09 -13.78 41.04 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.986 2.457 . . . . 0.0 112.362 -176.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -85.35 -12.28 52.59 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.1 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 71' ' ' ARG . 16.2 tpt180 72.32 31.9 1.76 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-O 123.886 1.803 . . . . 0.0 107.261 -171.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -74.27 127.27 32.55 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.626 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -92.46 115.81 32.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 125.492 1.517 . . . . 0.0 108.062 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.446 ' HB3' ' CG ' ' A' ' 63' ' ' PRO . 5.8 mp -97.48 129.07 44.7 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 122.326 1.06 . . . . 0.0 111.805 177.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.1 m -121.9 137.38 54.81 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.485 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -131.72 150.38 19.52 Favored Glycine 0 CA--C 1.474 -2.52 0 C-N-CA 119.331 -1.414 . . . . 0.0 109.672 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.511 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 11.1 t0 -163.4 173.91 12.61 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 174.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -69.95 134.94 48.9 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 118.853 0.751 . . . . 0.0 109.718 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.578 HG23 HD12 ' A' ' 27' ' ' ILE . 3.2 m -65.27 -28.19 69.16 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-O 121.756 0.789 . . . . 0.0 110.857 -177.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 p -67.66 -29.47 68.77 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.679 -176.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.93 11.9 34.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 122.438 1.113 . . . . 0.0 111.199 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.511 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 6.5 m-85 . . . . . 0 C--N 1.301 -1.508 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.465 -178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.523 ' CE3' HG21 ' A' ' 41' ' ' THR . 18.6 m95 . . . . . 0 N--CA 1.44 -0.936 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HD2' ' CG ' ' A' ' 43' ' ' ASN . 34.8 mmtp -77.96 -171.94 2.5 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.436 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 1.2 t70 -80.74 -31.38 36.0 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.205 1.002 . . . . 0.0 110.856 -172.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.4 m -120.44 146.63 46.03 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.239 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.572 HD12 HG23 ' A' ' 79' ' ' THR . 11.4 tt -118.01 133.46 64.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 75' ' ' SER . 28.3 mm -124.94 113.25 35.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -173.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.505 ' HB2' ' OG ' ' A' ' 75' ' ' SER . 82.2 mt-30 -96.01 133.22 40.5 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.723 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.475 HH11 ' ND2' ' A' ' 38' ' ' ASN . 27.3 ttt180 -98.87 110.97 23.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.638 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 59.8 m-85 . . . . . 0 C--N 1.296 -1.719 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 8.4 p . . . . . 0 N--CA 1.435 -1.183 0 CA-C-O 122.295 1.045 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -93.0 -60.68 1.74 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.615 -174.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.475 ' ND2' HH11 ' A' ' 30' ' ' ARG . 97.6 m-20 -122.27 161.72 22.78 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.779 -176.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 24.8 mm -121.17 137.32 55.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.889 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -142.2 164.52 29.93 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.523 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.6 t -152.66 144.49 23.62 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.24 150.14 45.15 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 123.506 0.504 . . . . 0.0 110.98 -173.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.405 ' CG ' ' HD2' ' A' ' 24' ' ' LYS . 48.1 m-20 -75.12 156.0 36.47 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.514 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 6.8 ptt180 -60.61 109.82 1.13 Allowed 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 171.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 88.1 m-20 78.65 62.48 0.03 OUTLIER 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.254 1.822 . . . . 0.0 110.37 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -138.9 134.93 33.89 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.987 -178.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 2.6 mp0 -91.84 118.95 31.19 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 172.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.7 pt -98.37 174.08 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.324 0 N-CA-C 105.609 -1.996 . . . . 0.0 105.609 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 1.3 m -136.3 117.88 14.88 Favored 'General case' 0 N--CA 1.404 -2.755 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 176.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.434 HD12 HD21 ' A' ' 74' ' ' LEU . 73.1 mt -108.17 102.04 13.41 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.662 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 58.81 40.27 23.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.387 0.613 . . . . 0.0 112.483 170.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 73.27 9.6 5.18 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.246 1.818 . . . . 0.0 113.803 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -104.42 106.19 16.6 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -82.05 141.36 33.26 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.534 -178.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.0 t -132.79 119.46 37.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.518 -171.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 63.6 t80 -93.13 121.72 34.78 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.9 t -102.99 125.11 57.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 174.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -74.58 176.76 6.59 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 124.555 1.16 . . . . 0.0 108.657 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.514 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 9.8 pt-20 -65.44 -20.15 66.24 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.9 106.57 17.12 Favored 'General case' 0 N--CA 1.413 -2.318 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 170.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.4 m -40.42 89.45 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 127.578 2.351 . . . . 0.0 115.344 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -159.72 126.04 2.45 Favored Pre-proline 0 N--CA 1.438 -1.026 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.61 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 56.1 Cg_endo -85.76 146.68 9.34 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.888 2.392 . . . . 0.0 114.333 -175.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 54.9 m-85 -131.02 126.23 21.54 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.513 172.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 72.5 Cg_endo -81.95 164.11 75.47 Favored 'Cis proline' 0 C--N 1.323 -0.808 0 C-N-CA 122.742 -1.774 . . . . 0.0 113.173 -0.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 74' ' ' LEU . 92.6 t -82.59 -43.72 19.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.305 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 67' ' ' ILE . 4.7 mm -91.89 124.48 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 172.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.2 mt -89.27 168.38 15.43 Favored Pre-proline 0 C--N 1.303 -1.445 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.449 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -73.95 -1.17 10.47 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 123.198 2.598 . . . . 0.0 111.703 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -95.77 -9.06 32.69 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.186 -1.824 . . . . 0.0 109.073 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 60.25 57.22 2.99 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 123.572 1.653 . . . . 0.0 108.2 -169.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 m -102.57 135.05 44.91 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 173.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.638 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.6 t -91.61 115.61 31.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 125.496 1.748 . . . . 0.0 107.783 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.434 HD21 HD12 ' A' ' 50' ' ' ILE . 4.7 mp -101.04 135.82 41.87 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.426 -0.796 . . . . 0.0 111.758 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.505 ' OG ' ' HB2' ' A' ' 29' ' ' GLN . 81.1 p -117.36 142.76 46.71 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.61 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -128.68 132.99 7.46 Favored Glycine 0 CA--C 1.479 -2.173 0 C-N-CA 119.64 -1.267 . . . . 0.0 110.345 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -150.69 172.54 15.4 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -75.56 135.05 40.58 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.572 HG23 HD12 ' A' ' 27' ' ' ILE . 2.8 m -59.93 -19.91 54.45 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -175.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.8 p -66.94 -40.05 87.48 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.594 1.158 . . . . 0.0 110.947 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.24 11.29 6.78 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.397 1.094 . . . . 0.0 112.009 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 . . . . . 0 C--N 1.298 -1.665 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.561 -178.645 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.488 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.2 m95 . . . . . 0 N--CA 1.437 -1.1 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -84.59 -172.2 4.04 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.956 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -78.47 -27.39 46.29 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.956 0.884 . . . . 0.0 112.571 -171.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.8 m -124.29 148.54 47.34 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.611 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.586 HD12 HG23 ' A' ' 79' ' ' THR . 13.9 tt -120.79 133.62 66.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 27' ' ' ILE . 31.8 mm -128.75 112.29 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -173.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 75' ' ' SER . 27.5 mt-30 -97.45 131.67 43.88 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.589 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 46.3 ttt180 -97.13 114.17 25.82 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.642 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 21.3 m-85 . . . . . 0 N--CA 1.427 -1.617 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 9.5 p . . . . . 0 N--CA 1.447 -0.602 0 CA-C-O 121.656 0.741 . . . . 0.0 112.227 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.68 -50.79 2.97 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.663 0.744 . . . . 0.0 110.483 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.589 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 8.2 m120 -119.22 151.87 37.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.914 -173.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 mp -120.06 122.59 68.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -126.18 167.32 15.58 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.488 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.4 t -153.45 142.31 21.12 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.73 154.19 43.22 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 124.232 0.958 . . . . 0.0 108.914 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -75.71 161.71 28.84 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.021 0.438 . . . . 0.0 111.045 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -66.14 116.79 7.6 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.454 0.645 . . . . 0.0 110.303 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.587 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 38.8 m-80 72.95 64.79 0.1 Allowed 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 126.826 2.05 . . . . 0.0 109.161 -172.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -142.23 131.16 23.02 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 33.9 tt0 -98.19 113.66 25.65 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.443 177.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.8 pt -94.3 -176.2 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.2 m -135.97 136.69 40.58 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.3 mt -127.64 108.49 18.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 54.46 40.49 31.84 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.781 0.801 . . . . 0.0 111.695 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.257 36.0 mm-40 70.23 12.91 7.68 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 126.03 1.732 . . . . 0.0 115.068 -178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -103.37 122.2 44.35 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 172.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -85.77 142.08 29.22 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 118.591 -1.243 . . . . 0.0 109.853 -178.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 86.1 t -133.29 124.62 49.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.571 -175.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 62.8 t80 -96.08 119.02 33.83 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 61.0 t -94.97 120.14 43.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -77.16 174.54 10.59 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.587 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 9.7 pt-20 -75.63 -6.27 49.56 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -172.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.66 11.18 36.3 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.816 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 80.3 m 66.2 55.26 0.89 Allowed 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.377 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -136.74 122.59 13.35 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.463 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 98.2 Cg_endo -81.71 146.51 14.98 Favored 'Trans proline' 0 C--N 1.328 -0.512 0 C-N-CA 123.436 2.757 . . . . 0.0 114.098 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -129.84 134.84 26.64 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.651 172.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.87 161.35 79.03 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.158 -2.017 . . . . 0.0 111.495 -2.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.4 t -79.15 -29.78 13.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.274 -176.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 67' ' ' ILE . 8.3 mm -103.96 121.83 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-O 121.773 0.797 . . . . 0.0 110.265 173.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.3 mt -85.75 165.57 34.32 Favored Pre-proline 0 C--N 1.3 -1.58 0 CA-C-N 113.899 -1.501 . . . . 0.0 109.135 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.47 -18.11 54.23 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.723 2.282 . . . . 0.0 112.737 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -87.19 -0.18 56.3 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.231 -1.349 . . . . 0.0 109.598 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 64.48 58.33 1.07 Allowed 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 124.725 2.202 . . . . 0.0 108.823 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.1 m -115.29 135.08 54.52 Favored 'General case' 0 N--CA 1.403 -2.821 0 CA-C-N 111.95 -2.386 . . . . 0.0 106.331 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.642 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.2 t -91.13 123.8 43.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 127.197 2.199 . . . . 0.0 107.792 -176.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mp -100.72 122.28 43.09 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.922 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.408 ' HB3' ' HB2' ' A' ' 29' ' ' GLN . 42.8 t -101.85 118.63 37.33 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -125.66 139.84 11.8 Favored Glycine 0 N--CA 1.424 -2.159 0 C-N-CA 119.015 -1.564 . . . . 0.0 111.647 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -159.57 177.39 10.96 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -73.47 139.88 46.08 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.586 HG23 HD12 ' A' ' 27' ' ' ILE . 1.3 m -67.66 -10.55 53.32 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.643 0.735 . . . . 0.0 111.535 -177.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.9 t -67.53 -40.24 85.07 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.46 14.69 12.35 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.486 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 . . . . . 0 C--N 1.293 -1.863 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.059 -177.201 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.521 ' CE3' HG21 ' A' ' 41' ' ' THR . 16.7 m95 . . . . . 0 N--CA 1.44 -0.974 0 CA-C-O 121.119 0.485 . . . . 0.0 111.537 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.487 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 70.6 mmtt -91.96 -171.89 2.99 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.464 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -81.28 -33.99 32.32 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 122.069 0.937 . . . . 0.0 110.835 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 70.3 m -120.5 144.31 48.09 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.57 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.668 HD12 HG23 ' A' ' 79' ' ' THR . 14.7 tt -121.09 133.49 67.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-O 121.225 0.536 . . . . 0.0 109.952 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.401 HD12 ' C ' ' A' ' 27' ' ' ILE . 1.7 mp -113.07 112.77 41.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 122.564 1.173 . . . . 0.0 109.529 -178.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.51 ' OE1' HG21 ' A' ' 36' ' ' VAL . 66.2 mm-40 -91.51 112.33 24.2 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 113.245 -1.798 . . . . 0.0 106.761 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.401 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 56.1 ttt180 -92.22 110.89 22.29 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.664 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 76.4 m-85 . . . . . 0 C--N 1.304 -1.398 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.51 HG21 ' OE1' ' A' ' 29' ' ' GLN . 7.7 p . . . . . 0 N--CA 1.439 -0.989 0 CA-C-O 122.1 0.952 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -91.25 -48.48 6.9 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.118 0.961 . . . . 0.0 111.027 -174.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 30' ' ' ARG . 15.6 m120 -123.26 152.83 40.95 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.694 -177.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.2 mt -128.31 120.77 53.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.717 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -118.69 165.75 13.6 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.521 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.5 t -150.64 143.65 24.72 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.53 153.88 45.15 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.162 -174.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -78.71 160.29 27.54 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.746 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 44' ' ' ARG . 4.2 ptt180 -56.81 118.38 4.86 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.58 173.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.51 ' ND2' ' HB3' ' A' ' 59' ' ' GLU 0.266 58.8 m-80 68.35 68.69 0.32 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.704 1.602 . . . . 0.0 110.488 -173.432 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -146.89 136.28 22.78 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.755 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 42.1 tt0 -104.83 120.38 41.27 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.336 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.7 pt -103.04 -177.54 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.2 m -137.87 139.57 39.95 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.2 mt -134.49 113.21 16.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 53.39 39.04 29.3 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.88 0.848 . . . . 0.0 111.938 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 69.61 17.62 7.82 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 125.494 1.518 . . . . 0.0 112.826 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -103.93 117.77 35.11 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 172.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.447 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -78.95 146.25 33.56 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.984 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.8 t -138.08 115.84 12.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.828 -174.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 90.7 t80 -94.57 127.11 40.3 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.157 0.503 . . . . 0.0 110.205 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.8 t -104.25 122.01 56.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -78.7 175.24 10.62 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 123.639 0.587 . . . . 0.0 109.539 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.51 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -64.99 -21.9 66.92 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -171.524 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.75 12.15 28.9 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.664 -177.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 56.4 m 66.29 80.86 0.21 Allowed 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 124.032 0.833 . . . . 0.0 111.535 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -161.44 127.68 2.4 Favored Pre-proline 0 N--CA 1.442 -0.858 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.535 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 28.3 Cg_endo -92.19 149.9 3.1 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.069 2.513 . . . . 0.0 114.985 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -131.21 135.8 27.74 Favored Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.734 169.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -77.06 165.62 84.45 Favored 'Cis proline' 0 C--N 1.326 -0.641 0 C-N-CA 122.865 -1.723 . . . . 0.0 112.479 -1.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 74' ' ' LEU . 57.6 t -87.41 -47.98 15.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -176.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -92.02 121.3 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 121.883 0.849 . . . . 0.0 109.186 170.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.3 mt -85.31 164.78 39.4 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 114.247 -1.342 . . . . 0.0 108.274 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -70.33 -10.56 28.37 Favored 'Trans proline' 0 N--CA 1.483 0.909 0 C-N-CA 122.849 2.366 . . . . 0.0 111.658 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -84.89 -11.05 56.45 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.565 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.404 17.2 ttm180 65.69 58.69 0.78 Allowed 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 124.528 2.109 . . . . 0.0 111.813 -174.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.9 m -114.25 138.27 50.7 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 111.231 -2.713 . . . . 0.0 106.616 172.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.664 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -91.42 115.92 31.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 125.408 1.692 . . . . 0.0 107.993 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.452 ' O ' HG13 ' A' ' 66' ' ' VAL . 6.6 mp -99.89 122.76 43.32 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.975 0.893 . . . . 0.0 112.091 177.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.8 m -119.12 118.81 32.39 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.268 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.535 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -101.82 131.39 10.57 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -139.76 168.93 18.7 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -75.61 139.5 42.08 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.668 HG23 HD12 ' A' ' 27' ' ' ILE . 2.4 m -68.54 -20.38 64.55 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.244 0.545 . . . . 0.0 110.966 -177.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.4 t -58.73 -38.58 78.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.157 -177.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.72 21.26 8.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.392 0.615 . . . . 0.0 112.371 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 . . . . . 0 C--N 1.302 -1.461 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -178.236 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.559 ' CE3' HG21 ' A' ' 41' ' ' THR . 10.7 m95 . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.45 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 32.3 mmtp -96.14 -175.63 3.43 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 175.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.486 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 3.6 m-20 -75.24 -33.16 61.28 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.505 0.669 . . . . 0.0 112.592 -176.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.2 m -121.64 140.01 52.82 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.654 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.52 HD12 HG23 ' A' ' 79' ' ' THR . 5.4 tt -113.36 131.72 64.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -177.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.7 mm -119.57 112.37 36.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-O 121.891 0.853 . . . . 0.0 108.732 -173.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -94.69 125.5 39.38 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.488 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.433 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 52.8 ttt180 -95.09 112.72 24.4 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.695 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 25.8 m-85 . . . . . 0 CA--C 1.484 -1.569 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.432 -1.361 0 CA-C-O 121.979 0.895 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -84.99 -50.69 7.26 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.486 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.433 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 16.9 m120 -119.07 149.76 41.12 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.95 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.9 mp -116.51 116.33 51.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -119.07 169.44 9.92 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.559 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.6 t -154.43 146.86 23.98 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.4 154.51 40.95 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -75.51 157.09 34.45 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.586 176.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.486 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 2.1 ptt180 -59.91 116.4 4.09 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 121.333 0.587 . . . . 0.0 109.986 170.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.6 m120 75.23 67.27 0.07 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.193 -1.822 . . . . 0.0 108.331 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -152.64 128.84 10.47 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.478 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 2.7 mp0 -86.85 135.89 33.16 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.004 173.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.7 pt -113.99 -179.99 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.12 132.09 37.68 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 86.5 mt -125.53 107.01 17.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 55.06 41.26 31.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.302 1.049 . . . . 0.0 112.65 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 71.51 6.87 5.87 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.943 2.097 . . . . 0.0 112.433 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -93.87 112.34 24.17 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 175.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -83.1 130.61 35.13 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 63.3 t -126.43 120.61 56.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.05 -173.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 56.8 t80 -94.5 121.99 36.62 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.4 t -97.25 125.07 50.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -78.67 175.28 10.56 Favored 'General case' 0 N--CA 1.439 -1.018 0 O-C-N 124.72 1.263 . . . . 0.0 108.002 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.486 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -74.12 -16.52 61.01 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -173.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.63 6.13 21.91 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.089 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 76.7 m 71.49 30.32 2.5 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 122.29 1.043 . . . . 0.0 113.319 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -114.54 124.07 31.22 Favored Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 113.736 -1.575 . . . . 0.0 107.898 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.507 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 60.3 Cg_endo -83.97 147.25 11.81 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 123.469 2.779 . . . . 0.0 114.549 -177.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -132.38 131.25 22.21 Favored Pre-proline 0 CA--C 1.493 -1.229 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.065 172.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -76.65 161.66 93.23 Favored 'Cis proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.644 -1.815 . . . . 0.0 112.948 -0.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 74' ' ' LEU . 57.3 t -82.98 -48.24 17.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.539 HG12 ' NH2' ' A' ' 71' ' ' ARG . 1.7 mp -96.38 122.6 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.261 172.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.426 ' C ' ' H ' ' A' ' 70' ' ' ASP . 54.0 mt -80.19 169.61 19.13 Favored Pre-proline 0 C--N 1.296 -1.76 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.101 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -76.04 5.64 4.36 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.99 2.46 . . . . 0.0 109.72 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 68' ' ' LEU . 27.5 t70 -99.93 -10.52 21.59 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 112.686 -2.052 . . . . 0.0 111.223 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.539 ' NH2' HG12 ' A' ' 67' ' ' ILE . 8.6 tpm_? 75.38 18.28 2.37 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.57 1.148 . . . . 0.0 110.243 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.4 m -82.6 140.52 33.17 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 170.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.695 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 7.7 t -90.85 124.76 43.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 126.336 1.854 . . . . 0.0 108.063 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 66' ' ' VAL . 5.4 mp -103.74 122.68 45.58 Favored 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.689 173.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.5 m -117.28 118.2 31.62 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.507 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -114.03 147.38 18.72 Favored Glycine 0 N--CA 1.419 -2.482 0 C-N-CA 118.84 -1.647 . . . . 0.0 110.546 -177.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -150.2 176.51 10.79 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -78.08 136.55 37.91 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.52 HG23 HD12 ' A' ' 27' ' ' ILE . 3.7 m -69.76 -19.11 63.53 Favored 'General case' 0 C--O 1.242 0.686 0 O-C-N 122.058 -0.401 . . . . 0.0 110.014 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.3 p -56.53 -33.16 65.79 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.33 1.452 . . . . 0.0 111.761 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.54 12.71 31.0 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.648 0.737 . . . . 0.0 112.511 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 C--N 1.302 -1.459 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -175.818 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.681 ' HB3' HG21 ' A' ' 79' ' ' THR . 82.2 m95 . . . . . 0 N--CA 1.427 -1.614 0 CA-C-O 121.581 0.705 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.413 ' HD2' ' OD1' ' A' ' 43' ' ' ASN . 43.9 mmtm -87.0 -170.88 3.25 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.499 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.516 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 21.2 m-20 -76.02 -28.87 57.92 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.707 0.765 . . . . 0.0 112.298 -174.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.8 m -127.18 147.11 50.2 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.421 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.555 HD12 HG23 ' A' ' 79' ' ' THR . 10.7 tt -118.42 133.35 65.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.9 mm -123.98 112.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -97.21 125.54 41.81 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -93.26 111.02 22.55 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.658 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 34.7 m-85 . . . . . 0 C--N 1.303 -1.456 0 C-N-CA 123.61 0.764 . . . . 0.0 110.453 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 4.1 p . . . . . 0 N--CA 1.429 -1.522 0 CA-C-O 122.366 1.079 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -84.31 -58.74 2.63 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.473 -175.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -121.93 157.67 30.73 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.246 0.546 . . . . 0.0 111.443 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.0 mm -116.35 136.17 54.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.506 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -142.73 164.3 30.49 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.6 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.6 t -152.15 142.61 22.6 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 176.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.12 155.52 46.95 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.495 -173.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.413 ' OD1' ' HD2' ' A' ' 24' ' ' LYS . 83.3 m-20 -73.16 154.44 40.31 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.516 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 14.1 ptt180 -66.62 116.22 7.32 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 121.819 -0.551 . . . . 0.0 110.651 172.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.7 m120 76.95 67.33 0.05 Allowed 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 126.059 1.744 . . . . 0.0 108.62 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -146.27 131.25 18.21 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.521 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 42.2 tt0 -97.66 109.0 21.84 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.425 ' CG1' ' HB ' ' A' ' 55' ' ' VAL . 23.6 pt -92.53 -179.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 3.1 m -136.89 129.79 30.73 Favored 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 172.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.444 HD12 HD21 ' A' ' 74' ' ' LEU . 68.7 mt -119.43 110.23 28.86 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 57.51 39.37 27.94 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.879 0.847 . . . . 0.0 111.625 172.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 73.67 7.22 5.02 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.411 1.884 . . . . 0.0 113.312 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -102.42 119.57 39.04 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -81.0 153.38 27.47 Favored 'General case' 0 N--CA 1.435 -1.225 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.849 -178.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 95.9 t -146.24 125.08 4.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.993 -175.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 77.7 t80 -98.66 118.9 36.41 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.9 t -97.98 118.08 43.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -81.28 170.86 15.53 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -65.75 -15.58 62.98 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -172.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.13 0.51 31.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.938 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 71.9 m 72.44 26.79 2.53 Favored 'General case' 0 CA--C 1.487 -1.449 0 C-N-CA 124.55 1.14 . . . . 0.0 112.625 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -113.22 121.19 38.54 Favored Pre-proline 0 C--N 1.287 -2.113 0 CA-C-N 112.9 -1.955 . . . . 0.0 108.306 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.556 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 45.7 Cg_endo -85.66 144.19 8.72 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 124.093 3.195 . . . . 0.0 115.26 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -129.58 134.07 25.8 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.729 172.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -79.05 153.52 89.8 Favored 'Cis proline' 0 C--N 1.323 -0.815 0 C-N-CA 122.67 -1.804 . . . . 0.0 112.603 1.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 74' ' ' LEU . 86.2 t -75.05 -35.39 34.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.82 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.0 mm -102.87 125.18 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.359 174.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.1 mt -84.68 165.46 37.55 Favored Pre-proline 0 C--N 1.29 -1.983 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.17 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -70.4 -8.85 24.59 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 C-N-CA 123.038 2.492 . . . . 0.0 112.167 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -88.61 -7.62 56.09 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.587 177.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 67.82 57.76 0.51 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 123.886 1.803 . . . . 0.0 108.817 -173.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.9 m -112.8 140.63 47.43 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-N 112.665 -2.061 . . . . 0.0 107.082 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.658 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.7 t -91.81 115.93 31.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 125.233 1.583 . . . . 0.0 108.696 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.444 HD21 HD12 ' A' ' 50' ' ' ILE . 3.6 mp -96.24 122.68 39.36 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.049 174.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 64.9 m -117.82 117.46 29.36 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.556 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -120.82 137.8 12.25 Favored Glycine 0 N--CA 1.411 -2.993 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.963 -177.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.436 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 9.3 m-20 -145.56 173.73 11.79 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -72.58 138.43 46.83 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.681 HG21 ' HB3' ' A' ' 23' ' ' TRP . 1.8 m -68.84 -18.54 64.17 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.224 0.535 . . . . 0.0 111.802 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 p -63.02 -25.5 68.41 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.368 0.604 . . . . 0.0 111.523 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.71 20.2 18.34 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.026 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.436 ' CE1' ' HB2' ' A' ' 77' ' ' ASP . 7.7 m-85 . . . . . 0 C--N 1.308 -1.224 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.794 -174.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.596 ' HB3' HG21 ' A' ' 79' ' ' THR . 71.4 m95 . . . . . 0 N--CA 1.429 -1.506 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.553 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 10.8 mmpt? -88.91 -170.21 2.82 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 123.498 0.719 . . . . 0.0 111.449 -176.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.495 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 4.7 m-20 -69.3 -34.46 74.73 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -173.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.0 m -126.97 147.22 50.12 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.869 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.553 HD12 HG23 ' A' ' 79' ' ' THR . 8.2 tt -116.74 133.35 63.66 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 75' ' ' SER . 33.4 mm -125.94 111.61 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -174.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.535 ' HB2' ' HB3' ' A' ' 75' ' ' SER . 25.6 mt-30 -102.51 132.09 48.79 Favored 'General case' 0 C--N 1.282 -2.336 0 O-C-N 121.652 -0.655 . . . . 0.0 109.675 -177.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -92.9 109.85 21.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.587 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 10.2 m-85 . . . . . 0 C--N 1.297 -1.696 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 31' ' ' TYR 0.253 7.1 p . . . . . 0 N--CA 1.432 -1.361 0 CA-C-O 122.108 0.956 . . . . 0.0 110.894 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -97.11 -60.67 1.54 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.689 -174.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.402 ' C ' HD12 ' A' ' 39' ' ' ILE . 96.5 m-20 -119.91 158.38 26.8 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.35 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.402 HD12 ' C ' ' A' ' 38' ' ' ASN . 2.9 mp -125.54 121.75 60.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -123.02 169.94 10.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.489 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.6 t -149.95 142.08 24.04 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.4 160.06 40.49 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.496 -173.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -79.73 158.49 26.9 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.495 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 5.2 ptt180 -64.94 111.89 3.05 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 170.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.554 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 89.4 m-20 76.63 67.53 0.06 Allowed 'General case' 0 C--O 1.243 0.735 0 CA-C-O 123.321 1.534 . . . . 0.0 109.949 -176.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -144.16 123.08 12.74 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 112.581 -2.099 . . . . 0.0 110.46 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 46.6 tt0 -89.4 109.73 20.61 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 173.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.6 pt -92.99 -176.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 177.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 4.5 m -136.32 131.37 34.24 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 176.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 97.5 mt -132.62 108.45 13.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 58.81 35.01 24.08 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 122.91 1.338 . . . . 0.0 110.342 176.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 72.79 5.13 5.16 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 127.847 2.459 . . . . 0.0 113.683 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -92.01 114.27 26.77 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 174.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -80.36 140.54 36.03 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 117.925 -1.51 . . . . 0.0 108.135 178.316 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 86.1 t -133.23 123.18 46.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.011 -170.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 92.7 t80 -91.26 118.69 30.69 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.276 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 45' ' ' ASN . 64.6 t -95.67 119.33 43.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 174.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -77.33 165.03 24.98 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 124.33 1.018 . . . . 0.0 108.738 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.554 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -62.33 -19.98 63.88 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -173.338 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.82 11.36 11.37 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.401 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.6 m 62.65 68.05 0.67 Allowed 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.163 0.982 . . . . 0.0 110.438 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -153.19 120.54 3.01 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.608 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 55.6 Cg_endo -86.24 154.27 9.49 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.768 2.979 . . . . 0.0 114.314 -177.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -135.78 132.09 19.37 Favored Pre-proline 0 CA--C 1.483 -1.634 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.898 172.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.42 168.19 75.97 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.805 -1.748 . . . . 0.0 112.378 -2.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.0 t -88.61 -48.09 15.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.752 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -92.5 124.81 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.683 0.754 . . . . 0.0 109.893 173.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.5 mt -83.82 168.22 23.34 Favored Pre-proline 0 C--N 1.299 -1.593 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.983 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -64.67 -21.24 65.37 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.458 2.105 . . . . 0.0 111.135 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -83.43 -3.55 57.68 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 125.848 1.659 . . . . 0.0 110.934 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 18.4 tpt180 77.38 6.44 3.0 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.049 1.74 . . . . 0.0 110.747 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.1 m -67.95 134.09 50.19 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 122.134 0.969 . . . . 0.0 109.601 173.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.7 t -91.07 125.32 43.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 C-N-CA 128.493 2.717 . . . . 0.0 107.647 -175.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 mp -98.28 122.35 41.34 Favored 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.964 174.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' ' 29' ' ' GLN . 30.3 t -97.83 118.36 34.22 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.608 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -122.0 126.04 6.31 Favored Glycine 0 N--CA 1.416 -2.686 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.457 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 5.4 t70 -153.71 172.06 17.87 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -73.31 140.87 47.05 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.596 HG21 ' HB3' ' A' ' 23' ' ' TRP . 3.7 m -71.68 -16.45 62.24 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.559 0.695 . . . . 0.0 109.632 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . 0.264 1.5 m -59.99 -22.55 62.7 Favored 'General case' 0 N--CA 1.411 -2.417 0 C-N-CA 126.238 1.815 . . . . 0.0 111.627 178.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.8 15.99 16.33 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 122.541 1.162 . . . . 0.0 110.066 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.457 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 31.9 m-85 . . . . . 0 C--N 1.296 -1.732 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.202 -176.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.55 ' CE3' HG21 ' A' ' 41' ' ' THR . 13.5 m0 . . . . . 0 N--CA 1.445 -0.676 0 CA-C-O 121.518 0.675 . . . . 0.0 109.919 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.526 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 34.8 mmtp -73.51 -173.47 1.43 Allowed 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.129 0.966 . . . . 0.0 108.675 174.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.553 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 6.7 m-20 -83.5 -33.58 25.52 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.704 -174.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 69.2 m -123.5 140.41 53.03 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.358 -176.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.64 HD12 HG23 ' A' ' 79' ' ' THR . 7.2 tt -113.87 133.26 60.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.4 mm -122.23 112.33 34.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -174.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.614 ' HB2' ' OG ' ' A' ' 75' ' ' SER . 96.8 mt-30 -96.69 127.63 42.86 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.5 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 58.5 ttt180 -95.78 112.33 24.08 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.529 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 56.9 m-85 . . . . . 0 C--N 1.3 -1.549 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 10.9 p . . . . . 0 N--CA 1.433 -1.319 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -99.44 -46.52 5.46 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.316 -173.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.5 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 14.6 m120 -130.18 159.01 38.13 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.841 -176.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.8 mm -118.73 134.11 63.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 123.524 0.73 . . . . 0.0 110.799 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -141.18 165.09 28.48 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.55 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.4 t -157.33 144.35 18.4 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.445 ' HB2' HG23 ' A' ' 48' ' ' ILE . . . -140.17 156.43 46.53 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.189 0.596 . . . . 0.0 110.733 -174.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -74.88 157.58 34.82 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.553 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 8.1 ptt180 -62.81 107.86 1.06 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 171.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 83.57 62.09 0.01 OUTLIER 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.95 2.1 . . . . 0.0 110.681 -176.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -144.79 132.28 20.87 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.872 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 3.5 mp0 -87.3 112.45 22.08 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 172.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.445 HG23 ' HB2' ' A' ' 42' ' ' ALA . 23.1 pt -88.79 179.65 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 172.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.7 m -132.13 133.83 44.73 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 85.8 mt -127.1 106.08 14.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 56.24 38.83 30.18 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.408 1.099 . . . . 0.0 111.821 176.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 64.78 28.7 12.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.742 -1.572 . . . . 0.0 114.335 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -113.42 109.98 19.56 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 169.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.67 136.96 37.59 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 118.005 -1.478 . . . . 0.0 108.827 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.4 t -124.4 114.35 40.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.513 -174.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 79.1 t80 -82.92 115.79 21.93 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.1 t -97.18 118.75 44.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -75.38 173.07 11.41 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 125.162 1.539 . . . . 0.0 108.415 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -20.83 65.99 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -172.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.73 12.19 11.34 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.51 0.671 . . . . 0.0 110.006 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.9 m 68.58 31.1 4.87 Favored 'General case' 0 C--O 1.199 -1.585 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.925 175.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -109.72 119.79 46.79 Favored Pre-proline 0 C--N 1.288 -2.069 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.349 -177.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.604 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 83.7 Cg_endo -83.34 143.16 11.01 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.447 2.765 . . . . 0.0 113.516 -177.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 86.9 m-85 -129.43 132.02 24.0 Favored Pre-proline 0 N--CA 1.432 -1.329 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.691 173.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 62.9 Cg_endo -80.7 165.97 76.04 Favored 'Cis proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.514 -1.869 . . . . 0.0 112.181 -2.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.3 t -83.44 -39.7 15.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.866 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 mp -96.67 123.55 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 CA-C-O 121.386 0.612 . . . . 0.0 109.503 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.4 mt -84.6 167.44 26.85 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.012 177.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -70.72 -7.3 21.03 Favored 'Trans proline' 0 N--CA 1.484 0.951 0 C-N-CA 122.915 2.41 . . . . 0.0 112.671 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -89.82 -12.01 40.38 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.048 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.38 37.1 ttm180 67.62 58.69 0.5 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 124.032 1.872 . . . . 0.0 110.516 -169.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.7 m -103.48 136.44 43.21 Favored 'General case' 0 N--CA 1.408 -2.527 0 CA-C-N 111.861 -2.427 . . . . 0.0 105.11 172.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.3 t -93.27 115.69 32.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 124.855 1.347 . . . . 0.0 108.29 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.6 mp -97.22 126.87 42.7 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.452 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 29' ' ' GLN . 51.4 p -107.69 129.7 55.0 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.604 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -114.42 118.01 4.26 Favored Glycine 0 N--CA 1.418 -2.534 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.953 -177.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -131.28 169.48 15.92 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -86.84 134.07 33.58 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 177.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.64 HG23 HD12 ' A' ' 27' ' ' ILE . 1.5 m -71.55 -13.85 61.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.954 0.407 . . . . 0.0 111.854 -175.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.4 p -69.69 -31.83 70.08 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.53 0.681 . . . . 0.0 110.765 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.24 17.46 21.27 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 122.437 1.113 . . . . 0.0 110.222 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 . . . . . 0 C--N 1.302 -1.489 0 C-N-CA 125.83 1.652 . . . . 0.0 108.55 -178.422 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.562 ' HB3' HG21 ' A' ' 79' ' ' THR . 41.7 m95 . . . . . 0 N--CA 1.435 -1.215 0 CA-C-O 121.283 0.564 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.517 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . 9.1 mmpt? -79.47 -173.68 3.85 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.151 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -76.15 -24.38 54.84 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.5 m -132.52 155.58 48.36 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.462 HD12 HG23 ' A' ' 79' ' ' THR . 8.6 tt -125.37 133.68 68.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -178.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.438 HD13 ' O ' ' A' ' 27' ' ' ILE . 25.6 mm -125.08 111.3 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -175.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -103.38 130.33 50.66 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.144 0.497 . . . . 0.0 110.21 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -99.44 115.27 28.89 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.404 -175.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.743 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 27.9 m-85 . . . . . 0 C--N 1.294 -1.847 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 N--CA 1.435 -1.176 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -91.61 -43.79 9.42 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.217 -171.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -129.72 151.16 50.61 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -119.72 115.06 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -119.17 166.01 13.48 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.56 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.3 t -150.81 142.72 23.89 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.11 160.91 41.85 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -174.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.436 ' OD1' ' HB3' ' A' ' 24' ' ' LYS . 90.7 m-20 -85.27 164.93 17.73 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 121.769 0.795 . . . . 0.0 112.217 176.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.423 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 5.5 ptt85 -62.26 110.16 1.55 Allowed 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.947 169.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 75.6 67.21 0.07 Allowed 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.719 1.208 . . . . 0.0 109.015 -177.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -152.48 143.71 23.22 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 124.662 1.185 . . . . 0.0 107.932 -178.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -115.56 135.96 53.55 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 121.489 0.661 . . . . 0.0 110.655 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.478 ' CG1' ' HB ' ' A' ' 55' ' ' VAL . 29.1 pt -119.05 -179.99 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 1.7 m -137.62 135.13 36.3 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.6 mt -127.55 108.2 17.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.85 49.54 20.85 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 70.09 5.73 5.43 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.023 1.329 . . . . 0.0 113.277 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -104.16 109.63 21.5 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -75.1 154.11 38.0 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.991 0.9 . . . . 0.0 112.245 178.619 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.478 ' HB ' ' CG1' ' A' ' 48' ' ' ILE . 88.6 t -142.59 118.08 5.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 CA-C-N 113.546 -1.661 . . . . 0.0 109.842 -173.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -102.51 123.7 46.74 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.2 t -97.99 119.38 45.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -80.62 172.0 14.31 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.423 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 9.9 pt-20 -67.27 -5.58 14.67 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -172.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.61 13.68 31.16 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.711 172.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.0 m 69.83 33.96 2.74 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.518 1.152 . . . . 0.0 111.8 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -114.88 119.05 39.91 Favored Pre-proline 0 C--N 1.286 -2.17 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.672 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.577 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 83.6 Cg_endo -83.98 147.95 11.96 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.795 2.997 . . . . 0.0 114.115 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 70.7 m-85 -130.07 129.91 23.02 Favored Pre-proline 0 CA--C 1.488 -1.433 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.227 172.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.27 161.25 81.46 Favored 'Cis proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.923 -1.699 . . . . 0.0 112.354 -2.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.1 t -81.88 -36.76 14.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.265 0.555 . . . . 0.0 109.631 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.9 mm -106.42 127.08 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 173.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 39.4 mt -87.44 171.77 9.2 Favored Pre-proline 0 C--N 1.289 -2.035 0 CA-C-N 114.174 -1.376 . . . . 0.0 109.865 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -71.29 -12.02 29.38 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.551 2.167 . . . . 0.0 110.864 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -87.56 -0.14 56.43 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 125.836 1.654 . . . . 0.0 108.303 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 60.34 26.93 16.47 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 127.849 2.46 . . . . 0.0 109.361 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.13 135.57 47.72 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.743 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 5.5 t -90.89 117.48 34.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 125.704 1.878 . . . . 0.0 108.301 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.45 121.83 42.66 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.586 -1.246 . . . . 0.0 112.265 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.0 m -97.51 118.04 33.12 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 175.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.577 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -116.93 111.66 2.35 Favored Glycine 0 N--CA 1.422 -2.262 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.498 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.474 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 19.3 m-20 -142.69 177.21 8.47 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -78.03 139.53 39.11 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.562 HG21 ' HB3' ' A' ' 23' ' ' TRP . 0.2 OUTLIER -62.8 -21.77 66.13 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.139 0.975 . . . . 0.0 112.854 -176.272 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 p -71.49 -24.85 62.06 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.595 0.712 . . . . 0.0 111.32 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.37 14.9 24.62 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.916 0.865 . . . . 0.0 111.178 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.474 ' CE1' ' HB2' ' A' ' 77' ' ' ASP . 37.5 m-85 . . . . . 0 C--N 1.305 -1.354 0 C-N-CA 124.716 1.206 . . . . 0.0 111.432 -176.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.543 ' CE3' HG21 ' A' ' 41' ' ' THR . 12.1 m95 . . . . . 0 N--CA 1.438 -1.056 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -92.37 -173.74 3.49 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.403 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 1.3 m-20 -73.87 -33.86 64.23 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.935 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.6 m -122.16 145.21 48.4 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.787 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.571 HD12 HG23 ' A' ' 79' ' ' THR . 9.2 tt -114.8 133.31 61.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.8 mm -124.36 112.51 32.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -174.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -95.92 127.53 42.02 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.463 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 28.1 ttt180 -95.24 110.93 22.85 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.647 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 30.3 m-85 . . . . . 0 CA--C 1.483 -1.612 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 5.6 p . . . . . 0 N--CA 1.432 -1.371 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -88.98 -45.98 9.24 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.588 -171.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.463 ' HB2' ' HB3' ' A' ' 30' ' ' ARG . 18.6 m120 -122.03 157.48 31.27 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.676 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.4 mm -121.42 134.87 63.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.671 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -141.49 166.64 24.19 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.543 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.8 t -158.13 141.49 15.2 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.34 156.84 45.27 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -173.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -79.72 157.98 27.03 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.898 175.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.41 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 4.1 ptt180 -59.06 115.78 3.39 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 169.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 75.49 59.34 0.06 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 126.163 1.785 . . . . 0.0 109.173 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -141.65 136.12 30.62 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.114 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 45.3 tt0 -101.67 109.94 21.82 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.7 pt -91.6 -178.11 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.5 m -136.36 126.78 26.74 Favored 'General case' 0 N--CA 1.405 -2.712 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 68.4 mt -118.34 104.15 15.71 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 56.3 43.49 26.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 122.108 0.956 . . . . 0.0 112.154 170.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 71.96 8.92 6.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.242 1.817 . . . . 0.0 114.512 -178.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -103.3 118.13 36.06 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 104.411 -2.441 . . . . 0.0 104.411 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 139.96 30.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 117.665 -1.614 . . . . 0.0 109.038 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 93.0 t -131.81 124.1 52.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.463 -173.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 75.5 t80 -96.7 121.76 38.89 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.1 t -100.74 124.28 54.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 175.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -83.41 -175.46 5.83 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.41 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 4.3 pm0 -70.59 -17.93 62.9 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -173.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.48 14.79 13.82 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.08 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 84.7 m 66.27 36.61 5.31 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.849 1.309 . . . . 0.0 112.355 174.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -116.48 120.4 34.73 Favored Pre-proline 0 C--N 1.293 -1.861 0 CA-C-N 113.223 -1.808 . . . . 0.0 108.169 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.474 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 63.9 Cg_endo -84.79 144.9 10.02 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.672 2.915 . . . . 0.0 114.422 -177.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -131.1 129.92 22.61 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.646 172.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.57 164.94 81.11 Favored 'Cis proline' 0 C--N 1.325 -0.67 0 C-N-CA 122.965 -1.681 . . . . 0.0 112.93 0.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.01 -36.59 10.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.638 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 67' ' ' ILE . 20.7 mm -101.13 127.95 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.92 173.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.5 mt -86.42 169.86 14.08 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.608 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -72.09 -11.21 26.97 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.342 2.028 . . . . 0.0 111.329 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -99.15 12.94 34.66 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.196 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 71' ' ' ARG . 9.8 tpt180 61.76 27.6 16.9 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 123.274 1.511 . . . . 0.0 110.102 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.35 139.82 32.8 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.647 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 3.0 t -91.35 124.43 43.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 125.996 1.719 . . . . 0.0 108.843 -177.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mp -101.79 125.99 48.57 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.566 173.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.5 m -116.64 118.62 33.08 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.265 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.474 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -110.55 142.0 16.53 Favored Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 120.503 -0.855 . . . . 0.0 112.78 -176.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -156.26 177.35 11.54 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -80.33 136.02 36.32 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.571 HG23 HD12 ' A' ' 27' ' ' ILE . 2.3 m -61.78 -25.61 67.58 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 p -64.44 -40.64 96.12 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.42 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.35 13.17 10.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.988 0.899 . . . . 0.0 111.654 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 C--N 1.298 -1.649 0 CA-C-N 114.815 -1.084 . . . . 0.0 113.505 -178.079 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.464 ' CE3' HG21 ' A' ' 41' ' ' THR . 14.8 m0 . . . . . 0 N--CA 1.441 -0.922 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -84.2 -171.48 3.63 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.431 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -81.8 -28.39 33.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -172.737 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.6 m -123.5 144.26 49.65 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.044 -177.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.612 HD12 HG23 ' A' ' 79' ' ' THR . 11.0 tt -117.31 133.08 65.19 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.7 mm -125.48 112.77 32.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -172.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -101.05 136.26 41.18 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.413 ' HG3' HD11 ' A' ' 74' ' ' LEU . 3.6 ttp180 -99.58 111.02 23.41 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.677 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 29.6 m-85 . . . . . 0 C--N 1.296 -1.76 0 C-N-CA 123.223 0.609 . . . . 0.0 109.861 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.424 -1.754 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -89.17 -43.46 11.0 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.85 -168.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -129.12 148.97 51.12 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -118.0 120.74 65.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -126.6 169.22 13.32 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.464 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.5 t -149.76 145.34 26.58 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.33 154.02 44.33 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 123.673 0.789 . . . . 0.0 110.016 -174.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -75.05 151.05 38.72 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 122.026 -0.421 . . . . 0.0 110.049 173.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.449 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 8.6 ptt85 -57.55 114.83 2.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 171.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 74.67 67.74 0.08 Allowed 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 125.477 1.511 . . . . 0.0 109.553 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -151.46 139.6 20.19 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.764 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -97.13 121.88 39.51 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.2 pt -102.08 177.06 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 172.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.4 m -136.62 124.6 22.8 Favored 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.434 HD12 HD21 ' A' ' 74' ' ' LEU . 98.8 mt -114.88 105.59 18.94 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 57.26 46.75 18.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.605 0.717 . . . . 0.0 112.564 174.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 71.65 3.01 4.51 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.861 1.665 . . . . 0.0 112.897 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -99.36 109.36 21.97 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.45 143.52 34.89 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 117.959 -1.496 . . . . 0.0 109.707 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -133.74 121.21 39.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.113 -174.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -91.56 128.81 37.53 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.4 t -108.83 121.71 62.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -78.14 169.09 18.84 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 124.407 1.083 . . . . 0.0 108.223 178.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.449 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 10.5 pt-20 -72.35 -4.0 27.28 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.86 7.42 45.02 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 172.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 70.8 m 64.83 35.59 8.46 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.097 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -123.01 129.07 25.11 Favored Pre-proline 0 C--N 1.29 -2.013 0 CA-C-N 114.308 -1.314 . . . . 0.0 107.789 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.422 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 46.6 Cg_endo -84.73 159.43 12.19 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.038 2.492 . . . . 0.0 116.01 -175.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 40.8 m-85 -134.7 131.03 20.0 Favored Pre-proline 0 C--N 1.312 -1.064 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.101 171.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 91.4 Cg_endo -83.85 161.06 70.84 Favored 'Cis proline' 0 C--N 1.319 -1.022 0 C-N-CA 122.907 -1.705 . . . . 0.0 111.425 -2.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 74' ' ' LEU . 90.7 t -81.17 -38.44 16.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.695 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 67' ' ' ILE . 8.3 mm -97.44 116.61 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-O 122.106 0.955 . . . . 0.0 109.932 173.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.9 mt -76.87 165.77 49.88 Favored Pre-proline 0 C--N 1.297 -1.701 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.935 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.07 -3.41 13.6 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.428 2.085 . . . . 0.0 111.366 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -93.17 -12.15 31.02 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.019 -1.901 . . . . 0.0 110.462 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.278 40.0 ttm180 66.88 59.05 0.57 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 123.819 1.771 . . . . 0.0 109.763 -171.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.3 m -120.7 139.55 52.89 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 112.269 -2.241 . . . . 0.0 106.743 172.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.677 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.7 t -90.62 115.78 30.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 125.439 1.712 . . . . 0.0 108.975 -175.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.452 ' O ' HG13 ' A' ' 66' ' ' VAL . 4.0 mp -92.92 122.64 35.5 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 118.693 -1.203 . . . . 0.0 109.794 173.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.6 m -118.67 118.71 32.37 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.422 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -110.85 152.72 17.41 Favored Glycine 0 N--CA 1.415 -2.763 0 C-N-CA 119.763 -1.208 . . . . 0.0 111.405 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 61' ' ' CYS . 2.9 t70 -157.53 177.1 11.79 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 174.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -82.91 137.05 34.37 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.612 HG23 HD12 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -68.19 -25.31 65.17 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 118.213 0.461 . . . . 0.0 111.867 -175.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.2 t -67.91 -38.15 82.58 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.19 17.41 4.32 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.434 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.303 -1.442 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.939 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -143.32 176.24 9.3 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -94.91 113.41 25.14 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-O 122.955 1.359 . . . . 0.0 113.238 -178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -134.29 -59.04 0.83 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 102.916 -2.994 . . . . 0.0 102.916 171.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.92 159.21 27.36 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 172.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -83.37 79.25 9.47 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.685 0.755 . . . . 0.0 110.495 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -143.68 91.42 2.24 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.329 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -138.6 132.04 30.38 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.98 -71.46 0.23 Allowed Glycine 0 N--CA 1.431 -1.696 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -136.9 148.48 47.05 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.424 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -152.97 88.3 1.32 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.865 0.841 . . . . 0.0 111.373 -173.081 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.24 95.6 1.02 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.03 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.527 ' CE3' HG21 ' A' ' 41' ' ' THR . 12.1 m95 -99.33 -177.83 3.72 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.391 173.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.524 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 34.4 mmtp -83.34 -173.87 4.96 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.513 0.673 . . . . 0.0 110.102 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.97 -37.47 55.14 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.775 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.2 m -122.02 144.32 48.97 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.87 -176.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.511 HD12 HG23 ' A' ' 79' ' ' THR . 7.1 tt -118.89 133.24 66.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.3 mm -121.97 112.72 36.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -92.91 128.72 38.87 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.074 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -98.31 114.28 26.52 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.45 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 35.5 m-85 -96.41 130.72 43.49 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 177.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -122.64 119.27 30.26 Favored 'General case' 0 N--CA 1.4 -2.965 0 N-CA-C 105.326 -2.102 . . . . 0.0 105.326 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 60.99 30.85 19.85 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.41 5.66 65.08 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.895 -0.593 . . . . 0.0 114.473 176.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -135.25 151.13 50.3 Favored 'General case' 0 CA--C 1.485 -1.535 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.67 114.04 12.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-O 122.442 1.115 . . . . 0.0 109.523 -175.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -97.16 -60.49 1.57 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.082 -1.417 . . . . 0.0 110.445 -173.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -121.92 156.83 32.53 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.512 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 mp -120.05 118.04 55.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -119.93 169.12 10.46 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.527 HG21 ' CE3' ' A' ' 23' ' ' TRP . 4.2 t -155.37 147.95 24.1 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.76 157.85 43.61 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.582 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -72.64 155.35 40.11 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 172.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -57.65 121.11 9.59 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 166.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.56 HD21 ' HB3' ' A' ' 59' ' ' GLU . 2.0 m120 74.9 55.05 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 126.464 1.906 . . . . 0.0 110.054 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -139.54 139.54 36.9 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.803 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 5.8 mp0 -95.85 125.8 40.66 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 176.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.4 pt -105.47 -176.94 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 172.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.2 m -136.93 134.67 37.01 Favored 'General case' 0 N--CA 1.414 -2.266 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.413 HD12 HD21 ' A' ' 74' ' ' LEU . 80.1 mt -126.77 105.05 13.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 54.26 46.08 25.95 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.721 0.772 . . . . 0.0 111.841 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 69.7 9.42 7.18 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -103.92 115.26 30.14 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.45 142.62 31.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.003 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 95.1 t -134.33 125.04 46.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.768 -172.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 82.9 t80 -94.74 122.03 36.93 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.0 t -97.53 121.75 48.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.427 ' OD1' ' HG2' ' A' ' 59' ' ' GLU . 40.1 t30 -71.53 165.77 23.18 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 124.923 1.389 . . . . 0.0 109.3 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.56 ' HB3' HD21 ' A' ' 45' ' ' ASN . 10.7 pt-20 -58.28 -24.3 59.01 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 126.012 1.725 . . . . 0.0 114.1 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.12 16.6 22.2 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.2 m 64.85 69.45 0.49 Allowed 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.341 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.403 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 4.3 t-80 -148.07 124.42 5.4 Favored Pre-proline 0 C--N 1.313 -0.981 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.477 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 52.2 Cg_endo -83.58 140.49 9.43 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.252 2.635 . . . . 0.0 114.033 -176.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -129.41 131.68 23.78 Favored Pre-proline 0 CA--C 1.494 -1.183 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.148 174.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -77.28 166.62 81.63 Favored 'Cis proline' 0 C--N 1.325 -0.704 0 C-N-CA 122.726 -1.781 . . . . 0.0 112.74 -1.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.0 t -88.33 -28.43 5.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.565 0.698 . . . . 0.0 110.344 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.554 HG23 ' HA ' ' A' ' 71' ' ' ARG . 32.4 mm -108.75 132.56 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.529 0 CA-C-O 121.525 0.679 . . . . 0.0 109.936 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.41 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 45.3 mt -91.15 171.87 7.5 Favored Pre-proline 0 C--N 1.302 -1.499 0 CA-C-N 114.464 -1.244 . . . . 0.0 109.582 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.41 ' CD ' ' HB3' ' A' ' 68' ' ' LEU . 25.5 Cg_exo -67.99 -15.33 43.27 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.593 2.195 . . . . 0.0 111.85 -177.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -86.41 -12.29 49.56 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.55 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.554 ' HA ' HG23 ' A' ' 67' ' ' ILE . 23.7 ttm180 72.17 31.11 1.99 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 124.081 1.896 . . . . 0.0 109.013 -173.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 m -70.24 138.85 52.01 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 169.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 1.4 t -96.8 125.58 49.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 O-C-N 125.01 1.444 . . . . 0.0 109.571 -175.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.413 HD21 HD12 ' A' ' 50' ' ' ILE . 3.0 mp -103.96 138.66 40.2 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 121.438 0.637 . . . . 0.0 109.63 174.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.9 m -136.34 122.06 19.79 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.505 175.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.477 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -107.12 142.81 15.78 Favored Glycine 0 N--CA 1.428 -1.899 0 C-N-CA 120.247 -0.977 . . . . 0.0 110.973 -177.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -147.05 173.01 12.86 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 103.688 -2.708 . . . . 0.0 103.688 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -79.69 138.45 37.36 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.511 HG23 HD12 ' A' ' 27' ' ' ILE . 1.9 m -68.49 -15.36 63.51 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.465 0.65 . . . . 0.0 110.437 -177.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.5 t -56.59 -42.23 78.33 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 126.079 1.752 . . . . 0.0 108.903 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.15 21.33 11.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.555 0.693 . . . . 0.0 112.107 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -129.45 -78.84 0.55 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.826 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.23 -30.48 34.18 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.5 t70 73.16 -56.84 0.65 Allowed 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 125.328 1.451 . . . . 0.0 114.368 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 21' ' ' MET . 25.8 t70 63.16 99.11 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.673 0 O-C-N 124.828 1.33 . . . . 0.0 108.168 -172.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.21 111.36 1.32 Allowed 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -81.65 129.51 34.72 Favored 'General case' 0 N--CA 1.425 -1.7 0 C-N-CA 119.509 -0.876 . . . . 0.0 113.223 -173.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.9 m -63.41 130.52 44.81 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-N 114.278 -1.328 . . . . 0.0 109.341 178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 61.6 m . . . . . 0 C--N 1.301 -1.508 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 179.405 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.925 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -83.75 117.92 23.56 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.43 -61.57 2.35 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 124.219 1.008 . . . . 0.0 110.618 -169.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -126.17 -58.41 1.37 Allowed 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -163.2 177.63 8.89 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 175.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.43 ' HE2' ' O ' ' A' ' 22' ' ' ALA . 68.1 t80 -82.8 85.42 7.09 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 65.91 -99.43 0.06 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.618 1.567 . . . . 0.0 108.881 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -146.9 77.93 1.48 Allowed 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 169.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.28 153.17 20.75 Favored Glycine 0 N--CA 1.417 -2.632 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.4 t-160 -71.58 -39.29 70.68 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 176.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -161.18 136.0 7.4 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.693 1.997 . . . . 0.0 105.854 171.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.43 ' O ' ' HE2' ' A' ' 16' ' ' TYR . . . -153.21 90.02 1.4 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.55 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.3 m95 -115.36 -167.73 1.29 Allowed 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.632 -174.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.538 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 50.8 mmtt -85.15 -171.91 3.89 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.423 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 2.0 m-20 -82.26 -29.85 31.0 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.453 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 71.9 m -127.21 141.99 51.6 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.173 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.581 HD12 HG23 ' A' ' 79' ' ' THR . 11.0 tt -119.17 133.06 67.21 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.6 mm -123.56 111.92 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -173.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -95.48 125.99 40.46 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.577 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -94.76 113.75 25.56 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.636 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 11.3 m-85 -95.37 136.28 35.93 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.632 ' HB3' ' HB2' ' A' ' 37' ' ' ASN . 11.5 tmtt? -155.31 128.38 8.19 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 -173.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.8 29.8 18.1 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.79 -0.63 76.99 Favored Glycine 0 N--CA 1.438 -1.209 0 N-CA-C 114.588 0.595 . . . . 0.0 114.588 174.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -140.7 161.19 38.36 Favored 'General case' 0 CA--C 1.486 -1.515 0 CA-C-N 117.993 0.896 . . . . 0.0 109.045 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.2 p -70.68 110.63 3.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 122.599 1.19 . . . . 0.0 107.824 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.632 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 27.1 t-20 -87.15 -50.96 6.27 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.439 -174.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -128.97 155.32 45.54 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.202 -178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -119.14 119.04 59.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -120.25 167.83 11.87 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.55 HG21 ' CE3' ' A' ' 23' ' ' TRP . 4.3 t -154.55 147.33 24.36 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -149.11 160.74 43.08 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -82.06 162.34 22.6 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.794 175.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.423 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 6.5 ptt85 -60.86 113.48 2.53 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.297 174.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.605 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 32.1 m-80 73.46 67.79 0.11 Allowed 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 126.489 1.916 . . . . 0.0 109.102 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -147.38 130.02 15.99 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.069 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 43.0 tt0 -97.62 116.84 30.62 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 121.501 0.667 . . . . 0.0 109.868 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 30.0 pt -98.26 -178.31 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 3.0 m -137.06 136.22 38.19 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 92.1 mt -128.01 107.96 17.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 56.8 34.78 25.27 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 74.7 14.56 3.37 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 127.015 2.126 . . . . 0.0 112.719 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -102.64 110.31 22.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 172.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.518 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -78.67 145.31 34.66 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.72 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -137.23 118.99 18.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.663 -173.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 69.2 t80 -89.89 118.71 29.67 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.2 t -94.11 117.97 38.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -71.98 168.29 18.34 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.605 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 13.5 pt-20 -64.38 -15.48 60.55 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.653 1.181 . . . . 0.0 113.663 -177.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.13 6.18 43.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.8 m 69.48 36.55 2.2 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.595 1.158 . . . . 0.0 112.127 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -122.39 124.3 26.85 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 113.632 -1.622 . . . . 0.0 107.52 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.416 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 72.2 Cg_endo -81.72 153.62 17.57 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.218 2.612 . . . . 0.0 115.047 -176.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -136.39 131.45 18.51 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.174 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -79.07 161.69 88.06 Favored 'Cis proline' 0 C--N 1.322 -0.843 0 C-N-CA 122.526 -1.864 . . . . 0.0 111.513 -3.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.3 t -78.92 -36.68 19.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.373 0.606 . . . . 0.0 110.125 -176.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.29 126.74 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 121.614 0.721 . . . . 0.0 110.782 176.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.1 mt -89.62 170.7 10.07 Favored Pre-proline 0 C--N 1.305 -1.336 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.017 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -69.3 -9.48 26.39 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.551 2.167 . . . . 0.0 112.456 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.69 -11.07 54.66 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.463 175.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.411 ' HD2' ' HA ' ' A' ' 71' ' ' ARG . 11.5 tpt180 76.16 22.58 1.35 Allowed 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 126.375 1.87 . . . . 0.0 107.925 -172.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.4 m -67.45 134.68 51.83 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.379 -1.282 . . . . 0.0 107.657 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.636 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -92.93 116.74 34.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 126.002 1.721 . . . . 0.0 108.796 -178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 mp -96.84 122.55 39.93 Favored 'General case' 0 C--N 1.291 -1.964 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.117 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.9 m -114.36 118.7 34.59 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.416 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -117.27 134.99 11.55 Favored Glycine 0 N--CA 1.431 -1.693 0 C-N-CA 119.933 -1.127 . . . . 0.0 112.551 -175.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -141.35 168.37 19.94 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -72.6 139.98 47.75 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.581 HG23 HD12 ' A' ' 27' ' ' ILE . 1.7 m -71.93 -15.71 62.09 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.798 0.808 . . . . 0.0 109.709 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . 0.276 0.7 OUTLIER -56.82 -32.64 65.93 Favored 'General case' 0 N--CA 1.414 -2.244 0 C-N-CA 126.399 1.88 . . . . 0.0 111.015 179.01 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.69 19.41 20.52 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 122.1 0.952 . . . . 0.0 109.851 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -141.74 -174.72 4.14 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.235 -1.348 . . . . 0.0 110.236 -176.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 58.01 9.27 0.89 Allowed 'General case' 0 CA--C 1.509 -0.631 0 C-N-CA 125.781 1.632 . . . . 0.0 115.356 171.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -77.43 64.86 2.87 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.8 t70 42.68 56.03 4.03 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 127.175 2.19 . . . . 0.0 108.867 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -133.41 116.89 16.59 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 112.757 -2.019 . . . . 0.0 110.852 -171.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -101.84 154.27 19.08 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.0 m -81.82 90.55 6.41 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.32 0.581 . . . . 0.0 110.412 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 67.3 m . . . . . 0 C--O 1.25 1.114 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.159 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 37' ' ' ASN . . . . . . . . 0 CA--C 1.498 -0.982 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.505 ' HD3' ' O ' ' A' ' 39' ' ' ILE . 67.8 ttt180 79.44 85.47 0.06 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 125.625 1.57 . . . . 0.0 112.771 -177.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -96.6 109.22 21.87 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 172.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -64.85 -59.16 4.51 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.604 0.716 . . . . 0.0 110.383 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.5 mt -151.19 176.7 10.95 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -80.82 83.95 6.45 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 172.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.458 ' CE2' ' HG2' ' A' ' 87' ' ' GLU . 38.6 p90 -96.64 99.37 10.99 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.225 178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -92.57 103.8 16.16 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -157.66 -171.17 23.32 Favored Glycine 0 N--CA 1.429 -1.795 0 C-N-CA 119.558 -1.306 . . . . 0.0 111.838 -176.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -95.13 148.74 22.05 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.599 ' HG3' ' O ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -70.85 118.9 14.22 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.911 0.862 . . . . 0.0 111.686 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -146.24 77.94 1.5 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 174.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.534 ' HB2' HG21 ' A' ' 79' ' ' THR . 14.3 m0 -94.89 -165.52 1.32 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 113.235 -1.802 . . . . 0.0 109.876 -175.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -88.51 -170.75 3.06 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -77.96 -29.87 50.05 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.075 0.941 . . . . 0.0 111.116 -171.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.2 m -124.55 143.22 50.8 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.709 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.596 HD12 HG23 ' A' ' 79' ' ' THR . 13.5 tt -117.89 133.05 65.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.41 HG23 ' HG3' ' A' ' 63' ' ' PRO . 30.8 mm -126.45 114.24 37.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -172.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -98.92 135.14 40.78 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.505 ' HG3' HD11 ' A' ' 74' ' ' LEU . 4.7 ttp180 -103.8 112.88 26.03 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.642 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 33.7 m-85 -96.45 147.88 23.38 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 124.367 1.067 . . . . 0.0 110.016 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -144.9 120.0 10.09 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 60.9 30.6 19.73 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.57 -13.37 64.21 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.851 -0.69 . . . . 0.0 114.449 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -123.59 159.07 30.02 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.2 p -73.23 135.21 28.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-O 121.72 0.771 . . . . 0.0 111.604 -175.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.477 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 16.1 t-20 -111.4 -62.68 1.51 Allowed 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 125.016 1.326 . . . . 0.0 112.537 -174.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.403 ' O ' HD12 ' A' ' 39' ' ' ILE . 6.9 m-80 -121.61 167.32 13.03 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 122.764 0.426 . . . . 0.0 111.041 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.505 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 1.7 mp -131.71 135.88 58.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 125.118 1.367 . . . . 0.0 108.426 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -141.79 163.83 31.84 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.444 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.7 t -149.14 139.53 22.41 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 173.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.72 163.77 31.71 Favored 'General case' 0 C--N 1.311 -1.068 0 O-C-N 124.003 0.815 . . . . 0.0 109.272 -173.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -77.56 159.73 29.08 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 120.467 -0.493 . . . . 0.0 109.836 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -67.75 116.37 8.36 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 120.924 0.392 . . . . 0.0 110.029 173.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.581 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 26.3 m-80 75.36 67.63 0.07 Allowed 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 126.901 2.08 . . . . 0.0 109.332 -174.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -149.68 134.57 17.86 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.609 -177.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 44.3 tt0 -101.19 119.46 38.79 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-O 121.839 0.828 . . . . 0.0 110.209 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 39.5 pt -100.01 179.27 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.789 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.1 m -136.9 134.25 36.62 Favored 'General case' 0 N--CA 1.412 -2.335 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.417 HD12 HG21 ' A' ' 55' ' ' VAL . 95.2 mt -124.88 106.63 16.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 59.05 34.9 23.71 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.119 0.961 . . . . 0.0 111.193 176.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.26 42.9 mm-40 67.39 21.19 9.79 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.625 1.57 . . . . 0.0 113.523 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -104.2 111.28 23.82 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 103.264 -2.865 . . . . 0.0 103.264 169.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -81.45 133.64 35.43 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 121.649 0.737 . . . . 0.0 109.241 -176.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.417 HG21 HD12 ' A' ' 50' ' ' ILE . 94.1 t -127.38 119.12 51.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.744 -173.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 79.4 t80 -92.89 121.52 34.33 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.9 t -94.01 114.62 31.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -69.03 165.03 21.04 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.581 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 9.1 pt-20 -70.14 -7.81 44.66 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 123.768 0.827 . . . . 0.0 112.428 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -82.41 -2.37 52.9 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 172.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 79.1 m 69.35 32.81 3.4 Favored 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 114.108 -1.405 . . . . 0.0 111.917 177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -122.05 128.37 25.56 Favored Pre-proline 0 C--N 1.293 -1.85 0 CA-C-N 113.027 -1.897 . . . . 0.0 106.708 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.41 ' HG3' HG23 ' A' ' 28' ' ' ILE . 42.6 Cg_endo -85.01 156.07 11.35 Favored 'Trans proline' 0 C--N 1.329 -0.447 0 C-N-CA 123.267 2.645 . . . . 0.0 115.4 -175.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -135.17 131.32 19.66 Favored Pre-proline 0 N--CA 1.441 -0.906 0 C-N-CA 124.678 1.191 . . . . 0.0 111.571 172.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -79.5 169.7 70.17 Favored 'Cis proline' 0 C--N 1.322 -0.82 0 C-N-CA 122.435 -1.902 . . . . 0.0 112.306 -1.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.8 t -86.79 -42.17 15.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.093 -176.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.447 HG12 ' NH2' ' A' ' 71' ' ' ARG . 1.7 mp -98.3 128.02 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 CA-C-O 121.71 0.767 . . . . 0.0 110.49 173.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.6 mt -88.41 169.11 14.31 Favored Pre-proline 0 C--N 1.306 -1.298 0 CA-C-N 114.297 -1.319 . . . . 0.0 108.243 176.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.35 -9.18 25.34 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.281 1.988 . . . . 0.0 110.904 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -88.7 1.2 55.54 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.687 -1.597 . . . . 0.0 109.492 178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.447 ' NH2' HG12 ' A' ' 67' ' ' ILE . 8.3 tpm_? 74.93 9.43 4.0 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 125.253 1.421 . . . . 0.0 109.671 176.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 67' ' ' ILE . 0.9 OUTLIER -70.86 138.15 50.0 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.703 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.642 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.3 t -92.1 124.07 44.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 125.614 1.566 . . . . 0.0 109.479 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.505 HD11 ' HG3' ' A' ' 30' ' ' ARG . 7.6 mp -100.23 122.74 43.51 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 121.959 0.885 . . . . 0.0 110.307 172.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 52.3 m -118.03 117.74 30.04 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -118.07 152.28 17.6 Favored Glycine 0 N--CA 1.422 -2.279 0 C-N-CA 119.395 -1.383 . . . . 0.0 111.38 -176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -155.84 177.13 11.75 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -79.65 139.2 37.49 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.596 HG23 HD12 ' A' ' 27' ' ' ILE . 1.6 m -72.11 -10.9 60.4 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.568 0.699 . . . . 0.0 110.409 -178.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.4 p -69.09 -22.93 63.97 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.425 0.631 . . . . 0.0 111.034 176.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.36 17.14 24.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 122.07 0.938 . . . . 0.0 109.909 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -145.1 -169.3 3.16 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.955 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.599 ' O ' ' HG3' ' A' ' 21' ' ' MET 0.284 . . 60.49 87.55 0.09 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 126.084 1.754 . . . . 0.0 114.459 175.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -151.47 29.88 0.61 Allowed 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 110.566 -3.015 . . . . 0.0 102.954 173.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -62.16 154.42 27.3 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 111.857 -2.429 . . . . 0.0 113.13 -175.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -97.79 74.41 2.35 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.82 -1.082 . . . . 0.0 112.327 -172.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.458 ' HG2' ' CE2' ' A' ' 17' ' ' PHE . 3.2 mp0 -96.16 -43.49 7.71 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 173.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.0 m -82.02 81.17 8.07 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 175.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 3.8 p . . . . . 0 C--N 1.307 -1.266 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.814 -175.616 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.8 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -71.36 -28.99 64.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.608 0.718 . . . . 0.0 110.371 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -170.73 96.5 0.22 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 102.792 -3.04 . . . . 0.0 102.792 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -120.3 167.7 12.03 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.49 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.6 mt -87.2 168.32 13.33 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 123.889 0.743 . . . . 0.0 110.504 -174.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.427 ' HE1' ' SD ' ' A' ' 21' ' ' MET . 83.6 t80 -78.2 81.53 4.57 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 171.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -86.04 -45.28 11.57 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.539 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.405 ' H ' ' HG2' ' A' ' 18' ' ' GLN . 15.1 pt20 -101.11 150.49 22.88 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.308 -174.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.75 -39.25 93.57 Favored Glycine 0 C--N 1.331 0.263 0 O-C-N 124.247 0.967 . . . . 0.0 111.481 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.3 m170 -97.37 87.9 4.27 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.427 ' SD ' ' HE1' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -65.45 147.76 52.88 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.056 175.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.48 90.94 2.93 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.186 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.441 ' CB ' HG21 ' A' ' 79' ' ' THR . 11.5 m0 -93.43 -171.63 2.69 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.234 -0.893 . . . . 0.0 109.41 175.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.499 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . 11.2 mmpt? -88.55 -170.58 2.99 Favored 'General case' 0 C--N 1.317 -0.81 0 O-C-N 121.923 -0.485 . . . . 0.0 110.759 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.11 -29.18 54.7 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.091 0.472 . . . . 0.0 112.013 -175.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 68.1 m -122.34 144.81 48.79 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 121.884 0.85 . . . . 0.0 110.766 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.623 HD12 HG23 ' A' ' 79' ' ' THR . 8.6 tt -119.48 133.66 65.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.4 mm -119.01 133.07 67.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -174.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -117.23 132.56 56.6 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -174.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -94.6 112.98 24.74 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.641 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 23.2 m-85 -95.54 110.82 22.84 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.58 ' HB3' ' HB2' ' A' ' 37' ' ' ASN . 11.8 tmtt? -121.07 126.32 49.54 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 -175.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 61.04 29.59 19.05 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 124.913 1.285 . . . . 0.0 111.765 -175.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.71 -10.0 76.02 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 114.646 0.618 . . . . 0.0 114.646 177.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -123.73 155.12 38.45 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.7 p -73.12 110.29 6.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-O 122.524 1.154 . . . . 0.0 109.53 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.58 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 4.6 t-20 -88.19 -57.54 2.89 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.801 -173.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -121.09 159.88 24.82 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.876 -178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.6 tp -122.73 155.85 28.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -151.02 167.88 26.3 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.424 HG21 ' CE3' ' A' ' 23' ' ' TRP . 2.0 t -149.63 146.82 27.49 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.374 0.606 . . . . 0.0 110.029 177.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.85 158.87 44.25 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -80.99 158.82 25.04 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.483 ' HB2' ' HA ' ' A' ' 59' ' ' GLU . 6.8 ptt85 -61.58 114.42 3.25 Favored 'General case' 0 N--CA 1.436 -1.128 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 171.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.467 HD21 ' HB3' ' A' ' 59' ' ' GLU . 9.4 m-80 76.52 67.15 0.06 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 127.112 2.165 . . . . 0.0 108.914 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -146.72 128.5 15.29 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.561 -177.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -89.86 109.93 20.9 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.368 0.604 . . . . 0.0 109.696 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.9 pt -96.7 -178.97 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 175.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.9 m -133.24 130.68 39.34 Favored 'General case' 0 N--CA 1.403 -2.789 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 174.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.44 HD12 HG21 ' A' ' 55' ' ' VAL . 87.7 mt -122.75 101.82 10.44 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 61.14 36.96 17.95 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.947 0.879 . . . . 0.0 111.251 172.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 70.64 18.94 6.25 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 113.751 -1.568 . . . . 0.0 113.798 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -112.52 107.66 16.48 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 172.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 49' ' ' THR 0.31 0.0 OUTLIER -78.78 152.92 31.16 Favored 'General case' 0 N--CA 1.424 -1.771 0 C-N-CA 117.654 -1.618 . . . . 0.0 111.81 -179.534 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.44 HG21 HD12 ' A' ' 50' ' ' ILE . 91.8 t -142.72 129.83 18.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.299 -170.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -100.34 120.8 40.5 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 66.2 t -98.32 117.68 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -71.76 167.65 19.47 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 124.586 1.179 . . . . 0.0 109.336 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.483 ' HA ' ' HB2' ' A' ' 44' ' ' ARG . 9.5 pt-20 -58.65 -20.8 51.05 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 126.0 1.72 . . . . 0.0 114.851 -174.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.56 19.89 18.16 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 120.953 0.406 . . . . 0.0 109.965 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.9 m 62.33 69.97 0.59 Allowed 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.403 177.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -148.0 121.79 4.84 Favored Pre-proline 0 N--CA 1.439 -0.997 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.515 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 48.7 Cg_endo -87.73 142.74 5.9 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.564 2.843 . . . . 0.0 114.912 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -131.79 134.61 25.56 Favored Pre-proline 0 C--N 1.309 -1.165 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.491 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -77.01 158.08 96.84 Favored 'Cis proline' 0 C--N 1.332 -0.342 0 C-N-CA 122.572 -1.845 . . . . 0.0 112.831 0.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.14 -40.13 21.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.362 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 29.9 mm -98.76 124.17 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 C-N-CA 118.926 -1.109 . . . . 0.0 109.39 175.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.0 mt -85.61 168.24 20.88 Favored Pre-proline 0 C--N 1.287 -2.127 0 CA-C-N 113.192 -1.822 . . . . 0.0 108.644 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -68.64 -11.96 33.35 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.126 1.884 . . . . 0.0 111.177 -176.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -91.98 10.82 27.37 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.155 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 68.62 9.59 7.4 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.473 1.909 . . . . 0.0 111.45 172.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.9 m -82.21 150.7 27.21 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.825 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.641 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.3 t -91.29 131.0 39.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 126.436 1.894 . . . . 0.0 109.751 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.6 mp -105.94 123.56 48.17 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.09 0.948 . . . . 0.0 111.03 173.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.4 t -107.62 147.09 31.11 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.515 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -130.58 140.35 11.69 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -152.86 175.75 12.57 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 175.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -86.21 132.78 33.93 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.623 HG23 HD12 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -67.52 -21.96 65.46 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.278 0.561 . . . . 0.0 111.503 -175.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.4 p -65.95 -26.81 67.75 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.916 -177.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.33 21.13 17.46 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.822 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -132.0 -69.46 0.6 Allowed 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -174.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.596 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . . . -81.22 -6.77 59.23 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.548 -174.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.9 t70 72.28 22.63 3.48 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.897 1.679 . . . . 0.0 110.391 176.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.596 ' OD1' ' HB3' ' A' ' 83' ' ' ALA . 3.6 m-20 -58.9 156.41 11.5 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 114.385 -1.279 . . . . 0.0 108.073 174.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -82.12 75.8 9.03 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 59.74 37.93 21.89 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.901 2.081 . . . . 0.0 109.958 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.0 m 68.42 -76.71 0.05 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.972 1.709 . . . . 0.0 112.095 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.0 p . . . . . 0 C--N 1.305 -1.334 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -175.742 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.097 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 62.62 81.95 0.19 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.363 1.465 . . . . 0.0 112.161 -175.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -107.76 105.38 15.18 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 173.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -79.04 147.55 32.8 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.436 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.0 mt -77.3 158.26 30.3 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.562 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -85.21 78.92 9.72 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 122.052 0.929 . . . . 0.0 109.481 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.41 ' O ' ' HB3' ' A' ' 21' ' ' MET . 71.9 m-85 -82.96 91.98 7.25 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.903 178.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.22 164.76 20.99 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.516 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.95 -80.75 0.79 Allowed Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 108.684 -1.767 . . . . 0.0 108.684 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -121.4 98.66 6.07 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.376 0.607 . . . . 0.0 110.546 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.41 ' HB3' ' O ' ' A' ' 17' ' ' PHE . 20.3 ptp -115.65 100.07 7.78 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.297 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.47 103.49 14.39 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.636 0.731 . . . . 0.0 109.286 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.509 ' CE3' HG21 ' A' ' 41' ' ' THR . 17.9 m95 -93.29 -175.36 3.8 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 174.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -101.87 -171.35 1.96 Allowed 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.541 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.49 -27.49 58.81 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -173.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.8 m -126.28 142.56 51.48 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.022 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.647 HD12 HG23 ' A' ' 79' ' ' THR . 12.7 tt -115.22 133.46 61.39 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.41 HD13 ' O ' ' A' ' 27' ' ' ILE . 34.9 mm -127.22 116.94 45.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -173.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 75' ' ' SER . 95.9 mt-30 -105.75 139.12 40.82 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.759 -0.588 . . . . 0.0 110.358 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.536 ' HD2' HG21 ' A' ' 50' ' ' ILE . 24.1 mtp180 -95.82 115.74 27.87 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 121.528 -0.069 . . . . 0.0 110.971 175.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.648 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 29.2 m-85 -95.89 115.87 28.07 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.511 ' HE3' ' OD2' ' A' ' 70' ' ' ASP . 11.2 tppt? -142.01 114.4 8.32 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.323 -174.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.383 0.7 OUTLIER 61.43 52.69 3.66 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 112.996 -1.911 . . . . 0.0 116.124 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.8 -4.57 61.41 Favored Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 117.18 1.632 . . . . 0.0 117.18 172.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -162.14 174.24 13.21 Favored 'General case' 0 CA--C 1.492 -1.267 0 CA-C-N 119.114 1.457 . . . . 0.0 107.981 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.3 p -77.13 115.76 19.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -94.78 -51.78 4.55 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 114.823 -1.081 . . . . 0.0 111.037 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -119.8 154.25 34.52 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.893 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -121.92 127.26 75.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -133.73 168.99 17.71 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.509 HG21 ' CE3' ' A' ' 23' ' ' TRP . 2.3 t -155.45 139.63 16.55 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 175.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.23 152.96 46.38 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.456 -174.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -76.69 160.6 29.22 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 120.881 0.372 . . . . 0.0 110.562 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.53 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 4.0 ptt180 -60.56 115.59 3.72 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.895 172.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.426 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 82.9 m-20 73.62 65.01 0.09 Allowed 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 125.969 1.708 . . . . 0.0 109.678 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -145.74 137.46 25.17 Favored 'General case' 0 N--CA 1.416 -2.164 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.26 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 39.2 tt0 -107.75 109.5 21.09 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.733 0.778 . . . . 0.0 109.225 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.4 pt -90.59 -177.33 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.839 -1.073 . . . . 0.0 108.812 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.2 m -130.98 134.34 46.63 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 175.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.536 HG21 ' HD2' ' A' ' 30' ' ' ARG . 82.1 mt -128.95 110.31 20.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 51.79 38.04 22.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.07 0.938 . . . . 0.0 112.676 177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 69.12 29.05 4.83 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 113.337 -1.756 . . . . 0.0 112.829 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -118.35 116.82 27.52 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 169.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -82.12 140.9 33.54 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 118.494 -1.283 . . . . 0.0 109.7 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.452 HG21 HD12 ' A' ' 50' ' ' ILE . 69.2 t -132.22 125.99 55.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.837 -172.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 54.6 t80 -96.03 121.01 37.32 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -178.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.34 116.99 44.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -70.78 164.72 24.6 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 124.295 0.997 . . . . 0.0 108.374 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.53 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 9.3 pt-20 -62.76 -13.14 29.45 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 -177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.39 11.63 29.91 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.009 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.2 m 62.14 69.44 0.62 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.882 0.848 . . . . 0.0 111.937 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -152.01 124.87 4.08 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.578 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 64.0 Cg_endo -87.03 141.2 6.01 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.323 2.682 . . . . 0.0 114.226 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -126.48 129.22 24.18 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 174.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.16 159.68 92.72 Favored 'Cis proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.613 -1.828 . . . . 0.0 112.585 -0.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.8 t -78.94 -44.02 24.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.458 HG21 ' NH2' ' A' ' 71' ' ' ARG . 1.7 mp -94.7 123.69 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 121.597 0.713 . . . . 0.0 109.151 171.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 44.6 mt -83.19 169.51 17.36 Favored Pre-proline 0 C--N 1.299 -1.596 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.774 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -71.61 -2.51 11.47 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.498 2.132 . . . . 0.0 111.343 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.511 ' OD2' ' HE3' ' A' ' 32' ' ' LYS . 18.3 t70 -97.48 4.72 50.38 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.62 -1.627 . . . . 0.0 109.401 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.458 ' NH2' HG21 ' A' ' 67' ' ' ILE . 0.4 OUTLIER 66.14 21.26 11.16 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.111 1.364 . . . . 0.0 109.323 177.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.2 m -85.5 139.73 31.25 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.648 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -90.5 125.48 43.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 125.956 1.702 . . . . 0.0 108.409 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.8 mp -101.56 130.13 47.79 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-O 122.201 1.001 . . . . 0.0 111.214 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.435 ' HB3' ' HB2' ' A' ' 29' ' ' GLN . 37.6 t -106.02 121.34 43.91 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.578 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -117.69 131.98 9.65 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 119.922 -1.132 . . . . 0.0 110.293 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -150.12 172.97 14.43 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -80.8 135.44 35.96 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.647 HG23 HD12 ' A' ' 27' ' ' ILE . 2.4 m -70.61 -14.46 62.49 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 121.867 -0.521 . . . . 0.0 111.795 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.584 ' HA ' ' HB2' ' A' ' 84' ' ' ASP . 1.9 t -69.45 -28.93 66.53 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 122.27 1.033 . . . . 0.0 108.879 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -94.56 16.17 16.13 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.681 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -130.09 -80.52 0.55 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.172 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.83 -85.9 0.44 Allowed 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.584 ' HB2' ' HA ' ' A' ' 80' ' ' SER . 15.1 t70 62.15 13.93 6.2 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.54 1.136 . . . . 0.0 111.6 174.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -73.81 11.3 0.89 Allowed 'General case' 0 C--O 1.24 0.566 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -171.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -84.38 77.9 9.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 55.45 75.81 0.3 Allowed 'General case' 0 C--O 1.241 0.626 0 CA-C-N 113.503 -1.681 . . . . 0.0 111.28 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.0 m -75.52 100.51 4.56 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.066 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 42.8 t . . . . . 0 C--N 1.306 -1.291 0 N-CA-C 105.483 -2.044 . . . . 0.0 105.483 -179.372 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.656 ' HA2' ' OXT' ' A' ' 89' ' ' CYS . . . . . . . . 0 CA--C 1.497 -1.071 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -72.0 100.19 2.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.237 0.519 . . . . 0.0 111.41 -176.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 60.6 24.67 14.39 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.755 1.222 . . . . 0.0 112.745 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.596 ' O ' ' HB3' ' A' ' 17' ' ' PHE . 23.0 m120 -74.42 -34.86 63.36 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.3 mt 54.34 -157.16 0.2 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.938 1.295 . . . . 0.0 110.917 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -95.48 32.44 1.79 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 124.087 1.899 . . . . 0.0 108.747 173.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.596 ' HB3' ' O ' ' A' ' 14' ' ' ASN . 52.8 t80 -81.89 -25.99 34.52 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 103.302 -2.851 . . . . 0.0 103.302 169.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.535 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -91.15 92.42 8.67 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 112.316 -2.22 . . . . 0.0 105.567 173.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -130.38 -109.83 1.34 Allowed Glycine 0 C--N 1.297 -1.621 0 N-CA-C 103.575 -3.81 . . . . 0.0 103.575 172.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -85.32 101.88 12.92 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 164.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.535 ' SD ' ' HA ' ' A' ' 18' ' ' GLN . 7.3 tpt -84.89 56.44 3.92 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.226 -166.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.15 88.7 5.99 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.392 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.432 ' CB ' HG21 ' A' ' 79' ' ' THR . 12.4 m0 -75.73 -172.05 1.77 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.029 177.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.488 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 10.5 mmpt? -84.93 -174.57 5.34 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.886 0.374 . . . . 0.0 110.229 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.406 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 5.4 m-20 -70.19 -38.38 75.34 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -176.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 74.2 m -123.78 145.28 49.15 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.717 -174.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.544 HD12 HG23 ' A' ' 79' ' ' THR . 9.8 tt -118.13 127.66 75.28 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 -176.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.405 HD12 ' C ' ' A' ' 27' ' ' ILE . 1.6 mp -117.14 114.54 46.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 121.915 0.864 . . . . 0.0 110.094 -175.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -91.69 124.84 36.14 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.793 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.462 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 63.9 ttt180 -96.51 110.38 22.78 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.655 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 83.1 m-85 -95.67 110.2 22.35 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.473 ' HE2' ' OD2' ' A' ' 70' ' ' ASP . 5.7 tmtt? -99.6 119.19 37.68 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 61.77 30.33 18.31 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 124.069 0.948 . . . . 0.0 112.1 -176.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.3 -12.67 66.48 Favored Glycine 0 N--CA 1.429 -1.778 0 CA-C-N 115.421 -0.809 . . . . 0.0 114.434 176.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -123.27 149.68 44.47 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-N 118.939 1.369 . . . . 0.0 108.738 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 9.0 p -68.37 115.59 6.94 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 CA-C-O 122.694 1.235 . . . . 0.0 112.782 -171.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -96.96 -55.56 2.83 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.918 -177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.462 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 16.3 m120 -120.12 153.37 36.27 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.477 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 mp -119.2 116.36 50.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -118.72 166.78 12.35 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 24' ' ' LYS . 4.0 t -146.84 139.86 25.32 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 173.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.2 161.2 38.21 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.165 -1.38 . . . . 0.0 107.771 -174.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.411 ' OD1' ' HB3' ' A' ' 24' ' ' LYS . 90.5 m-20 -87.02 160.99 18.43 Favored 'General case' 0 C--N 1.284 -2.281 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.632 176.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.422 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 3.5 ptt85 -58.68 119.43 7.08 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.956 171.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.1 m120 68.33 64.36 0.35 Allowed 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 125.57 1.548 . . . . 0.0 108.643 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -144.58 133.29 22.3 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 113.755 -1.566 . . . . 0.0 108.403 -177.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 36.4 tt0 -108.13 109.31 20.7 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.753 0.787 . . . . 0.0 109.766 -178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 32.0 pt -87.8 -178.91 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.214 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.8 m -136.4 135.63 38.9 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.9 mt -127.38 108.34 18.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 53.28 42.88 32.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.356 1.074 . . . . 0.0 112.201 177.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 72.72 8.91 5.6 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.766 2.026 . . . . 0.0 113.865 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -100.12 115.77 30.57 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 174.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.63 144.51 33.72 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.702 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 68.2 t -137.05 117.42 16.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.358 -174.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 64.3 t80 -92.06 123.04 35.12 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.023 0.44 . . . . 0.0 110.841 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 93.0 t -97.46 123.39 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 173.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -76.03 173.87 10.72 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 124.611 1.194 . . . . 0.0 108.822 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.422 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 1.3 pm0 -71.51 -20.73 62.01 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -173.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.5 19.92 11.46 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.559 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.7 m 61.69 79.63 0.25 Allowed 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 124.639 1.212 . . . . 0.0 113.103 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -162.62 128.56 2.29 Favored Pre-proline 0 C--N 1.314 -0.936 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.497 ' CG ' ' HB3' ' A' ' 74' ' ' LEU . 42.6 Cg_endo -88.54 149.93 6.32 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.248 2.632 . . . . 0.0 114.604 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -135.86 134.07 20.34 Favored Pre-proline 0 CA--C 1.498 -1.053 0 C-N-CA 125.167 1.387 . . . . 0.0 110.265 173.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.35 163.63 84.22 Favored 'Cis proline' 0 C--N 1.317 -1.093 0 C-N-CA 122.633 -1.82 . . . . 0.0 112.219 0.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.0 t -82.47 -40.88 17.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.553 -174.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 72' ' ' SER . 1.7 mp -104.16 127.68 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 CA-C-O 121.45 0.643 . . . . 0.0 110.034 172.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 48.0 mt -94.77 170.82 7.46 Favored Pre-proline 0 C--N 1.3 -1.561 0 CA-C-N 114.708 -1.133 . . . . 0.0 108.193 175.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -69.94 -12.5 32.67 Favored 'Trans proline' 0 N--CA 1.486 1.086 0 C-N-CA 122.669 2.246 . . . . 0.0 111.56 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.473 ' OD2' ' HE2' ' A' ' 32' ' ' LYS . 29.8 t70 -84.83 -0.22 53.18 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.778 -1.556 . . . . 0.0 108.646 177.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 22.4 tpt180 59.72 37.79 22.04 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.461 1.904 . . . . 0.0 109.118 -177.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 67' ' ' ILE . 21.5 m -85.92 127.57 34.64 Favored 'General case' 0 N--CA 1.409 -2.485 0 CA-C-N 113.438 -1.71 . . . . 0.0 106.54 172.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.655 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.3 t -90.99 116.66 32.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 C-N-CA 127.673 2.389 . . . . 0.0 106.748 177.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.497 ' HB3' ' CG ' ' A' ' 63' ' ' PRO . 6.6 mp -102.09 124.36 47.56 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 122.208 1.004 . . . . 0.0 113.44 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.5 m -117.93 129.11 55.42 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.679 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.416 ' HA2' ' O ' ' A' ' 27' ' ' ILE . . . -119.84 137.36 12.33 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.397 -178.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -141.8 172.46 12.65 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -77.82 138.41 38.94 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.544 HG23 HD12 ' A' ' 27' ' ' ILE . 3.4 m -66.78 -21.21 66.06 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -174.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.7 t -71.57 -40.22 70.1 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -174.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.28 9.07 2.26 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.258 1.028 . . . . 0.0 113.296 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -125.92 -79.11 0.6 Allowed 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.038 -1.437 . . . . 0.0 109.873 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.53 ' HB1' ' HB2' ' A' ' 86' ' ' ASP . . . -98.41 -65.71 0.95 Allowed 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.691 -174.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.0 t70 66.77 -62.34 0.3 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.807 2.043 . . . . 0.0 107.746 -169.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.48 ' HA ' ' HB3' ' A' ' 21' ' ' MET . 25.4 t70 -152.41 86.07 1.27 Allowed 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 104.211 -2.514 . . . . 0.0 104.211 175.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.53 ' HB2' ' HB1' ' A' ' 83' ' ' ALA . 5.2 t70 -84.73 173.36 10.75 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.041 -173.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -117.7 -179.52 3.76 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 122.764 0.425 . . . . 0.0 111.42 -172.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.6 m -79.05 126.22 30.41 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.656 ' OXT' ' HA2' ' A' ' 11' ' ' GLY . 15.2 m . . . . . 0 C--O 1.257 1.454 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -176.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.224 0 N-CA-C 109.451 -1.459 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.59 83.89 6.76 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 174.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -114.19 103.05 10.72 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 112.884 -1.962 . . . . 0.0 112.026 -169.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -99.59 159.03 15.34 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.23 163.1 27.38 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -80.99 75.49 7.96 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.455 1.121 . . . . 0.0 109.547 -175.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -75.25 89.53 2.56 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 113.396 -1.729 . . . . 0.0 107.104 179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.524 ' HA ' ' CE ' ' A' ' 21' ' ' MET . 53.5 tp60 -139.27 131.04 27.49 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 113.682 -1.599 . . . . 0.0 108.082 -174.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.06 30.8 13.25 Favored Glycine 0 N--CA 1.441 -1.021 0 C-N-CA 119.67 -1.252 . . . . 0.0 111.207 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 28.6 t60 176.33 105.48 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 104.396 -2.446 . . . . 0.0 104.396 176.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.524 ' CE ' ' HA ' ' A' ' 18' ' ' GLN . 2.1 mpt? -144.63 178.54 7.9 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -155.3 76.9 0.99 Allowed 'General case' 0 C--N 1.31 -1.118 0 O-C-N 124.217 0.948 . . . . 0.0 109.317 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.504 ' CE3' HG21 ' A' ' 41' ' ' THR . 17.7 m95 -78.46 175.58 10.18 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.777 178.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 41' ' ' THR . 95.6 mttt -90.34 -172.57 3.5 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.155 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -74.55 -36.04 63.1 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.841 0.829 . . . . 0.0 111.858 -172.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.0 m -122.1 143.31 49.61 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.222 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.499 HD12 HG23 ' A' ' 79' ' ' THR . 4.0 tt -115.79 133.05 63.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.0 mm -122.93 119.33 57.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.4 ' HG2' ' CD1' ' A' ' 39' ' ' ILE . 95.4 mt-30 -95.53 127.57 41.68 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -99.25 111.28 23.69 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.619 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 31.5 m-85 -95.83 113.65 25.3 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.486 0.66 . . . . 0.0 109.228 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.34 118.61 36.78 Favored 'General case' 0 N--CA 1.407 -2.61 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 -179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.258 45.2 m-20 61.33 30.83 19.26 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.01 -10.97 64.11 Favored Glycine 0 N--CA 1.434 -1.435 0 CA-C-N 115.21 -0.905 . . . . 0.0 115.054 174.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -122.52 151.91 40.87 Favored 'General case' 0 CA--C 1.48 -1.733 0 CA-C-N 118.381 1.09 . . . . 0.0 108.258 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 7.7 p -70.23 110.1 3.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-O 122.493 1.14 . . . . 0.0 109.82 -177.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -85.64 -58.64 2.58 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.518 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -119.91 161.25 21.18 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.938 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.4 ' CD1' ' HG2' ' A' ' 29' ' ' GLN . 7.5 tp -115.48 151.04 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 N-CA-C 103.372 -2.825 . . . . 0.0 103.372 171.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -147.06 166.11 27.86 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.504 HG21 ' CE3' ' A' ' 23' ' ' TRP . 2.1 t -151.99 142.74 22.88 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.13 149.73 44.83 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -75.71 156.97 34.19 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -57.13 121.51 10.21 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-O 121.206 0.526 . . . . 0.0 110.415 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.9 m120 70.32 63.1 0.22 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 112.957 -1.929 . . . . 0.0 108.677 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -141.83 131.68 24.35 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.54 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 33.8 tt0 -95.44 114.18 25.91 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.034 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 29.0 pt -96.65 -177.24 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.84 138.12 42.2 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 175.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 92.9 mt -129.61 106.96 14.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 50.73 49.37 21.09 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 70.86 1.61 3.83 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 125.042 1.337 . . . . 0.0 114.489 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -95.33 115.82 27.95 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 176.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.82 147.12 30.58 Favored 'General case' 0 N--CA 1.434 -1.239 0 C-N-CA 119.714 -0.794 . . . . 0.0 108.934 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 96.9 t -139.9 118.34 11.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.881 -174.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 80.4 t80 -93.21 119.41 32.36 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.0 t -98.36 120.87 48.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 176.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -73.24 168.51 18.99 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 124.647 1.217 . . . . 0.0 110.199 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -68.35 -8.02 36.4 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 125.771 1.628 . . . . 0.0 114.572 -176.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.89 14.7 27.69 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.8 m 63.84 71.25 0.49 Allowed 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 124.415 1.072 . . . . 0.0 111.455 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -151.05 124.66 4.33 Favored Pre-proline 0 N--CA 1.435 -1.219 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.479 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 88.7 Cg_endo -84.89 143.04 9.22 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.112 2.541 . . . . 0.0 114.964 -177.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 32.9 m-85 -129.63 127.4 22.95 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.038 170.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 73.5 Cg_endo -81.87 163.49 76.77 Favored 'Cis proline' 0 C--N 1.319 -1.007 0 C-N-CA 122.876 -1.718 . . . . 0.0 112.26 -0.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 74' ' ' LEU . 85.0 t -81.53 -39.83 17.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.708 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.04 128.07 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-O 121.574 0.702 . . . . 0.0 109.483 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.2 mt -88.0 172.07 8.45 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.757 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -73.99 -13.32 23.88 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.295 1.997 . . . . 0.0 109.703 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -84.82 -6.6 59.35 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.115 -2.311 . . . . 0.0 108.349 177.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.387 12.3 ttm180 52.61 55.92 8.38 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 124.631 2.158 . . . . 0.0 112.224 -176.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.9 m -101.95 135.23 43.87 Favored 'General case' 0 N--CA 1.398 -3.048 0 CA-C-N 111.098 -2.774 . . . . 0.0 104.961 170.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.619 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -91.3 117.03 33.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 O-C-N 126.105 2.128 . . . . 0.0 108.395 -176.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.445 ' O ' HG13 ' A' ' 66' ' ' VAL . 5.6 mp -101.49 134.46 44.57 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 122.016 0.912 . . . . 0.0 111.703 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.8 m -120.77 137.12 54.68 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.834 175.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.479 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -129.01 133.67 7.68 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 119.659 -1.258 . . . . 0.0 113.021 -175.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -146.82 171.83 14.59 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 174.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -71.91 139.37 48.74 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.499 HG23 HD12 ' A' ' 27' ' ' ILE . 3.2 m -67.2 -18.04 65.08 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 123.093 0.557 . . . . 0.0 111.624 -176.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.6 p -69.21 -23.85 63.95 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.362 0.601 . . . . 0.0 111.719 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.6 20.61 15.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.752 0.786 . . . . 0.0 110.824 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -152.81 -161.33 1.27 Allowed 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 125.713 1.605 . . . . 0.0 108.816 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 70.69 136.93 0.04 OUTLIER 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 117.219 2.304 . . . . 0.0 117.219 168.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.4 86.18 1.51 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 111.881 -2.418 . . . . 0.0 105.777 165.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -127.79 155.19 44.47 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 174.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -81.24 89.4 6.04 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.77 0.795 . . . . 0.0 112.09 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -90.4 140.65 29.51 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 114.765 -1.107 . . . . 0.0 108.673 176.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.4 p -120.42 162.45 19.49 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.9 p . . . . . 0 C--N 1.304 -1.401 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.705 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.973 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 63.17 75.29 0.4 Allowed 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 123.054 1.407 . . . . 0.0 109.805 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -161.39 104.8 1.27 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 112.591 -2.095 . . . . 0.0 107.367 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -118.29 166.78 12.22 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.3 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -85.52 164.78 17.6 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -77.37 81.92 3.84 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.984 -0.686 . . . . 0.0 111.826 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 49.16 64.95 1.52 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 125.734 1.613 . . . . 0.0 111.746 175.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -76.58 101.7 5.8 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 113.952 -1.477 . . . . 0.0 109.131 -178.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -76.4 93.89 1.02 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.254 47.7 m80 67.27 154.54 0.09 Allowed 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 125.067 1.347 . . . . 0.0 114.619 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.41 107.18 8.49 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 113.682 -1.599 . . . . 0.0 110.63 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -105.4 91.62 3.85 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.454 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.5 m95 -112.33 -177.97 3.29 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.717 -174.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 42' ' ' ALA . 50.7 mttm -88.95 -172.38 3.67 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.904 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.42 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 2.8 m-20 -74.76 -34.34 62.48 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -174.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.5 m -121.49 140.87 51.63 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.942 -175.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.588 HD12 HG23 ' A' ' 79' ' ' THR . 9.7 tt -112.85 128.54 69.51 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -177.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.0 mm -113.39 120.57 63.64 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.427 ' HA ' HD12 ' A' ' 39' ' ' ILE . 43.5 mt-30 -100.77 116.68 33.23 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 114.236 -1.347 . . . . 0.0 107.678 -172.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 32.2 ttt180 -96.44 109.47 22.01 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.692 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 69.2 m-85 -96.14 144.19 26.6 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 37' ' ' ASN . 22.9 tptp -156.22 117.26 3.8 Favored 'General case' 0 N--CA 1.406 -2.653 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -178.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 62.44 37.84 13.23 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 125.739 1.615 . . . . 0.0 115.06 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.28 -9.01 64.95 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.342 -0.845 . . . . 0.0 115.208 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -134.87 160.81 37.05 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.899 -0.765 . . . . 0.0 108.996 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 9.6 p -75.87 110.72 11.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 13.9 t-20 -83.8 -45.18 13.58 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.308 -175.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -130.69 153.27 49.15 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.206 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 29' ' ' GLN . 7.8 tp -116.32 153.86 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.029 0 N-CA-C 103.936 -2.616 . . . . 0.0 103.936 173.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -148.63 168.11 23.68 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 104.056 -2.572 . . . . 0.0 104.056 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.454 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.7 t -150.48 145.57 26.09 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 24' ' ' LYS . . . -141.92 155.97 45.5 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -175.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -79.94 161.65 25.38 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.566 173.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.42 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 8.2 ptt180 -59.12 116.21 3.69 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.744 170.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 75.07 50.07 0.08 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.056 1.743 . . . . 0.0 110.728 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -130.57 134.56 47.11 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.526 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 44.1 tt0 -102.7 109.22 20.74 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.7 pt -90.64 -177.65 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.2 m -135.52 129.1 32.54 Favored 'General case' 0 N--CA 1.401 -2.897 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 173.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.411 HD12 HD21 ' A' ' 74' ' ' LEU . 67.5 mt -118.72 105.07 16.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 60.21 36.69 20.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.93 0.871 . . . . 0.0 111.605 172.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 69.88 17.07 7.64 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.159 1.783 . . . . 0.0 113.221 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -106.49 111.36 23.89 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.44 141.59 41.32 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.448 -177.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 88.0 t -135.42 114.5 16.51 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.738 -173.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 64.4 t80 -90.08 118.72 29.84 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.3 t -101.3 116.91 45.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -73.95 166.09 23.98 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.098 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 17.1 pt-20 -56.04 -21.4 21.41 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 126.861 2.064 . . . . 0.0 113.454 -175.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.22 11.06 26.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.841 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.8 m 59.37 66.08 1.08 Allowed 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 122.264 1.03 . . . . 0.0 111.763 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.442 ' CD2' ' HD2' ' A' ' 63' ' ' PRO . 9.7 t-80 -149.79 124.91 4.83 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 175.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.442 ' HD2' ' CD2' ' A' ' 62' ' ' HIS . 64.6 Cg_endo -82.59 152.32 15.25 Favored 'Trans proline' 0 C--N 1.328 -0.517 0 C-N-CA 123.463 2.775 . . . . 0.0 114.972 -175.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -134.87 137.11 26.53 Favored Pre-proline 0 CA--C 1.493 -1.231 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.32 171.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -78.93 168.29 75.09 Favored 'Cis proline' 0 C--N 1.314 -1.287 0 C-N-CA 122.671 -1.804 . . . . 0.0 111.442 -3.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 74' ' ' LEU . 64.4 t -86.5 -30.7 6.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.993 -173.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 67' ' ' ILE . 18.5 mm -107.44 129.28 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 CA-C-O 121.972 0.891 . . . . 0.0 110.625 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.1 mt -88.32 165.74 27.02 Favored Pre-proline 0 C--N 1.305 -1.331 0 CA-C-N 114.383 -1.28 . . . . 0.0 108.907 177.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -72.5 -4.57 15.53 Favored 'Trans proline' 0 N--CA 1.484 0.939 0 C-N-CA 122.77 2.313 . . . . 0.0 111.839 -175.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -95.78 -1.96 48.67 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.309 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 71.7 13.64 6.21 Favored 'General case' 0 C--N 1.351 0.669 0 C-N-CA 126.514 1.926 . . . . 0.0 110.045 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.81 137.05 53.65 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 175.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.692 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 3.1 t -90.69 117.97 35.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 125.859 1.663 . . . . 0.0 109.044 -175.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.411 HD21 HD12 ' A' ' 50' ' ' ILE . 6.1 mp -97.29 139.43 33.26 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.06 173.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.6 m -138.93 154.07 48.3 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -139.2 146.08 17.57 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 118.829 -1.653 . . . . 0.0 111.852 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -141.76 171.78 13.59 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -80.98 134.86 35.77 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.588 HG23 HD12 ' A' ' 27' ' ' ILE . 1.7 m -70.83 -13.99 62.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.419 0.628 . . . . 0.0 110.556 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 p -66.29 -21.96 66.28 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.128 0.971 . . . . 0.0 111.449 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -106.48 13.69 28.13 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 122.285 1.041 . . . . 0.0 110.367 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -138.26 -166.74 2.04 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.363 -174.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 68.27 101.92 0.05 Allowed 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 126.557 1.943 . . . . 0.0 113.755 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -148.32 69.94 1.12 Allowed 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 101.961 -3.348 . . . . 0.0 101.961 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -150.33 169.56 21.1 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.758 -1.565 . . . . 0.0 108.766 -174.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -94.31 6.63 48.09 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 123.012 1.387 . . . . 0.0 112.072 -174.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -101.28 174.33 6.04 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 114.41 -1.268 . . . . 0.0 112.093 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.7 m -161.69 168.59 23.06 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 105.646 -1.983 . . . . 0.0 105.646 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 83.0 m . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 118.83 0.741 . . . . 0.0 109.406 -179.666 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.259 0 N-CA-C 108.472 -1.851 . . . . 0.0 108.472 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -123.44 122.23 37.74 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 75.11 84.35 0.1 Allowed 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 125.956 1.702 . . . . 0.0 109.152 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -137.88 154.99 49.41 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.463 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 3.1 mm? -107.78 177.69 4.75 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -77.08 79.46 3.61 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.459 0.647 . . . . 0.0 109.322 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.463 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 80.1 m-85 -99.42 -66.35 0.91 Allowed 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 175.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -97.83 73.57 2.3 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.76 0.05 12.07 Favored Glycine 0 N--CA 1.435 -1.41 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -83.39 129.54 35.0 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -177.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -81.3 76.28 8.24 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.935 1.35 . . . . 0.0 111.464 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.42 75.71 0.93 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 113.615 -1.63 . . . . 0.0 107.114 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.518 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.0 m0 -106.82 -167.38 1.27 Allowed 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.628 -1.624 . . . . 0.0 108.592 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -86.77 -170.6 3.14 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.165 0.507 . . . . 0.0 109.994 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.45 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 1.1 m-20 -78.57 -25.92 45.44 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.7 m -131.32 152.75 50.28 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.535 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.411 ' HB ' HG23 ' A' ' 79' ' ' THR . 11.9 tt -125.08 133.86 68.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.4 mm -120.24 112.3 35.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -173.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.9 mm100 -96.62 117.76 31.66 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 -176.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.411 ' HG3' HD11 ' A' ' 74' ' ' LEU . 8.7 ttp180 -91.62 110.38 21.7 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.687 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 14.5 m-85 -96.18 144.44 26.4 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -134.56 112.07 10.57 Favored 'General case' 0 N--CA 1.401 -2.907 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.284 72.9 m-20 50.6 52.56 14.62 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.05 2.53 88.2 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 115.926 1.13 . . . . 0.0 115.926 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -131.79 154.71 48.82 Favored 'General case' 0 CA--C 1.485 -1.527 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.0 p -78.56 131.92 33.43 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -178.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -109.9 -60.09 1.84 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.043 -1.036 . . . . 0.0 111.784 -173.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -127.96 159.94 33.4 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.3 mp -123.01 130.57 74.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 C-N-CA 124.106 0.962 . . . . 0.0 109.264 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -134.34 168.74 18.35 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.518 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.7 t -150.03 142.36 24.23 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.48 -0.934 . . . . 0.0 108.48 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.2 157.91 44.33 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.872 -172.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -81.36 160.21 24.18 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 176.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.45 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 6.8 ptt85 -67.92 108.92 3.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.444 0.64 . . . . 0.0 111.73 175.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.531 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 42.3 m-80 83.7 57.07 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.136 2.575 . . . . 0.0 110.087 -175.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -133.76 129.72 37.04 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.708 -1.133 . . . . 0.0 109.106 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.482 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 45.1 tt0 -99.18 108.87 21.57 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 pt -94.12 -176.62 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.446 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 6.1 m -133.72 136.28 44.55 Favored 'General case' 0 N--CA 1.413 -2.308 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 175.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.436 HD12 HG21 ' A' ' 55' ' ' VAL . 95.0 mt -132.07 106.65 11.56 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 58.05 36.4 25.99 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 122.432 1.111 . . . . 0.0 111.256 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 70.5 16.01 7.1 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 112.687 -2.051 . . . . 0.0 113.994 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -103.64 118.18 36.12 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 172.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -82.14 144.62 30.62 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 118.385 -1.326 . . . . 0.0 108.666 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.482 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 88.9 t -135.19 122.35 35.92 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.609 -173.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 93.9 t80 -93.34 118.16 30.95 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.7 t -96.8 114.02 32.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 -73.97 173.28 10.21 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.531 ' HB3' ' ND2' ' A' ' 45' ' ' ASN 0.262 10.3 pt-20 -74.38 0.67 13.74 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -173.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.17 12.24 37.95 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 85.6 m 69.18 33.06 3.44 Favored 'General case' 0 CA--C 1.493 -1.231 0 CA-C-N 114.326 -1.306 . . . . 0.0 111.545 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.7 t-160 -111.65 117.39 48.88 Favored Pre-proline 0 C--N 1.291 -1.946 0 CA-C-N 113.45 -1.704 . . . . 0.0 108.398 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.587 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 40.8 Cg_endo -88.86 144.69 5.32 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.983 3.122 . . . . 0.0 114.861 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -130.06 134.76 26.51 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.044 173.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -74.87 157.15 99.77 Favored 'Cis proline' 0 CA--C 1.529 0.246 0 C-N-CA 123.045 -1.648 . . . . 0.0 113.307 0.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 61.9 t -82.1 -37.37 14.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.449 HG23 ' HA ' ' A' ' 71' ' ' ARG . 17.6 mm -103.18 118.61 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-O 122.008 0.909 . . . . 0.0 108.704 172.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.7 mt -82.36 170.32 15.21 Favored Pre-proline 0 C--N 1.293 -1.867 0 CA-C-N 113.347 -1.751 . . . . 0.0 109.162 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -69.25 -13.06 35.31 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.437 2.092 . . . . 0.0 111.944 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -92.28 1.38 57.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 122.136 0.97 . . . . 0.0 108.42 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.449 ' HA ' HG23 ' A' ' 67' ' ' ILE . 16.6 ttm180 63.7 29.77 14.89 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 124.288 1.995 . . . . 0.0 109.954 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.1 m -75.07 136.42 41.17 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-N 112.457 -2.156 . . . . 0.0 106.309 173.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.687 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 6.3 t -91.53 119.11 38.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 C-N-CA 125.352 1.461 . . . . 0.0 108.614 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.411 HD11 ' HG3' ' A' ' 30' ' ' ARG . 5.2 mp -99.72 122.84 43.32 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 122.052 0.929 . . . . 0.0 111.427 175.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.8 m -111.2 123.83 50.98 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 177.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.587 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -115.38 124.18 6.21 Favored Glycine 0 N--CA 1.419 -2.443 0 C-N-CA 119.865 -1.16 . . . . 0.0 112.192 -175.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -139.07 172.89 12.17 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -81.65 137.0 35.5 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 176.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.411 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.2 OUTLIER -62.01 -21.52 64.95 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 124.24 1.016 . . . . 0.0 112.18 -176.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.8 p -64.84 -31.75 73.13 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.247 1.019 . . . . 0.0 110.881 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.42 16.69 23.71 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.649 0.738 . . . . 0.0 110.765 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -139.86 -165.19 1.84 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.819 -175.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 70.85 -65.07 0.35 Allowed 'General case' 0 C--N 1.347 0.468 0 C-N-CA 127.038 2.135 . . . . 0.0 111.101 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -70.47 -30.85 67.77 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -122.17 81.02 1.78 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 113.458 -1.701 . . . . 0.0 107.743 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -135.44 168.24 19.58 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.783 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -76.72 -23.13 53.09 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 124.163 0.985 . . . . 0.0 112.884 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.2 m -64.67 116.46 6.26 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 60.6 m . . . . . 0 N--CA 1.426 -1.641 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.212 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.915 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -134.79 -73.68 0.47 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.993 0.896 . . . . 0.0 112.318 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -88.83 -48.23 7.63 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 116.866 2.173 . . . . 0.0 116.866 -165.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.49 ' OD1' ' HB2' ' A' ' 17' ' ' PHE . 34.5 t-20 -109.25 -43.75 4.08 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 118.591 -1.243 . . . . 0.0 111.711 -170.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.6 mp 67.91 -167.41 0.2 Allowed 'General case' 0 C--O 1.247 0.97 0 CA-C-N 115.367 -0.833 . . . . 0.0 108.851 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -76.16 96.77 3.95 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 118.08 -1.448 . . . . 0.0 107.45 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.49 ' HB2' ' OD1' ' A' ' 14' ' ' ASN . 80.8 t80 -69.27 106.38 2.86 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.625 174.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -95.5 131.91 41.17 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -156.3 -175.0 26.77 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -68.42 122.16 17.83 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 50.1 ttm -84.82 125.3 32.47 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.467 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.98 89.2 2.46 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.169 175.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.479 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.0 m0 -101.91 -162.67 0.95 Allowed 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.438 ' HD2' ' CG ' ' A' ' 43' ' ' ASN . 34.6 mmtp -89.23 -178.62 5.69 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.445 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 1.1 m-20 -71.12 -34.24 70.88 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.573 -175.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 61.8 m -121.07 143.14 49.23 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.063 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.578 HD12 HG23 ' A' ' 79' ' ' THR . 6.1 tt -113.69 133.32 60.02 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -177.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.8 mm -121.43 115.31 46.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -173.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -95.17 127.5 41.27 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -98.24 110.83 23.35 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.626 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 7.4 m-85 -94.86 110.76 22.6 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.401 ' C ' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -95.63 110.28 22.41 Favored 'General case' 0 N--CA 1.411 -2.377 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 -177.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.381 3.7 m-20 50.93 49.18 21.66 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 113.099 -1.864 . . . . 0.0 115.909 -172.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.3 -13.18 64.8 Favored Glycine 0 N--CA 1.435 -1.423 0 N-CA-C 116.474 1.35 . . . . 0.0 116.474 173.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -125.77 147.0 49.53 Favored 'General case' 0 CA--C 1.483 -1.624 0 CA-C-N 119.675 1.737 . . . . 0.0 108.959 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.61 110.89 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 O-C-N 124.51 1.131 . . . . 0.0 111.424 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -97.55 -52.71 3.68 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.354 -175.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -121.74 161.76 22.02 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.718 -177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 39' ' ' ILE . 13.7 mm -124.9 128.49 73.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 124.496 1.118 . . . . 0.0 109.118 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -135.14 169.51 17.34 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.479 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.8 t -153.68 144.01 22.3 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 177.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.8 152.61 40.59 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -175.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.438 ' CG ' ' HD2' ' A' ' 24' ' ' LYS . 61.2 m-20 -74.16 164.11 27.02 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.592 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.445 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 3.4 ptt180 -62.88 116.56 5.38 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 171.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 74.4 50.08 0.1 Allowed 'General case' 0 C--O 1.242 0.695 0 C-N-CA 126.237 1.815 . . . . 0.0 110.744 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -128.59 131.34 48.15 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.671 -175.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 44.2 tt0 -101.98 114.62 28.9 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 115.179 -0.919 . . . . 0.0 109.53 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 pt -98.94 -176.75 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 124.25 1.02 . . . . 0.0 108.49 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.47 131.2 43.32 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.475 HD12 HG21 ' A' ' 55' ' ' VAL . 97.5 mt -127.62 106.52 15.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 54.19 43.02 31.23 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.958 0.885 . . . . 0.0 112.001 175.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 75.53 -1.51 3.0 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 127.14 2.176 . . . . 0.0 115.116 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -95.16 118.22 31.57 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 177.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.26 141.57 32.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 118.173 -1.411 . . . . 0.0 108.74 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 92.5 t -133.29 122.41 44.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.406 -173.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -96.54 121.47 38.39 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.336 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.8 t -100.23 118.78 47.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -68.07 163.7 21.83 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.979 1.712 . . . . 0.0 108.465 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.402 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 1.4 pm0 -66.15 -17.68 64.87 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -171.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.02 14.37 22.06 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.233 179.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 60.6 m 65.83 76.82 0.31 Allowed 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 124.64 1.213 . . . . 0.0 112.281 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 -157.18 120.54 2.21 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 175.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.485 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 73.7 Cg_endo -82.54 143.9 12.41 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 C-N-CA 123.391 2.727 . . . . 0.0 114.399 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -130.51 131.16 23.17 Favored Pre-proline 0 CA--C 1.489 -1.391 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.654 172.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -72.08 162.12 90.49 Favored 'Cis proline' 0 C--N 1.313 -1.301 0 C-N-CA 124.416 -1.077 . . . . 0.0 114.225 -1.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 74' ' ' LEU . 65.6 t -89.34 -42.68 14.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.075 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mp -99.22 129.49 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.476 0.655 . . . . 0.0 109.533 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.4 ' HB3' ' CD ' ' A' ' 69' ' ' PRO . 51.0 mt -97.56 171.12 6.28 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.032 177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.4 ' CD ' ' HB3' ' A' ' 68' ' ' LEU . 31.0 Cg_exo -67.09 -13.78 41.04 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.986 2.457 . . . . 0.0 112.362 -176.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -85.35 -12.28 52.59 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.036 -1.438 . . . . 0.0 110.1 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 71' ' ' ARG . 16.2 tpt180 72.32 31.9 1.76 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-O 123.886 1.803 . . . . 0.0 107.261 -171.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 m -74.27 127.27 32.55 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 172.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.626 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -92.46 115.81 32.2 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 125.492 1.517 . . . . 0.0 108.062 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.446 ' HB3' ' CG ' ' A' ' 63' ' ' PRO . 5.8 mp -97.48 129.07 44.7 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 122.326 1.06 . . . . 0.0 111.805 177.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.1 m -121.9 137.38 54.81 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.485 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -131.72 150.38 19.52 Favored Glycine 0 CA--C 1.474 -2.52 0 C-N-CA 119.331 -1.414 . . . . 0.0 109.672 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.511 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 11.1 t0 -163.4 173.91 12.61 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 174.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -69.95 134.94 48.9 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 118.853 0.751 . . . . 0.0 109.718 -178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.578 HG23 HD12 ' A' ' 27' ' ' ILE . 3.2 m -65.27 -28.19 69.16 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-O 121.756 0.789 . . . . 0.0 110.857 -177.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 85' ' ' ASP . 3.2 p -67.66 -29.47 68.77 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 114.449 -1.25 . . . . 0.0 111.679 -176.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.93 11.9 34.26 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 122.438 1.113 . . . . 0.0 111.199 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.511 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 6.5 m-85 -118.9 -83.15 0.65 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.465 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.87 1.54 52.16 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 121.939 0.876 . . . . 0.0 111.91 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.9 t70 69.09 39.14 1.8 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 113.363 -1.744 . . . . 0.0 108.986 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 80' ' ' SER . 13.7 t70 -58.76 116.41 3.72 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 166.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -90.9 78.09 6.08 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 116.801 -1.96 . . . . 0.0 114.207 -169.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -101.66 82.73 2.32 Favored 'General case' 0 N--CA 1.413 -2.289 0 C-N-CA 117.566 -1.653 . . . . 0.0 107.38 166.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.5 p -86.61 100.04 12.14 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 173.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 2.0 p . . . . . 0 C--N 1.309 -1.17 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.189 -176.882 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.8 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.453 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 10.6 ptm85 -162.6 178.27 8.69 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 176.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.93 147.31 25.7 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 122.055 0.931 . . . . 0.0 111.073 176.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -161.3 -50.38 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -112.22 157.83 20.42 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 167.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -93.83 79.01 4.18 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.096 -175.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 55.65 81.84 0.11 Allowed 'General case' 0 C--O 1.239 0.511 0 O-C-N 124.853 1.345 . . . . 0.0 110.076 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -131.87 149.16 52.53 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -174.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.27 -54.94 11.24 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.43 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -89.11 141.89 28.11 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 19.4 ptp -134.3 151.24 51.15 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -166.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.32 99.82 8.08 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.043 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.523 ' CE3' HG21 ' A' ' 41' ' ' THR . 18.6 m95 -110.65 167.6 10.1 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' HD2' ' CG ' ' A' ' 43' ' ' ASN . 34.8 mmtp -77.96 -171.94 2.5 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.436 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 1.2 t70 -80.74 -31.38 36.0 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 122.205 1.002 . . . . 0.0 110.856 -172.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.4 m -120.44 146.63 46.03 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.239 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.572 HD12 HG23 ' A' ' 79' ' ' THR . 11.4 tt -118.01 133.46 64.75 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -178.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 75' ' ' SER . 28.3 mm -124.94 113.25 35.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -173.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.505 ' HB2' ' OG ' ' A' ' 75' ' ' SER . 82.2 mt-30 -96.01 133.22 40.5 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.723 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.475 HH11 ' ND2' ' A' ' 38' ' ' ASN . 27.3 ttt180 -98.87 110.97 23.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.638 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 59.8 m-85 -95.63 141.21 29.4 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.4 tmtm? -135.84 116.54 13.97 Favored 'General case' 0 N--CA 1.402 -2.838 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.6 t0 60.21 52.27 5.08 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.683 1.23 . . . . 0.0 113.042 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.57 -4.54 42.55 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 113.716 -1.584 . . . . 0.0 116.181 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -127.05 154.93 44.04 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 8.4 p -75.95 116.89 19.6 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 CA-C-O 122.295 1.045 . . . . 0.0 110.142 -176.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -93.0 -60.68 1.74 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.615 -174.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.475 ' ND2' HH11 ' A' ' 30' ' ' ARG . 97.6 m-20 -122.27 161.72 22.78 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.779 -176.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.453 ' O ' ' HD2' ' A' ' 12' ' ' ARG . 24.8 mm -121.17 137.32 55.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.889 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -142.2 164.52 29.93 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.523 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.6 t -152.66 144.49 23.62 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.24 150.14 45.15 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 123.506 0.504 . . . . 0.0 110.98 -173.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.405 ' CG ' ' HD2' ' A' ' 24' ' ' LYS . 48.1 m-20 -75.12 156.0 36.47 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 175.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.514 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 6.8 ptt180 -60.61 109.82 1.13 Allowed 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 171.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 88.1 m-20 78.65 62.48 0.03 OUTLIER 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.254 1.822 . . . . 0.0 110.37 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -138.9 134.93 33.89 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.987 -178.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 2.6 mp0 -91.84 118.95 31.19 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 172.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 40.7 pt -98.37 174.08 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.324 0 N-CA-C 105.609 -1.996 . . . . 0.0 105.609 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 1.3 m -136.3 117.88 14.88 Favored 'General case' 0 N--CA 1.404 -2.755 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 176.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.434 HD12 HD21 ' A' ' 74' ' ' LEU . 73.1 mt -108.17 102.04 13.41 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.662 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 58.81 40.27 23.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.387 0.613 . . . . 0.0 112.483 170.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 73.27 9.6 5.18 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.246 1.818 . . . . 0.0 113.803 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -104.42 106.19 16.6 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 104.259 -2.497 . . . . 0.0 104.259 173.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -82.05 141.36 33.26 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.534 -178.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 93.0 t -132.79 119.46 37.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.518 -171.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 63.6 t80 -93.13 121.72 34.78 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.9 t -102.99 125.11 57.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 174.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -74.58 176.76 6.59 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 124.555 1.16 . . . . 0.0 108.657 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.514 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 9.8 pt-20 -65.44 -20.15 66.24 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.9 106.57 17.12 Favored 'General case' 0 N--CA 1.413 -2.318 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 170.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.4 m -40.42 89.45 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 127.578 2.351 . . . . 0.0 115.344 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -159.72 126.04 2.45 Favored Pre-proline 0 N--CA 1.438 -1.026 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 177.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.61 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 56.1 Cg_endo -85.76 146.68 9.34 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.888 2.392 . . . . 0.0 114.333 -175.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 54.9 m-85 -131.02 126.23 21.54 Favored Pre-proline 0 C--N 1.306 -1.324 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.513 172.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 72.5 Cg_endo -81.95 164.11 75.47 Favored 'Cis proline' 0 C--N 1.323 -0.808 0 C-N-CA 122.742 -1.774 . . . . 0.0 113.173 -0.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 74' ' ' LEU . 92.6 t -82.59 -43.72 19.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.305 -178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 67' ' ' ILE . 4.7 mm -91.89 124.48 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 172.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.2 mt -89.27 168.38 15.43 Favored Pre-proline 0 C--N 1.303 -1.445 0 CA-C-N 114.706 -1.133 . . . . 0.0 109.449 177.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -73.95 -1.17 10.47 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 123.198 2.598 . . . . 0.0 111.703 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -95.77 -9.06 32.69 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.186 -1.824 . . . . 0.0 109.073 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 60.25 57.22 2.99 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 123.572 1.653 . . . . 0.0 108.2 -169.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 m -102.57 135.05 44.91 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 173.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.638 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.6 t -91.61 115.61 31.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 O-C-N 125.496 1.748 . . . . 0.0 107.783 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.434 HD21 HD12 ' A' ' 50' ' ' ILE . 4.7 mp -101.04 135.82 41.87 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.426 -0.796 . . . . 0.0 111.758 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.505 ' OG ' ' HB2' ' A' ' 29' ' ' GLN . 81.1 p -117.36 142.76 46.71 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.61 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -128.68 132.99 7.46 Favored Glycine 0 CA--C 1.479 -2.173 0 C-N-CA 119.64 -1.267 . . . . 0.0 110.345 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -150.69 172.54 15.4 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -75.56 135.05 40.58 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.572 HG23 HD12 ' A' ' 27' ' ' ILE . 2.8 m -59.93 -19.91 54.45 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -175.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.8 p -66.94 -40.05 87.48 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.594 1.158 . . . . 0.0 110.947 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -83.24 11.29 6.78 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 122.397 1.094 . . . . 0.0 112.009 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -130.09 -72.25 0.58 Allowed 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.321 -1.309 . . . . 0.0 111.561 -178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -105.22 -60.8 1.56 Allowed 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.036 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.5 t70 66.53 -66.5 0.18 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.347 1.459 . . . . 0.0 110.618 -174.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -169.24 78.11 0.11 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 102.606 -3.109 . . . . 0.0 102.606 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -73.75 104.44 4.66 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 114.178 -1.374 . . . . 0.0 113.472 -171.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -86.16 -8.99 57.43 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.348 -1.297 . . . . 0.0 109.18 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.7 m 60.35 -174.24 0.12 Allowed 'General case' 0 C--O 1.242 0.667 0 C-N-CA 125.014 1.326 . . . . 0.0 112.386 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.432 -1.331 0 N-CA-C 105.261 -2.125 . . . . 0.0 105.261 175.183 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.813 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.454 ' H ' ' HD3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -101.14 -47.93 4.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.468 1.134 . . . . 0.0 110.573 177.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 54.79 -76.81 0.01 OUTLIER 'General case' 0 C--O 1.241 0.629 0 C-N-CA 126.39 1.876 . . . . 0.0 115.5 176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -112.02 162.29 15.53 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 122.902 1.334 . . . . 0.0 114.171 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.7 tp -152.53 174.97 13.26 Favored 'General case' 0 C--N 1.293 -1.863 1 N-CA-C 99.236 -4.357 . . . . 0.0 99.236 177.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -82.64 85.26 7.04 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 116.902 -1.919 . . . . 0.0 110.866 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -79.69 113.19 17.66 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 172.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -78.79 82.71 4.99 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 122.63 1.205 . . . . 0.0 112.297 -173.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -108.12 14.6 36.92 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 114.254 -1.339 . . . . 0.0 112.435 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 86.1 t60 70.24 147.13 0.07 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.539 1.136 . . . . 0.0 111.806 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.473 ' HG2' ' HB1' ' A' ' 83' ' ' ALA . 1.1 mpt? -81.38 77.51 8.25 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 113.237 0.828 . . . . 0.0 113.237 177.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.33 73.44 1.12 Allowed 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 171.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.488 ' CE3' HG21 ' A' ' 41' ' ' THR . 11.2 m95 -100.18 -176.82 3.34 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 113.21 -1.814 . . . . 0.0 108.422 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -84.59 -172.2 4.04 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.956 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -78.47 -27.39 46.29 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.956 0.884 . . . . 0.0 112.571 -171.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.8 m -124.29 148.54 47.34 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.611 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.586 HD12 HG23 ' A' ' 79' ' ' THR . 13.9 tt -120.79 133.62 66.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 27' ' ' ILE . 31.8 mm -128.75 112.29 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -173.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' A' ' 75' ' ' SER . 27.5 mt-30 -97.45 131.67 43.88 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.589 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 46.3 ttt180 -97.13 114.17 25.82 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.642 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 21.3 m-85 -95.78 109.26 21.59 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -96.99 115.7 27.9 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -175.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 59.69 30.6 20.21 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.53 -1.213 . . . . 0.0 112.879 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.75 -11.13 64.6 Favored Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 115.434 -0.803 . . . . 0.0 114.949 176.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -121.76 152.06 39.88 Favored 'General case' 0 CA--C 1.486 -1.502 0 CA-C-N 118.843 1.322 . . . . 0.0 108.674 178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 9.5 p -73.61 120.54 22.76 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-O 121.656 0.741 . . . . 0.0 112.227 -172.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -108.68 -50.79 2.97 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.663 0.744 . . . . 0.0 110.483 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.589 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 8.2 m120 -119.22 151.87 37.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.914 -173.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.0 mp -120.06 122.59 68.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -126.18 167.32 15.58 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.488 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.4 t -153.45 142.31 21.12 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.73 154.19 43.22 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 124.232 0.958 . . . . 0.0 108.914 -174.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -75.71 161.71 28.84 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 121.021 0.438 . . . . 0.0 111.045 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -66.14 116.79 7.6 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-O 121.454 0.645 . . . . 0.0 110.303 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.587 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 38.8 m-80 72.95 64.79 0.1 Allowed 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 126.826 2.05 . . . . 0.0 109.161 -172.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -142.23 131.16 23.02 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 33.9 tt0 -98.19 113.66 25.65 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.443 177.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.8 pt -94.3 -176.2 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.2 m -135.97 136.69 40.58 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 87.3 mt -127.64 108.49 18.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 -179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 54.46 40.49 31.84 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.781 0.801 . . . . 0.0 111.695 177.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.257 36.0 mm-40 70.23 12.91 7.68 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 126.03 1.732 . . . . 0.0 115.068 -178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -103.37 122.2 44.35 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 172.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -85.77 142.08 29.22 Favored 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 118.591 -1.243 . . . . 0.0 109.853 -178.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 86.1 t -133.29 124.62 49.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.571 -175.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 62.8 t80 -96.08 119.02 33.83 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 61.0 t -94.97 120.14 43.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -77.16 174.54 10.59 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.587 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 9.7 pt-20 -75.63 -6.27 49.56 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -172.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.66 11.18 36.3 Favored 'General case' 0 C--N 1.313 -0.998 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.816 174.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 80.3 m 66.2 55.26 0.89 Allowed 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.377 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -136.74 122.59 13.35 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 176.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.463 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 98.2 Cg_endo -81.71 146.51 14.98 Favored 'Trans proline' 0 C--N 1.328 -0.512 0 C-N-CA 123.436 2.757 . . . . 0.0 114.098 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -129.84 134.84 26.64 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.651 172.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -81.87 161.35 79.03 Favored 'Cis proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.158 -2.017 . . . . 0.0 111.495 -2.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 53.4 t -79.15 -29.78 13.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.274 -176.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 67' ' ' ILE . 8.3 mm -103.96 121.83 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-O 121.773 0.797 . . . . 0.0 110.265 173.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.3 mt -85.75 165.57 34.32 Favored Pre-proline 0 C--N 1.3 -1.58 0 CA-C-N 113.899 -1.501 . . . . 0.0 109.135 177.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.47 -18.11 54.23 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.723 2.282 . . . . 0.0 112.737 -174.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -87.19 -0.18 56.3 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.231 -1.349 . . . . 0.0 109.598 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 64.48 58.33 1.07 Allowed 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 124.725 2.202 . . . . 0.0 108.823 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 7.1 m -115.29 135.08 54.52 Favored 'General case' 0 N--CA 1.403 -2.821 0 CA-C-N 111.95 -2.386 . . . . 0.0 106.331 176.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.642 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.2 t -91.13 123.8 43.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 127.197 2.199 . . . . 0.0 107.792 -176.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mp -100.72 122.28 43.09 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 118.763 -1.175 . . . . 0.0 110.922 175.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.408 ' HB3' ' HB2' ' A' ' 29' ' ' GLN . 42.8 t -101.85 118.63 37.33 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.463 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -125.66 139.84 11.8 Favored Glycine 0 N--CA 1.424 -2.159 0 C-N-CA 119.015 -1.564 . . . . 0.0 111.647 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -159.57 177.39 10.96 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 174.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -73.47 139.88 46.08 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.586 HG23 HD12 ' A' ' 27' ' ' ILE . 1.3 m -67.66 -10.55 53.32 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.643 0.735 . . . . 0.0 111.535 -177.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.9 t -67.53 -40.24 85.07 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.46 14.69 12.35 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.486 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -143.5 -170.11 3.22 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.059 -177.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.473 ' HB1' ' HG2' ' A' ' 21' ' ' MET . . . 58.36 92.33 0.04 OUTLIER 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 125.051 1.34 . . . . 0.0 112.01 177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.9 t70 76.11 -43.4 0.47 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 112.986 -1.915 . . . . 0.0 111.139 -174.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -96.49 142.42 28.6 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -116.79 96.31 5.42 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 120.922 0.391 . . . . 0.0 111.123 -175.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -129.65 -179.25 5.07 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.131 0.972 . . . . 0.0 109.911 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.8 t -133.96 -55.52 0.87 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.437 -1.107 0 N-CA-C 103.614 -2.736 . . . . 0.0 103.614 178.026 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.863 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -90.38 125.35 35.51 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -102.96 -43.33 5.55 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -148.16 -71.1 0.21 Allowed 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.763 0.792 . . . . 0.0 110.36 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.502 ' HG ' ' H ' ' A' ' 16' ' ' TYR 0.26 23.5 tp -179.37 -168.42 0.12 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 -168.652 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.502 ' H ' ' HG ' ' A' ' 15' ' ' LEU . 35.5 t80 -77.0 80.87 3.53 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 104.988 -2.227 . . . . 0.0 104.988 168.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -103.53 -23.21 13.52 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 113.335 -1.757 . . . . 0.0 112.447 -171.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -64.81 134.13 53.45 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.438 0.637 . . . . 0.0 112.059 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 99.09 -90.19 0.97 Allowed Glycine 0 N--CA 1.431 -1.679 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -150.9 177.14 10.42 Favored 'General case' 0 C--N 1.314 -0.938 0 C-N-CA 124.054 0.942 . . . . 0.0 108.579 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.0 tpt -77.87 79.3 4.34 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.98 90.81 4.76 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.862 0.839 . . . . 0.0 111.011 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.521 ' CE3' HG21 ' A' ' 41' ' ' THR . 16.7 m95 -97.41 -176.67 3.57 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.537 177.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.487 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 70.6 mmtt -91.96 -171.89 2.99 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.464 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -81.28 -33.99 32.32 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 122.069 0.937 . . . . 0.0 110.835 -173.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 70.3 m -120.5 144.31 48.09 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.57 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.668 HD12 HG23 ' A' ' 79' ' ' THR . 14.7 tt -121.09 133.49 67.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-O 121.225 0.536 . . . . 0.0 109.952 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.401 HD12 ' C ' ' A' ' 27' ' ' ILE . 1.7 mp -113.07 112.77 41.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 122.564 1.173 . . . . 0.0 109.529 -178.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.51 ' OE1' HG21 ' A' ' 36' ' ' VAL . 66.2 mm-40 -91.51 112.33 24.2 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 113.245 -1.798 . . . . 0.0 106.761 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.401 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 56.1 ttt180 -92.22 110.89 22.29 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.664 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 76.4 m-85 -94.69 128.75 41.58 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -138.7 127.11 23.05 Favored 'General case' 0 N--CA 1.407 -2.61 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 -175.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 61.61 31.1 18.81 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.89 10.73 83.67 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.857 -0.611 . . . . 0.0 114.228 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -141.78 159.73 41.62 Favored 'General case' 0 CA--C 1.486 -1.482 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.51 HG21 ' OE1' ' A' ' 29' ' ' GLN . 7.7 p -77.68 110.77 13.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-O 122.1 0.952 . . . . 0.0 109.385 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -91.25 -48.48 6.9 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.118 0.961 . . . . 0.0 111.027 -174.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 30' ' ' ARG . 15.6 m120 -123.26 152.83 40.95 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.694 -177.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.2 mt -128.31 120.77 53.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.717 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -118.69 165.75 13.6 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.521 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.5 t -150.64 143.65 24.72 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.53 153.88 45.15 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.162 -174.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -78.71 160.29 27.54 Favored 'General case' 0 C--N 1.286 -2.156 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.746 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 44' ' ' ARG . 4.2 ptt180 -56.81 118.38 4.86 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.58 173.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.51 ' ND2' ' HB3' ' A' ' 59' ' ' GLU 0.266 58.8 m-80 68.35 68.69 0.32 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.704 1.602 . . . . 0.0 110.488 -173.432 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -146.89 136.28 22.78 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.755 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 42.1 tt0 -104.83 120.38 41.27 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.336 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 27.7 pt -103.04 -177.54 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.2 m -137.87 139.57 39.95 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 96.2 mt -134.49 113.21 16.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 53.39 39.04 29.3 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.88 0.848 . . . . 0.0 111.938 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 69.61 17.62 7.82 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 125.494 1.518 . . . . 0.0 112.826 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -103.93 117.77 35.11 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 172.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.447 ' H ' ' HD3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -78.95 146.25 33.56 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.984 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.8 t -138.08 115.84 12.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.828 -174.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 90.7 t80 -94.57 127.11 40.3 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 121.157 0.503 . . . . 0.0 110.205 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.8 t -104.25 122.01 56.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 176.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -78.7 175.24 10.62 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 123.639 0.587 . . . . 0.0 109.539 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.51 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 0.0 OUTLIER -64.99 -21.9 66.92 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -171.524 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.75 12.15 28.9 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.664 -177.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 56.4 m 66.29 80.86 0.21 Allowed 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 124.032 0.833 . . . . 0.0 111.535 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -161.44 127.68 2.4 Favored Pre-proline 0 N--CA 1.442 -0.858 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.535 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 28.3 Cg_endo -92.19 149.9 3.1 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 123.069 2.513 . . . . 0.0 114.985 -177.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -131.21 135.8 27.74 Favored Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.734 169.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -77.06 165.62 84.45 Favored 'Cis proline' 0 C--N 1.326 -0.641 0 C-N-CA 122.865 -1.723 . . . . 0.0 112.479 -1.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 74' ' ' LEU . 57.6 t -87.41 -47.98 15.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -176.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -92.02 121.3 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 CA-C-O 121.883 0.849 . . . . 0.0 109.186 170.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 37.3 mt -85.31 164.78 39.4 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 114.247 -1.342 . . . . 0.0 108.274 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -70.33 -10.56 28.37 Favored 'Trans proline' 0 N--CA 1.483 0.909 0 C-N-CA 122.849 2.366 . . . . 0.0 111.658 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -84.89 -11.05 56.45 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 113.449 -1.705 . . . . 0.0 109.565 177.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.404 17.2 ttm180 65.69 58.69 0.78 Allowed 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 124.528 2.109 . . . . 0.0 111.813 -174.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 65.9 m -114.25 138.27 50.7 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 111.231 -2.713 . . . . 0.0 106.616 172.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.664 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.4 t -91.42 115.92 31.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 125.408 1.692 . . . . 0.0 107.993 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.452 ' O ' HG13 ' A' ' 66' ' ' VAL . 6.6 mp -99.89 122.76 43.32 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.975 0.893 . . . . 0.0 112.091 177.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.8 m -119.12 118.81 32.39 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.268 178.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.535 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -101.82 131.39 10.57 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -139.76 168.93 18.7 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 177.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -75.61 139.5 42.08 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 175.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.668 HG23 HD12 ' A' ' 27' ' ' ILE . 2.4 m -68.54 -20.38 64.55 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.244 0.545 . . . . 0.0 110.966 -177.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.4 t -58.73 -38.58 78.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.315 -1.311 . . . . 0.0 109.157 -177.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.72 21.26 8.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.392 0.615 . . . . 0.0 112.371 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -135.14 -66.23 0.59 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -178.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.13 -18.37 43.12 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.001 -176.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.17 39.04 30.35 Favored 'General case' 0 N--CA 1.426 -1.643 0 O-C-N 124.922 1.389 . . . . 0.0 107.667 -175.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 89' ' ' CYS . 2.8 p30 -38.1 130.22 1.21 Allowed 'General case' 0 CA--C 1.507 -0.689 0 O-C-N 126.21 2.194 . . . . 0.0 113.203 -177.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -82.6 72.3 9.68 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.242 -1.345 . . . . 0.0 108.171 -174.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -107.16 -58.4 1.95 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 63.1 m -137.1 10.53 3.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.416 1.103 . . . . 0.0 108.27 173.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 85' ' ' ASP . 37.5 t . . . . . 0 C--O 1.246 0.903 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.709 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -83.72 93.91 8.03 Favored 'General case' 0 CA--C 1.51 -0.565 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 173.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -134.26 166.76 22.06 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 113.905 -1.498 . . . . 0.0 110.903 -170.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -139.86 178.13 7.47 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.4 mt -107.76 178.74 4.43 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -84.08 77.65 9.9 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 62.41 -141.21 0.42 Allowed 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.01 -1.45 . . . . 0.0 107.719 -177.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.89 117.32 17.49 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 103.215 -2.883 . . . . 0.0 103.215 174.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.49 68.27 1.21 Allowed Glycine 0 N--CA 1.437 -1.25 0 O-C-N 123.456 0.472 . . . . 0.0 113.199 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -64.37 131.93 48.64 Favored 'General case' 0 C--O 1.252 1.233 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 174.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . 0.267 1.3 pmm? -75.03 83.91 2.27 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 123.498 1.618 . . . . 0.0 114.098 -174.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -128.05 69.56 1.34 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 170.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.559 ' CE3' HG21 ' A' ' 41' ' ' THR . 10.7 m95 -115.1 -167.22 1.2 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 112.633 -2.076 . . . . 0.0 107.481 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.45 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 32.3 mmtp -96.14 -175.63 3.43 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 175.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.486 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 3.6 m-20 -75.24 -33.16 61.28 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.505 0.669 . . . . 0.0 112.592 -176.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 60.2 m -121.64 140.01 52.82 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.654 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.52 HD12 HG23 ' A' ' 79' ' ' THR . 5.4 tt -113.36 131.72 64.3 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -177.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.7 mm -119.57 112.37 36.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 CA-C-O 121.891 0.853 . . . . 0.0 108.732 -173.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -94.69 125.5 39.38 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.488 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.433 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 52.8 ttt180 -95.09 112.72 24.4 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.695 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 25.8 m-85 -95.69 110.87 22.94 Favored 'General case' 0 CA--C 1.484 -1.569 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -136.33 125.03 23.81 Favored 'General case' 0 N--CA 1.397 -3.111 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 -174.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 63.96 33.92 11.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 122.813 1.292 . . . . 0.0 112.304 -173.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.97 -23.06 37.33 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-N 113.612 -1.631 . . . . 0.0 114.938 172.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -126.91 162.33 26.18 Favored 'General case' 0 CA--C 1.481 -1.702 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.23 110.43 3.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.846 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -84.99 -50.69 7.26 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.486 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.433 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 16.9 m120 -119.07 149.76 41.12 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.95 -176.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.9 mp -116.51 116.33 51.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -119.07 169.44 9.92 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.559 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.6 t -154.43 146.86 23.98 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.4 154.51 40.95 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -175.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -75.51 157.09 34.45 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.586 176.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.486 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 2.1 ptt180 -59.91 116.4 4.09 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 121.333 0.587 . . . . 0.0 109.986 170.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.6 m120 75.23 67.27 0.07 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.193 -1.822 . . . . 0.0 108.331 -177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -152.64 128.84 10.47 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.478 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 2.7 mp0 -86.85 135.89 33.16 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.004 173.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.7 pt -113.99 -179.99 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 172.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.12 132.09 37.68 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 177.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 86.5 mt -125.53 107.01 17.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 55.06 41.26 31.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.302 1.049 . . . . 0.0 112.65 178.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 71.51 6.87 5.87 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.943 2.097 . . . . 0.0 112.433 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -93.87 112.34 24.17 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 175.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -83.1 130.61 35.13 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 63.3 t -126.43 120.61 56.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.05 -173.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 56.8 t80 -94.5 121.99 36.62 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.4 t -97.25 125.07 50.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -78.67 175.28 10.56 Favored 'General case' 0 N--CA 1.439 -1.018 0 O-C-N 124.72 1.263 . . . . 0.0 108.002 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.486 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -74.12 -16.52 61.01 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -173.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -83.63 6.13 21.91 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.089 177.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 76.7 m 71.49 30.32 2.5 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 122.29 1.043 . . . . 0.0 113.319 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -114.54 124.07 31.22 Favored Pre-proline 0 C--N 1.29 -2.012 0 CA-C-N 113.736 -1.575 . . . . 0.0 107.898 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.507 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 60.3 Cg_endo -83.97 147.25 11.81 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 123.469 2.779 . . . . 0.0 114.549 -177.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -132.38 131.25 22.21 Favored Pre-proline 0 CA--C 1.493 -1.229 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.065 172.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -76.65 161.66 93.23 Favored 'Cis proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.644 -1.815 . . . . 0.0 112.948 -0.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.439 HG13 ' O ' ' A' ' 74' ' ' LEU . 57.3 t -82.98 -48.24 17.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.539 HG12 ' NH2' ' A' ' 71' ' ' ARG . 1.7 mp -96.38 122.6 48.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 C-N-CA 119.819 -0.753 . . . . 0.0 109.261 172.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.426 ' C ' ' H ' ' A' ' 70' ' ' ASP . 54.0 mt -80.19 169.61 19.13 Favored Pre-proline 0 C--N 1.296 -1.76 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.101 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -76.04 5.64 4.36 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.99 2.46 . . . . 0.0 109.72 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 68' ' ' LEU . 27.5 t70 -99.93 -10.52 21.59 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 112.686 -2.052 . . . . 0.0 111.223 175.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.539 ' NH2' HG12 ' A' ' 67' ' ' ILE . 8.6 tpm_? 75.38 18.28 2.37 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 124.57 1.148 . . . . 0.0 110.243 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.4 m -82.6 140.52 33.17 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 170.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.695 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 7.7 t -90.85 124.76 43.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 126.336 1.854 . . . . 0.0 108.063 -179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 66' ' ' VAL . 5.4 mp -103.74 122.68 45.58 Favored 'General case' 0 C--N 1.283 -2.289 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.689 173.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.5 m -117.28 118.2 31.62 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.507 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -114.03 147.38 18.72 Favored Glycine 0 N--CA 1.419 -2.482 0 C-N-CA 118.84 -1.647 . . . . 0.0 110.546 -177.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -150.2 176.51 10.79 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -78.08 136.55 37.91 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.52 HG23 HD12 ' A' ' 27' ' ' ILE . 3.7 m -69.76 -19.11 63.53 Favored 'General case' 0 C--O 1.242 0.686 0 O-C-N 122.058 -0.401 . . . . 0.0 110.014 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.639 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 12.3 p -56.53 -33.16 65.79 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.33 1.452 . . . . 0.0 111.761 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.54 12.71 31.0 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.648 0.737 . . . . 0.0 112.511 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -122.92 -79.64 0.62 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -175.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.57 -13.31 23.04 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.807 0.813 . . . . 0.0 110.38 -177.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.639 ' HB3' ' HA ' ' A' ' 80' ' ' SER . 15.2 t70 -93.16 6.25 48.67 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 175.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -122.77 165.14 17.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 113.901 -1.5 . . . . 0.0 107.969 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -98.33 108.93 21.74 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 -173.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -130.86 106.26 8.32 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 166.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 25.4 m 70.72 -63.32 0.42 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.868 1.267 . . . . 0.0 112.503 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 76.5 m . . . . . 0 C--O 1.251 1.181 0 C-N-CA 124.945 1.298 . . . . 0.0 112.941 -179.549 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.775 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 12' ' ' ARG . 18.7 ptt180 -146.63 -41.08 0.2 Allowed 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 62.15 -90.97 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.776 1.63 . . . . 0.0 112.44 175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 173.46 -60.11 0.01 OUTLIER 'General case' 0 CA--C 1.499 -1.001 0 C-N-CA 126.963 2.105 . . . . 0.0 107.45 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.6 mt 70.92 176.46 0.28 Allowed 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.393 -1.276 . . . . 0.0 107.953 -174.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -92.42 80.18 4.92 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 116.515 -2.074 . . . . 0.0 111.443 -177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.549 ' HB2' ' SD ' ' A' ' 21' ' ' MET . 87.9 m-85 -128.99 88.18 2.68 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 171.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -120.31 122.73 41.48 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -175.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.46 -55.68 0.49 Allowed Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 107.227 -2.349 . . . . 0.0 107.227 -174.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -133.71 103.98 6.12 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.003 -1.098 . . . . 0.0 109.715 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.549 ' SD ' ' HB2' ' A' ' 17' ' ' PHE . 16.4 tpt -74.07 94.91 2.46 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 104.464 -2.421 . . . . 0.0 104.464 170.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.96 95.41 2.99 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.091 -173.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.681 ' HB3' HG21 ' A' ' 79' ' ' THR . 82.2 m95 -88.04 160.23 17.93 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.581 0.705 . . . . 0.0 110.198 175.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.413 ' HD2' ' OD1' ' A' ' 43' ' ' ASN . 43.9 mmtm -87.0 -170.88 3.25 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.499 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.516 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 21.2 m-20 -76.02 -28.87 57.92 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.707 0.765 . . . . 0.0 112.298 -174.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.8 m -127.18 147.11 50.2 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.421 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.555 HD12 HG23 ' A' ' 79' ' ' THR . 10.7 tt -118.42 133.35 65.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.9 mm -123.98 112.29 32.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -97.21 125.54 41.81 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -93.26 111.02 22.55 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.658 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 34.7 m-85 -95.63 143.15 27.15 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 123.61 0.764 . . . . 0.0 110.453 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -148.87 120.65 8.1 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.262 79.4 m-20 58.7 36.06 24.73 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.03 -21.38 46.35 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 115.295 0.878 . . . . 0.0 115.295 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -119.08 165.32 14.29 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 118.512 1.156 . . . . 0.0 108.222 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 4.1 p -80.66 116.72 25.39 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-O 122.366 1.079 . . . . 0.0 110.392 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -84.31 -58.74 2.63 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.473 -175.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -121.93 157.67 30.73 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.246 0.546 . . . . 0.0 111.443 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 33.0 mm -116.35 136.17 54.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.506 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -142.73 164.3 30.49 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.6 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.6 t -152.15 142.61 22.6 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 176.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.12 155.52 46.95 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.495 -173.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.413 ' OD1' ' HD2' ' A' ' 24' ' ' LYS . 83.3 m-20 -73.16 154.44 40.31 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.516 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 14.1 ptt180 -66.62 116.22 7.32 Favored 'General case' 0 N--CA 1.441 -0.92 0 O-C-N 121.819 -0.551 . . . . 0.0 110.651 172.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 12.7 m120 76.95 67.33 0.05 Allowed 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 126.059 1.744 . . . . 0.0 108.62 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -146.27 131.25 18.21 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.521 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 42.2 tt0 -97.66 109.0 21.84 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.425 ' CG1' ' HB ' ' A' ' 55' ' ' VAL . 23.6 pt -92.53 -179.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 3.1 m -136.89 129.79 30.73 Favored 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 172.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.444 HD12 HD21 ' A' ' 74' ' ' LEU . 68.7 mt -119.43 110.23 28.86 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 57.51 39.37 27.94 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.879 0.847 . . . . 0.0 111.625 172.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 73.67 7.22 5.02 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.411 1.884 . . . . 0.0 113.312 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -102.42 119.57 39.04 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -81.0 153.38 27.47 Favored 'General case' 0 N--CA 1.435 -1.225 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.849 -178.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 95.9 t -146.24 125.08 4.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.993 -175.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 77.7 t80 -98.66 118.9 36.41 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.9 t -97.98 118.08 43.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -81.28 170.86 15.53 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.6 pm0 -65.75 -15.58 62.98 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -172.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.13 0.51 31.87 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.938 176.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 71.9 m 72.44 26.79 2.53 Favored 'General case' 0 CA--C 1.487 -1.449 0 C-N-CA 124.55 1.14 . . . . 0.0 112.625 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -113.22 121.19 38.54 Favored Pre-proline 0 C--N 1.287 -2.113 0 CA-C-N 112.9 -1.955 . . . . 0.0 108.306 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.556 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 45.7 Cg_endo -85.66 144.19 8.72 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 124.093 3.195 . . . . 0.0 115.26 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -129.58 134.07 25.8 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.729 172.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -79.05 153.52 89.8 Favored 'Cis proline' 0 C--N 1.323 -0.815 0 C-N-CA 122.67 -1.804 . . . . 0.0 112.603 1.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 74' ' ' LEU . 86.2 t -75.05 -35.39 34.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.82 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.0 mm -102.87 125.18 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 C-N-CA 119.594 -0.843 . . . . 0.0 109.359 174.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.1 mt -84.68 165.46 37.55 Favored Pre-proline 0 C--N 1.29 -1.983 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.17 177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -70.4 -8.85 24.59 Favored 'Trans proline' 0 N--CA 1.486 1.049 0 C-N-CA 123.038 2.492 . . . . 0.0 112.167 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -88.61 -7.62 56.09 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.721 -1.581 . . . . 0.0 109.587 177.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 67.82 57.76 0.51 Allowed 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 123.886 1.803 . . . . 0.0 108.817 -173.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.9 m -112.8 140.63 47.43 Favored 'General case' 0 N--CA 1.419 -2.006 0 CA-C-N 112.665 -2.061 . . . . 0.0 107.082 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.658 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.7 t -91.81 115.93 31.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 125.233 1.583 . . . . 0.0 108.696 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.444 HD21 HD12 ' A' ' 50' ' ' ILE . 3.6 mp -96.24 122.68 39.36 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.049 174.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 64.9 m -117.82 117.46 29.36 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.556 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -120.82 137.8 12.25 Favored Glycine 0 N--CA 1.411 -2.993 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.963 -177.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.436 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 9.3 m-20 -145.56 173.73 11.79 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 178.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -72.58 138.43 46.83 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.681 HG21 ' HB3' ' A' ' 23' ' ' TRP . 1.8 m -68.84 -18.54 64.17 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.224 0.535 . . . . 0.0 111.802 -177.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.2 p -63.02 -25.5 68.41 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.368 0.604 . . . . 0.0 111.523 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -109.71 20.2 18.34 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.026 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.436 ' CE1' ' HB2' ' A' ' 77' ' ' ASP . 7.7 m-85 -144.25 -170.76 3.43 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.794 -174.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 76.16 110.21 0.07 Allowed 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.764 2.025 . . . . 0.0 113.218 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -69.84 -38.5 76.54 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.074 -1.421 . . . . 0.0 110.061 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -100.42 87.29 3.36 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 172.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -92.22 144.12 25.73 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.828 -1.078 . . . . 0.0 108.367 -176.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -79.56 172.07 14.29 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 119.377 -0.344 . . . . 0.0 110.252 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 89' ' ' CYS . 5.3 m -49.9 -59.4 3.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.36 0.664 . . . . 0.0 109.837 -179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 88' ' ' SER . 30.3 t . . . . . 0 C--O 1.254 1.32 0 N-CA-C 103.112 -2.921 . . . . 0.0 103.112 174.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.2 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -137.44 150.19 47.43 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 177.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -95.69 -173.0 2.75 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 118.629 0.65 . . . . 0.0 110.457 -177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.2 t30 77.9 -74.67 0.06 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.659 1.584 . . . . 0.0 109.308 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.3 mt 61.69 178.24 0.12 Allowed 'General case' 0 C--O 1.24 0.602 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 176.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -83.8 84.21 7.65 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.123 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -93.97 98.83 11.29 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.469 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -95.01 95.93 8.93 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 175.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.31 -167.19 22.59 Favored Glycine 0 C--N 1.3 -1.44 0 N-CA-C 108.219 -1.953 . . . . 0.0 108.219 -176.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.468 ' CD2' ' HA ' ' A' ' 86' ' ' ASP . 36.7 m80 -140.34 142.56 35.57 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 118.022 0.911 . . . . 0.0 110.144 -177.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.408 ' HB3' ' HE1' ' A' ' 23' ' ' TRP . 16.4 tpt -69.98 150.54 46.57 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 175.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.84 102.14 14.4 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 120.235 -0.586 . . . . 0.0 109.96 178.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.596 ' HB3' HG21 ' A' ' 79' ' ' THR . 71.4 m95 -98.34 155.07 17.39 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.553 ' HE2' ' HA ' ' A' ' 24' ' ' LYS . 10.8 mmpt? -88.91 -170.21 2.82 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 123.498 0.719 . . . . 0.0 111.449 -176.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.495 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 4.7 m-20 -69.3 -34.46 74.73 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -173.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.0 m -126.97 147.22 50.12 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.869 -175.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.553 HD12 HG23 ' A' ' 79' ' ' THR . 8.2 tt -116.74 133.35 63.66 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.469 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -177.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 75' ' ' SER . 33.4 mm -125.94 111.61 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -174.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.535 ' HB2' ' HB3' ' A' ' 75' ' ' SER . 25.6 mt-30 -102.51 132.09 48.79 Favored 'General case' 0 C--N 1.282 -2.336 0 O-C-N 121.652 -0.655 . . . . 0.0 109.675 -177.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -92.9 109.85 21.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.587 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 10.2 m-85 -95.53 109.7 21.89 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? -89.73 110.76 21.64 Favored 'General case' 0 N--CA 1.398 -3.05 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 -177.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 53.88 40.58 31.71 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 113.489 -1.687 . . . . 0.0 114.238 -178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.16 -18.69 56.72 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 115.038 -0.983 . . . . 0.0 115.048 176.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -108.3 150.23 27.6 Favored 'General case' 0 CA--C 1.477 -1.855 0 CA-C-N 119.075 1.437 . . . . 0.0 107.829 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 31' ' ' TYR 0.253 7.1 p -79.53 115.34 21.7 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 C-N-CA 118.45 -1.3 . . . . 0.0 110.894 -175.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -97.11 -60.67 1.54 Allowed 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.689 -174.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.402 ' C ' HD12 ' A' ' 39' ' ' ILE . 96.5 m-20 -119.91 158.38 26.8 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.35 -179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.402 HD12 ' C ' ' A' ' 38' ' ' ASN . 2.9 mp -125.54 121.75 60.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -123.02 169.94 10.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.489 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.6 t -149.95 142.08 24.04 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.4 160.06 40.49 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.496 -173.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -79.73 158.49 26.9 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 174.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.495 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 5.2 ptt180 -64.94 111.89 3.05 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 170.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.554 ' ND2' ' HB3' ' A' ' 59' ' ' GLU . 89.4 m-20 76.63 67.53 0.06 Allowed 'General case' 0 C--O 1.243 0.735 0 CA-C-O 123.321 1.534 . . . . 0.0 109.949 -176.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -144.16 123.08 12.74 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 112.581 -2.099 . . . . 0.0 110.46 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 46.6 tt0 -89.4 109.73 20.61 Favored 'General case' 0 N--CA 1.418 -2.035 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 173.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 16.6 pt -92.99 -176.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 177.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 4.5 m -136.32 131.37 34.24 Favored 'General case' 0 N--CA 1.417 -2.123 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 176.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 97.5 mt -132.62 108.45 13.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -176.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 58.81 35.01 24.08 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 122.91 1.338 . . . . 0.0 110.342 176.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 72.79 5.13 5.16 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 127.847 2.459 . . . . 0.0 113.683 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -92.01 114.27 26.77 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 174.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -80.36 140.54 36.03 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 117.925 -1.51 . . . . 0.0 108.135 178.316 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 86.1 t -133.23 123.18 46.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.011 -170.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 92.7 t80 -91.26 118.69 30.69 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.276 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 45' ' ' ASN . 64.6 t -95.67 119.33 43.59 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 174.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -77.33 165.03 24.98 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 124.33 1.018 . . . . 0.0 108.738 178.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.554 ' HB3' ' ND2' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -62.33 -19.98 63.88 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -173.338 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -85.82 11.36 11.37 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.401 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.6 m 62.65 68.05 0.67 Allowed 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 122.163 0.982 . . . . 0.0 110.438 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -153.19 120.54 3.01 Favored Pre-proline 0 N--CA 1.435 -1.188 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.608 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 55.6 Cg_endo -86.24 154.27 9.49 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.768 2.979 . . . . 0.0 114.314 -177.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -135.78 132.09 19.37 Favored Pre-proline 0 CA--C 1.483 -1.634 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.898 172.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.42 168.19 75.97 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.805 -1.748 . . . . 0.0 112.378 -2.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.0 t -88.61 -48.09 15.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.752 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.6 mp -92.5 124.81 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-O 121.683 0.754 . . . . 0.0 109.893 173.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 41.5 mt -83.82 168.22 23.34 Favored Pre-proline 0 C--N 1.299 -1.593 0 CA-C-N 114.606 -1.179 . . . . 0.0 108.983 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -64.67 -21.24 65.37 Favored 'Trans proline' 0 C--N 1.353 0.805 0 C-N-CA 122.458 2.105 . . . . 0.0 111.135 -176.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -83.43 -3.55 57.68 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 125.848 1.659 . . . . 0.0 110.934 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 18.4 tpt180 77.38 6.44 3.0 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.049 1.74 . . . . 0.0 110.747 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.1 m -67.95 134.09 50.19 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 122.134 0.969 . . . . 0.0 109.601 173.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.587 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.7 t -91.07 125.32 43.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 C-N-CA 128.493 2.717 . . . . 0.0 107.647 -175.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.9 mp -98.28 122.35 41.34 Favored 'General case' 0 C--N 1.282 -2.328 0 C-N-CA 118.5 -1.28 . . . . 0.0 110.964 174.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.535 ' HB3' ' HB2' ' A' ' 29' ' ' GLN . 30.3 t -97.83 118.36 34.22 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.608 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -122.0 126.04 6.31 Favored Glycine 0 N--CA 1.416 -2.686 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.457 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 5.4 t70 -153.71 172.06 17.87 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 178.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -73.31 140.87 47.05 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.596 HG21 ' HB3' ' A' ' 23' ' ' TRP . 3.7 m -71.68 -16.45 62.24 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.559 0.695 . . . . 0.0 109.632 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . 0.264 1.5 m -59.99 -22.55 62.7 Favored 'General case' 0 N--CA 1.411 -2.417 0 C-N-CA 126.238 1.815 . . . . 0.0 111.627 178.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.8 15.99 16.33 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 122.541 1.162 . . . . 0.0 110.066 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.457 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 31.9 m-85 -138.67 -166.85 2.08 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.202 -176.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 56.17 86.79 0.06 Allowed 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 123.55 1.643 . . . . 0.0 111.598 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -79.61 4.99 14.31 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 111.908 -2.405 . . . . 0.0 113.34 -172.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.62 -46.65 89.5 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 168.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.468 ' HA ' ' CD2' ' A' ' 20' ' ' HIS . 6.6 t70 -83.13 98.33 9.28 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -177.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.8 135.31 33.4 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -176.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.9 m 82.94 99.97 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 126.08 1.752 . . . . 0.0 112.575 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 59.2 m . . . . . 0 C--N 1.31 -1.149 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 175.833 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.845 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -122.21 -15.93 7.57 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -62.12 -45.54 93.02 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 54.99 -157.8 0.21 Allowed 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.368 1.467 . . . . 0.0 109.412 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -119.03 149.53 41.5 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 172.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -89.68 85.49 6.47 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 102.982 -2.97 . . . . 0.0 102.982 175.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . 0.401 4.9 t80 -71.4 104.57 3.24 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 -172.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.442 ' OE1' ' HA ' ' A' ' 18' ' ' GLN . 7.9 mm-40 -153.11 -49.27 0.1 Allowed 'General case' 0 C--N 1.29 -2.006 1 N-CA-C 98.854 -4.499 . . . . 0.0 98.854 169.71 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 10.85 -91.42 0.01 OUTLIER Glycine 0 CA--C 1.498 -1.009 0 C-N-CA 128.167 2.794 . . . . 0.0 118.541 167.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.261 88.1 m-70 63.36 104.82 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 -166.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.635 ' SD ' ' HA ' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -60.69 103.36 0.25 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 112.482 -2.144 . . . . 0.0 115.188 -167.38 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.55 60.75 1.68 Allowed 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.266 -2.864 . . . . 0.0 103.266 172.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.55 ' CE3' HG21 ' A' ' 41' ' ' THR . 13.5 m0 -73.65 -162.11 0.12 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 111.833 -2.44 . . . . 0.0 109.919 -177.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.526 ' HB2' ' OG1' ' A' ' 41' ' ' THR . 34.8 mmtp -73.51 -173.47 1.43 Allowed 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.129 0.966 . . . . 0.0 108.675 174.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.553 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 6.7 m-20 -83.5 -33.58 25.52 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.704 -174.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 69.2 m -123.5 140.41 53.03 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.358 -176.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.64 HD12 HG23 ' A' ' 79' ' ' THR . 7.2 tt -113.87 133.26 60.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.4 mm -122.23 112.33 34.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -174.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.614 ' HB2' ' OG ' ' A' ' 75' ' ' SER . 96.8 mt-30 -96.69 127.63 42.86 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -178.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.5 ' HD3' ' OD1' ' A' ' 38' ' ' ASN . 58.5 ttt180 -95.78 112.33 24.08 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.529 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 56.9 m-85 -94.71 145.93 24.51 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 177.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -149.99 117.68 6.19 Favored 'General case' 0 N--CA 1.404 -2.741 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.256 0.8 OUTLIER 57.86 34.51 24.45 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 177.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.54 -1.09 59.98 Favored Glycine 0 N--CA 1.436 -1.333 0 C-N-CA 120.255 -0.974 . . . . 0.0 114.279 175.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -135.55 158.53 44.15 Favored 'General case' 0 CA--C 1.484 -1.573 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 10.9 p -80.7 124.0 38.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -99.44 -46.52 5.46 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.239 -0.585 . . . . 0.0 111.316 -173.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.5 ' OD1' ' HD3' ' A' ' 30' ' ' ARG . 14.6 m120 -130.18 159.01 38.13 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.841 -176.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.8 mm -118.73 134.11 63.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 123.524 0.73 . . . . 0.0 110.799 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -141.18 165.09 28.48 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.55 HG21 ' CE3' ' A' ' 23' ' ' TRP . 3.4 t -157.33 144.35 18.4 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.445 ' HB2' HG23 ' A' ' 48' ' ' ILE . . . -140.17 156.43 46.53 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.189 0.596 . . . . 0.0 110.733 -174.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -74.88 157.58 34.82 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.553 ' HG2' ' CB ' ' A' ' 25' ' ' ASP . 8.1 ptt180 -62.81 107.86 1.06 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 171.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 83.57 62.09 0.01 OUTLIER 'General case' 0 C--O 1.238 0.461 0 C-N-CA 126.95 2.1 . . . . 0.0 110.681 -176.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -144.79 132.28 20.87 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.872 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 3.5 mp0 -87.3 112.45 22.08 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 172.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.445 HG23 ' HB2' ' A' ' 42' ' ' ALA . 23.1 pt -88.79 179.65 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 172.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.7 m -132.13 133.83 44.73 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 85.8 mt -127.1 106.08 14.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 56.24 38.83 30.18 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.408 1.099 . . . . 0.0 111.821 176.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 64.78 28.7 12.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 113.742 -1.572 . . . . 0.0 114.335 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -113.42 109.98 19.56 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 169.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.67 136.96 37.59 Favored 'General case' 0 N--CA 1.428 -1.57 0 C-N-CA 118.005 -1.478 . . . . 0.0 108.827 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.4 t -124.4 114.35 40.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 CA-C-N 114.31 -1.314 . . . . 0.0 108.513 -174.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 79.1 t80 -82.92 115.79 21.93 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -178.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.1 t -97.18 118.75 44.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -75.38 173.07 11.41 Favored 'General case' 0 C--N 1.31 -1.112 0 O-C-N 125.162 1.539 . . . . 0.0 108.415 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.88 -20.83 65.99 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -172.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -86.73 12.19 11.34 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.51 0.671 . . . . 0.0 110.006 178.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 83.9 m 68.58 31.1 4.87 Favored 'General case' 0 C--O 1.199 -1.585 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.925 175.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -109.72 119.79 46.79 Favored Pre-proline 0 C--N 1.288 -2.069 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.349 -177.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.604 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 83.7 Cg_endo -83.34 143.16 11.01 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.447 2.765 . . . . 0.0 113.516 -177.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 86.9 m-85 -129.43 132.02 24.0 Favored Pre-proline 0 N--CA 1.432 -1.329 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.691 173.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 62.9 Cg_endo -80.7 165.97 76.04 Favored 'Cis proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.514 -1.869 . . . . 0.0 112.181 -2.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.3 t -83.44 -39.7 15.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.866 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 mp -96.67 123.55 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 CA-C-O 121.386 0.612 . . . . 0.0 109.503 172.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.4 mt -84.6 167.44 26.85 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.012 177.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -70.72 -7.3 21.03 Favored 'Trans proline' 0 N--CA 1.484 0.951 0 C-N-CA 122.915 2.41 . . . . 0.0 112.671 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -89.82 -12.01 40.38 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.048 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.38 37.1 ttm180 67.62 58.69 0.5 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 124.032 1.872 . . . . 0.0 110.516 -169.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 6.7 m -103.48 136.44 43.21 Favored 'General case' 0 N--CA 1.408 -2.527 0 CA-C-N 111.861 -2.427 . . . . 0.0 105.11 172.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.3 t -93.27 115.69 32.68 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 O-C-N 124.855 1.347 . . . . 0.0 108.29 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.6 mp -97.22 126.87 42.7 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.452 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.614 ' OG ' ' HB2' ' A' ' 29' ' ' GLN . 51.4 p -107.69 129.7 55.0 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.604 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -114.42 118.01 4.26 Favored Glycine 0 N--CA 1.418 -2.534 0 C-N-CA 120.218 -0.991 . . . . 0.0 111.953 -177.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -131.28 169.48 15.92 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -86.84 134.07 33.58 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 177.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.64 HG23 HD12 ' A' ' 27' ' ' ILE . 1.5 m -71.55 -13.85 61.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 120.954 0.407 . . . . 0.0 111.854 -175.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.4 p -69.69 -31.83 70.08 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.53 0.681 . . . . 0.0 110.765 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.24 17.46 21.27 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 122.437 1.113 . . . . 0.0 110.222 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -142.0 -165.89 2.11 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 125.83 1.652 . . . . 0.0 108.55 -178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 57.62 90.39 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 124.936 1.398 . . . . 0.0 109.914 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -42.54 -36.86 1.47 Allowed 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 128.057 2.543 . . . . 0.0 114.931 -170.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.635 ' HA ' ' SD ' ' A' ' 21' ' ' MET . 10.0 t70 56.66 63.58 1.92 Allowed 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 104.194 -2.521 . . . . 0.0 104.194 -172.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -41.68 91.22 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 111.523 -2.581 . . . . 0.0 113.109 -170.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -77.5 84.44 3.89 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 123.386 1.565 . . . . 0.0 112.758 -175.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.5 m -151.78 36.31 0.56 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 112.295 -2.23 . . . . 0.0 106.292 176.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.439 -0.984 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 179.613 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.847 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . 0.296 6.5 mmt180 68.02 110.67 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -97.77 89.86 4.76 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -77.17 155.36 32.34 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.491 -171.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.409 ' HB2' ' CE2' ' A' ' 17' ' ' PHE . 62.6 mt -87.83 168.52 12.85 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 176.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -69.85 85.6 0.5 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.897 0.856 . . . . 0.0 111.746 -176.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.409 ' CE2' ' HB2' ' A' ' 15' ' ' LEU . 78.8 m-85 -108.37 69.24 0.72 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.347 174.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -154.37 37.78 0.43 Allowed 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 127.356 2.263 . . . . 0.0 105.184 175.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -139.41 10.11 3.22 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.421 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 68.62 90.45 0.1 Allowed 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 125.835 1.654 . . . . 0.0 112.759 176.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 17.4 ttt -88.49 145.53 25.69 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 172.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.87 90.75 5.91 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.562 ' HB3' HG21 ' A' ' 79' ' ' THR . 41.7 m95 -72.17 165.52 24.21 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.094 -177.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.517 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . 9.1 mmpt? -79.47 -173.68 3.85 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.151 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -76.15 -24.38 54.84 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 64.5 m -132.52 155.58 48.36 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.462 HD12 HG23 ' A' ' 79' ' ' THR . 8.6 tt -125.37 133.68 68.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -178.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.438 HD13 ' O ' ' A' ' 27' ' ' ILE . 25.6 mm -125.08 111.3 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -175.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -103.38 130.33 50.66 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.144 0.497 . . . . 0.0 110.21 -178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -99.44 115.27 28.89 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.404 -175.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.743 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 27.9 m-85 -96.5 125.73 41.19 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 176.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 37' ' ' ASN . 10.2 tmtt? -131.57 125.63 32.79 Favored 'General case' 0 N--CA 1.411 -2.414 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 -178.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 60.89 30.16 19.47 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.65 1.18 . . . . 0.0 112.449 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.86 0.68 90.37 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.221 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -122.14 156.98 32.51 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.9 p -77.39 110.11 12.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.485 ' HB2' ' HB3' ' A' ' 32' ' ' LYS . 3.2 t-20 -91.61 -43.79 9.42 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.217 -171.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -129.72 151.16 50.61 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -119.72 115.06 46.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -119.17 166.01 13.48 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.56 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.3 t -150.81 142.72 23.89 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -147.11 160.91 41.85 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 -174.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.436 ' OD1' ' HB3' ' A' ' 24' ' ' LYS . 90.7 m-20 -85.27 164.93 17.73 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 121.769 0.795 . . . . 0.0 112.217 176.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.423 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 5.5 ptt85 -62.26 110.16 1.55 Allowed 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.947 169.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 75.6 67.21 0.07 Allowed 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.719 1.208 . . . . 0.0 109.015 -177.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -152.48 143.71 23.22 Favored 'General case' 0 N--CA 1.433 -1.293 0 C-N-CA 124.662 1.185 . . . . 0.0 107.932 -178.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -115.56 135.96 53.55 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 121.489 0.661 . . . . 0.0 110.655 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.478 ' CG1' ' HB ' ' A' ' 55' ' ' VAL . 29.1 pt -119.05 -179.99 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 1.7 m -137.62 135.13 36.3 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 175.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 82.6 mt -127.55 108.2 17.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.85 49.54 20.85 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 70.09 5.73 5.43 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.023 1.329 . . . . 0.0 113.277 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -104.16 109.63 21.5 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -75.1 154.11 38.0 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.991 0.9 . . . . 0.0 112.245 178.619 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.478 ' HB ' ' CG1' ' A' ' 48' ' ' ILE . 88.6 t -142.59 118.08 5.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 CA-C-N 113.546 -1.661 . . . . 0.0 109.842 -173.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -102.51 123.7 46.74 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.2 t -97.99 119.38 45.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -80.62 172.0 14.31 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.423 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 9.9 pt-20 -67.27 -5.58 14.67 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 -172.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.61 13.68 31.16 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.389 -0.525 . . . . 0.0 109.711 172.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.0 m 69.83 33.96 2.74 Favored 'General case' 0 CA--C 1.495 -1.172 0 CA-C-O 122.518 1.152 . . . . 0.0 111.8 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -114.88 119.05 39.91 Favored Pre-proline 0 C--N 1.286 -2.17 0 CA-C-N 113.693 -1.594 . . . . 0.0 108.672 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.577 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 83.6 Cg_endo -83.98 147.95 11.96 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 123.795 2.997 . . . . 0.0 114.115 -177.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 70.7 m-85 -130.07 129.91 23.02 Favored Pre-proline 0 CA--C 1.488 -1.433 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.227 172.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -81.27 161.25 81.46 Favored 'Cis proline' 0 C--N 1.317 -1.094 0 C-N-CA 122.923 -1.699 . . . . 0.0 112.354 -2.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.1 t -81.88 -36.76 14.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 121.265 0.555 . . . . 0.0 109.631 -177.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.9 mm -106.42 127.08 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 173.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 39.4 mt -87.44 171.77 9.2 Favored Pre-proline 0 C--N 1.289 -2.035 0 CA-C-N 114.174 -1.376 . . . . 0.0 109.865 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -71.29 -12.02 29.38 Favored 'Trans proline' 0 C--N 1.355 0.88 0 C-N-CA 122.551 2.167 . . . . 0.0 110.864 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -87.56 -0.14 56.43 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 125.836 1.654 . . . . 0.0 108.303 176.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.3 ttp180 60.34 26.93 16.47 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 127.849 2.46 . . . . 0.0 109.361 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.13 135.57 47.72 Favored 'General case' 0 N--CA 1.417 -2.082 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.743 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 5.5 t -90.89 117.48 34.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 125.704 1.878 . . . . 0.0 108.301 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.45 121.83 42.66 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.586 -1.246 . . . . 0.0 112.265 175.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.0 m -97.51 118.04 33.12 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 175.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.577 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -116.93 111.66 2.35 Favored Glycine 0 N--CA 1.422 -2.262 0 C-N-CA 120.616 -0.802 . . . . 0.0 111.498 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.474 ' HB2' ' CE1' ' A' ' 82' ' ' TYR . 19.3 m-20 -142.69 177.21 8.47 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -78.03 139.53 39.11 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.562 HG21 ' HB3' ' A' ' 23' ' ' TRP . 0.2 OUTLIER -62.8 -21.77 66.13 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.139 0.975 . . . . 0.0 112.854 -176.272 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 p -71.49 -24.85 62.06 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.595 0.712 . . . . 0.0 111.32 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -97.37 14.9 24.62 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 121.916 0.865 . . . . 0.0 111.178 177.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.474 ' CE1' ' HB2' ' A' ' 77' ' ' ASP . 37.5 m-85 -146.09 -170.31 3.46 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 124.716 1.206 . . . . 0.0 111.432 -176.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . 54.78 99.6 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 126.039 1.735 . . . . 0.0 114.684 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -88.91 70.11 8.58 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.218 -1.355 . . . . 0.0 107.563 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -166.88 -37.46 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 111.838 -2.437 . . . . 0.0 105.608 -174.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -72.44 129.8 39.2 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.363 174.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -100.02 142.26 31.74 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.142 0.496 . . . . 0.0 111.676 -177.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.6 m -76.65 -24.04 53.29 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.571 -175.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 6.3 p . . . . . 0 C--N 1.306 -1.295 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 176.877 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.901 0 CA-C-O 118.168 -1.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? 57.08 31.87 20.71 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 122.515 1.15 . . . . 0.0 108.014 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.485 ' HA ' ' OE1' ' A' ' 13' ' ' GLU . 4.6 tp10 -83.0 113.29 20.47 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.948 -168.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -125.05 -47.48 1.78 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.058 176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.3 mt 60.04 -165.78 0.2 Allowed 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.449 -1.251 . . . . 0.0 109.468 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -91.94 76.74 5.49 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -129.63 15.56 5.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.245 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.75 115.42 6.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 103.72 -2.696 . . . . 0.0 103.72 174.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.79 -31.07 0.41 Allowed Glycine 0 C--N 1.298 -1.577 0 N-CA-C 107.086 -2.405 . . . . 0.0 107.086 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -114.01 102.26 10.02 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 170.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 49.0 ttm -130.1 114.32 15.6 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.09 84.59 2.11 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.543 ' CE3' HG21 ' A' ' 41' ' ' THR . 12.1 m95 -91.4 -175.29 4.19 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.513 177.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -92.37 -173.74 3.49 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.403 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 1.3 m-20 -73.87 -33.86 64.23 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.935 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 62.6 m -122.16 145.21 48.4 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.787 -176.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.571 HD12 HG23 ' A' ' 79' ' ' THR . 9.2 tt -114.8 133.31 61.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.8 mm -124.36 112.51 32.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -174.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -95.92 127.53 42.02 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.463 ' HB3' ' HB2' ' A' ' 38' ' ' ASN . 28.1 ttt180 -95.24 110.93 22.85 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.647 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 30.3 m-85 -95.77 137.06 35.36 Favored 'General case' 0 CA--C 1.483 -1.612 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -153.13 123.33 7.05 Favored 'General case' 0 N--CA 1.404 -2.759 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -176.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 63.0 29.58 16.42 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.963 1.705 . . . . 0.0 114.122 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.98 -4.85 75.44 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.901 176.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -124.72 160.63 28.17 Favored 'General case' 0 CA--C 1.482 -1.635 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 5.6 p -84.9 110.22 18.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 175.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -88.98 -45.98 9.24 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.588 -171.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.463 ' HB2' ' HB3' ' A' ' 30' ' ' ARG . 18.6 m120 -122.03 157.48 31.27 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.676 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.4 mm -121.42 134.87 63.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.671 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -141.49 166.64 24.19 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.543 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.8 t -158.13 141.49 15.2 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.34 156.84 45.27 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -173.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -79.72 157.98 27.03 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.898 175.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.41 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 4.1 ptt180 -59.06 115.78 3.39 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 169.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.7 m120 75.49 59.34 0.06 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 126.163 1.785 . . . . 0.0 109.173 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -141.65 136.12 30.62 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.114 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 56' ' ' PHE . 45.3 tt0 -101.67 109.94 21.82 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 25.7 pt -91.6 -178.11 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.5 m -136.36 126.78 26.74 Favored 'General case' 0 N--CA 1.405 -2.712 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 68.4 mt -118.34 104.15 15.71 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 56.3 43.49 26.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 122.108 0.956 . . . . 0.0 112.154 170.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 71.96 8.92 6.07 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 126.242 1.817 . . . . 0.0 114.512 -178.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -103.3 118.13 36.06 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 104.411 -2.441 . . . . 0.0 104.411 174.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 139.96 30.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 117.665 -1.614 . . . . 0.0 109.038 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 93.0 t -131.81 124.1 52.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.463 -173.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.466 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 75.5 t80 -96.7 121.76 38.89 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.1 t -100.74 124.28 54.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 175.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -83.41 -175.46 5.83 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.41 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 4.3 pm0 -70.59 -17.93 62.9 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -173.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.48 14.79 13.82 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.08 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 84.7 m 66.27 36.61 5.31 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-O 122.849 1.309 . . . . 0.0 112.355 174.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -116.48 120.4 34.73 Favored Pre-proline 0 C--N 1.293 -1.861 0 CA-C-N 113.223 -1.808 . . . . 0.0 108.169 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.474 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 63.9 Cg_endo -84.79 144.9 10.02 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 123.672 2.915 . . . . 0.0 114.422 -177.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -131.1 129.92 22.61 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.646 172.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.57 164.94 81.11 Favored 'Cis proline' 0 C--N 1.325 -0.67 0 C-N-CA 122.965 -1.681 . . . . 0.0 112.93 0.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.4 t -86.01 -36.59 10.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.638 -178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.425 HD13 ' HA ' ' A' ' 67' ' ' ILE . 20.7 mm -101.13 127.95 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 C-N-CA 119.575 -0.85 . . . . 0.0 108.92 173.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.5 mt -86.42 169.86 14.08 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 114.018 -1.446 . . . . 0.0 109.608 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -72.09 -11.21 26.97 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 122.342 2.028 . . . . 0.0 111.329 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -99.15 12.94 34.66 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.196 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 71' ' ' ARG . 9.8 tpt180 61.76 27.6 16.9 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 123.274 1.511 . . . . 0.0 110.102 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.35 139.82 32.8 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.647 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 3.0 t -91.35 124.43 43.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 C-N-CA 125.996 1.719 . . . . 0.0 108.843 -177.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.1 mp -101.79 125.99 48.57 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.566 173.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.5 m -116.64 118.62 33.08 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.265 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.474 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -110.55 142.0 16.53 Favored Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 120.503 -0.855 . . . . 0.0 112.78 -176.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -156.26 177.35 11.54 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 174.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -80.33 136.02 36.32 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.571 HG23 HD12 ' A' ' 27' ' ' ILE . 2.3 m -61.78 -25.61 67.58 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 p -64.44 -40.64 96.12 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.42 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.35 13.17 10.32 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.988 0.899 . . . . 0.0 111.654 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -124.85 -79.12 0.61 Allowed 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.815 -1.084 . . . . 0.0 113.505 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 84' ' ' ASP . . . -85.71 -3.13 58.81 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.947 -173.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 83' ' ' ALA . 9.2 t70 81.82 -56.96 0.24 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.912 1.685 . . . . 0.0 109.031 -177.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.0 t70 48.45 83.03 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.472 1.509 . . . . 0.0 112.488 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -79.27 117.59 20.41 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.453 -1.249 . . . . 0.0 112.422 -176.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -96.12 -11.91 25.55 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 173.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.5 m 76.76 -46.59 0.51 Allowed 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 126.472 1.909 . . . . 0.0 110.291 -175.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 31.5 t . . . . . 0 N--CA 1.433 -1.324 0 N-CA-C 104.039 -2.578 . . . . 0.0 104.039 177.09 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.836 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -148.12 82.13 1.49 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -116.96 105.05 11.91 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.778 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -101.71 160.84 14.12 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 171.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 mp -128.47 171.93 11.62 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.911 -174.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -81.13 77.09 8.06 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -77.93 -51.58 10.18 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.412 ' HG2' ' H ' ' A' ' 20' ' ' HIS . 36.1 tt0 -119.51 143.98 47.28 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.05 20.57 50.29 Favored Glycine 0 CA--C 1.497 -1.08 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.412 ' H ' ' HG2' ' A' ' 18' ' ' GLN . 85.4 m-70 -142.54 173.86 11.16 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.515 ' HG3' ' O ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -118.35 101.71 8.39 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.458 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -128.65 78.34 1.84 Allowed 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 113.413 -1.721 . . . . 0.0 106.81 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.464 ' CE3' HG21 ' A' ' 41' ' ' THR . 14.8 m0 -92.93 -164.06 1.13 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 113.389 -1.732 . . . . 0.0 108.559 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -84.2 -171.48 3.63 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.431 ' CB ' ' HG2' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -81.8 -28.39 33.19 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -172.737 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 58.6 m -123.5 144.26 49.65 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.044 -177.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.612 HD12 HG23 ' A' ' 79' ' ' THR . 11.0 tt -117.31 133.08 65.19 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.7 mm -125.48 112.77 32.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -172.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -101.05 136.26 41.18 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.413 ' HG3' HD11 ' A' ' 74' ' ' LEU . 3.6 ttp180 -99.58 111.02 23.41 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.677 ' HB2' ' HB ' ' A' ' 73' ' ' VAL . 29.6 m-85 -95.41 136.57 35.62 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 123.223 0.609 . . . . 0.0 109.861 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.44 123.57 15.55 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -176.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . 0.29 15.6 m-20 50.9 31.37 6.08 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.44 -15.84 61.52 Favored Glycine 0 N--CA 1.432 -1.583 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.809 177.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -104.26 152.84 21.72 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.9 p -83.02 109.5 16.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 174.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -89.17 -43.46 11.0 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.85 -168.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -129.12 148.97 51.12 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mp -118.0 120.74 65.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -126.6 169.22 13.32 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.464 HG21 ' CE3' ' A' ' 23' ' ' TRP . 1.5 t -149.76 145.34 26.58 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 175.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.33 154.02 44.33 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 123.673 0.789 . . . . 0.0 110.016 -174.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -75.05 151.05 38.72 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 122.026 -0.421 . . . . 0.0 110.049 173.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.449 ' CB ' ' HA ' ' A' ' 59' ' ' GLU . 8.6 ptt85 -57.55 114.83 2.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 171.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 74.67 67.74 0.08 Allowed 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 125.477 1.511 . . . . 0.0 109.553 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -151.46 139.6 20.19 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.764 -177.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -97.13 121.88 39.51 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 33.2 pt -102.08 177.06 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 172.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 2.4 m -136.62 124.6 22.8 Favored 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.434 HD12 HD21 ' A' ' 74' ' ' LEU . 98.8 mt -114.88 105.59 18.94 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.529 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 57.26 46.75 18.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.605 0.717 . . . . 0.0 112.564 174.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 71.65 3.01 4.51 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.861 1.665 . . . . 0.0 112.897 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -99.36 109.36 21.97 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.45 143.52 34.89 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 117.959 -1.496 . . . . 0.0 109.707 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -133.74 121.21 39.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.113 -174.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -91.56 128.81 37.53 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.4 t -108.83 121.71 62.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -78.14 169.09 18.84 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 124.407 1.083 . . . . 0.0 108.223 178.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.449 ' HA ' ' CB ' ' A' ' 44' ' ' ARG . 10.5 pt-20 -72.35 -4.0 27.28 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -176.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.86 7.42 45.02 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 172.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 77' ' ' ASP . 70.8 m 64.83 35.59 8.46 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.097 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -123.01 129.07 25.11 Favored Pre-proline 0 C--N 1.29 -2.013 0 CA-C-N 114.308 -1.314 . . . . 0.0 107.789 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.422 ' HD3' ' HA3' ' A' ' 76' ' ' GLY . 46.6 Cg_endo -84.73 159.43 12.19 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.038 2.492 . . . . 0.0 116.01 -175.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 40.8 m-85 -134.7 131.03 20.0 Favored Pre-proline 0 C--N 1.312 -1.064 0 CA-C-N 113.715 -1.584 . . . . 0.0 110.101 171.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 64' ' ' TYR . 91.4 Cg_endo -83.85 161.06 70.84 Favored 'Cis proline' 0 C--N 1.319 -1.022 0 C-N-CA 122.907 -1.705 . . . . 0.0 111.425 -2.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 74' ' ' LEU . 90.7 t -81.17 -38.44 16.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.695 -178.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 67' ' ' ILE . 8.3 mm -97.44 116.61 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.386 0 CA-C-O 122.106 0.955 . . . . 0.0 109.932 173.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 38.9 mt -76.87 165.77 49.88 Favored Pre-proline 0 C--N 1.297 -1.701 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.935 178.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.07 -3.41 13.6 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.428 2.085 . . . . 0.0 111.366 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -93.17 -12.15 31.02 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.019 -1.901 . . . . 0.0 110.462 177.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . 0.278 40.0 ttm180 66.88 59.05 0.57 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 123.819 1.771 . . . . 0.0 109.763 -171.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 45.3 m -120.7 139.55 52.89 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 112.269 -2.241 . . . . 0.0 106.743 172.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.677 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.7 t -90.62 115.78 30.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 125.439 1.712 . . . . 0.0 108.975 -175.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.452 ' O ' HG13 ' A' ' 66' ' ' VAL . 4.0 mp -92.92 122.64 35.5 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 118.693 -1.203 . . . . 0.0 109.794 173.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 57.6 m -118.67 118.71 32.37 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.422 ' HA3' ' HD3' ' A' ' 63' ' ' PRO . . . -110.85 152.72 17.41 Favored Glycine 0 N--CA 1.415 -2.763 0 C-N-CA 119.763 -1.208 . . . . 0.0 111.405 -177.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 61' ' ' CYS . 2.9 t70 -157.53 177.1 11.79 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 174.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -82.91 137.05 34.37 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.612 HG23 HD12 ' A' ' 27' ' ' ILE . 0.7 OUTLIER -68.19 -25.31 65.17 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 118.213 0.461 . . . . 0.0 111.867 -175.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.2 t -67.91 -38.15 82.58 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -87.19 17.41 4.32 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.434 177.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.04 -68.59 0.63 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.556 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . . . -87.84 -7.13 57.66 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.5 t70 77.6 21.86 0.95 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.701 2.0 . . . . 0.0 110.483 175.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.556 ' OD1' ' HB3' ' A' ' 83' ' ' ALA . 3.0 m-20 -46.86 114.83 0.91 Allowed 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 114.025 -1.443 . . . . 0.0 112.143 176.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -93.7 95.98 9.51 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.799 0.809 . . . . 0.0 108.978 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -101.31 33.44 2.9 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.0 m 68.98 18.76 8.37 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-O 123.242 1.496 . . . . 0.0 108.173 -170.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 59.2 m . . . . . 0 N--CA 1.421 -1.922 0 N-CA-C 102.113 -3.292 . . . . 0.0 102.113 179.043 . . . . . . . . 0 0 . 1 stop_ save_